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1. Vanillyl alcohol oxidase reacts with both deprotonated and protonated phenolic 
substrates.  
(this thesis) 
 
2. Flavin-dependent alcohol oxidases catalyse the oxidation of thiols to thiocarbonyls.  
(this thesis) 
 
3. Catalytic efficiency (kcat/Km) is a poor measure by which to compare enzymes.  
 
4. General conclusions regarding the mechanism of an enzyme should not be drawn 
from experiments involving only a single substrate.  
 
5. The era of biocatalysis requires the exploration of the interdisciplinary field of 
biocatalytic enzymology. 
 
6. Big data necessitates big legislation. 
 
7. The greatest threat to a productive working day is waking up to find that one has 
run out of coffee. 
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Summary 
Flavoprotein oxidases catalyse the two-electron oxidation of their substrates using molecular 
oxygen as an electron acceptor. This makes them interesting candidates for biocatalytic 
applications. Many flavin-dependent oxidases belong to one of a number of families of 
structurally related proteins. One such family is the VAO/PCMH family, which contains 
enzymes that share a common FAD-binding fold. Within this family, a subfamily of enzymes 
is found that catalyse the oxidation of para-substituted phenols, the 4-phenol oxidising (4PO) 
subfamily. Enzymes from this subfamily include the oxidases vanillyl alcohol oxidase (VAO) 
and eugenol oxidase (EUGO) and the dehydrogenase para-cresol methylhydroxylase (PCMH). 
This thesis focusses on understanding the mode of action of these enzymes and exploring 
their potential for biocatalytic applications. Although the main focus is on the 4PO subfamily, 
other flavin-dependent enzymes are also discussed at some points. 
Broadly speaking, the thesis consists of two parts. In the first, the emphasis is on 
understanding the mode of action of 4PO subfamily members at the molecular level. Chapter 
2 provides an overview of the current state of our knowledge on members of the VAO/PCMH 
family. The family was divided into eleven subfamilies based on a phylogenetic analysis of 
115 members. These subfamilies are discussed in terms of the reactions they catalyse and our 
mechanistic understanding thereof. Chapter 3 explores the differing oligomerisation states of 
VAO and EUGO. Despite their highly similar secondary and tertiary structures, VAO forms 
octamers, which can be described as tetramers of stable dimers, whereas EUGO is exclusively 
dimeric. A single loop, which is located at the dimer-dimer interface of a VAO octamer, was 
shown to be essential for the octamerisation of VAO. Its deletion led to a VAO variant that is 
exclusively dimeric in solution and displays similar catalytic properties to the wild-type 
enzyme. Chapter 4 focusses on understanding the mechanism of substrate activation in VAO. 
To enable catalysis, the substrate must first be bound in the active site in its phenolate form. 
The role of two tyrosine residues, Tyr-108 and Tyr-503, in facilitating substrate deprotonation 
was studied by site-directed mutagenesis. These tyrosine residues play a crucial role in 
enabling substrate activation by VAO, both by stimulating preferential binding of the 
phenolate form of the substrate and by deprotonating the substrate when it is bound in its 
protonated form. 
The second part of the thesis focusses on the biocatalytic applications of flavin-dependent 
oxidases. Chapter 5 provides an overview of how flavin-dependent oxidases can be used in 
synthetic organic chemistry. Chapter 6 describes the development of a high-throughput 
screening assay for the substrate specificity of variants of VAO and EUGO based on the 
detection of hydrogen peroxide formed by the enzymes using a xylenol orange assay. This 
assay was used to screen the substrate specificity of the wild-type enzymes and a small library 
of variants, leading to the identification of novel substrates of the enzymes and two variants 
with improved activity towards at least one substrate. Chapter 7 describes the scale-up of the 
synthesis of a chiral secondary alcohol, (R)-1-(4′-hydroxyphenyl)ethanol, using VAO. Under 
optimised reaction conditions, we obtained 4.1 g of pure (R)-1-(4′-hydroxyphenyl)ethanol. In 
Chapter 8, the focus moves away from the 4PO subfamily. It describes the oxidation of thiols 
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by a number of flavin-dependent alcohol oxidases. Alditol oxidase (AldO) and 5-
(hydroxymethyl)furfural oxidase (HMFO) were shown to oxidise thiol analogues of their 
alcohol substrates to the corresponding thiocarbonyls, which have a number of potential 
applications in organic synthesis.  
These results provide advances in our understanding of the mode of action and potential 
applications of flavoprotein oxidases and will facilitate their future application in industrial 
biocatalytic processes.   
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Nederlandse samenvatting 
Flavine-afhankelijke oxidases katalyseren redoxreacties waarbij twee elektronen van hun 
substraat worden overgedragen aan een zuurstof molecuul. Hierdoor zijn ze uitstekend 
geschikt voor gebruik in een verscheidenheid aan toepassingen binnen de biokatalyse. Een 
groot deel van de flavine-afhankelijke oxidases behoort tot een van een aantal eiwitfamilies 
bestaande uit eiwitten met een soortgelijke driedimensionale structuur. Een van deze families 
is de VAO/PCMH familie. De leden van deze familie zijn flavine-afhankelijke enzymen die 
allen een geconserveerd FAD-bindend domein bevatten. De familie kan opgedeeld worden in 
een aantal subfamilies bestaande uit enzymen die structureel sterk op elkaar lijken en 
(meestal) hetzelfde type reactie katalyseren. Een voorbeeld van een dergelijke subfamilie is de 
4-fenol oxiderende (4PO) subfamilie. Deze subfamilie bestaat uit enzymen die allen de 
oxidatie van para-gesubstitueerde fenolen katalyseren. Lid van deze subfamilie zijn onder 
andere de oxidases vanillyl alcohol oxidase (VAO) en eugenol oxidase (EUGO) en de 
dehydrogenase para-cresol methylhydroxylase (PCMH). Het onderzoek dat in deze thesis 
omschreven wordt betreft het moleculaire werkingsmechanisme van deze enzymen en hun 
mogelijke toepassingen binnen de biokatalyse. Het grootste deel van het omschreven werk 
betreft enzymen uit de 4PO subfamilie. Flavine-afhankelijke enzymen uit andere (sub)families 
zullen op bepaalde plekken ook aan bod komen.  
De thesis kan beschouwd worden als bestaande uit twee thematisch verschillende delen. In 
het eerste deel ligt de nadruk op de moleculaire werkingsmechanismen van de leden van de 
4PO subfamilie. In hoofdstuk 2 wordt een overzicht gegeven van onze huidige kennis van de 
leden van de VAO/PCMH familie. Op basis van een fylogenetische analyse wordt de familie 
opgedeeld in elf subfamilies. Vervolgens wordt per subfamilie besproken welke reacties door 
haar leden gekatalyseerd worden en wat de huidige stand van zaken is betreffende ons begrip 
van het moleculaire mechanisme van deze reacties. In hoofdstuk 3 worden de verschillende 
oligomerisatie toestanden van de oxidases VAO en EUGO onder het licht gehouden. Ondanks 
het feit dat VAO en EUGO qua secundaire en tertiaire structuur erg op elkaar lijken, 
verschillen ze qua quaternaire structuur van elkaar. VAO moleculen vormen vooral 
octamerische structuren bestaande uit vier stabiele dimeren die door middel van relatief losse 
contacten de octameer vormen. EUGO moleculen vormen uitsluitend dimerische structuren 
die erg lijken op een VAO dimeer. In hoofdstuk 3 bewijzen we dat een enkel lusvormig 
structuurelement, dat zich in een VAO octameer op het raakvlak tussen twee stabiele dimeren 
bevindt, van essentieel belang is voor het vormen van VAO octameren. Een mutant van VAO 
waaruit deze lus verwijderd was vormde uitsluitend dimerische structuren, maar behield wel 
dezelfde katalytische eigenschappen als het ongemuteerde enzym. Hoofdstuk 4 betreft het 
mechanisme waarmee VAO haar substraten voor de oxidatie reactie activeert. Om geoxideerd 
te kunnen worden, moeten deze substraten eerst als een gedeprotoneerde fenolaat-anion 
binden in het actieve centrum van het enzym. In hoofdstuk 4 laten we met behulp van 
plaatsgerichte mutagenese zien dat twee tyrosine residuen, Tyr-108 en Tyr-503, een cruciale 
rol spelen bij het activeren van de substraten van VAO door het binden van het fenolaat-anion 
in het actieve centrum te faciliteren. 
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In het tweede deel van de thesis ligt de nadruk op de mogelijke toepassingen van flavine-
afhankelijke oxidases in de biokatalyse. Hoofdstuk 5 geeft een overzicht van hoe alcohol 
oxidases toegepast kunnen worden in de synthetische chemie. Hoofdstuk 6 omschrijft de 
ontwikkeling van een screening methode voor de substraatspecificiteit van VAO en EUGO. 
Deze methode is gebaseerd op het meten van de hoeveelheid waterstofperoxide die in een 
bepaalde tijd door de enzymen gevormd wordt door middel van een reactie tussen 
waterstofperoxide, ijzer ionen en xylenol orange. Hierbij ontstaat een gekleurd complex, 
waarbij de intensiteit van de kleur afhangt van de hoeveelheid waterstofperoxide dat 
gevormd is. Deze methode werd toegepast om nieuwe substraten van VAO en EUGO te 
identificeren en om mutanten van de enzymen te vinden die verhoogde activiteit hadden met 
een of meerdere substraten. In hoofdstuk 7 omschrijven we de multigram schaal synthese van 
een chiraal secundair alcohol met behulp van VAO. Na optimalisatie van de 
reactieomstandigheden waren we in staat om 4.1 g zuiver (R)-1-(4′-hydroxyfenyl)ethanol in 
handen te krijgen. In hoofdstuk 8 beschrijven we de vinding dat een aantal flavine-
afhankelijke alcohol oxidases, bijvoorbeeld alditol oxidase (AldO) of 5-
(hydroxymethyl)furfural oxidase (HMFO), in staat zijn thiolen om te zetten in thiocarbonyl 
verbindingen. Zulke thiocarbonylen hebben een aantal mogelijke toepassingen in de 
synthetische chemie.  
De hier gepresenteerde resultaten vergroten ons begrip van de moleculaire 
werkingsmechanismen van flavine-afhankelijke oxidases. Bovendien geven ze nieuwe 
inzichten in de mogelijke toepassingen van deze enzymen binnen de biokatalyse. Deze 
kennis zal bruikbaar zijn bij het ontwikkelen van toekomstige industriële processen waarbij 
gebruik wordt gemaakt van dit type enzymen.  
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Flavins and flavoproteins 
Flavins are organic molecules that contain a tricyclic isoalloxazine ring structure. They are 
well known for their biologically important role as protein cofactors, with flavin-dependent 
proteins being present in all kingdoms of life (1). In proteins, flavin is usually present as flavin 
mononucleotide (FMN) or flavin adenine dinucleotide (FAD) (Scheme 1). Both are 
biosynthetically derived from riboflavin (vitamin B2), which is an essential vitamin in humans 
(2). Most flavin-dependent proteins function as oxidoreductase enzymes. Classes of flavin-
dependent oxidoreductases include monooxygenases, which catalyse the introduction of an 
oxygen atom originating from molecular oxygen into their substrates, reductases, which 
catalyse the two-electron reduction of their substrates, and oxidases and dehydrogenesases, 
which catalyse the two-electron oxidation of their substrates using either molecular oxygen 
(oxidases) or other molecules (dehydrogenases) as an electron acceptor (3–7). Although 
flavoproteins are best-known for their role as oxidoreductases, they may also act as electron-
transfer proteins (e.g. flavodoxins or electron-transfer flavoproteins), photo- or magneto-
receptors (e.g. cryptochromes) or as non-oxidoreductase enzymes such as transferases or 
lyases (e.g. alkyl-dihydroxyacetone phosphate synthase or DNA photolyase) (8–13). 
 
Scheme 1: Structures of riboflavin, FMN and FAD. Scheme adapted from (14). 
Flavoproteins achieve their diverse range of functions by using the redox properties of the 
isoalloxazine ring system, which can be present in one of three redox states: fully oxidised, 
one-electron reduced, or two-electron reduced (Scheme 2). These redox states can readily be 
distinguished from each other by their distinct spectral properties and thus colour. In their 
oxidised form, flavins are typically yellow [hence flavin, from the latin flavus (yellow)]. The 
one-electron reduced form, a radical that is referred to as the flavin semiquinone, can exist as  
Chapter 1 
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Scheme 2: Redox states of the isoalloxazine ring system. Under physiological conditions, flavins can be 
present in the fully oxidised (quinone), one-electron reduced (semiquinone) or fully reduced 
(hydroquinone) form. The semiquinone and hydroquinone may be present in their neutral protonated 
or anionic deprotonated form. Scheme adapted from (15). 
a red anionic form or a blue neutral form. The fully reduced hydroquinone form is colourless. 
The catalytic mechanism of flavin-dependent oxidoreductases varies depending on the 
reaction they catalyse. In reductases and monooxygenases, the flavin cofactor is first reduced 
to the hydroquinone form by accepting two electrons from an electron donor, typically 
nicotinamide adenine dinucleotide (phosphate) (NAD[P]H). In reductases, the electrons are 
subsequently transferred to the substrate, achieving its two-electron reduction and 
regenerating the oxidised flavin. In monooxygenases, the reduced flavin reacts with 
molecular oxygen, yielding a (hydro)peroxyflavin intermediate. This intermediate 
subsequently attacks the substrate, yielding the oxygenated product and a hydroxyflavin 
intermediate. Release of water from the hydroxyflavin regenerates the oxidised flavin cofactor. 
Oxidases and dehydrogenases catalyse the two-electron oxidation of their substrates. After 
formation of the reduced flavin cofactor by abstraction of two electrons from the substrate, 
the flavin is reoxidised by its reaction with molecular oxygen (oxidases) or other electron 
acceptors (dehydrogenases). In recent years, a number of flavin-dependent enzymes have 
been identified that do not follow one of these canonical flavin-dependent oxidoreductase 
mechanisms. Examples include EncM from Streptomyces maritimus, which uses an unusual 
flavin oxidation state, the flavin-N5-oxide, to catalyse a sequential monooxygenation-
oxidation of its substrate and fungal Fdc1, which uses a prenylated flavin cofactor to catalyse 
the decarboxylation of its substrate (16–18).  
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Reaction mechanism of flavin-dependent oxidases and dehydrogenases 
The catalytic cycle of flavin-dependent oxidases and dehydrogenases can be divided into two 
distinct half-reactions (Scheme 3). During the reductive half-reaction, a hydride equivalent is 
transferred from the site of oxidation on the substrate to the N5 atom of the flavin cofactor. 
Although the mechanism by which this transfer occurs has historically been a major point of 
debate in the field of flavoenzymology, the current consensus is that the direct transfer of a 
hydrogen anion is the most probable mechanism for the majority of oxidases and 
dehydrogenases (19). After completion of the reductive half-reaction, the flavin cofactor must 
be reoxidised to enable further rounds of catalysis. This occurs during the oxidative half-
reaction. In dehydrogenases, the electrons are transferred to other proteins or to small organic 
molecules. In oxidases, the electrons are transferred to molecular oxygen. The reaction of 
reduced flavin with molecular oxygen occurs through two sequential single-electron transfer 
steps (20). The first electron transfer yields a short-lived flavin semiquinone and superoxide 
anion radical pair. Subsequently, the second electron transfer yields hydrogen peroxide and 
oxidised flavin. The second electron transfer may proceed either through the direct transfer 
of an electron from the flavin semiquinone to superoxide anion (concomitant with its 
protonation) or  
through the formation of a covalent (hydro)peroxyflavin intermediate, as is found in 
monooxygenases. Such an intermediate has been observed in pyranose-2-oxidase, but it is 
unclear whether it is also formed in other oxidases (21). Detailed studies on the oxidative half-
reaction of choline oxidase revealed that it does not involve the formation of a 
(hydro)peroxyflavin intermediate (22). In recent years, much progress has been made in 
understanding the molecular determinants of the oxygen reactivity of flavoenzymes. 
Important factors include the presence of a hydrophobic oxygen binding pocket close to the 
C4a locus of the isoalloxazine ring and the presence of a positive charge in the vicinity of this 
binding site, which helps activate oxygen for the electron transfer reaction (23–29). 
4-Phenol oxidising flavoenzymes 
Many flavoenzymes that catalyse different reactions share common structural elements and 
as such can be classified as belonging to structurally related protein families (5, 30). One such 
family of structurally related flavoenzymes is the VAO/PCMH family. This family contains 
FAD-dependent oxidases, dehydrogenases, reductases and transferases that catalyse a wide 
range of reactions (31, Chapter 2). Family members are characterised by a two-domain 
architecture consisting of a conserved FAD-binding domain and a more variable substrate-
binding or cap domain (32). The FAD-binding domain is responsible for forming the majority 
of interactions with the FAD cofactor. The ribityl and adenosine diphosphate moieties of FAD 
are deeply embedded within it, while the isoalloxazine ring is positioned at the interface 
between the FAD-binding and substrate-binding domains. The shape of the substrate binding 
pocket is predominantly defined by the substrate-binding domain. This two-domain 
architecture allows for a wide variety in the type of substrates that are converted by  
Chapter 1 
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Scheme 3: Catalytic cycle of flavin-dependent oxidases. The catalytic cycle of oxidases consists of two 
half-reactions. In the reductive half-reaction, the substrate undergoes a two-electron oxidation by 
transferring a hydride equivalent to the flavin cofactor. During the oxidative half-reaction, the flavin 
cofactor is oxidised by its reaction with molecular oxygen, which is converted to hydrogen peroxide. 
Flavin-dependent dehydrogenases follow a similar catalytic cycle, but they are poorly reactive with 
molecular oxygen, instead transferring the electrons to a different electron acceptor in the oxidative 
half-reaction. 
VAO/PCMH family members while maintaining the conserved interactions with the FAD 
cofactor. Various subfamilies of structurally and functionally related enzymes can be defined 
within the VAO/PCMH family. One of them, the 4-phenol oxidising (4PO) subfamily, which 
contains a number of enzymes that catalyse the oxidation of para-substituted phenols, will be 
the main focus of this thesis. 
The three enzymes from the 4PO subfamily that have been most extensively characterised are 
vanillyl alcohol oxidase (VAO, EC 1.1.3.38) from the fungus Penicillium simplicissimum, 
eugenol oxidase (EUGO) from the actinobacterium Rhodococcus jostii RHA1 and para-cresol 
methylhydroxylase (PCMH, EC 1.17.99.1) from the proteobacterium Pseudomonas putida (33–
35). These three enzymes catalyse the same basic reaction, the two-electron oxidation of para-
substituted phenols at the Cα atom of their side chain. However, they differ in terms of their 
substrate specificity, preferred electron acceptor and oligomerisation state. VAO displays the 
broadest substrate scope of the three, catalysing the oxidation of benzyl alcohols, the oxidative 
deamination of benzylic amines, the oxidative demethylation of 4-(methoxymethyl)phenol, 
the hydroxylation of 4-allylphenols and the hydroxylation or dehydrogenation of 4-
alkylphenols (Scheme 4) (36, 37). EUGO catalyses many of the same reactions as VAO, but is 
poorly active with 4-alkylphenols and 4-(methoxymethyl)phenol (35, 38). PCMH is primarily 
active on short-chain 4-alkylphenols and benzyl alcohols (33, 39). The oxidases VAO and 
EUGO use molecular oxygen as their electron acceptor, whereas PCMH does not react with 
molecular oxygen and relies on the presence of alternative electron acceptors for its activity. 
In terms of their structure, all three enzymes share a highly similar core structural unit 
consisting of two flavoprotein subunits that form a closely packed homodimer (38, 40, 41). In 
VAO, four of these dimers can associate to form a homo-octamer (Fig. 1). In solution, VAO is 
present as an equilibrium of dimers and octamers, with the octameric form predominating 
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(42). PCMH forms heterotetramers, with two cytochrome c subunits bound to the dimeric 
flavoprotein core. In vivo, the heme cofactor of the cytochrome c subunit acts as an electron 
shuttle, accepting electrons from reduced FAD and transferring them to an azurin electron 
acceptor protein (43). EUGO forms homodimers consisting simply of the flavoprotein dimer 
core. In all three enzymes, the FAD cofactor is covalently bound to the protein. In VAO and 
EUGO, the covalent bond is to a histidine residue (8α-N3-histidyl-FAD bond), wherease in 
PCMH it is to a tyrosine residue (8α-O-tyrosyl-FAD bond).  
 
Scheme 4: Reactions catalysed by 4PO subfamily members. From top to bottom: the oxidation of 
vanillyl alcohol (4-hydroxy-3-methoxybenzyl alcohol) to vanillin (4-hydroxy-3-methoxybenzaldehyde) 
as catalysed by VAO or EUGO; the oxidation of eugenol (4-allyl-2-methoxyphenol) to coniferyl alcohol 
[4-(3-hydroxyprop-1-en-1-yl)-2-methoxyphenol] as catalysed by VAO or EUGO; the oxidation of para-
cresol (4-methylphenol) to 4-hydroxybenzyl alcohol as catalysed by PCMH; the oxidation of 4-
hydroxybenzyl alcohol to 4-hydroxybenzaldehyde as catalysed by PCMH; the oxidation of 4-
ethylphenol to a mixture of (R)-1-(4′-hydroxyphenyl)ethanol and 4-vinylphenol as catalysed by VAO. 
In addition to these well-characterised enzymes, the 4PO subfamily contains a number of 
enzymes about which less is known. Two Pseudomonas sp. strains (OPS1 and HR199) that are 
able to use eugenol (4-allyl-2-methoxyphenol) as a carbon source have been shown to contain 
eugenol hydroxylases, flavocytochromes that catalyse the oxidation of eugenol to coniferyl  
Chapter 1 
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Figure 1: Crystal structures of VAO, EUGO and PCMH. Structures are shown in cartoon representation 
with the FAD-binding domain of the flavoprotein subunits shown in green, the substrate-binding 
domain of the flavoprotein subunits shown in red and the cytochrome c subunit of PCMH shown in 
cyan. The FAD cofactor is shown as yellow sticks and the heme cofactor of PCMH is shown as black 
sticks. VAO forms homo-octamers that can be described as tetramers of dimers. Each quarter of the 
ring-like octameric structure corresponds to a tightly packed dimer, with the inter-dimer packing being 
more loose. EUGO forms homodimers that structurally closely resemble a VAO dimer. PCMH forms 
heterotetramers consisting of two flavoprotein subunits and two cytochrome c subunits. The 
flavoprotein subunits form a dimer that closely resembles a VAO or EUGO dimer. One cytochrome c 
subunit binds to each flavoprotein subunit at a binding site located far from the dimer interface. Figures 
were prepared from PDB files downloaded from the Protein Data Bank website [PDB IDs: 1VAO for 
VAO, 1WVE for PCMH and 5FXD for EUGO] using PyMOL (Schrödinger LLC, New York, NY, USA). 
alcohol [4-(3-hydroxyprop-1-en-1-yl)-2-methoxyphenol], the first step in its degradation (44, 
45). The sequences of these proteins reveal that they belong to the 4PO subfamily, showing 
highest similarity to PCMH, and they are predicted to contain 8α-O--tyrosyl-FAD as a cofactor. 
Although the purified enzymes from these strains have not been characterised, a 
flavocytochrome that converts eugenol to coniferyl alcohol has been purified from the 
eugenol-degrading bacterium Pseudomonas fluorescens E118 and named eugenol 
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dehydrogenase (46). N-terminal sequencing revealed that it displays significant similarity to 
eugenol hydroxylase from Pseudomonas sp. HR199. In addition to eugenol, 4-alkylphenols and 
4-hydroxybenzyl alcohols were converted by the enzyme. Another flavocytochrome that 
likely belongs to the 4PO subfamily, but for which no sequence information is available, is 4-
ethlyphenol methylenehydroxylase from Pseudomonas putida JD1. This enzyme catalyses the 
oxidation of 4-alkylphenols and 4-allylphenols, with linear 4-alkylphenols with side chains of 
two to five carbon atoms being most efficiently converted (47, 48). In addition to in Penicillium 
simplicissimum, enzymes that display VAO activity have been identified in the fungi 
Byssochlamys fulva V107 and Fusarium moniliforme MRC 6155 (49, 50). The 4PO subfamily also 
contains two enzymes that catalyse the oxidative decarboxylation of N-substituted tyrosine 
derivatives: CndG from Chondromyces crocatus and FeeG from an unidentified soil microbe (51, 
52).  
Despite their different substrate scopes, all 4PO subfamily members share a strict requirement 
for a para-substituted phenol as their substrate. This can be understood by taking their 
catalytic mechanism into account (Scheme 5) (36, 53–55). In VAO, the substrate must first be 
bound in the active site in its phenolate form. Deprotonation to the phenolate activates the 
substrate for oxidation by allowing the formation of a para-quinone methide intermediate 
upon transfer of a hydride to the enzyme’s FAD cofactor. Following hydride transfer, the para-
quinone methide intermediate either rearranges to form a dehydrogenated product or reacts 
with water to yield a hydroxylated product. In VAO, the reaction of the reduced flavin with 
molecular oxygen takes place either with the para-quinone methide intermediate still bound 
in the active site (ternary complex mechanism) or after the release of the final product (ping-
pong mechanism). The mechanism that is followed depends on the substrate: with 4-
(methoxymethyl)phenol the enzyme exclusively follows a ternary complex mechanism, 
whereas with vanillyl alcohol a ping-pong mechanism is also possible (54). 
Although the catalytic mechanisms of other 4PO subfamily members have not been studied 
in as much detail, they presumably act through a similar mechanism involving the formation 
and breakdown of a para-quinone methide intermediate. 
Biocatalytic applications of 4-phenol oxidising flavoenzymes 
In recent decades, biocatalysis, the use of enzymes to achieve organic chemical 
transformations, has been gathering attention as a potential alternative to traditional methods 
of chemical synthesis. Biocatalytic processes have a number of advantages as compared to 
conventional chemical ones. Enzymes are often highly regioselective, making them ideally 
suited to converting one of multiple identical functional groups on a molecule without the 
need for protection chemistry. For example, many enzymes are known to catalyse the 
oxidation of a specific hydroxyl group of carbohydrate molecules (56). In addition, the 
asymmetric nature of an enzyme’s active site enables them to perform highly enantioselective 
reactions. This is of particular interest to the pharmaceutical industry, as it makes enzymes 
highly suitable for the challenging task of generating the chiral centres that are often required 
in active pharmaceutical ingredients (57). Biocatalytic processes may also have benefits in  
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Scheme 5: Catalytic mechanism of VAO. First, the substrate must be bound in the enzyme’s active site 
in its phenolate form. Subsequently, transfer of a hydride to the FAD cofactor yields a para-quinone 
methide intermediate that is stabilised in the enzyme’s active site. Depending on the substrate, this 
intermediate either rearranges or is hydroxylated at the Cα or Cγ position to give the reaction product. 
Meanwhile, the FAD cofactor is reoxidised by its reaction with molecular oxygen, which is converted 
to hydrogen peroxide. Depending on the substrate, this reoxidation may occur with the para-quinone 
methide intermediate still bound in the active site (ternary complex mechanism) or after product release 
(ping-pong mechanism). Other members of the 4PO subfamily are thought to operate via a similar 
mechanism. 
terms of their environmental impact, as enzymes can be sustainably sourced from biological 
materials and are active under mild process conditions. 
A number of the reactions that are catalysed by 4PO subfamily members are of interest from 
the point of view of biocatalytic applications. One interesting target compound is vanillin (4-
hydroxy-3-methoxybenzaldehyde), the main flavour and fragrance compound in vanilla. 
Vanillin is one of the most-used flavouring compounds in the world, with an annual market 
of approximately 16,000 tonnes (58). Most of this is currently produced synthetically from the 
petrochemical guaiacol (2-methoxyphenol). VAO could potentially be used to synthesise 
vanillin from precursors found in natural sources such as para-creosol (4-methyl-2-
methoxyphenol), which is found in wood tar, or capsaicin, which is found in chilli peppers 
(Scheme 6) (59). para-Creosol can be converted to vanillin by VAO in a two-step reaction 
involving its hydroxylation to vanillyl alcohol (4-hydroxy-3-methoxybenzyl alcohol) followed 
by oxidation of the formed vanillyl alcohol to vanillin. Hydrolysis of capsaicin, by e.g. 
penicillin G acylase, yields vanillyl amine [4-(aminomethyl)-2-methoxyphenol], which can 
subsequently be converted to vanillin via oxidative deamination by VAO. The conversion of 
eugenol to coniferyl alcohol by VAO has also gathered interest as a potential starting point for 
the synthesis of vanillin by microbial fermentation (60–65). Eugenol is the major constituent 
of the essential oil from cloves and is therefore readily available from natural sources. The 
coniferyl alcohol formed by its conversion can be converted to vanillin in four biosynthetic 
steps. 
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In addition to the synthesis of vanillin, members of the 4PO subfamily can be employed for 
the synthesis of chiral secondary alcohols. Creating chiral centres in achiral compounds is one 
of the most challenging reactions in synthetic organic chemistry, yet it is of great importance 
for the synthesis of active pharmaceutical ingredients (66, 67). A number of 4PO subfamily 
members are capable of catalysing the synthesis of chiral 1-(4′-hydroxyphenyl)alcohols from 
linear 4-alkylphenols. The enantiomer that is formed depends on the enzyme, e.g. VAO 
catalyses the formation of the (R)-enantiomers (Scheme 4, bottom panel), whereas PCMH 
catalyses the formation of the (S)-enantiomers (68, 69). In VAO, this enantioselectivity can be 
explained by the presence of an active site base (Asp-170) that activates water for attack on 
one side of the planar para-quinone methide intermediate. Replacing this base with one that 
is positioned on the opposite side of the para-quinone methide intermediate was sufficient to 
reverse the enantioselectivity of the reaction, with the resulting D170S/T457E variant 
preferentially forming the (S)-enantiomers of the alcohol products (70).  
Another potential biocatalytic application of VAO is the synthesis of the plant lignan 
pinoresinol, which is of interest due to its potential health benefits (71). Pinoresinol was 
synthesised via a cascade reaction combining the oxidation of eugenol to coniferyl alcohol by 
VAO with the dimerisation of coniferyl alcohol catalysed by a laccase (Scheme 7) (72).  
Subsequent reduction of the formed pinoresinol by enantioselective reductases was used to 
form both pure enantiomers by kinetic resolution (73). The oxidation of eugenol to coniferyl 
alcohol by EUGO has been used in a cascade reaction for the synthesis of lignin model 
 
 
Scheme 6: Biocatalytic pathways for the synthesis of vanillin from naturally-sourced precursors 
involving VAO. VAO can convert eugenol, which is found in clove oil, to coniferyl alcohol as the first 
step in a fermentation process that yields vanillin as the final product. Capsaicin, which is found in 
chilli peppers, can be deacylated to vanillyl amine by penicillin G acylase. The formed vanillyl amine 
can be converted to vanillin by VAO. para-Creosol, which is found in wood tar, can be converted to 
vanillin in a two-step reaction involving its hydroxylation to vanillyl alcohol followed by the oxidation 
of the alcohol to vanillin. Both steps of the reaction are catalysed by VAO.  
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compounds (Scheme 7). The heterogeneous aromatic polymer lignin is one of the major 
constituents of lignocellulosic biomass. It is formed by polymerisation of the monolignols 
para-coumaryl alcohol, coniferyl alcohol and sinapyl alcohol through a radical reaction 
catalysed by laccases and peroxidases (74). This yields a complex polymer in which the 
monolignols are linked through a variety of different bond types. In order to synthesise lignin 
model compounds, the oxidation of eugenol to coniferyl alcohol by EUGO was followed by 
the radical polymerisation of coniferyl alcohol catalysed by a peroxidase (75). Many of the 
bond types commonly found in natural lignin could be identified in the resulting lignin model 
compounds. As EUGO can also oxidise chavicol (4-allylphenol) and 4-allyl-2,6-
dimethoxyphenol to para-coumaryl alcohol and sinapyl alcohol respectively, the cascade 
could be employed to synthesise lignin model compounds reflecting the heterogeneity of 
natural lignin both in terms of the presence of all three monolignols and the various bond 
types between them. 
 
Scheme 7: Biocatalytic pathways for the synthesis of pinoresinol or lignin model compounds involving 
VAO or EUGO. VAO/EUGO catalyses the conversion of eugenol to coniferyl alcohol. Subsequently, 
radical polymerisation of coniferyl alcohol is induced by a laccase or peroxidase. One of the main 
products from the laccase-catalysed reaction is pinoresinol, a coniferyl alcohol dimer that is of interest 
due to its potential health benefits. The peroxidase-catalysed reaction yields heterogenous lignin model 
compounds, containing most of the bond types commonly found in natural lignin. 
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Outline of this thesis 
The research described in this thesis primarily concerns the 4PO subfamily members VAO 
and EUGO. Two main themes can be distinguished within the thesis. Chapters two through 
four consist of fundamental enzymological studies. The goal here is to understand how the 
enzymes function at a molecular level: mechanistic enzymology. The focus of chapters five 
through eight lies more towards the biocatalytic applications of these enzymes. Here, the goal 
is to study how they can be used to produce industrially relevant compounds and how they 
may be modified in order to achieve this goal. This field of research, which focussess on 
studying enzymes in the context of their biocatalytic applications can be referred to as 
biocatalytic enzymology. Although the main focus of the thesis is on 4PO subfamily members, 
other members of the VAO/PCMH flavoprotein family and other, structurally unrelated, 
alcohol oxidases are also discussed at certain points. 
Chapter 2 provides an overview of the members of the VAO/PCMH flavoprotein family 
characterised to date. The family is divided into eleven subgroups based on a phylogenetic 
analysis and the subgroups are discussed in terms of their enzymological properties. 
Chapter 3 concerns the differing oligomerisation states of 4PO subfamily members. The 
molecular determinants and function of the octamerisation of VAO are studied by protein 
engineering. 
In Chapter 4, the role played by two conserved tyrosine residues in activating the substrates 
of 4PO subfamily members for oxidation is studied by site-directed mutagenesis. 
Chapter 5 marks the start of the biocatalytically oriented part of the thesis. This chapter 
provides an overview of the use of alcohol oxidases in organic chemical synthesis. 
Chapter 6 describes the development of an assay for efficient screening of VAO and EUGO 
variants for changes in their substrate specificity and its use to discover novel substrates for 
the wild-type enzymes. 
Chapter 7 concerns the use of VAO to synthesise the chiral secondary alcohol (R)-1-(4′-
hydroxyphenyl)ethanol at multigram scale. 
In Chapter 8, the focus shifts away from the 4PO subfamily. It describes the oxidation of thiols 
to thioaldehydes by a number of different flavin-dependent oxidases. 
Finally, Chapter 9 provides a general discussion of the most important findings of this thesis. 
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Summary 
 
The VAO/PCMH flavoprotein family consists of structurally homologous flavin-dependent 
enzymes that catalyse a wide range of chemical reactions. Family members share an 
architecture consisting of a conserved FAD-binding domain and a more variable substrate-
binding domain, which enables varying interactions with a range of substrates while 
maintaining the same cofactor binding fold. Here, we provide an overview of the current state 
of our knowledge on the members of the VAO/PCMH family. Based on a phylogenetic 
analysis, we divide the family into eleven subfamilies. We discuss the properties of these 
subfamilies, focusing on recent developments in terms of the discovery of new family 
members and mechanistic advances. We also highlight open questions that will provide 
challenges for future research. 
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Introduction 
Flavoenzymes, which contain one of the vitamin B2-derived cofactors flavin adenine 
dinucleotide (FAD) or flavin mononucleotide (FMN), are found in all domains of life and 
fulfill important roles in a variety of biological processes (1, 2). They utilise the reactive 
isoalloxazine ring of their cofactor to catalyse a diverse range of chemical reactions. Most 
flavoenzymes are oxidoreductases, using the electron transferring properties of the 
isoalloxazine ring system to catalyse the two electron oxidation or reduction of their substrates 
(3, 4). However, in recent years, a number of new chemical reactivities of the isoalloxazine 
ring have been unearthed, including some where it is used to catalyse non-redox reactions (5, 
6). The VAO/PCMH (vanillyl alcohol oxidase/para-cresol methylhydroxylase) flavoprotein 
family contains flavoproteins that are characterised by the presence of a shared FAD-binding 
domain (pfam_FAD_binding_4). In addition to this conserved FAD-binding domain, which is 
responsible for binding the adenosine diphosphate and ribityl moieties of FAD, members of 
the VAO/PCMH family contain a more variable substrate-binding domain, which is 
positioned over the isoalloxazine ring of the cofactor (Fig. 1A). This architecture allows for 
great variation in the structure of the active sites and therefore the catalytic activity of these 
enzymes, while maintaining the conserved cofactor binding fold. The VAO/PCMH family was 
originally identified in 1998 and at that time was found to encompass thirteen enzymes of 
known function (7). Almost a decade ago, the family was reviewed and found to encompass 
around 50 characterised enzymes (8). Here, we provide an update on the state of our 
knowledge on the members of this flavoprotein family. 
Phylogenetic analysis of the VAO/PCMH family 
In order to identify members of the VAO/PCMH family, we performed a search in the 
structure and sequence databases. The Swissprot sequence database and Protein Data Bank 
were searched for annotated sequences and deposited structures respectively that contain a 
domain belonging to the pfam_FAD_binding_4 family. In addition, we searched the primary 
literature for VAO/PCMH family members of known sequence and enzymatic function. This 
led to the identification of 115 sequences of VAO/PCMH family members with known 
enzymatic activity, as determined either by characterisation of the purified protein or by 
genetic analysis. Of the 115 sequences, 35 encode proteins of which the three-dimensional 
structure has been determined. Most of the identified enzymes are classic flavin-dependent 
oxidoreductases that catalyse two-electron reductions (known as reductases) or oxidations 
(known as oxidases if molecular oxygen is used as an electron acceptor and as 
dehydrogenases if another molecule is used as an electron acceptor). In addition, a small 
number of the identified enzymes display oxygenase or non-redox transferase activity (see 
below for details).  
Almost all of the enzymes for which the presence of a cofactor has been studied contain FAD, 
as would be expected based on the presence of the conserved FAD-binding domain. The only 
exceptions are D-arabinono-1,4-lactone oxidase from Trypanosoma brucei and L-galactono-1,4-
lactone dehydrogenase from Brassica oleracea (cauliflower), which have been reported to 
contain FMN, and L-gulono-1,4-lactone dehydrogenase from Mycobacterium tuberculosis, in 
which no flavin could be identified (9–11). However, two other VAO/PCMH-type enzymes  
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Figure 1: Structural architecture and cofactor binding modes of VAO/PCMH family members. (A) 
Cartoon representation of the three-dimensional structure of vanillyl alcohol oxidase (VAO) from 
Penicillium simplicissimum (PDB ID: 1VAO) showing the two-domain topology that is characteristic of 
members of the VAO/PCMH family. The FAD-binding domain, which is conserved throughout the 
family, is shown in green. The substrate-binding domain, which is more variable, is shown in red. The 
FAD cofactor, which is covalently bound to the enzyme via an 8α-N3-histidyl-FAD bond, is shown as 
yellow sticks. (B-F) Stick representations of flavin binding modes found in members of the VAO/PCMH 
family. (B) Monocovalent 8α-N1-histidyl-FAD of cholesterol oxidase (ChoX) from Brevibacterium 
sterolicum (PDB ID: 1I19). (C) Bicovalent 6-S-cysteinyl-8α-N1-histidyl-FAD of glucooligosaccharide 
oxidase (GOOX) from Sarocladium strictum (PDB ID: 1ZR6). (D) Monocovalent 8α-N3-histidyl-FAD of 
VAO. (E) 8α-O-tyrosyl-FAD of para-cresol methylhydroxylase (PCMH) from Pseudomonas putida (PDB 
ID: 1WVF). (F) Non-covalent FAD of MurB from Escherichia coli (PDB ID: 2MBR).  
that were originally reported to contain FMN, were later found to contain FAD (Dbv29 from 
Nonomuraea sp. ATCC 39727 and L-galactono-1,4-lactone oxidoreductase from Trypanosoma 
cruzi) with the original misassignment being attributed to the hydrolysis of FAD during 
analysis (12, 13). Therefore, further research is required to confirm the identity of the flavin 
cofactor in the above-mentioned enzymes. 
A large number of VAO/PCMH family members contain a covalently bound flavin cofactor. 
In total, five different types of flavin binding mode can be distinguished within the family 
(Fig. 1B-F): non-covalent, monocovalent 8α-N1-histidyl-FAD, monocovalent 8α-N3-histidyl-
FAD, monocovalent 8α-O-tyrosyl-FAD and bicovalent 6-S-cysteinyl-8α-N1-histidyl-FAD. 
Covalent flavinylation increases the redox potential of the cofactor and thus enhances the 
oxidative power of the enzymes (14).  A structure-based alignment of the identified sequences 
was performed using the PROMALS3D webserver and subsequently used to generate a 
phylogenetic tree using the phylogeny.fr webserver’s BioNJ function. This phylogenetic tree 
is shown in Figure 2. Using this tree, we divided the VAO/PCMH family into eleven 
subfamilies of related enzymes based on sequence similarity (and in most cases) function. One 
sequence, glycolate oxidoreductase subunit E from Escherichia coli, did not belong to any of 
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the identified subfamilies. Below, we will discuss these subfamilies in terms of their shared 
properties and functions and highlight newly discovered members and recent developments 
in our mechanistic understanding of the enzymes. 
Subfamily 1: BBE-like 
The subfamily with most characterised members is the berberine bridge enzyme (BBE)-like 
subfamily. This subfamily is named after berberine bridge enzyme, or reticuline oxidase (EC 
1.21.3.3), which catalyses the oxidative ring closure of (S)-reticuline to (S)-scoulerine, a key 
intermediate in the biosynthesis of protoberberine and benzophenanthridine alkaloids in 
plants (15). The BBE-like subfamily is the most functionally diverse of the identified 
subfamilies. Many of the members are involved in the biosynthesis of secondary metabolites 
in plants (16–18) or microorganisms (12, 19–30). The subfamily also contains a number of 
enzymes that catalyse the oxidation of the C1 hydroxyl groups of the aldose moieties of 
(oligo)saccharides (31–36). Examples include glucooligosaccharide oxidase from Sariocladum 
strictum (previously known as Acremonium strictum), chitooligosaccharide oxidase from 
Fusarium graminearum and the recently identified xylooligosaccharide oxidase from 
Myceliophthora thermophila C1. Many members of the BBE-like subfamily contain a 
bicovalently-linked 6-S-cysteinyl-8α-N1-histidyl-FAD cofactor. The bicovalent linkage 
increases the redox potential of FAD and may be of importance in maintaining the correct 
position of the flavin cofactor in the active site, which is typically quite open in bicovalent 
flavoproteins. 
An interesting recent development is the characterisation of EncM, a BBE-like enzyme that 
utilises a hitherto unknown flavin redox state, the flavin-N5-oxide, to catalyse the oxidative 
ring closure required to form the tricyclic core of the antibiotic enterocin in Streptomyces 
maritimus (27, 37). This occurs through a mechanism where the oxygen atom from the flavin-
N5-oxide is first incorporated into the substrate at the C4 position, yielding hydroxylated 
substrate and oxidised FAD. Subsequent oxidation of the formed hydroxyl group, yielding a 
ketone and reduced flavin, triggers a Favorskii-type rearrangement reaction that leads to 
lactone formation, yielding the tricyclic enterocin core (Scheme 1). Subsequently, reduced 
flavin reacts with molecular oxygen, regenerating the flavin-N5-oxide. This has been 
proposed to occur via the initial formation of an N5-peroxide intermediate, which forms the 
flavin-N5-oxide after expelling water. However, a mechanism consisting of the formation and 
subsequent rearrangement of a C4a-peroxide intermediate, as typically found in flavin-
dependent monooxygenases, is also possible. Elucidating the mechanism by which EncM 
enables the formation and stabilisation of the flavin-N5-oxide will be an interesting challenge 
for future research. In addition to EncM, a flavin-N5-oxide was also found to be an 
intermediate in the catalytic cycle of the non-VAO/PCMH-type flavoenzyme DszA (38). It will 
be interesting to see whether more flavoenzymes that utilise this redox state will be identified 
in future. For a more comprehensive overview of the BBE-like subgroup, see (39). 
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Figure 2: Phylogenetic tree of the VAO/PCMH family showing the division into eleven subfamilies. The 
subfamilies are indicated by the colours of the branches. They are: berberine bridge enzyme-like (blue), 
cytokinin dehydrogenases (light red), MurBs (dark green), 4-phenol oxidising (yellow), alkyl-
dihydroxyacetone phosphate synthases (dark red), α-hydroxy acid dehydrogenases (grey) DprE1s 
(pink) sterol reductases (brown), aldonolactone oxidoreductases (purple), alditol oxidases (orange) and 
cholesterol oxidases (light green). Glycolate oxidoreductase subunit E from Escherichia coli (black) was 
not deemed to belong to any of the identified subfamilies. The sequences in the tree are: Sc Pac11: Pac11 
from Streptomyces coeruleorubidus, Sl MCRA: mitomycin radical oxidase from Streptomyces lavendulae, 
Pn HDNO: 6-hydroxy-D-nicotine oxidase from Paenarthrobacter nicotinovorans, Sm EncM: EncM from 
Streptomyces maritimus, Fg ChitO: chitooligosaccharide oxidase from Fusarium graminearum, Ss GOOX: 
glucooligosaccharide oxidase from Sarocladium strictum, Mt XylO: xylooligosaccharide oxidase from 
Myceliophthora thermophila C1, Mn LAO: lactose oxidase from Microdochium nivale, Cc HOX: hexose 
oxidase from Chondrus crispus, Sg GilR: GilR from Streptomyces griseoflavus, Ss SpnJ: SpnJ from 
Saccharopolyspora spinosa, Ac CrmK: CrmK from Actinoalloteichus cyanogriseus WH1-2216-6, Ssp ClmD2: 
ClmD2 from Streptomyces sp. CS40, Sg AknOx, aclacinomycin oxidoreductase from Streptomyces 
galilaeus, Nsp Dbv29: Dbv29 from Nonomuraea sp. ATCC 39727, Ssp TamL: TamL from Streptomyces sp. 
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307-9, Ec BBE1: berberine bridge enzyme from Eschscholzia californica (california poppy), Pp Phlp4: Phl 
p 4 from Phleum pratense (timothy-grass), Ha CHO: carbohydrate oxidase from Helianthus annuus 
(sunflower), Cs CBDAS: cannabidiolic acid synthase from Cannabis sativa, Cs THCAS: 
tetrahydrocannabinolic acid synthase from Cannabis sativa, At BBE-like 15: BBE-like protein 15 from 
Arabidopsis thaliana, At BBE-like 13: BBE-like protein 13 from Arabidopsis thaliana, Am STOX: (S)-
tetrahydroprotoberberine oxidase from Argemone mexicana, Bw STOX: (S)-tetrahydroprotoberberine 
oxidase from Berberis wilsoniae, An YanF: YanF from Aspergillus niger, As SPS: solanapyrone synthase 
from Alternaria solani, Cg CHGG01242-2: CHGG_01242-2 from Chaetomium globosum, Ao IAAO: isoamyl 
alcohol oxidase from Aspergillus oryzae, Fg ZEB1: ZEB1 from Fusarium graminearum, Zm CKX: cytokinin 
dehydrogenase from Zea mays (maize, numbered by isoform), At CKX: cytokinin dehydrogenase from 
Arabidopsis thaliana (numbered by isoform), Tc MurB: MurB from Thermus caldophilus, Sp MurB: MurB 
from Streptococcus pneumoniae, Sa MurB: MurB from Staphylococcus aureus, Lm MurB: MurB from Listeria 
monocytogenes, Mt MurB: MurB from Mycobacterium tuberculosis, Pa MurB: MurB from Pseudomonas 
aeruginosa, Vc MurB: MurB from Vibrio cholerae, Ec MurB: MurB from Escherichia coli, Cc CndG: CndG 
from Chondromyces crocatus Cm c5, FeeG: FeeG from an unidentified soil microbe, Ps VAO: vanillyl 
alcohol oxidase from Penicillium simplicissimum, Rj EUGO: eugenol oxidase from Rhodococcus jostii 
RHA1, Pp PCMH: para-cresol methylhydroxylase from Pseudomonas putida, POPS1 EUGH: eugenol 
hydroxylase from Pseudomonas sp. OPS1, PHR199 EUGH: eugenol hydroxylase from Pseudomonas sp. 
HR199, Ec GlcE: glycolate oxidoreductase subunit E from Escherichia coli, Tb ADPS: alkyl-
dihydroxyacetone phosphate synthase (ADPS) from Trypanosoma brucei, Dd ADPS: ADPS from 
Dictyostelium discoideum, Ce ADPS: ADPS from Caenorhabditis elegans, Cp ADPS: ADPS from Cavia 
porcellus (guinea pig), Hs ADPS, human ADPS, Ec DLDH: D-lactate dehydrogenase (DLDH) from 
Escherichia coli, Asp DLDH: DLDH from Acidocella sp. MX-AZ02, Aa DLDH: DLDH from Acetobacter 
aceti, Af DLDH: DLDH from Archaeoglobus fulgidus, Ec GlcD: glycolate oxidoreductase subunit D from 
Escherichia coli, St DLDH: DLDH from Sulfolobus tokodaii 7, At DLDH: DLDH from Arabidopsis thaliana, 
Kl DLDH: DLDH from Kluyveromyces lactis, Sc DLD1: DLD1 from Saccharomyces cerevisiae, Hs D2HGDH: 
human D-2-hydroxyglutarate dehydrogenase, At D2HGDH: D-2-hydroxyglutarate dehydrogenase 
from Arabidopsis thaliana, Sc DLD3: DLD3 from Saccharomyces cerevisiae, Sc DLD2: DLD2 from 
Saccharomyces cerevisiae, Ms DprE1: DprE1 from Mycobacterium smegmatis, Mt DprE1: DprE1 from 
Mycobacterium tuberculosis, Bm DHCR24: 24-dehydrocholesterol reductase (DHCR24) from Bombyx mori 
(silkworm), Mm DHCR24: DHCR24 from Mus musculus (mouse), Hs DHCR24: human DHCR24, Sl 
SSR2: sterol side chain reductase (SSR) 2 from Solanum lycopersicum (tomato), St SSR2: SSR2 from 
Solanum tuberosum (potato), Os DWF1: DWARF1 from Oryza sativa (rice), Zm DWF1: DWARF1 from Zea 
mays (maize), At DWF1: DWARF1 from Arabidopsis thaliana, Ar DWF1: DWARF1 from Ajuga reptans, St 
SSR1: SSR1 from Solanum tuberosum (potato), Sl SSR1: SSR1 from Solanum lycopersicum (tomato), Ac 
AldO: alditol oxidase from Acidothermus cellulolyticus 11B, Ssp SorbO: sorbitol oxidase from 
Streptomyces sp. H-7775, Sc AldO: alditol oxidase from Streptomyces coelicolor A3(2), Ssp XylOx: xylitol 
oxidase from Streptomyces sp. IKD472, Pg GLO: D-glucono-1,4-lactone oxidase from Penicillium 
griseoroseum, Mt GUDH: L-gulono-1,4-lactone dehydrogenase from Mycobacterium tuberculosis, Nt 
GALDH: L-galactono-1,4-lactone dehydrogenase (GALDH) from Nicotiana tabacum (tobacco), Ib 
GALDH: GALDH from Ipomoea batatas (sweet potato), At GALDH: GALDH from Arabidopsis thaliana, 
Bo GALDH: GALDH from Brassica oleracea (cauliflower), Sc ALO: D-arabinono-1,4-lactone oxidase 
(ALO) from Saccharomyces cerevisiae, Ca ALO: ALO from Candida albicans, Ld ALO: ALO from 
Leishmania donovani, Tc GALO: L-galactono-1,4-lactone oxidoreductase from Trypanosoma cruzi, Tb ALO: 
ALO from Trypanosoma brucei, St GUO: L-gulono-1,4-lactone oxidase (GUO) from Scyliorhinus torazame 
(cloudy catshark), Ss GUO: GUO from Sus scrofa (pig), Rn GUO: GUO from Rattus norvegicus (rat), Mm 
GUO: GUO from Mus musculus (mouse), Bs ChoX: cholesterol oxidase (ChoX) from Brevibacterium 
sterolicum, Re ChoX: ChoX from Rhodococcus erythropolis CECT3014, Rr ChoX: ChoX from Rhodococcus 
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ruber Chol-4, Pa ChoX: ChoX from Pseudomonas aeruginosa PA157, Bc ChoX: ChoX from Burkholderia 
cepacia ST-200, Csp ChoX: ChoX from Chromobacterium sp. DS-1. The scale bar indicates the branch 
length corresponding to 0.5 changes per position. 
 
Scheme 1: Synthesis of the tricyclic core of the antibiotic enterocin catalysed by EncM. EncM utilises a 
novel flavin oxidation state, the flavin-N5-oxide, to catalyse a double oxidation of its substrate. The 
proposed physiological substrate, a dihydrooctaketide intermediate bound to the carrier protein EncC, 
is bound in the enzyme’s active site with EncM’s FAD cofactor in the N5-oxide form. Subsequently, the 
flavin-N5-oxide oxygenates the substrate at the C4 position, yielding an alcohol and oxidised FAD. 
Following this, oxidation of the formed alcohol to a ketone takes place, yielding fully reduced FAD. 
The product is then released from the enzyme and undergoes a Favorskii-type rearrangement to yield 
the tricyclic enterocin core. Meanwhile, the reduced flavin reacts with molecular oxygen, regenerating 
the flavin-N5-oxide. 
Subfamily 2: Cytokinin dehydrogenases 
Cytokinin dehydrogenases (CKX, EC 1.5.99.12) are found in a wide variety of plants, where 
they are responsible for the breakdown of cytokinins, plant hormones that are involved in cell 
division and differentiation. Cytokinins are adenine derivatives with a substituent bound to 
the N6 atom, which can be an isoprenoid or aromatic functionality. CKX oxidises the side 
chain amine of cytokinins to an imine, which is subsequently hydrolysed, yielding adenine 
and an aldehyde (40) (Scheme 2). Following this, the FAD cofactor of CKX, which is covalently 
linked to the enzyme through an 8α-N1-histidyl-FAD bond, is reoxidised. Various electron 
acceptors, such as quinones or 2,6-dichlorophenolindophenol (DCPIP) can be used by the 
enzyme in vitro (41). For the Zea mays (maize) CKX1 (ZmCKX1) isoform, evidence exists that 
the physiological electron acceptor is a free radical formed by the oxidation of 2,4-dihydroxy-
7-methoxy-1,4-benzoxazin-3-one, a compound found in maize phloem sap, by laccases or 
peroxidases (42). Higher plants typically contain multiple genes encoding CKXs, with the best 
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studied CKX families being those from Arabidopsis thaliana (seven isoforms) and Z. mays 
(thirteen isoforms). The various members of these families differ in terms of their tissue-
specific expression patterns, (predicted) subcellular localisation and substrate specificity, 
suggesting they have distinct functions in vivo (43–47). The crystal structure of ZmCKX1 
revealed that the substrate binding site consists of an internal cavity, where the isoprenoid or 
aromatic side chain of the substrate binds, linked to the surface through a narrow pore (48). 
The C-N bond that is cleaved occupies the pore, with the adenine ring structure bound to a 
funnel-shaped pocket on the surface of the protein. Based on the crystal structure, a 
mechanism for substrate oxidation was proposed where a conserved aspartate residue (Asp-
169 in ZmCKX1) plays a crucial role in catalysis. By interacting with the N10 atom of the 
cytokinin, Asp-169 induces polarisation of the substrate, facilitating the transfer of a hydride 
from the C11 atom to FAD. The importance of Asp-169 for catalysis is supported by a recent 
site-directed mutagenesis study, which showed that the ZmCKX1 D169N variant displays 
significantly lowered activity towards all tested substrates, while Km values were not affected 
(49).  
 
Scheme 2: Oxidation of cytokinins as catalysed by cytokinin dehydrogenase (CKX). The cytokinin is 
first oxidised at its side chain amine group, yielding an imine. The imine is subsequently hydrolysed, 
yielding adenine and an aldehyde. 
Subfamily 3: MurBs 
UDP-N-acetylglucosamine enolpyruvate reductase, also known as MurB (EC 1.3.1.98), is 
involved in bacterial cell wall synthesis, where it catalyses the second step in the biosynthesis 
of peptidoglycan, the reduction of UDP-N-acetylglucosamine enolpyruvate (UDP-GlcNAc-
EP) to UDP-N-acetylmuramic acid (UDP-MurNAc) (Scheme 3). The enzyme achieves this by 
utilising a non-covalently bound FAD cofactor to transfer a hydride equivalent from 
nicotinamide adenine dinucleotide phosphate (NADPH) to UDP-GlcNAc-EP (50).  
Based on their three-dimensional structures, two different types of MurB can be distinguished. 
The two types share a similar overall fold, but differ in terms of their mechanism of substrate 
binding. Type I MurB, which is found in Gram-negative bacteria such as Escherichia coli and 
Pseudomonas aeruginosa, is characterised by the presence of a loop region that is involved in 
substrate binding, closing the active site after binding (51, 52). The loop contains a tyrosine 
residue (Tyr-190 in E. coli MurB) that forms an interaction with one of the phosphate groups 
of UDP-GlcNAc-EP or NADPH, which bind at a similar position. Type II MurBs are found in 
bacteria such as Staphylococcus aureus and Thermus caldophilus and lack this loop region as well 
as part of the substrate-binding domain that forms interactions with the uridine moiety of 
UDP-GlcNAc-EP in Type I MurBs (53, 54). Type II MurBs can be further divided into two 
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groups based on the identity of an active site acid that protonates the carbanion intermediate 
formed after hydride transfer to UDP-GlcNAc-EP. In S. aureus MurB, this role is performed 
by a serine residue (Type II-a), while in T. caldophilus MurB, it is performed by a cysteine 
residue (Type II-b). All type I MurBs contain a serine residue that acts as the proton donor 
(55). 
Recently, it was found that Verrucomicrobium spinosum contains a novel form of MurB, where 
it is fused to MurC, the enzyme that catalyses the following step in peptidoglycan synthesis, 
the addition of L-alanine to the carboxylic acid group of UDP-MurNAc (56). Expression of the 
fusion protein was found to complement the phenotype of E. coli murB and murC mutants. 
However, although MurC activity could be detected using the purified enzyme in vitro, MurB 
activity could not. Further characterisation of this novel MurB will be an interesting future 
research line. MurB’s role in bacterial cell wall synthesis makes it an interesting target for the 
development of novel antibiotics and various inhibitors have been identified and shown to 
possess antibacterial activity [see (57) for a review]. 
 
Scheme 3: Reduction of UDP-N-acetylglucosamine enolpyruvate to UDP-N-acetylmuramic acid 
catalysed by MurB. 
Subfamily 4: 4-Phenol oxidising 
The 4-phenol oxidising (4PO) subfamily contains enzymes that catalyse the oxidation of para-
substituted phenols at the Cα atom of the para-substituent. The subfamily contains both 
oxidases, such as vanillyl alcohol oxidase (VAO, EC 1.1.3.38) from Penicillium simplicissimum, 
and eugenol oxidase (EUGO) from Rhodococcus jostii RHA1, and dehydrogenases, such as 
para-cresol methylhydroxylase (PCMH, EC 1.17.99.1) from Pseudomonas putida and eugenol 
hydroxylase (EUGH) from Pseudomonas sp., that utilise a cytochrome c subunit as an electron 
acceptor (58–62). Depending on the enzyme and type of substrate, these 4PO subfamily 
members can catalyse the oxidation of benzylic alcohols to aldehydes, the oxidative 
deamination of benzylic amines, the oxidative demethylation of 4-(methoxymethyl)phenol, 
the hydroxylation of 4-allylphenols, and the hydroxylation or dehydrogenation of 4-
alkylphenols (Scheme 4A-C) (63–65). Catalysis proceeds through the abstraction of a hydride 
from the Cα atom of the side chain of an enzyme-bound phenolate form of the substrate, 
yielding a para-quinone methide intermediate that subsequently rearranges or reacts with 
water to give the reaction products (66, 67). In vivo, these enzymes are presumably involved 
in the metabolism of para-substituted phenolic compounds, possibly derived from the 
degradation of lignin (68).  
These 4PO subfamily members are unique among the VAO/PCMH family members in that 
their FAD cofactor is covalently bound to a loop that is close to the C-terminus of the protein, 
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rather than the more commonly found covalent linkages to a loop close to the N-terminus of 
the protein. This occurs through an 8α-N3-histidyl-FAD bond in the case of VAO and EUGO 
and an 8α-O-tyrosyl-FAD bond in the case of PCMH and (as predicted from its sequence) 
EUGH (69–71). Recent progress in studying this group of enzymes includes the publication of 
the crystal structure of EUGO and a mutagenesis study that focused on understanding the 
molecular determinants and function of the differing oligomerisation states of the oxidases 
VAO and EUGO (71, 72). Although the secondary and tertiary structures of these proteins are 
rather similar, they differ in terms of their quaternary structure. EUGO is exclusively dimeric 
in solution, whereas VAO forms both dimers and octamers, which can be described as 
tetramers of dimers. A loop that is positioned at the dimer-dimer interface of VAO, but is not 
present in EUGO, was shown to be responsible for this difference, with its deletion leading to 
the formation of a VAO variant that exclusively forms dimers without significantly affecting 
catalytic function. However, a recent report described the expression of a number of VAO 
homologues that displayed an octameric quaternary structure, despite not containing such a 
loop region (73). Further research is required to understand the mechanism by which these 
novel VAO-like enzymes obtain their octameric oligomerisation state. 
In addition to these well characterised enzymes, the 4PO subfamily contains two enzymes 
that catalyse the oxidative decarboxylation of N-substituted tyrosine derivatives: CndG from 
Chondromyces crocatus and FeeG from an unidentified soil microbe (Scheme 4D) (74, 75). These 
enzymes both contain three residues that are thought to be crucial for enabling the formation 
of the para-quinone methide intermediate in other 4PO subfamily members (Tyr-108, Tyr-503 
and Arg-504 in VAO). This suggests that the decarboxylation reaction proceeds through the 
initial formation of a para-quinone methide intermediate, which subsequently expels carbon 
dioxide. Unlike the other 4PO subfamily members, CndG contains a non-covalently bound 
FAD cofactor, in agreement with the fact that neither the histidine residue involved in covalent 
flavin binding in VAO nor the tyrosine residue involved in covalent flavin binding in PCMH 
are conserved in this enzyme.  
 
Scheme 4: Examples of reactions catalysed by members of the 4-phenol oxidising subfamily. (A) The 
oxidation of vanillyl alcohol to vanillin by eugenol oxidase (EUGO) or vanillyl alcohol oxidase (VAO). 
(B) The oxidation of para-cresol to 4-hydroxybenzyl alcohol by para-cresol methylhydroxylase (PCMH). 
(C) The oxidation of eugenol to coniferyl alcohol by eugenol hydroxylase (EUGH), EUGO or VAO. (D) 
The oxidative decarboxylation of N-substituted tyrosine derivatives by CndG. 
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Subfamily 5: Alkyl-dihydroxyacetone phosphate synthases 
Alkyl-dihydroxyacetone phosphate synthase (ADPS, EC 2.5.1.26) is involved in the 
biosynthesis of ether phospholipids, lipids which contain an ether-bond linked alkyl chain 
instead of one of the ester-bond linked acyl chains found in most phospholipids. Ether lipids 
form a major constituent of mammalian membranes and defects in their biosynthesis, in some 
cases caused by mutations in the gene encoding ADPS, are linked to the genetic disorder 
rhizomelic chondrodysplasia punctata in humans (76). Ether phospholipid biosynthesis starts 
in the peroxisomes with the synthesis of acyl-dihydroxyacetone phosphate (acyl-DHAP) from 
DHAP and acyl-CoA, catalysed by an acyltransferase. Subsequently, ADPS catalyses the 
conversion of the acyl-DHAP to an alkyl-DHAP by the incorporation of a long-chain fatty 
alcohol, thus yielding the ether bond that is characteristic of ether phospholipids. ADPS is 
unique among VAO/PCMH family members in that it is not an oxidoreductase, but a 
transferase that uses a non-covalently bound FAD cofactor to catalyse a reaction that does not 
involve any change in the redox states of the substrates (77). The reaction occurs through the 
formation of a covalent intermediate between acyl-DHAP and FAD and is proposed to 
proceed as follows (Scheme 5) (78, 79). First, acyl-DHAP is bound to the enzyme’s active site 
in its enolate form. Tautomerisation to the enolate may be stimulated by Tyr-578 (numbering 
according to Cavia porcellus [guinea pig] ADPS), which could act as a proton acceptor, and 
His-616 and His-617, which could stabilise a negative charge on the DHAP O2 atom. These 
residues are conserved among all ADPS sequences included in our alignment and have been 
shown to be essential for activity by site-directed mutagenesis (77–79). This tautomerisation 
enables the subsequent nucleophilic attack of the C1 atom of DHAP on the N5 atom of FAD, 
yielding a covalent N5-acyl-DHAP adduct. Next, a fatty acid is expelled from the intermediate, 
yielding an N5-DHAP iminium intermediate. This intermediate breaks down through the 
attack of a fatty alcohol, yielding the alkyl-DHAP product and the oxidised FAD cofactor. In 
addition to the two domains typically found in VAO/PCMH family members, ADPS contains 
a third domain at its N-terminus (78, 79). This domain contains a gating helix that closes off 
the substrate-binding cavity. Recently, ADPS has gained interest as a potential anti-cancer 
drug target, as its inhibition leads to significant changes in the lipid composition of tumour 
cells and impairs their pathogenicity (80, 81). 
Subfamily 6: α-Hydroxy acid dehydrogenases 
α-Hydroxy acid dehydrogenases catalyse the oxidation of the hydroxyl group of α-hydroxy 
acids to a carbonyl group, using electron acceptors other than molecular oxygen (Scheme 6). 
Depending on their substrate specificity and physiological function they are known either as 
D-lactate dehydrogenase (DLDH, EC 1.1.2.4), D-2-hydroxyglutarate dehydrogenase 
(D2HGDH, EC 1.1.99.39) or glycolate oxidoreductase. DLDH is found in bacteria, archaea, 
yeasts and plants, where it catalyses the oxidation of D-lactate to pyruvate, the first step in its 
metabolism (82–86). The crystal structure of Escherichia coli DLDH revealed that it contains a 
non-covalently bound FAD cofactor and that, in addition to the FAD-binding and substrate-
binding domains typically found in VAO/PCMH family members, it contains a third domain 
that is responsible for association of the protein with the cytoplasmic membrane (87). Similar 
to DLDH, D2HGDH catalyses the oxidation of the hydroxyl groups of α-hydroxy acids, but it 
shows highest activity for the oxidation of D-2-hydroxyglutarate to α-ketoglutarate (88).  
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Scheme 5: Mechanism of the synthesis of alkyl-dihydroxyacetone phosphate (alkyl-DHAP) from acyl-
DHAP by alkyl-dihydroxyacetone phosphate synthase (ADPS). Upon binding to the enzyme, acyl-
DHAP is tautomerised to its enolate form. This enables the formation of a covalent adduct between the 
enzyme’s FAD cofactor and acyl-DHAP. Subsequently, a fatty acid is released from this intermediate, 
yielding a covalent iminium intermediate. This subsequently reacts with a fatty alcohol, yielding the 
alkyl-DHAP product. 
Mutations in the human D2HGDH gene cause the genetic disorder D-2-hydroxyglutaric 
aciduria, which is characterised by heightened levels of D-2-hydroxyglutarate in body fluids, 
with patients displaying severe developmental defects (89). 
A recent study revealed that Saccharomyces cerevisiae contains three α-hydroxy acid 
dehydrogenases (named DLD1, DLD2 and DLD3). DLD1 functions as a conventional DLDH. 
However, DLD2 and DLD3 do not only catalyse the oxidation of α-hydroxy acids using 
electron acceptors such as DCPIP, but can also transfer the electrons to α-keto acids, yielding 
new α-hydroxy acids (90). Based on the fact that a dld3Δ mutant displayed increased D-2-
hydroxyglutarate levels and decreased D-lactate levels, it was suggested that the enzyme may 
function as a transhydrogenase in vivo, converting D-2-hydroxyglutarate and pyruvate to α-
ketoglutarate and D-lactate respectively.  
Glycolate oxidoreductase from E. coli catalyses the first step of glycolate metabolism, its 
oxidation to glyoxylate (91). Two genes encoding the putative VAO/PCMH-type 
oxidoreductases glcD and glcE have been shown to be required for glycolate oxidoreductase 
activity (92). However, the function of the two gene products has not been studied in detail. 
It should be noted that the sequence of glcE is significantly shorter than that of the other α-
hydroxy acid dehydrogenases and it is not closely related to the other sequences according to 
the phylogenetic tree. As such, we do not deem it to belong to the α-hydroxy acid 
dehydrogenase subfamily. 
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Scheme 6: Oxidation of α-hydroxy acids catalysed by the α-hydroxy acid dehydrogenases glycolate 
oxidoreductase, D-lactate dehydrogenase (DLDH) and D-2-hydroxyglutarate dehydrogenase 
(D2HGDH). 
Subfamily 7: Sterol reductases 
Members of the sterol reductase subfamily are responsible for the reduction of a carbon-
carbon double bond during sterol biosynthesis. Their exact physiological function differs 
depending on the source organism. Sterol reductases from mammals are known as 24-
dehydrocholesterol reductase (DHCR24, also known as seladin-1, EC 1.3.1.72) and catalyse 
the final step of cholesterol biosynthesis, the reduction of 24-dehydrocholesterol (desmosterol) 
to cholesterol (Scheme 7A) (93). The reaction is NADPH dependent and stimulated by the 
presence of FAD, suggesting DHCR24 contains a non-covalently bound FAD cofactor and uses 
NADPH as an electron donor. Mutations in the human DHCR24 gene cause the congenital 
disorder desmosterolosis, with patients displaying heightened plasma desmosterol levels and 
various congenital and developmental abnormalities (93). In addition to mammals, DHCR24 
has been identified in Bombyx mori (silkworm) (94). This invertebrate cannot synthesise 
cholesterol de novo, but rather converts plant sterols to cholesterol via a process where they 
are first dealkylated to desmosterol, which is subsequently reduced by DHCR24.  
Sterol reductases have also been identified in plants such as Arabidopsis thaliana and Oryza 
sativa (rice), where they are involved in the biosynthesis of C24-alkylated sterols such as 
campesterol or sitosterol (95, 96). These sterols are synthesised from their Δ24-28 unsaturated 
derivatives, which are reduced by the sterol reductase DWARF1 (Scheme 7B). Typically, this 
reaction is believed to take place in two steps, with the Δ24-28 unsaturated sterols first being 
isomerised to the Δ24-25 unsaturated derivatives, which are subsequently reduced to the 
saturated products. Thus, like DHCR24, DWARF1 catalyses the reduction of Δ24-25 double 
bonds, with the main difference in the reactions lying in the prior isomerisation step. 
Interestingly, Ajuga reptans DWARF1 was recently reported to catalyse direct reduction of 
Δ24-28 double bonds without the prior isomerisation step (97). 
Cholesterol is generally only found in trace amounts in plants. However, plants from the 
genus Solanum, such as Solanum tuberosum (potato) and Solanum lycopersicum (tomato) rely on 
cholesterol as a precursor to steroidal glycoalkyloid toxins. Both S. tuberosum and S. 
lycopersicum contain two sterol reductase-encoding genes. One encodes a typical DWARF1-
type reductase that catalyses the Δ24-28 double bond reduction required for the synthesis of 
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plant sterols (SSR1), while the other encodes a reductase that only catalyses the reduction of 
Δ24-25 double bonds enabling it to convert desmosterol to cholesterol (SSR2) (98).  
A thorough understanding of the molecular determinants of the differences in the reactions 
catalysed by sterol reductases is hampered by a lack of structural data. Homology modelling 
of human DHCR24 did lead to a hypothesis regarding the cause of desmosterolosis (99). 
Mutations found in patients may affect interactions with the FAD cofactor, the desmosterol 
substrate and the endoplasmic reticulum membrane, with which DHCR24 is associated (100, 
101). Further structural and biochemical studies are required to confirm these hypotheses. 
 
Scheme 7: Reductions of sterols catalysed by sterol reductases. (A) The mammalian enzyme DHCR24 
reduces the Δ24-25 double bond of desmosterol, yielding cholesterol. (B) The plant enzyme DWARF1 
catalyses the isomerisation of the Δ24-28 double bond of sterols such as 24-methylenecholesterol to a 
Δ24-25 double bond, followed by the reduction of this double bond, in this case yielding campesterol. 
Ajuga reptans DWARF1 (Ar DWARF1) can catalyse the direct reduction of Δ24-28 double bonds without 
the prior isomerisation step.  
Subfamily 8: DprE1s 
The most recently identified subfamily of the VAO/PCMH family consists of DprE1 (EC 
1.1.98.3). Together with a second enzyme, DprE2, DprE1 is responsible for the epimerisation 
of decaprenylphosphoryl-β-D-ribofuranose (DPR) to decaprenylphosphoryl-β-D-
arabinofuranose (DPA), the precursor of the arabinan moiety of the cell wall of mycobacteria 
such as Mycobacterium tuberculosis, the pathogen that causes tuberculosis (102). The 
importance of this reaction is highlighted by the fact that the dprE1 gene has been shown to 
be essential for growth in Mycobacterium smegmatis (103). Epimerisation of DPR to DPA occurs 
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in a two-step process, where DPR is first oxidised to decaprenylphosphoryl-2-keto-β-D-
erythro-pentofuranose (DPX) by DprE1, after which DPX is reduced to DPA by DprE2 (Scheme 
8A) (104). To achieve substrate oxidation, DprE1 uses a non-covalently bound FAD cofactor. 
Though DprE1 can use oxygen as an electron acceptor, artificial electron acceptors such as 
DCPIP lead to more efficient catalysis, suggesting the enzyme is a dehydrogenase rather than 
an oxidase. It has been suggested that membrane-embedded menaquinone may be the 
physiological electron acceptor (105).  
Due to its crucial role in mycobacterial cell wall synthesis, DprE1 has gathered major interest 
as a potential antitubercular drug target in recent years. The DprE1 inhibitors identified so far 
can be classed into two groups: nitro-group containing suicide inhibitors and non-covalent 
competitive inhibitors (106). The covalent inhibitors are first activated by reduction of their 
nitro group to a nitroso group, which only occurs after reduction of the enzyme’s FAD cofactor 
by its substrate (Scheme 8B) (104, 105, 107, 108). The nitroso group subsequently reacts with 
the thiol group of an active site cysteine (Cys-387 in M. tuberculosis DprE1), leading to the 
bulky compounds permanently blocking the active site and preventing catalysis. The 
identification of further DprE1 inhibitors and their application as antitubercular drugs will 
likely be an important line of research in the coming years. 
 
Scheme 8: (A) Epimerisation of decaprenylphosphoryl-β-D-ribofuranose (DPR) to 
decaprenylphosphoryl-β-D-arabinofuranose (DPA) as catalysed by DprE1 and DprE2. DPR is first 
oxidised to decaprenylphosphoryl-2-keto-β-D-erythro-pentofuranose (DPX) by DprE1. DPX is 
subsequently reduced to DPA by the NADH-dependent reductase DprE2. (B) Mechanism of inhibition 
of DprE1 by the benzothiazone inhibitor BTZ043. In order for inhibition to occur, the enzyme’s FAD 
cofactor must first be reduced by its substrate. Subsequently, the nitro group of BTZ043 is reduced to a 
nitroso group by reaction with the FAD cofactor. This nitroso group reacts with the thiol group of an 
active site cysteine residue (Cys-387 in Mycobacterium tuberculosis DprE1), covalently modifying the 
enzyme and blocking the active site.   
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Subfamily 9: Aldonolactone oxidoreductases 
Aldonolactone oxidoreductases are found in a wide variety of organisms where they catalyse 
the final step in the synthesis of L-ascorbic acid (vitamin C) or related antioxidant compounds. 
The exact reaction that is catalysed depends on the host organism (Scheme 9) (109, 110). In 
animals, L-ascorbic acid is synthesised from L-gulono-1,4-lactone by L-gulono-1,4-lactone 
oxidase (GUO, EC 1.1.3.8) (111, 112). In plants, L-ascorbic acid is mainly synthesised from L-
galactono-1,4-lactone by L-galactono-1,4-lactone dehydrogenase (GALDH, EC 1.3.2.3) (113–
116). Another enzyme that catalyses the formation of L-ascorbic acid is L-gulono-1,4-lactone 
dehydrogenase (GUDH) from Mycobacterium tuberculosis (10). However, it is unclear what the 
physiological function of this enzyme is. Fungal aldonolactone oxidoreductases do not 
synthesise L-ascorbic acid, but rather the similar compounds D-erythorbic acid, which is 
synthesised from D-glucono-1,4-lactone by D-glucono-1,4-lactone oxidase (GLO) in Penicillium 
griseoroseum (also known as Penicillium cyaneo-fulvum), or dehydro-D-arabinono-1,4-lactone 
(also known as D-erythroascorbic acid), which is synthesised from D-arabinono-1,4-lactone by 
D-arabinono-1,4-lactone oxidase (ALO, EC 1.1.3.37) in yeasts such as Saccharomyces cerevisiae 
and Candida albicans (117–120). Aldonolactone oxidoreductases have also been identified in 
the protozoans Trypanosoma brucei (ALO), Trypanosoma cruzi (L-galactono-1,4-lactone 
oxidoreductase, GALO), and Leishmania donovani (ALO) (11, 121, 122). These enzymes are 
named after the best substrate identified in in vitro experiments. However, the identity of their 
physiological substrate is unclear.  
Despite the differences in substrate specificity, the basic reaction catalysed by all 
aldonolactone oxidoreductases is similar. The C2-C3 bond of the lactone substrate is oxidised 
to a double bond by transfer of two electrons to the enzyme’s flavin cofactor. The subsequent 
reoxidation of the flavin cofactor can occur either by its reaction with molecular oxygen (GUO, 
yeast ALO, GLO) or electron acceptors such as cytochrome c (GUDH, GALDH). Arabidopsis 
thaliana GALDH can be converted to an oxidase by a single alanine to glycine mutation (123). 
A glycine or proline is found at this position in the oxidases GUO, yeast ALO and GLO and it 
is predicted to be located close to the C4a atom of FAD, the site of the reaction with oxygen. 
This suggests that in GALDH, this alanine residue acts as a gatekeeper, blocking access of 
oxygen to the flavin cofactor. The binding mode of the flavin cofactor also differs depending 
on the enzyme, GUO, yeast ALO and GLO contain a covalently bound FAD cofactor, while 
GALDH from A. thaliana and GALO from T. cruzi contain non-covalently bound FAD (13, 124–
126). A number of arabinonolactone oxidoreductases have been reported to contain non-
covalently bound FMN (ALO from T. brucei and GALDH from B. oleracea) and no flavin was 
detected in GUDH (9–11). However, as hydrolysis of FAD during analysis may lead to 
misassignment of the cofactor of flavoproteins as FMN instead of FAD, further investigations 
are required to confirm the identity of the flavin in these enzymes. 
Subfamily 10: Alditol oxidases 
Members of the alditol oxidase subfamily [referred to as alditol oxidase (AldO), sorbitol 
oxidase or xylitol oxidase depending on their substrate specificity, EC 1.1.3.41] catalyse the 
oxidation of the primary hydroxyl groups of alditols (sugar alcohols), yielding the 
corresponding aldoses, with molecular oxygen acting as the electron acceptor (Scheme 10A).  
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Scheme 9: Oxidations catalysed by aldonolactone oxidoreductases. L-gulono-1,4-lactone oxidase (GUO) 
and L-galactono-1,4-lactone dehydrogenase (GALDH) catalyse the formation of L-ascorbic acid from L-
gulono-1,4-lactone and L-galactono-1,4-lactone respectively. D-arabinono-1,4-lactone oxidase (ALO) 
from yeast catalyses the oxidation of D-arabinono-1,4-lactone to dehydro-D-arabinono-1,4-lactone. D-
Glucono-1,4-lactone oxidase (GLO) catalyses the oxidation of D-glucono-1,4-lactone to D-erythorbic 
acid. 
They have been identified in various Streptomyces species and in the thermophilic bacterium 
Acidothermus cellulolyticus 11B (127–130). All characterised alditol oxidases contain a 
covalently bound FAD cofactor, which the crystal structure of the enzyme from Streptomyces 
coelicolor A3(2) revealed to be covalently bound to the enzyme via an 8α-N1-histidyl-FAD 
bond (131). The diffusion of oxygen into the active site of S. coelicolor AldO was studied by a 
combination of molecular dynamics simulations and site-directed mutagenesis (132). This 
revealed that there are multiple defined diffusion pathways through which oxygen reaches 
the active site of the enzyme. The majority of these pathways converge at a single point of 
entrance to the active site. The residue located at this site, Ala-105, is homologous to the 
gatekeeper alanine residue identified in GALDH, suggesting this may be a crucial site in 
determining the oxygen reactivity of VAO/PCMH-type flavoenzymes. 
In addition to the oxidation of alcohols, AldO from S. coelicolor, can catalyse the oxidation of 
thiol groups (133). For example, L-dithiothreitol, which is identical to the sugar alcohol L-
threitol except for the presence of thiol groups instead of hydroxyl groups at the terminal 
carbon atoms, is oxidised to the corresponding thioaldehyde, which subsequently cyclises to 
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a dithiohemiacetal (Scheme 10B). A number of other flavin-dependent alcohol oxidases from 
the structurally unrelated glucose-methanol-choline (GMC) oxidoreductase family were also 
shown to oxidise thiol analogues of their alcohol substrates, suggesting the ability to do so 
may be a general property of flavin-dependent alcohol oxidases. 
 
Scheme 10: (A) Oxidation of xylitol to D-xylose catalysed by alditol oxidase (AldO). (B) Oxidation of L-
dithiothreitol to the corresponding thioaldehyde, which rearranges to a cyclic dithiohemiacetal, 
catalysed by AldO. 
Subfamily 11: Cholesterol oxidases 
Cholesterol oxidase (ChoX, EC 1.1.3.6) is found in bacteria that are capable of metabolising 
cholesterol, where it catalyses the first two steps in its metabolism. The first is the oxidation 
of the 3β-hydroxyl group to a carbonyl, yielding cholest-5-en-3-one (Scheme 11). In most cases, 
this is subsequently isomerised to cholest-4-en-3-one (134). Molecular oxygen is utilised as the 
electron acceptor for the first step of the reaction, being converted to hydrogen peroxide. Two 
types of ChoX exist, a VAO/PCMH-type that contains a covalently bound FAD cofactor linked 
to the protein through an 8α-N1-histidyl-FAD bond and another type that belongs to the GMC 
oxidoreductase family and contains non-covalently bound FAD. VAO/PCMH-type ChoXs are 
found in Gram-positive bacteria such as Brevibacterium sterolicum and various species of 
Rhodococcus and Gram-negative bacteria such as Chromobacterium sp. DS-1, Pseudomonas 
aeruginosa and Burkholderia cepacia (135–140). Unlike most ChoXs, the VAO/PCMH-type 
enzymes from Gram-negative bacteria do not catalyse the isomerization of cholest-5-en-3-one 
to cholest-4-en-3-one and the main product of the reaction is 6-hydroperoxycholest-4-en-3-
one (Scheme 11) (141). The exact mechanism by which 6-hydroperoxycholest-4-en-3-one is 
formed is unclear. It has been proposed that it may be the result of dioxygenase activity of the 
enzyme, but a mechanism where the oxidation proceeds through enzyme-initiated radical 
reactions is also a possibility (141, 142). The molecular determinants of which product is 
formed are unclear and would be an interesting topic for future studies, particularly 
considering that a crystal structure is available of both the cholest-4-en-3-one-forming  
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Scheme 11: Oxidation of cholesterol as catalysed by cholesterol oxidase (ChoX). Cholesterol is first 
oxidised to cholest-5-en-3-one. VAO/PCMH-type ChoX from Gram-positive bacteria, such as 
Brevibacterium sterolicum (Bs ChoX), subsequently catalyses its isomerisation to cholest-4-en-3-one. 
VAO/PCMH-type ChoX from Gram-negative bacteria, such as Chromobacterium sp. DS-1 (Csp ChoX), 
does not catalyse this isomerisation step. Instead, oxygen is incorporated into the formed cholest-5-en-
3-one, yielding 6-hydroperoxycholest-4-en-3-one as the product. 
VAO/PCMH-type ChoX from Brevibacterium sterolicum and the 6-hydroperoxycholest-4-en-3-
one-forming VAO/PCMH-type ChoX from Chromobacterium sp. DS-1 (143, 144). 
Concluding remarks 
The past ten years have seen significant and surprising advances in our knowledge of 
enzymes of the VAO/PCMH family, including the characterisation of the flavin-N5-oxide, a 
novel flavin redox state, and DprE1, a promising potential antitubercular drug target. As 
highlighted above, open questions regarding the biochemical and mechanistic 
characterisation of these enzymes remain and will provide interesting challenges for future 
research. A number of interesting advances have already been reported since the publication 
of our analysis in June 2017. Jiang et al. reported the characterization of a DLDH from 
Pseudomonas putida KT2440 that contains an Fe-S cluster-binding domain in addition to its 
VAO/PCMH-type flavoprotein domains (145). After oxidation of D-lactate, electrons are 
transferred from the FAD cofactor to a quinone electron acceptor via the Fe-S clusters. Other 
advances include the characterisation of the novel VAO/PCMH family member 
daurichromenic acid synthase from Rhododendron dauricum, which catalyses the oxidative 
cyclisation of grifolic acid to daurichromenic acid and the determination of the crystal 
structure of Mycobacterium tuberculosis MurB, which could facilitate the design of 
antitubercular drugs targeting this enzyme (146, 147). 
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Methods 
To perform the phylogenetic analysis of the VAO/PCMH family, a list of family members with 
known sequence and enzymatic function was compiled by searching the Uniprot and Protein 
Data Bank databases and the primary literature. A structure-based multiple sequence 
alignment of 112 obtained sequences was performed using the PROMALS3D webserver (148). 
PDB files with the following PDB IDs were used for the alignment: 1F0X (Escherichia coli 
DLDH), 1HSK (Staphylococcus aureus MurB), 1I19 (Brevibacterium sterolicum ChoX), 1VAO 
(Penicillium simplicissimum VAO), 1W1O (Zea mays CKX1), 1WVF (Pseudomonas putida PCMH), 
1ZR6 (Sarocladium strictum glucooligosaccharide oxidase), 2BVF (Paenarthrobacter 
nicotinovorans 6-hydroxy-D-nicotine oxidase), 2EXR (Arabidopsis thaliana CKX7), 2GQT 
(Thermus caldophilus MurB), 2IPI (Streptomyces galilaeus aclacinomycin oxidoreductase), 2MBR 
(Escherichia coli MurB), 2UUU (Dictyostelium discoideum ADPS), 2VFR (Streptomyces coelicolor 
A3(2) AldO), 2Y08 (Streptomyces sp. 307-9 TamL), 3D2H (Eschscholzia californica BBE), 3JS8 
(Chromobacterium sp. DS-1 ChoX), 3RJ8 (Microdochium nivale lactose oxidase) and 3TSH 
(Phleum pratense Phl p 4). Subsequently, three sequences, GilR from Streptomyces griseoflavus, 
CndG from Chondromyces crocatus and FeeG from an unkown source organism, were added 
to the alignment using the MAFFT version 7 webserver (149). Subsequently, a phylogenetic 
tree was constructed using the phylogeny.fr webserver’s BioNJ function (150). The iTOL 
webserver was used for tree visualisation (151).  
Acknowledgements 
This work was supported by the European Union through the INDOX project (FP7-KBBE-
2013-7-613549). 
References 
1.  Macheroux, P., Kappes, B., and Ealick, S. E. (2011) Flavogenomics: A genomic and structural 
view of flavin-dependent proteins. FEBS J. 278, 2625–2634 
2.  Lienhart, W.-D., Gudipati, V., and Macheroux, P. (2013) The human flavoproteome. Arch. 
Biochem. Biophys. 535, 150–162 
3.  Fraaije, M. W., and Mattevi, A. (2000) Flavoenzymes: Diverse catalysts with recurrent features. 
Trends Biochem. Sci. 25, 126–132 
4.  Joosten, V., and van Berkel, W. J. H. (2007) Flavoenzymes. Curr. Opin. Chem. Biol. 11, 195–202 
5.  Leys, D., and Scrutton, N. S. (2016) Sweating the assets of flavin cofactors: New insight of 
chemical versatility from knowledge of structure and mechanism. Curr. Opin. Struct. Biol. 41, 
19–26 
6.  Piano, V., Palfey, B. A., and Mattevi, A. (2017) Flavins as covalent catalysts: New mechanisms 
emerge. Trends Biochem. Sci. 42, 457–469 
7.  Fraaije, M. W., van Berkel, W. J. H., Benen, J. A. E., Visser, J., and Mattevi, A. (1998) A novel 
oxidoreductase family sharing a conserved FAD-binding domain. Trends Biochem. Sci. 23, 206–
207 
8.  Leferink, N. G. H., Heuts, D. P. H. M., Fraaije, M. W., and van Berkel, W. J. H. (2008) The growing 
VAO flavoprotein family. Arch. Biochem. Biophys. 474, 292–301 
9.  Mapson, L. W., and Breslow, E. (1958) Biological synthesis of ascorbic acid: L-Galactono-γ-
lactone dehydrogenase. Biochem. J. 68, 395–406 
10.  Wolucka, B. A., and Communi, D. (2006) Mycobacterium tuberculosis possesses a functional 
Chapter 2 
52 
 
enzyme for the synthesis of vitamin C, L-gulono-1,4-lactone dehydrogenase. FEBS J. 273, 4435–
4445 
11.  Logan, F. J., Taylor, M. C., Wilkinson, S. R., Kaur, H., and Kelly, J. M. (2007) The terminal step in 
vitamin C biosynthesis in Trypanosoma cruzi is mediated by a FMN-dependent galactonolactone 
oxidase. Biochem. J. 407, 419–426 
12.  Liu, Y.-C., Li, Y.-S., Lyu, S.-Y., Hsu, L.-J., Chen, Y.-H., Huang, Y.-T., Chan, H.-C., Huang, C.-J., 
Chen, G.-H., Chou, C.-C., Tsai, M.-D., and Li, T.-L. (2011) Interception of teicoplanin oxidation 
intermediates yields new antimicrobial scaffolds. Nat. Chem. Biol. 7, 304–309 
13.  Kudryashova, E. V., Leferink, N. G. H., Slot, I. G. M., and van Berkel, W. J. H. (2011) 
Galactonolactone oxidoreductase from Trypanosoma cruzi employs a FAD cofactor for the 
synthesis of vitamin C. Biochim. Biophys. Acta - Proteins Proteomics. 1814, 545–552 
14.  Heuts, D. P. H. M., Scrutton, N. S., McIntire, W. S., and Fraaije, M. W. (2009) What’s in a covalent 
bond?: On the role and formation of covalently bound flavin cofactors. FEBS J. 276, 3405–3427 
15.  Winkler, A., Łyskowski, A., Riedl, S., Puhl, M., Kutchan, T. M., Macheroux, P., and Gruber, K. 
(2008) A concerted mechanism for berberine bridge enzyme. Nat. Chem. Biol. 4, 739–741 
16.  Taura, F., Sirikantaramas, S., Shoyama, Y., Yoshikai, K., Shoyama, Y., and Morimoto, S. (2007) 
Cannabidiolic-acid synthase, the chemotype-determining enzyme in the fiber-type Cannabis 
sativa. FEBS Lett. 581, 2929–2934 
17.  Gesell, A., Chávez, M. L. D., Kramell, R., Piotrowski, M., Macheroux, P., and Kutchan, T. M. 
(2011) Heterologous expression of two FAD-dependent oxidases with (S)-
tetrahydroprotoberberine oxidase activity from Argemone mexicana and Berberis wilsoniae in 
insect cells. Planta. 233, 1185–1197 
18.  Shoyama, Y., Tamada, T., Kurihara, K., Takeuchi, A., Taura, F., Arai, S., Blaber, M., Shoyama, Y., 
Morimoto, S., and Kuroki, R. (2012) Structure and function of Δ1-tetrahydrocannabinolic acid 
(THCA) synthase, the enzyme controlling the psychoactivity of Cannabis sativa. J. Mol. Biol. 423, 
96–105 
19.  Kim, Y.-T., Lee, Y.-R., Jin, J., Han, K.-H., Kim, H., Kim, J.-C., Lee, T., Yun, S.-H., and Lee, Y.-W. 
(2005) Two different polyketide synthase genes are required for synthesis of zearalenone in 
Gibberella zeae. Mol. Microbiol. 58, 1102–1113 
20.  Kim, H. J., Pongdee, R., Wu, Q., Hong, L., and Liu, H.-W. (2007) The biosynthesis of spinosyn in 
Saccharopolyspora spinosa: Synthesis of the cross-bridging precursor and identification of the 
function of SpnJ. J. Am. Chem. Soc. 129, 14582–14584 
21.  Alexeev, I., Sultana, A., Mäntsälä, P., Niemi, J., and Schneider, G. (2007) Aclacinomycin 
oxidoreductase (AknOx) from the biosynthetic pathway of the antibiotic aclacinomycin is an 
unusual flavoenzyme with a dual active site. Proc. Natl. Acad. Sci. U. S. A. 104, 6170–6175 
22.  Kasahara, K., Miyamoto, T., Fujimoto, T., Oguri, H., Tokiwano, T., Oikawa, H., Ebizuka, Y., and 
Fujii, I. (2010) Solanapyrone synthase, a possible Diels-Alderase and iterative type I polyketide 
synthase encoded in a biosynthetic gene cluster from Alternaria solani. ChemBioChem. 11, 1245–
1252 
23.  Carlson, J. C., Li, S., Gunatilleke, S. S., Anzai, Y., Burr, D. A., Podust, L. M., and Sherman, D. H. 
(2011) Tirandamycin biosynthesis is mediated by co-dependent oxidative enzymes. Nat. Chem. 
3, 628–633 
24.  Noinaj, N., Bosserman, M. A., Schickli, M. A., Piszczek, G., Kharel, M. K., Pahari, P., Buchanan, 
S. K., and Rohr, J. (2011) The crystal structure and mechanism of an unusual oxidoreductase, 
GilR, involved in gilvocarcin V biosynthesis. J. Biol. Chem. 286, 23533–23543 
25.  Ragab, A. E., Grüschow, S., Tromans, D. R., and Goss, R. J. M. (2011) Biogenesis of the unique 
4′,5′-dehydronucleoside of the uridyl peptide antibiotic pacidamycin. J. Am. Chem. Soc. 133, 
15288–15291 
26.  Ishiuchi, K., Nakazawa, T., Yagishita, F., Mino, T., Noguchi, H., Hotta, K., and Watanabe, K. 
(2013) Combinatorial generation of complexity by redox enzymes in the chaetoglobosin A 
biosynthesis. J. Am. Chem. Soc. 135, 7371–7377 
The VAO/PCMH family 
53 
 
27.  Teufel, R., Miyanaga, A., Michaudel, Q., Stull, F., Louie, G., Noel, J. P., Baran, P. S., Palfey, B., 
and Moore, B. S. (2013) Flavin-mediated dual oxidation controls an enzymatic Favorskii-type 
rearrangement. Nature. 503, 552–556 
28.  Garcia, I., Vior, N. M., González-Sabín, J., Braña, A. F., Rohr, J., Moris, F., Méndez, C., and Salas, 
J. A. (2013) Engineering the biosynthesis of the polyketide-nonribosomal peptide collismycin A 
for generation of analogs with neuroprotective activity. Chem. Biol. 20, 1022–1032 
29.  Holm, D. K., Petersen, L. M., Klitgaard, A., Knudsen, P. B., Jarczynska, Z. D., Nielsen, K. F., 
Gotfredsen, C. H., Larsen, T. O., and Mortensen, U. H. (2014) Molecular and chemical 
characterization of the biosynthesis of the 6-MSA-derived meroterpenoid yanuthone D in 
Aspergillus niger. Chem. Biol. 21, 519–529 
30.  Zhu, Y., Picard, M.-È., Zhang, Q., Barma, J., Després, X. M., Mei, X., Zhang, L., Duvignaud, J.-B., 
Couture, M., Zhu, W., Shi, R., and Zhang, C. (2016) Flavoenzyme CrmK-mediated substrate 
recycling in caerulomycin biosynthesis. Chem. Sci. 7, 4867–4874 
31.  Xu, F., Golightly, E. J., Fuglsang, C. C., Schneider, P., Duke, K. R., Lam, L., Christensen, S., Brown, 
K. M., Jørgensen, C. T., and Brown, S. H. (2001) A novel carbohydrate:acceptor oxidoreductase 
from Microdochium nivale. Eur. J. Biochem. 268, 1136–1142 
32.  Custers, J. H. H. V., Harrison, S. J., Sela-Buurlage, M. B., van Deventer, E., Lageweg, W., Howe, 
P. W., van der Meijs, P. J., Ponstein, A. S., Simons, B. H., Melchers, L. S., and Stuiver, M. H. (2004) 
Isolation and characterisation of a class of carbohydrate oxidases from higher plants, with a role 
in active defence. Plant J. 39, 147–160 
33.  Huang, C.-H., Lai, W.-L., Lee, M.-H., Chen, C.-J., Vasella, A., Tsai, Y.-C., and Liaw, S.-H. (2005) 
Crystal structure of glucooligosaccharide oxidase from Acremonium strictum: A novel 
flavinylation of 6-S-cysteinyl, 8α-N1-histidyl FAD. J. Biol. Chem. 280, 38831–38838 
34.  Rand, T., Qvist, K. B., Walter, C. P., and Poulsen, C. H. (2006) Characterization of the flavin 
association in hexose oxidase from Chondrus crispus. FEBS J. 273, 2693–2703 
35.  Heuts, D. P. H. M., Janssen, D. B., and Fraaije, M. W. (2007) Changing the substrate specificity 
of a chitooligosaccharide oxidase from Fusarium graminearum by model-inspired site-directed 
mutagenesis. FEBS Lett. 581, 4905–4909 
36.  Ferrari, A. R., Rozeboom, H. J., Dobruchowska, J. M., van Leeuwen, S. S., Vugts, A. S. C., Koetsier, 
M. J., Visser, J., and Fraaije, M. W. (2016) Discovery of a xylooligosaccharide oxidase from 
Myceliophthora thermophila C1. J. Biol. Chem. 291, 23709–23718 
37.  Teufel, R., Stull, F., Meehan, M. J., Michaudel, Q., Dorrestein, P. C., Palfey, B., and Moore, B. S. 
(2015) Biochemical establishment and characterization of EncM’s flavin-N5-oxide cofactor. J. Am. 
Chem. Soc. 137, 8078–8085 
38.  Adak, S., and Begley, T. P. (2016) Dibenzothiophene catabolism proceeds via a flavin-N5-oxide 
intermediate. J. Am. Chem. Soc. 138, 6424–6426 
39.  Daniel, B., Konrad, B., Toplak, M., Lahham, M., Messenlehner, J., Winkler, A., and Macheroux, 
P. (2017) The family of berberine bridge enzyme-like enzymes: A treasure-trove of oxidative 
reactions. Arch. Biochem. Biophys. 632, 88–103 
40.  Popelková, H., Fraaije, M. W., Novák, O., Frébortová, J., Bilyeu, K. D., and Frébort, I. (2006) 
Kinetic and chemical analyses of the cytokinin dehydrogenase-catalysed reaction: Correlations 
with the crystal structure. Biochem. J. 398, 113–124 
41.  Frébortová, J., Fraaije, M. W., Galuszka, P., Šebela, M., Peč, P., Hrbáč, J., Novák, O., Bilyeu, K. 
D., English, J. T., and Frébort, I. (2004) Catalytic reaction of cytokinin dehydrogenase: Preference 
for quinones as electron acceptors. Biochem. J. 380, 121–130 
42.  Frébortová, J., Novák, O., Frébort, I., and Jorda, R. (2010) Degradation of cytokinins by maize 
cytokinin dehydrogenase is mediated by free radicals generated by enzymatic oxidation of 
natural benzoxazinones. Plant J. 61, 467–481 
43.  Galuszka, P., Popelková, H., Werner, T., Frébortová, J., Pospíšilová, H., Mik, V., Köllmer, I., 
Schmülling, T., and Frébort, I. (2007) Biochemical characterization of cytokinin 
oxidases/dehydrogenases from Arabidopsis thaliana expressed in Nicotiana tabacum L. J. Plant 
Chapter 2 
54 
 
Growth Regul. 26, 255–267 
44.  Šmehilová, M., Galuszka, P., Bilyeu, K. D., Jaworek, P., Kowalska, M., Šebela, M., Sedlářová, M., 
English, J. T., and Frébort, I. (2009) Subcellular localization and biochemical comparison of 
cytosolic and secreted cytokinin dehydrogenase enzymes from maize. J. Exp. Bot. 60, 2701–2712 
45.  Gu, R., Fu, J., Guo, S., Duan, F., Wang, Z., Mi, G., and Yuan, L. (2010) Comparative expression 
and phylogenetic analysis of maize cytokinin dehydrogenase/oxidase (CKX) gene family. J. 
Plant Growth Regul. 29, 428–440 
46.  Kowalska, M., Galuszka, P., Frébortová, J., Šebela, M., Béres, T., Hluska, T., Šmehilová, M., 
Bilyeu, K. D., and Frébort, I. (2010) Vacuolar and cytosolic cytokinin dehydrogenases of 
Arabidopsis thaliana: Heterologous expression, purification and properties. Phytochemistry. 71, 
1970–1978 
47.  Zalabák, D., Galuszka, P., Mrízová, K., Podlešáková, K., Gu, R., and Frébortová, J. (2014) 
Biochemical characterization of the maize cytokinin dehydrogenase family and cytokinin 
profiling in developing maize plantlets in relation to the expression of cytokinin dehydrogenase 
genes. Plant Physiol. Biochem. 74, 283–293 
48.  Malito, E., Coda, A., Bilyeu, K. D., Fraaije, M. W., and Mattevi, A. (2004) Structures of Michaelis 
and product complexes of plant cytokinin dehydrogenase: Implications for flavoenzyme 
catalysis. J. Mol. Biol. 341, 1237–1249 
49.  Kopečný, D., Končitíková, R., Popelka, H., Briozzo, P., Vigouroux, A., Kopečná, M., Zalabák, D., 
Šebela, M., Skopalová, J., Frébort, I., and Moréra, S. (2016) Kinetic and structural investigation 
of the cytokinin oxidase/dehydrogenase active site. FEBS J. 283, 361–377 
50.  Benson, T. E., Marquardt, J. L., Marquardt, A. C., Etzkorn, F. A., and Walsh, C. T. (1993) 
Overexpression, purification, and mechanistic study of UDP-N-acetylenolpyruvylglucosamine 
reductase. Biochemistry. 32, 2024–2030 
51.  Benson, T. E., Walsh, C. T., and Hogle, J. M. (1996) The structure of the substrate-free form of 
MurB, an essential enzyme for the synthesis of bacterial cell walls. Structure. 4, 47–54 
52.  Chen, M. W., Lohkamp, B., Schnell, R., Lescar, J., and Schneider, G. (2013) Substrate channel 
flexibility in Pseudomonas aeruginosa MurB accommodates two distinct substrates. PLoS One. 8, 
e66936 
53.  Benson, T. E., Harris, M. S., Choi, G. H., Cialdella, J. I., Herberg, J. T., Martin, Jr., J. P., and 
Baldwin, E. T. (2001) A structural variation for MurB: X-ray crystal structure of Staphylococcus 
aureus UDP-N-acetylenolpyruvylglucosamine reductase (MurB). Biochemistry. 40, 2340–2350 
54.  Kim, M.-K., Cho, M. K., Song, H.-E., Kim, D., Park, B.-H., Lee, J. H., Kang, G. B., Kim, S. H., Im, 
Y. J., Lee, D.-S., and Eom, S. H. (2007) Crystal structure of UDP-N-
acetylenolpyruvylglucosamine reductase (MurB) from Thermus caldophilus. Proteins Struct. Funct. 
Bioinforma. 66, 751–754 
55.  Benson, T. E., Walsh, C. T., and Massey, V. (1997) Kinetic characterization of wild-type and 
S229A mutant MurB: Evidence for the role of Ser 229 as a general acid. Biochemistry. 36, 796–805 
56.  Naqvi, K. F., Patin, D., Wheatley, M. S., Savka, M. A., Dobson, R. C. J., Gan, H. M., Barreteau, H., 
Blanot, D., Mengin-Lecreulx, D., and Hudson, A. O. (2016) Identification and partial 
characterization of a novel UDP-N-acetylenolpyruvoylglucosamine reductase/UDP-N-
acetylmuramate:L-alanine ligase fusion enzyme from Verrucomicrobium spinosum DSM 4136T. 
Front. Microbiol. 7, 362 
57.  Hrast, M., Sosič, I., Šink, R., and Gobec, S. (2014) Inhibitors of the peptidoglycan biosynthesis 
enzymes MurA-F. Bioorg. Chem. 55, 2–15 
58.  Keat, M. J., and Hopper, D. J. (1978) p-Cresol and 3,5-xylenol methylhydroxylases in 
Pseudomonas putida N.C.I.B. 9869. Biochem. J. 175, 649–658 
59.  de Jong, E., van Berkel, W. J. H., van der Zwan, R. P., and de Bont, J. A. M. (1992) Purification 
and characterization of vanillyl-alcohol oxidase from Penicillium simplicissimum: A novel 
aromatic alcohol oxidase containing covalently bound FAD. Eur. J. Biochem. 208, 651–657 
60.  Priefert, H., Overhage, J., and Steinbüchel, A. (1999) Identification and molecular 
The VAO/PCMH family 
55 
 
characterization of the eugenol hydroxylase genes (ehyA/ehyB) of Pseudomonas sp. strain HR199. 
Arch. Microbiol. 172, 354–363 
61.  Brandt, K., Thewes, S., Overhage, J., Priefert, H., and Steinbüchel, A. (2001) Characterization of 
the eugenol hydroxylase genes (ehyA/ehyB) from the new eugenol-degrading Pseudomonas sp. 
strain OPS1. Appl. Microbiol. Biotechnol. 56, 724–730 
62.  Jin, J., Mazon, H., van den Heuvel, R. H. H., Janssen, D. B., and Fraaije, M. W. (2007) Discovery 
of a eugenol oxidase from Rhodococcus sp. strain RHA1. FEBS J. 274, 2311–2321 
63.  McIntire, W., Hopper, D. J., and Singer, T. P. (1985) p-Cresol methylhydroxylase: Assay and 
general properties. Biochem. J. 228, 325–335 
64.  Fraaije, M. W., Veeger, C., and van Berkel, W. J. H. (1995) Substrate specificity of flavin-
dependent vanillyl-alcohol oxidase from Penicillium simplicissimum: Evidence for the production 
of 4-hydroxycinnamyl alcohols from 4-allylphenols. Eur. J. Biochem. 234, 271–277 
65.  van den Heuvel, R. H. H., Fraaije, M. W., Laane, C., and van Berkel, W. J. H. (1998) Regio- and 
stereospecific conversion of 4-alkylphenols by the covalent flavoprotein vanillyl-alcohol oxidase. 
J. Bacteriol. 180, 5646–5651 
66.  Fraaije, M. W., and van Berkel, W. J. H. (1997) Catalytic mechanism of the oxidative 
demethylation of 4-(methoxymethyl)phenol by vanillyl-alcohol oxidase: Evidence for formation 
of a p-quinone methide intermediate. J. Biol. Chem. 272, 18111–18116 
67.  Fraaije, M. W., van den Heuvel, R. H. H., Roelofs, J. C. A. A., and van Berkel, W. J. H. (1998) 
Kinetic mechanism of vanillyl-alcohol oxidase with short-chain 4-alkylphenols. Eur. J. Biochem. 
253, 712–719 
68.  Fraaije, M. W., Pikkemaat, M., and van Berkel, W. J. H. (1997) Enigmatic gratuitous induction of 
the covalent flavoprotein vanillyl-alcohol oxidase in Penicillium simplicissimum. Appl. Environ. 
Microbiol. 63, 435–439 
69.  Mattevi, A., Fraaije, M. W., Mozzarelli, A., Olivi, L., Coda, A., and van Berkel, W. J. H. (1997) 
Crystal structures and inhibitor binding in the octameric flavoenzyme vanillyl-alcohol oxidase: 
The shape of the active-site cavity controls substrate specificity. Structure. 5, 907–920 
70.  Cunane, L. M., Chen, Z.-W., Shamala, N., Mathews, F. S., Cronin, C. N., and McIntire, W. S. 
(2000) Structures of the flavocytochrome p-cresol methylhydroxylase and its enzyme-substrate 
complex: Gated substrate entry and proton relays support the proposed catalytic mechanism. J. 
Mol. Biol. 295, 357–374 
71.  Nguyen, Q.-T., de Gonzalo, G., Binda, C., Rioz-Martínez, A., Mattevi, A., and Fraaije, M. W. 
(2016) Biocatalytic properties and structural analysis of eugenol oxidase from Rhodococcus jostii 
RHA1: A versatile oxidative biocatalyst. ChemBioChem. 17, 1359–1366 
72.  Ewing, T. A., Gygli, G., and van Berkel, W. J. H. (2016) A single loop is essential for the 
octamerization of vanillyl alcohol oxidase. FEBS J. 283, 2546–2559 
73.  Gygli, G., and van Berkel, W. J. H. (2017) Vanillyl alcohol oxidases produced in Komagataella 
phaffii contain a highly stable noncovalently bound anionic FAD semiquinone. Biocatalysis. 3, 17–
26 
74.  Brady, S. F., Chao, C. J., and Clardy, J. (2002) New natural product families from an 
environmental DNA (eDNA) gene cluster. J. Am. Chem. Soc. 124, 9968–9969 
75.  Rachid, S., Revermann, O., Dauth, C., Kazmaier, U., and Müller, R. (2010) Characterization of a 
novel type of oxidative decarboxylase involved in the biosynthesis of the styryl moiety of 
chondrochloren from an acylated tyrosine. J. Biol. Chem. 285, 12482–12489 
76.  Braverman, N. E., and Moser, A. B. (2012) Functions of plasmalogen lipids in health and disease. 
Biochim. Biophys. Acta - Mol. Basis Dis. 1822, 1442–1452 
77.  de Vet, E. C. J. M., Hilkes, Y. H. A., Fraaije, M. W., and van den Bosch, H. (2000) Alkyl-
dihydroxyacetonephosphate synthase: Presence and role of flavin adenine dinucleotide. J. Biol. 
Chem. 275, 6276–6283 
78.  Razeto, A., Mattiroli, F., Carpanelli, E., Aliverti, A., Pandini, V., Coda, A., and Mattevi, A. (2007) 
The crucial step in ether phospholipid biosynthesis: Structural basis of a noncanonical reaction 
Chapter 2 
56 
 
associated with a peroxisomal disorder. Structure. 15, 683–692 
79.  Nenci, S., Piano, V., Rosati, S., Aliverti, A., Pandini, V., Fraaije, M. W., Heck, A. J. R., Edmondson, 
D. E., and Mattevi, A. (2012) Precursor of ether phospholipids is synthesized by a flavoenzyme 
through covalent catalysis. Proc. Natl. Acad. Sci. U. S. A. 109, 18791–18796 
80.  Benjamin, D. I., Cozzo, A., Ji, X., Roberts, L. S., Louie, S. M., Mulvihill, M. M., Luo, K., and 
Nomura, D. K. (2013) Ether lipid generating enzyme AGPS alters the balance of structural and 
signaling lipids to fuel cancer pathogenicity. Proc. Natl. Acad. Sci. U. S. A. 110, 14912–14917 
81.  Piano, V., Benjamin, D. I., Valente, S., Nenci, S., Marrocco, B., Mai, A., Aliverti, A., Nomura, D. 
K., and Mattevi, A. (2015) Discovery of inhibitors for the ether lipid-generating enzyme AGPS 
as anti-cancer agents. ACS Chem. Biol. 10, 2589–2597 
82.  Futai, M. (1973) Membrane D-lactate dehydrogenase from Escherichia coli: Purification and 
properties. Biochemistry. 12, 2468–2474 
83.  Lodi, T., and Ferrero, I. (1993) Isolation of the DLD gene of Saccharomyces cerevisiae encoding the 
mitochondrial enzyme D-lactate ferricytochrome c oxidoreductase. Mol. Gen. Genet. 238, 315–324 
84.  Lodi, T., O’Connor, D., Goffrini, P., and Ferrero, I. (1994) Carbon catabolite repression in 
Kluyveromyces lactis: Isolation and characterization of the KIDLD gene encoding the 
mitochondrial enzyme D-lactate ferricytochrome c oxidoreductase. Mol. Gen. Genet. 244, 622–629 
85.  Reed, D. W., and Hartzell, P. L. (1999) The Archaeoglobus fulgidus D-lactate dehydrogenase is a 
Zn2+ flavoprotein. J. Bacteriol. 181, 7580–7587 
86.  Engqvist, M., Drincovich, M. F., Flügge, U.-I., and Maurino, V. G. (2009) Two D-2-hydroxy-acid 
dehydrogenases in Arabidopsis thaliana with catalytic capacities to participate in the last reactions 
of the methylglyoxal and β-oxidation pathways. J. Biol. Chem. 284, 25026–25037 
87.  Dym, O., Pratt, E. A., Ho, C., and Eisenberg, D. (2000) The crystal structure of D-lactate 
dehydrogenase, a peripheral membrane respiratory enzyme. Proc. Natl. Acad. Sci. U. S. A. 97, 
9413–9418 
88.  Achouri, Y., Noël, G., Vertommen, D., Rider, M. H., Veiga-da-Cunha, M., and van Schaftingen, 
E. (2004) Identification of a dehydrogenase acting on D-2-hydroxyglutarate. Biochem. J. 381, 35–
42 
89.  Struys, E. A., Salomons, G. S., Achouri, Y., van Schaftingen, E., Grosso, S., Craigen, W. J., 
Verhoeven, N. M., and Jakobs, C. (2005) Mutations in the D-2-hydroxyglutarate dehydrogenase 
gene cause D-2-hydroxyglutaric aciduria. Am. J. Hum. Genet. 76, 358–360 
90.  Becker-Kettern, J., Paczia, N., Conrotte, J.-F., Kay, D. P., Guignard, C., Jung, P. P., and Linster, 
C. L. (2016) Saccharomyces cerevisiae forms D-2-hydroxyglutarate and couples its degradation to 
D-lactate formation via a cytosolic transhydrogenase. J. Biol. Chem. 291, 6036–6058 
91.  Lord, J. M. (1972) Glycolate oxidoreductase in Escherichia coli. Biochim. Biophys. Acta - Bioenerg. 
267, 227–237 
92.  Pellicer, M.-T., Badía, J., Aguilar, J., and Baldomà, L. (1996) glc Locus of Escherichia coli: 
Characterization of genes encoding the subunits of glycolate oxidase and the glc regulator 
protein. J. Bacteriol. 178, 2051–2059 
93.  Waterham, H. R., Koster, J., Romeijn, G. J., Hennekam, R. C. M., Vreken, P., Andersson, H. C., 
Fitzpatrick, D. R., Kelley, R. I., and Wanders, R. J. A. (2001) Mutations in the 3β-hydroxysterol 
Δ24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol 
biosynthesis. Am. J. Hum. Genet. 69, 685–694 
94.  Ciufo, L. F., Murray, P. A., Thompson, A., Rigden, D. J., and Rees, H. H. (2011) Characterisation 
of a desmosterol reductase involved in phytosterol dealkylation in the silkworm, Bombyx mori. 
PLoS One. 6, e21316 
95.  Klahre, U., Noguchi, T., Fujioka, S., Takatsuto, S., Yokota, T., Nomura, T., Yoshida, S., and Chua, 
N.-H. (1998) The Arabidopsis DIMINUTO/DWARF1 gene encodes a protein involved in steroid 
synthesis. Plant Cell. 10, 1677–1690 
96.  Hong, Z., Ueguchi-Tanaka, M., Fujioka, S., Takatsuto, S., Yoshida, S., Hasegawa, Y., Ashikari, M., 
Kitano, H., and Matsuoka, M. (2005) The rice brassinosteroid-deficient dwarf2 mutant, defective in 
The VAO/PCMH family 
57 
 
the rice homolog of Arabidopsis DIMINUTO/DWARF1, is rescued by the endogenously 
accumulated alternative bioactive brassinosteroid, dolichosterone. Plant Cell. 17, 2243–2254 
97.  Tsukagoshi, Y., Suzuki, H., Seki, H., Muranaka, T., Ohyama, K., and Fujimoto, Y. (2016) Ajuga 
Δ24-sterol reductase catalyzes the direct reductive conversion of 24-methylenecholesterol to 
campesterol. J. Biol. Chem. 291, 8189–8198 
98.  Sawai, S., Ohyama, K., Yasumoto, S., Seki, H., Sakuma, T., Yamamoto, T., Takebayashi, Y., Kojima, 
M., Sakakibara, H., Aoki, T., Muranaka, T., Saito, K., and Umemoto, N. (2014) Sterol side chain 
reductase 2 is a key enzyme in the biosynthesis of cholesterol, the common precursor of toxic 
steroidal glycoalkaloids in potato. Plant Cell. 26, 3763–3774 
99.  Pedretti, A., Bocci, E., Maggi, R., and Vistoli, G. (2008) Homology modelling of human DHCR24 
(seladin-1) and analysis of its binding properties through molecular docking and dynamics 
simulations. Steroids. 73, 708–719 
100.  Lu, X., Li, Y., Liu, J., Cao, X., Wang, X., Wang, D., Seo, H., and Gao, B. (2012) The membrane 
topological analysis of 3β-hydroxysteroid-Δ24 reductase (DHCR24) on endoplasmic reticulum. 
J. Mol. Endocrinol. 48, 1–9 
101.  Zerenturk, E. J., Sharpe, L. J., and Brown, A. J. (2014) DHCR24 associates strongly with the 
endoplasmic reticulum beyond predicted membrane domains: Implications for the activities of 
this multi-functional enzyme. Biosci. Rep. 34, 107–117 
102.  Mikušová, K., Huang, H., Yagi, T., Holsters, M., Vereecke, D., D’Haeze, W., Scherman, M. S., 
Brennan, P. J., McNeil, M. R., and Crick, D. C. (2005) Decaprenylphosphoryl arabinofuranose, 
the donor of the D-arabinofuranosyl residues of mycobacterial arabinan, is formed via a two-
step epimerization of decaprenylphosphoryl ribose. J. Bacteriol. 187, 8020–8025 
103.  Crellin, P. K., Brammananth, R., and Coppel, R. L. (2011) Decaprenylphosphoryl-β-D-ribose 2′-
epimerase, the target of benzothiazinones and dinitrobenzamides, is an essential enzyme in 
Mycobacterium smegmatis. PLoS One. 6, e16869 
104.  Trefzer, C., Škovierová, H., Buroni, S., Bobovská, A., Nenci, S., Molteni, E., Pojer, F., Pasca, M. 
R., Makarov, V., Cole, S. T., Riccardi, G., Mikušová, K., and Johnsson, K. (2012) Benzothiazinones 
are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-D-ribofuranose 2′-oxidase 
DprE1. J. Am. Chem. Soc. 134, 912–915 
105.  Neres, J., Pojer, F., Molteni, E., Chiarelli, L. R., Dhar, N., Boy-Röttger, S., Buroni, S., Fullam, E., 
Degiacomi, G., Lucarelli, A. P., Read, R. J., Zanoni, G., Edmondson, D. E., De Rossi, E., Pasca, M. 
R., McKinney, J. D., Dyson, P. J., Riccardi, G., Mattevi, A., Cole, S. T., and Binda, C. (2012) 
Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis. Sci. Transl. 
Med. 4, 150ra121 
106.  Piton, J., Foo, C. S.-Y., and Cole, S. T. (2017) Structural studies of Mycobacterium tuberculosis 
DprE1 interacting with its inhibitors. Drug Discov. Today. 22, 526–533 
107.  Trefzer, C., Rengifo-Gonzalez, M., Hinner, M. J., Schneider, P., Makarov, V., Cole, S. T., and 
Johnsson, K. (2010) Benzothiazinones: Prodrugs that covalently modify the 
decaprenylphosphoryl-β-D-ribose 2′-epimerase DprE1 of Mycobacterium tuberculosis. J. Am. Chem. 
Soc. 132, 13663–13665 
108.  Batt, S. M., Jabeen, T., Bhowruth, V., Quill, L., Lund, P. A., Eggeling, L., Alderwick, L. J., Fütterer, 
K., and Besra, G. S. (2012) Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by 
benzothiazinone inhibitors. Proc. Natl. Acad. Sci. U. S. A. 109, 11354–11359 
109.  Leferink, N. G. H., and van Berkel, W. J. H. (2014) Aldonolactone oxidoreductases. In: Flavins 
and Flavoproteins: Methods and Protocols (Weber, S., and Schleicher, E. eds.), Methods Mol. Biol. vol. 
1146, pp. 95-111  
110.  Aboobucker, S. I., and Lorence, A. (2016) Recent progress on the characterization of 
aldonolactone oxidoreductases. Plant Physiol. Biochem. 98, 171–185 
111.  Nishikimi, M., Tolbert, B. M., and Udenfriend, S. (1976) Purification and characterization of L-
gulono-γ-lactone oxidase from rat and goat liver. Arch. Biochem. Biophys. 175, 427–435 
112.  Kiuchi, K., Nishikimi, M., and Yagi, K. (1982) Purification and characterization of L-
Chapter 2 
58 
 
gulonolactone oxidase from chicken kidney microsomes. Biochemistry. 21, 5076–5082 
113.  Østergaard, J., Persiau, G., Davey, M. W., Bauw, G., and van Montagu, M. (1997) Isolation of a 
cDNA coding for L-galactono-γ-lactone dehydrogenase, an enzyme involved in the biosynthesis 
of ascorbic acid in plants: Purification, characterization, cDNA cloning, and expression in yeast. 
J. Biol. Chem. 272, 30009–30016 
114.  Imai, T., Karita, S., Shiratori, G., Hattori, M., Nunome, T., Ôba, K., and Hirai, M. (1998) L-
Galactono-γ-lactone dehydrogenase from sweet potato: Purification and cDNA sequence 
analysis. Plant Cell Physiol. 39, 1350–1358 
115.  Yabuta, Y., Yoshimura, K., Takeda, T., and Shigeoka, S. (2000) Molecular characterization of 
tobacco mitochondrial L-galactono-γ-lactone dehydrogenase and its expression in Escherichia 
coli. Plant Cell Physiol. 41, 666–675 
116.  Leferink, N. G. H., van den Berg, W. A. M., and van Berkel, W. J. H. (2008) L-Galactono-γ-lactone 
dehydrogenase from Arabidopsis thaliana, a flavoprotein involved in vitamin C biosynthesis. 
FEBS J. 275, 713–726 
117.  Takahashi, T., Yamashita, H., Kato, E., Mitsumoto, M., and Murakawa, S. (1976) Purification and 
some properties of D-glucono-γ-lactone dehydrogenase: D-Erythorbic acid producing enzyme 
of Penicillium cyaneo-fulvum. Agric. Biol. Chem. 40, 121–129 
118.  Huh, W.-K., Kim, S.-T., Yang, K.-S., Seok, Y.-J., Hah, Y. C., and Kang, S.-O. (1994) 
Characterisation of D-arabinono-1,4-lactone oxidase from Candida albicans ATCC 10231. Eur. J. 
Biochem. 225, 1073–1079 
119.  Huh, W.-K., Lee, B.-H., Kim, S.-T., Kim, Y.-R., Rhie, G.-E., Baek, Y.-W., Hwang, C.-S., Lee, J.-S., 
and Kang, S.-O. (1998) D-Erythroascorbic acid is an important antioxidant molecule in 
Saccharomyces cerevisiae. Mol. Microbiol. 30, 895–903 
120.  Salusjärvi, T., Kalkkinen, N., and Miasnikov, A. N. (2004) Cloning and characterization of 
gluconolactone oxidase of Penicillium cyaneo-fulvum ATCC 10431 and evaluation of its use for 
production of D-erythorbic acid in recombinant Pichia pastoris. Appl. Environ. Microbiol. 70, 5503–
5510 
121.  Wilkinson, S. R., Prathalingam, S. R., Taylor, M. C., Horn, D., and Kelly, J. M. (2005) Vitamin C 
biosynthesis in trypanosomes: A role for the glycosome. Proc. Natl. Acad. Sci. U. S. A. 102, 11645–
11650 
122.  Biyani, N., and Madhubala, R. (2011) Leishmania donovani encodes a functional enzyme involved 
in vitamin c biosynthesis: Arabino-1,4-lactone oxidase. Mol. Biochem. Parasitol. 180, 76–85 
123.  Leferink, N. G. H., Fraaije, M. W., Joosten, H.-J., Schaap, P. J., Mattevi, A., and van Berkel, W. J. 
H. (2009) Identification of a gatekeeper residue that prevents dehydrogenases from acting as 
oxidases. J. Biol. Chem. 284, 4392–4397 
124.  Kenney, W. C., Edmondson, D. E., Singer, T. P., Nakagawa, H., Asano, A., and Sato, R. (1976) 
Identification of the covalently bound flavin of L-gulono-γ-lactone oxidase. Biochem. Biophys. Res. 
Commun. 71, 1194–1200 
125.  Kenney, W. C., Edmondson, D. E., Singer, T. P., Nishikimi, M., Noguchi, E., and Yagi, K. (1979) 
Identification of the covalently-bound flavin of L-galactonolactone oxidase from yeast. FEBS Lett. 
97, 40–42 
126.  Harada, Y., Shimizu, M., Murakawa, S., and Takahashi, T. (1979) Identification of FAD of D-
gluconolactone dehydrogenase: D-Erythorbic acid producing enzyme of Penicillium cyaneo-
fulvum. Agric. Biol. Chem. 43, 2635–2636 
127.  Hiraga, K., Eto, T., Yoshioka, I., and Oda, K. (1998) Molecular cloning and expression of a gene 
encoding a novel sorbitol oxidase from Streptomyces sp. H-7775. Biosci. Biotechnol. Biochem. 62, 
347–353 
128.  Yamashita, M., Omura, H., Okamoto, E., Furuya, Y., Yabuuchi, M., Fukahi, K., and Murooka, Y. 
(2000) Isolation, characterization, and molecular cloning of a thermostable xylitol oxidase from 
Streptomyces sp. IKD472. J. Biosci. Bioeng. 89, 350–360 
129.  Heuts, D. P. H. M., van Hellemond, E. W., Janssen, D. B., and Fraaije, M. W. (2007) Discovery, 
The VAO/PCMH family 
59 
 
characterization, and kinetic analysis of an alditol oxidase from Streptomyces coelicolor. J. Biol. 
Chem. 282, 20283–20291 
130.  Winter, R. T., Heuts, D. P. H. M., Rijpkema, E. M. A., van Bloois, E., Wijma, H. J., and Fraaije, M. 
W. (2012) Hot or not? Discovery and characterization of a thermostable alditol oxidase from 
Acidothermus cellulolyticus 11B. Appl. Microbiol. Biotechnol. 95, 389–403 
131.  Forneris, F., Heuts, D. P. H. M., Delvecchio, M., Rovida, S., Fraaije, M. W., and Mattevi, A. (2008) 
Structural analysis of the catalytic mechanism and stereoselectivity in Streptomyces coelicolor 
alditol oxidase. Biochemistry. 47, 978–985 
132.  Baron, R., Riley, C., Chenprakhon, P., Thotsaporn, K., Winter, R. T., Alfieri, A., Forneris, F., van 
Berkel, W. J. H., Chaiyen, P., Fraaije, M. W., Mattevi, A., and McCammon, J. A. (2009) Multiple 
pathways guide oxygen diffusion into flavoenzyme active sites. Proc. Natl. Acad. Sci. U. S. A. 106, 
10603–10608 
133.  Ewing, T. A., Dijkman, W. P., Vervoort, J. M., Fraaije, M. W., and van Berkel, W. J. H. (2014) The 
oxidation of thiols by flavoprotein oxidases: A biocatalytic route to reactive thiocarbonyls. 
Angew. Chem. Int. Ed. 53, 13206–13209 
134.  Doukyu, N. (2009) Characteristics and biotechnological applications of microbial cholesterol 
oxidases. Appl. Microbiol. Biotechnol. 83, 825–837 
135.  Gadda, G., Wels, G., Pollegioni, L., Zucchelli, S., Ambrosius, D., Pilone, M. S., and Ghisla, S. 
(1997) Characterization of cholesterol oxidase from Streptomyces hygroscopicus and 
Brevibacterium sterolicum. Eur. J. Biochem. 250, 369–376 
136.  Doukyu, N., and Aono, R. (2001) Cloning, sequence analysis and expression of a gene encoding 
an organic solvent- and detergent-tolerant cholesterol oxidase of Burkholderia cepacia strain ST-
200. Appl. Microbiol. Biotechnol. 57, 146–152 
137.  Doukyu, N., Shibata, K., Ogino, H., and Sagermann, M. (2008) Purification and characterization 
of Chromobacterium sp. DS-1 cholesterol oxidase with thermal, organic solvent, and detergent 
tolerance. Appl. Microbiol. Biotechnol. 80, 59–70 
138.  Fernández de las Heras, L., Mascaraque, V., García Fernández, E., Navarro-Llorens, J. M., Perera, 
J., and Drzyzga, O. (2011) ChoG is the main inducible extracellular cholesterol oxidase of 
Rhodococcus sp. strain CECT3014. Microbiol. Res. 166, 403–418 
139.  Fernández de las Heras, L., Perera, J., and Navarro Llorens, J. M. (2014) Cholesterol to 
cholestenone oxidation by ChoG, the main extracellular cholesterol oxidase of Rhodococcus ruber 
strain Chol-4. J. Steroid Biochem. Mol. Biol. 139, 33–34 
140.  Doukyu, N., and Nihei, S. (2015) Cholesterol oxidase with high catalytic activity from 
Pseudomonas aeruginosa: Screening, molecular genetic analysis, expression and characterization. 
J. Biosci. Bioeng. 120, 24–30 
141.  Doukyu, N., and Aono, R. (1999) Two moles of O2 consumption and one mole of H2O2 formation 
during cholesterol peroxidation with cholesterol oxidase from Pseudomonas sp. strain ST-200. 
Biochem. J. 341, 621–627 
142.  Sampson, N. S., and Kass, I. J. (1997) Isomerization, but not oxidation, is suppressed by a single 
point mutation, E361Q, in the reaction catalyzed by cholesterol oxidase. J. Am. Chem. Soc. 119, 
855–862 
143.  Coulombe, R., Yue, K. Q., Ghisla, S., and Vrielink, A. (2001) Oxygen access to the active site of 
cholesterol oxidase through a narrow channel is gated by an Arg-Glu pair. J. Biol. Chem. 276, 
30435–30441 
144.  Sagermann, M., Ohtaki, A., Newton, K., and Doukyu, N. (2010) Structural characterization of 
the organic solvent-stable cholesterol oxidase from Chromobacterium sp. DS-1. J. Struct. Biol. 170, 
32–40 
145.  Jiang, T., Guo, X., Yan, J., Zhang, Y., Wang, Y., Zhang, M., Sheng, B., Ma, C., Xu, P., and Gao, C. 
(2017) A bacterial multidomain NAD-independent D-lactate dehydrogenase utilizes flavin 
adenine dinucleotide and Fe-S clusters as cofactors and quinone as an electron acceptor for D-
lactate oxidization. J. Bacteriol. 199, e00342–17 
Chapter 2 
60 
 
146.  Iijima, M., Munakata, R., Takahashi, H., Kenmoku, H., Nakagawa, R., Kodama, T., Asakawa, Y., 
Abe, I., Yazaki, K., Kurosaki, F., and Taura, F. (2017) Identification and characterization of 
daurichromenic acid synthase active in anti-HIV biosynthesis. Plant Physiol. 174, 2213–2230 
147.  Eniyan, K., Dharavath, S., Vijayan, R., Bajpai, U., and Gourinath, S. (2018) Crystal structure of 
UDP-N-acetylglucosamine-enolpyruvate reductase (MurB) from Mycobacterium tuberculosis. 
Biochim. Biophys. Acta - Proteins Proteomics. 1866, 397–406 
148.  Pei, J., Kim, B.-H., and Grishin, N. V. (2008) PROMALS3D: A tool for multiple protein sequence 
and structure alignments. Nucleic Acids Res. 36, 2295–2300 
149.  Katoh, K., and Frith, M. C. (2012) Adding unaligned sequences into an existing alignment using 
MAFFT and LAST. Bioinformatics. 28, 3144–3146 
150.  Dereeper, A., Guignon, V., Blanc, G., Audic, S., Buffet, S., Chevenet, F., Dufayard, J.-F., Guindon, 
S., Lefort, V., Lescot, M., Claverie, J. M., and Gascuel, O. (2008) Phylogeny.fr: Robust 
phylogenetic analysis for the non-specialist. Nucleic Acids Res. 36, W465-469 
151.  Letunic, I., and Bork, P. (2011) Interactive Tree Of Life v2: Online annotation and display of 
phylogenetic trees made easy. Nucleic Acids Res. 39, W475-478 
 
Abbreviations 
4PO: 4-phenol oxidising, ADPS: alkyl-dihydroxyacetone phosphate synthase, AldO: alditol oxidase, 
ALO: D-arabinono-1,4-lactone oxidase, BBE: berberine bridge enzyme, ChoX: cholesterol oxidase, CKX: 
cytokinin dehydrogenase, D2HGDH: D-2-hydroxyglutarate dehydrogenase, DCPIP: 2,6-
dichlorophenolindophenol, DHAP: dihydroxyacetone phosphate, DHCR24: 24-dehydrocholesterol 
reductase, DLDH: D-lactate dehydrogenase, DPA: decaprenylphosphoryl-β-D-arabinofuranose, DPR: 
decaprenylphosphoryl-β-D-ribofuranose, DPX: decaprenylphosphoryl-2-keto-β-D-erythro-
pentofuranose, EUGH: eugenol hydroxylase, EUGO: eugenol oxidase, FAD: flavin adenine 
dinucleotide, FMN: flavin mononucleotide, GALDH: L-galactono-1,4-lactone dehydrogenase, GALO: 
L-galactono-1,4-lactone oxidoreductase, GLO: D-glucono-1,4-lactone oxidase, GMC: glucose-methanol-
choline, GUDH: L-gulono-1,4-lactone dehydrogenase, GUO: L-gulono-1,4-lactone oxidase, NAD(P)H: 
nicotinamide adenine dinucleotide (phosphate), PCMH: para-cresol methylhydroxylase, SSR: sterol 
side chain reductase, UDP-GlcNAc-EP: uridine diphosphate-N-acetylglucosamine enolpyruvate, UDP-
MurNAc: uridine diphosphate-N-acetylmuramic acid, VAO: vanillyl alcohol oxidase
  
  
  
 
  
  
 
3 
 
A single loop is essential for the octamerisation of  
vanillyl alcohol oxidase 
Tom A. Ewing, Gudrun Gygli and Willem J. H. van Berkel 
Laboratory of Biochemistry, Wageningen University & Research, Wageningen, The Netherlands 
 
Based on FEBS Journal (2016), 283, 2546-2559
Summary 
The VAO/PCMH family of flavoenzymes is a family of structurally related proteins that 
catalyse a wide range of reactions. It contains a subfamily of enzymes that catalyse the 
oxidation of para-substituted phenols (the 4PO subfamily). Among others, this subfamily 
contains the oxidases vanillyl alcohol oxidase (VAO) and eugenol oxidase (EUGO) and the 
flavocytochrome dehydrogenases para-cresol methylhydroxylase (PCMH) and eugenol 
hydroxylase (EUGH). Although they catalyse similar reactions, these enzymes differ in terms 
of their electron acceptor preference and oligomerisation state. For example, VAO forms 
homo-octamers that can be described as tetramers of stable dimers, whereas EUGO is 
exclusively dimeric in solution. A possible explanation for this difference is the presence of a 
loop at the dimer-dimer interface in VAO that is not present in EUGO. Here, the role played 
by this loop in determining the quaternary structure of these enzymes is investigated. A VAO 
variant where the loop was deleted, loopless VAO, exclusively formed dimers. However, 
introduction of the loop into EUGO was not sufficient to induce its octamerisation. Neither 
variant displayed major changes in its catalytic properties as compared to the wild-type 
enzyme. Bioinformatic analysis revealed that the presence of the loop is conserved within 
putative fungal oxidases of the 4PO subfamily, but it is never found in putative bacterial 
oxidases or dehydrogenases. Our results shed light on the molecular mechanism of homo-
oligomerisation of VAO and the importance of oligomerisation for its enzymatic function. 
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Introduction 
Homo-oligomerisation of proteins is often of great importance for their function, e.g. by 
allowing the formation of novel binding sites at the oligomerisation interface, enabling or 
preventing interactions with other proteins, allosterically modulating enzymatic activity or 
promoting structural stability (1, 2). Evolutionary mechanisms by which homo-
oligomerisation can be achieved include domain swapping, the introduction of structural 
oligomerisation motifs (e.g. coiled-coils) and amino acid substitutions, insertions or deletions 
at the interface region. Bioinformatic analyses have revealed that the deletion or insertion of 
loops at the oligomerisation interface is a common mechanism by which homologous proteins 
can obtain different oligomerisation states (3, 4). Here, we investigate the role of such a loop 
region in determining the oligomeric state of two flavin-dependent oxidases from the 
VAO/PCMH flavoprotein family: vanillyl alcohol oxidase (VAO, EC 1.1.3.38) from Penicillium 
simplicissimum and eugenol oxidase (EUGO) from Rhodococcus jostii RHA1. 
The VAO/PCMH flavoprotein family is a group of structurally related flavoenzymes that 
catalyse a wide range of reactions (5, 6, Chapter 2). Members of the family share a two-domain 
structure composed of a conserved flavin-binding domain and a variable substrate-binding 
domain. Phylogenetic analysis of the VAO/PCMH family revealed that it contains a subfamily 
of related enzymes that all catalyse the oxidation of para-substituted phenolic compounds at 
the Cα position of their sidechain, the 4-phenol oxidising (4PO) subfamily (6, Chapter 2). 
Characterised members of the 4PO subfamily include vanillyl alcohol oxidase (VAO) from 
Penicillium simplicissimum, eugenol oxidase (EUGO) from Rhodococcus jostii RHA1, para-cresol 
methylhydroxylase (PCMH) from Pseudomonas putida and eugenol hydroxylase (EUGH) from 
Pseudomonas sp. OPS1 and HR199. Although these enzymes all catalyse the oxidation of para-
substituted phenols, they differ significantly in terms of their substrate specificity and 
quaternary structures. 
VAO is a 560 amino acid (64 kDa) protein from the fungus Penicillium simplicissimum (7). It 
displays the broadest substrate scope of the 4PO subfamily members, catalysing the oxidation 
of benzylic alcohols and amines, the demethylation of 4-(methoxymethyl)phenol, the 
hydroxylation of 4-allylphenols and the hydroxylation or dehydrogenation of 4-alkylphenols 
(8, 9). Reoxidation of the flavin cofactor occurs through its reaction with molecular oxygen, 
which is converted to hydrogen peroxide. The crystal structure of VAO reveals that it forms 
homo-octameric structures that can be described as tetramers of stable dimers (10). In solution, 
VAO constitutes an equilibrium of octamers and dimers, with the octameric form 
predominating and both forms being catalytically active (11). VAO contains an FAD cofactor 
that is covalently linked to the protein through an 8α-N3--histidyl-FAD bond. Binding of FAD 
or ADP stimulates the octamerisation of the enzyme, suggesting that cofactor binding conveys 
subtle conformational changes to the protein’s surface that stabilise the octameric form of the 
protein (12, 13). 
EUGO is a 526 amino acid (59 kDa) enzyme from Rhodococcus jostii RHA1 that shares 45% 
sequence identity with VAO (14). Like VAO, EUGO contains an 8α-N3-histidyl-bound FAD 
cofactor and oxidises a range of para-substituted phenolic compounds with molecular oxygen 
acting as the final electron acceptor (15). However, it displays a number of interesting 
differences with VAO in terms of its substrate specificity. For example, the catalytic efficiency  
Chapter 3 
66 
 
 
Figure 1: Structures of VAO and PCMH. (A) Cartoon representation of the structure of a VAO octamer 
showing the prominent role played by the dimer-dimer interacting loop in forming the dimer-dimer 
interface. The FAD-binding domain is shown in green, the substrate-binding domain in red, the dimer-
dimer interacting loop in blue and the FAD cofactor as yellow sticks. (B) Surface representation of the 
structure of a VAO homo-octamer with a PCMH hetero-tetramer (two flavoprotein and two 
cytochrome subunits) aligned to one dimer of the VAO octamer. This displays the prominent role 
played by the dimer-dimer interacting loop at the dimer-dimer interface of VAO and the position that 
the cytochrome subunit of PCMH would occupy in a VAO octamer. The flavoprotein subunits of 
PCMH are shown in cyan and the cytochrome subunits are shown in red. The VAO dimer to which the 
flavoprotein subunits of PCMH are aligned is shown in green with the dimer-dimer interacting loop 
shown in blue. The other VAO dimers are shown in yellow with the dimer-dimer interacting loops in 
orange. In the left panel, the octamer is positioned as in A, in the right panel it is rotated 90° out of the 
plane. The VAO and PCMH structures were downloaded from the PDB website (PDB IDs: 1VAO and 
1WVE respectively). The figure was prepared using PyMOL (Schrödinger LLC, New York, NY, USA). 
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of the oxidation of vanillyl alcohol (4-hydroxy-3-methoxybenzyl alcohol) by EUGO is 
significantly higher than that of VAO, while 4-(methoxymethyl)phenol is hardly accepted as 
a substrate by EUGO. Another remarkable difference between the two enzymes lies in their 
oligomerisation state. In contrast to the octameric VAO, EUGO is exclusively dimeric in 
solution (14). The crystal structure of EUGO revealed that it forms dimers that, in terms of 
their global fold, are highly similar to VAO dimers (15). 
PCMH from Pseudomonas putida is a flavocytochrome that catalyses the hydroxylation of 
short-chain 4-alkylphenols and the oxidation of 4-hydroxybenzyl alcohols (16, 17). PCMH is 
a heterotetramer composed of two 59 kDa flavoprotein subunits and two 9 kDa cytochrome c 
subunits. The flavoprotein subunits each contain an FAD cofactor, which is covalently bound 
to the protein through an 8α-O-tyrosyl-FAD bond, and form dimers which are structurally 
similar to VAO dimers (19, 20). Unlike VAO and EUGO, PCMH cannot utilise molecular 
oxygen as an electron acceptor, instead requiring the addition of external electron acceptors. 
EUGH is not as well-studied as the enzymes described above. EUGH genes have been 
identified in Pseudomonas sp. HR199 and OPS1 (21, 22). Based on genetic evidence, both 
enzymes were proposed to be flavocytochromes that catalyse the oxidation of eugenol to 
coniferyl alcohol, but neither has been characterised further. However, a eugenol 
dehydrogenase has been purified from Pseudomonas fluorescens E118 and N-terminal 
sequencing of the protein revealed that it displays sequence similarity to the eugenol 
hydroxylases mentioned above (23). The purified enzyme was reported to form heterodimers 
composed of a 58 kDa flavoprotein subunit and a 10 kDa cytochrome subunit. It oxidises 
eugenol, 4-alkylphenols and 4-hydroxybenzyl alcohols, relying on the addition of an external 
electron acceptor for activity. Like PCMH, the flavoprotein subunit of EUGH is predicted to 
contain an 8α-O-tyrosyl-FAD cofactor. 
One of the striking differences between the members of the 4PO subfamily is the 
oligomerisation state of their flavoprotein subunits. Comparison of the crystal structures of  
VAO, EUGO and PCMH provides a potential explanation for these differences.  In octameric 
VAO, a large proportion of the dimer-dimer interface is formed by a loop consisting of 
residues 220-235 (Fig. 1). Contacts involving this dimer-dimer interacting loop are responsible 
for 42% of the solvent accessible surface area that is buried at the dimer-dimer interface, as 
calculated using the PDBePISA webserver (24). Such a loop is not present in EUGO or the 
flavoprotein subunit of PCMH. Thus, the presence of the dimer-dimer interacting loop may 
explain why VAO forms octamers, whereas EUGO and the flavoprotein subunits of PCMH 
form dimers. 
Here, we investigate the role of this loop in determining the oligomerisation state of VAO and 
the importance of said oligomerisation state for enzymatic function. To this end, we created a 
VAO variant where the loop was deleted, loopless VAO (ll-VAO), and a EUGO variant where 
the loop from VAO was introduced at the corresponding position in EUGO, loop-EUGO (lo-
EUGO). These variants were expressed, purified and characterised in terms of their 
hydrodynamic and catalytic properties. In addition, a bioinformatic analysis of the 4PO 
subfamily was performed to provide information on the conservation of the loop. Our results 
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provide insights into the role of the loop region in determining the oligomerisation state of 
VAO and the importance of this oligomerisation state for enzymatic function. 
Results 
Expression and purification of ll-VAO and lo-EUGO 
The ll-VAO variant was created by deleting residues 220-235 from the sequence of wild-type-
VAO (wt-VAO). Additionally, Asp-219 was mutated to glycine, which is found at this position 
in EUGO. The lo-EUGO variant was created by introducing the sequence of residues 220-235 
from VAO (PKRPETMGLKPEDQPW) between Gly-200 and Ser-201 in the sequence of wt-
EUGO, which corresponds to Asp-219 and Ser-236 respectively in VAO. ll-VAO and lo-EUGO 
were both successfully expressed in E. coli and purified. During the purification procedure, ll-
VAO displayed a tendency to aggregate, forming yellow precipitates when concentrated to 
concentrations of more than approximately 10 μM. wt-VAO could be concentrated to 
concentrations of >150 μM without displaying any such aggregation, suggesting the solubility 
of the enzyme has been significantly reduced by removal of the loop. SDS-PAGE analysis of 
the purified variants and wild-type enzymes is shown in Figure 2A. ll-VAO runs as a single 
band with a relative subunit molecular mass of 59 kDa (theoretical: 62 kDa), as compared to 
wt-VAO which runs at a relative molecular mass of 61 kDa (theoretical: 64 kDa). lo-EUGO 
runs as a single band with a relative molecular mass of 61 kDa (theoretical: 61 kDa), as 
compared to wt-EUGO, which runs at a relative molecular mass of 60 kDa (theoretical: 59 
kDa). Upon irradiation of the gel with UV light, the bands from all four proteins were 
fluorescent, demonstrating that all variants contain a covalently bound flavin cofactor.  
Hydrodynamic properties 
To evaluate the effect of the introduced mutations on the oligomerisation state of VAO and 
EUGO, the loop variants and wild-type enzymes were analysed by analytical gel filtration 
(Fig. 2B+C). wt-VAO elutes as a single peak with an elution volume of 10.3 mL. This 
corresponds to an apparent molecular mass of 485 kDa, in good agreement with the 
theoretical molecular mass of a wt-VAO octamer of 510 kDa. No peak corresponding to wt-
VAO dimers was observed under the utilised conditions. For ll-VAO, a single peak was 
observed with an elution volume of 13.3 mL, yielding an apparent molecular mass of 114 kDa. 
This corresponds well with the theoretical mass of an ll-VAO dimer (123 kDa). No peak was 
observed at the elution volume expected for octameric ll-VAO. Thus, deletion of the dimer-
dimer interacting loop leads to the formation of a VAO variant that exclusively forms dimers 
in solution. wt-EUGO elutes as a single peak with an elution volume of 13.3 mL, yielding an 
apparent molecular mass of 114 kDa, in good agreement with the expected molecular mass of 
a wt-EUGO dimer (119 kDa). lo-EUGO elutes as a single peak at 13.2 mL, corresponding to an 
apparent molecular mass of 120 kDa. This is close to the theoretical mass of a lo-EUGO dimer 
(123 kDa). Thus, although the deletion of the loop from VAO is sufficient to prevent its 
octamerisation, introduction of the loop into EUGO is not sufficient to cause this dimeric 
enzyme to octamerise.  
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Figure 2: SDS-PAGE and analytical gel filtration analysis of purified VAO and EUGO variants. (A) The 
top panel shows an SDS-PAGE gel stained with Coomassie Brilliant Blue, the bottom panel shows the 
same gel with the fluorescence of the covalently bound flavin cofactor visualised by irradiating the gel 
with UV light after soaking it in an aqueous solution of 7.5% acetic acid and 5% ethanol. (B+C) 
Analytical gel filtration analysis of VAO and EUGO variants. (B) wt-VAO (black solid line) and ll-VAO 
(red dashed line), (C) wt-EUGO (black solid line) and lo-EUGO (red dotted line). Samples were run on 
a Superdex 200 HR 10/30 column in 50 mM potassium phosphate buffer, pH 7.5, 150 mM KCl. Traces 
show the absorbance at 280 nm normalised to 1 at the elution maximum. 
Spectral properties 
To determine whether the introduced mutations affect the electronic environment of the 
enzymes’ flavin cofactor, absorption spectra were recorded. Figure 3A shows that the visible 
absorption spectrum of ll-VAO is highly similar to that of wt-VAO, displaying maxima at 437 
nm and 354 nm as compared to 438 nm and 354 nm for wt-VAO. The absorption spectra of 
wt-EUGO and lo-EUGO (Fig. 3B) are almost indistinguishable from each other, displaying 
maxima at 366 nm and 442 and 440 nm respectively. Thus, neither mutation leads to major 
changes in the electronic environment of the flavin cofactor. To evaluate whether the 
introduced mutations affect the secondary structure content of the proteins, far-UV CD 
spectra were recorded. The CD spectra of wt-VAO and ll-VAO are highly similar (Fig. 3C), as 
are those of wt-EUGO and lo-EUGO recorded at 20 °C (Fig. 3D), demonstrating that no major 
changes in secondary structure content occur due to the introduced mutations. 
Catalytic properties  
To evaluate the effect of the introduced mutations on the catalytic properties of VAO and 
EUGO, the enzyme variants were tested for activity towards a selection of VAO substrates: 
vanillyl alcohol, which is oxidised to the aldehyde vanillin (4-hydroxy-3-
methoxybenzaldehyde), eugenol (4-allyl-2-methoxyphenol), which is hydroxylated to  
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Figure 3: Spectral properties of VAO and EUGO variants. (A) Visible absorption spectra of wt-VAO 
(solid black line) and ll-VAO (dashed red line) normalised to an absorbance of 1.0 at 439 nm. (B) Visible 
absorption spectra of wt-EUGO (solid black line) and lo-EUGO (dashed red line) normalised to an 
absorbance of 1.0 at 441 nm. (C) CD spectra of wt-VAO (solid black line) and ll-VAO (dashed red line). 
(D) CD spectra of wt-EUGO at 20 ºC (solid black line), at 80 ºC (dotted blue line) and at 20 ºC after 20 
min incubation at 80 ºC (long green dashes) and of lo-EUGO at 20 ºC (short red dashes). Spectra were 
recorded in 50 mM potassium phosphate buffer, pH 7.5, at 25 ºC (A+B), 20 ºC (C), or 20 or 80 ºC as 
indicated (D). 
coniferyl alcohol [4-(3-hydroxyprop-1-en-1-yl)-2-methoxyphenol], and 4-ethylphenol, which 
is either hydroxylated or dehydrogenated, yielding a mixture of 1-(4′-hydroxyphenyl)ethanol 
and 4-vinylphenol. The steady-state kinetic parameters for these enzymatic oxidation 
reactions are given in Table 1. The catalytic efficiencies for the reactionswith ll-VAO are 
somewhat lower than those with wt-VAO. This is primarily due to an increase in the Km values, 
which are 2-5 times higher than those of the wild-type enzyme. The kcat values are almost 
identical, never differing by more than a factor two. lo-EUGO displays similar catalytic 
properties to wt-EUGO. No activity was found with 4-ethylphenol, while the catalytic 
efficiencies with vanillyl alcohol and eugenol were slightly changed.  
Thermostability 
To determine whether the introduced mutations affect the stability of EUGO and VAO, 
thermal unfolding of the proteins was monitored by following changes in secondary structure 
using CD spectroscopy. For each variant, a single transition was observed (Fig. 4). With wt-
VAO and ll-VAO, the CD signal went to zero upon heating and insoluble aggregates were  
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Table 1: Steady-state kinetic parameters for the oxidation of a set of VAO substrates by VAO and EUGO 
variants measured at 25 °C in 50 mM potassium phosphate buffer, pH 7.5. ND: not determined due to 
low reaction rate (no significant decrease in oxygen concentration was observed in reaction mixtures 
containing 2.3 μM enzyme and 200 μM 4-ethylphenol). 
   wt-VAO ll-VAO wt-EUGO lo-EUGO 
Vanillyl Alcohol 
 
kcat (s-1) 2.6 ± 0.1 3.0 ± 0.1 7.1 ± 0.2 4.7 ± 0.1 
Km (µM) 149 ± 6 676 ± 54 79 ± 8 42 ± 4 
kcat/Km (s-1 mM-1) 17 4 90 112 
Eugenol 
 
kcat (s-1) 11 ± 1 15 ± 1 2.9 ± 0.1 1.8 ± 0.1 
Km (µM) 3.9 ± 0.2 9.8 ± 1 2.2 ± 0.2 4.7 ± 0.4 
kcat/Km (s-1 mM-1) 2821 1531 1318 383 
4-Ethylphenol 
 
kcat (s-1) 2.6 ± 0.1 1.5 ± 0.1 ND ND 
Km (µM) 12 ± 1 31 ± 1 ND ND 
kcat/Km (s-1 mM-1) 217 48 ND ND 
 
observed in the sample after returning it to room temperature. For wt-EUGO and lo-EUGO, 
however, a significant CD signal was still observed even after the transition region, indicating 
that the proteins retain secondary structure at this point, and no insoluble aggregates were 
observed. The CD spectrum of wt-EUGO at 80 °C confirms that the protein retains secondary 
structure at this temperature, with a clear negative CD signal being observed in the 
wavelength range from 200 to 240 nm (Fig. 3D). However, the shape of the spectrum is 
significantly different from that recorded at 20 °C. In particular, the peak that is observed at 
222 nm in the spectrum of wt-EUGO at 20 °C is no longer present when the spectrum is 
recorded at 80 °C. After a 20 min treatment at 80 °C, wt-EUGO did not display any enzymatic 
activity and ran in the void volume of a Superdex 200 size exclusion column. A CD spectrum 
recorded at 20 °C after incubating wt-EUGO at 80 °C for 20 min displays a similar shape to 
the wt-EUGO spectrum recorded at 80 °C (Fig. 3D). Thus, it seems that wt-EUGO forms 
inactive, soluble aggregates upon temperature-induced unfolding and that this temperature-
induced aggregation is irreversible. Similar results were obtained with lo-EUGO. To evaluate 
whether the introduced mutations affect the thermostability of the enzymes, thermal 
midpoints of unfolding were determined by fitting a sigmoidal curve to the recorded thermal 
denaturation data (Table 2). ll-VAO displays slightly impaired thermostability compared to 
wt-VAO, with its Tm lying 1.9 °C lower. lo-EUGO is significantly less stable than wt-EUGO, 
with its Tm lying 9.3 °C lower. Apparently, the introduction of the loop at the surface of the 
enzyme leads to a significant drop in its conformational stability. 
Bioinformatics 
In order to investigate the conservation of the dimer-dimer interacting loop within the 4PO 
subfamily, a bioinformatic search for homologues of VAO, EUGO, PCMH and EUGH was 
performed. This led to the identification of 46 unique sequences of putative 4PO subfamily 
members (including query sequences). A phylogenetic tree of these sequences is shown in 
Figure 5. This tree reveals that the 4PO subfamily can be divided into four main groups of 
related enzymes. The first two groups, which are putative dehydrogenases (PCMH-like and  
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Figure 4: Thermal denaturation curves of VAO and EUGO variants. 1 μM enzyme was subjected to a 
temperature gradient in 50 mM potassium phosphate buffer, pH 7.5, and unfolding was followed by 
monitoring the CD signal at 220 nm. Data points are shown in black (average of two measurements) 
and the sigmoidal fits used to determine Tm in red. 
Table 2: Thermal midpoints of unfolding of VAO and EUGO variants determined by CD spectroscopy. 
Enzyme Tm  (°C) 
wt-VAO 54.6 ± 0.1 
ll-VAO 52.7 ± 0.1 
wt-EUGO 60.6 ± 1.4 
 lo-EUGO 51.3 ± 0.7 
 
EUGH-like), almost exclusively contain sequences from proteobacteria, the one exception 
being a putative PCMH from Nitrospira defluvii (WP_013246640.1), a Gram-negative bacterium 
from the phylum Nitrospirae. The other two groups are putative oxidases, one group that is 
most closely related to EUGO and exclusively contains sequences from actinobacteria, and 
one group that is most closely related to VAO, all of which are from ascomycetous fungi. 
When the search was performed with EUGO as a query sequence, a single sequence was found 
from the proteobacterium Cyclocasticus sp. (YP_006837036.1) that did not belong to any of the 
identified groups.  
Analysis of the sequence region containing the dimer-dimer interacting loop revealed that 
none of the identified bacterial sequences carry the loop, whereas all of the fungal sequences  
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Figure 5: Phylogenetic tree of protein sequences of homologues of VAO from Penicillium simplicissimum 
(P56216.1, highlighted in green), EUGO from Rhodococcus jostii RHA1 (YP_703243.1, highlighted in red), 
PCMH from Pseudomonas putida (WP_032489501.1, highlighted in yellow) and EUGH from Pseudomonas 
sp. OPS1 (AAM21269.1, highlighted in orange). Accession codes for the sequences identified from 
several sources (GenBank, RefSeq and UniProt databases) are shown. The blue, cyan and purple lines 
indicate sequences from proteobacteria, actinobacteria and ascomycetous fungi respectively. 
YP_006837036.1 was used as an outgroup. Branch length is proportional to the number of substitutions, 
as indicated by the bar (0.1 substitutions per sequence position). 
do contain a loop region (Fig. 6). No conserved motif is present in the sequences of the loop 
itself and the loops vary slightly in length. However, at least two proline residues are always 
present in the loop as well as a group of polar residues. The regions flanking the loop are 
highly conserved. The region opposite the loop in the crystal structure of VAO from P. 
simplicissimum was also analysed (Fig. 6). The loop is in direct contact with an α-helix formed 
by residues 478-498. The inter-subunit loop-helix contact is primarily formed by seven 
residues: Lys-221, Pro-223 and Met-226 from the loop and Arg-482, Gln-485, Trp-486 and Thr-
490 from the helix (Fig. 7). The ε-amino group of Lys-221 is positioned within hydrogen 
bonding distance of the backbone carbonyl atoms of Gln-485 and Trp-486 and the hydroxyl 
group of Thr-490, providing a potential driving force for octamerisation. In addition, the 
hydrophobic side chains of Pro-223, Met-226, and Trp-486 and the aliphatic part of the side 
chain of Arg-482 are (partially) buried within the dimer-dimer interface. Analysis of these 
interacting residues in the multiple sequence alignment reveals that they are generally not 
strongly conserved. In the context of the fact that incorporation of the loop into EUGO does  
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Figure 6: Excerpts from the multiple sequence alignment of 4PO enzymes. Coloured boxes indicate the 
sequences of P. simplicissimum VAO (green), R. jostii RHA1 EUGO (red), P. putida PCMH (yellow) and 
Pseudomonas sp. OPS1 EUGH (orange). The coloured bars at the bottom of the figure indicate the 
division into enzyme groups (VAO-like: green, EUGO-like: red, PCMH-like: yellow, EUGH-like: 
orange) based on the phylogenetic tree shown in Figure 5. The numbers behind the sequence IDs show 
the lengths of the aligned sequences. The bar charts below the alignment show the conservation and 
quality scores at each position, following the “Alignment Conservation Annotation” used by Jalview 
(25). Figure was prepared with Jalview, residue numbering was changed to match VAO. Residues are 
coloured according to the ClustalX colour scheme. 
not lead to its octamerisation, it is interesting to note that Arg-482, Gln-485, Trp-486 and Thr-
490 are not conserved in EUGO, being replaced by glutamic acid, leucine, glutamine and 
valine respectively. 
Discussion 
Our results demonstrate that the loop formed by residues 220-235 in VAO plays a crucial role 
in determining the oligomerisation state of this enzyme. Deletion of the loop leads to a VAO 
variant that is exclusively dimeric in solution, even under conditions where wt-VAO only 
forms octamers. The ll-VAO variant does not differ much from wt-VAO in terms of its in vitro 
enzymatic properties, displaying similar thermostability and spectral and catalytic properties. 
The major difference between the two enzymes, other than their oligomerisation state, is their 
solubility. Unlike wt-VAO, ll-VAO displays a strong tendency to aggregate. The decreased 
solubility of ll-VAO may be due to hydrophobic residues that are normally buried in the 
dimer-dimer interface becoming solvent exposed in the dimeric variant, e.g. Trp-486, which 
is in contact with the loop from an opposite dimer in the octameric structure of VAO. 
Although deletion of the loop was sufficient to cause VAO to dimerise, its introduction into 
EUGO was not sufficient to induce its octamerisation. Introduction of the loop from VAO at 
the surface of EUGO did not significantly alter the enzyme’s catalytic properties. It did, 
however, lead to a significant decrease in thermostability, with the Tm of lo-EUGO lying 9.3 °C 
lower than that of the wild-type enzyme. 
As the introduction of the loop was not sufficient to cause EUGO to octamerise, other factors 
must also be important in enabling the octamersiation of VAO. These may include specific 
contacts between residues in the dimer-dimer interacting loop and residues in the region 
opposite it. Although the loop and the face of the helix formed by residues 478-498 that 
interacts with it primarily contain polar residues, three relatively hydrophobic residues, Pro-
223, Met-226 and Trp-486 are positioned at the point where the loop and helix make direct 
contact (Fig. 7). Burial of these hydrophobic residues at the dimer-dimer interface may 
provide an important driving force for octamerisation and is consistent with the fact that VAO 
dimerises at low ionic strength (11). Hydrogen bonds between the ε-amino group of Lys-221 
and the main chain carbonyl groups of Gln-485 and Trp-486 and the hydroxyl group of Thr-
490 may also contribute to promoting octamerisation. Another factor that may be involved in 
promoting the octamerisation of VAO is interactions involving the extreme C-terminus of the 
enzyme (residues 554-560). This region of the protein is in contact with an α-helix formed by 
residues 519-535 from one monomer of the opposite dimer and a turn formed by residues 203-
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209 from the other monomer of the opposite dimer. In this context it is interesting to note that 
the C-termini of VAO (residues 550-560) and EUGO (residues 518-526) are not conserved. 
Bioinformatic analysis of the 4PO subfamily demonstrates that it can be divided into four 
groups of enzymes, fungal VAO-like enzymes and bacterial EUGO-like, PCMH-like and 
EUGH-like enzymes. All of the VAO-like enzymes contain a dimer-dimer interacting loop, 
whereas none of the bacterial enzymes contain it. Incorporation of the loop may have been an 
evolutionary mechanism by which these enzymes obtained differing oligomerisation states. 
Studies into the oligomeric nature of other members of the VAO-like group are necessary to 
evaluate this further. In this context, it should be noted that an enzyme has been isolated from 
the ascomycetous fungus Byssochlamys fulva V107 that displayed VAO activity, yet was 
reported to be exclusively dimeric in solution (26). However, no sequence or structural 
information is available on this protein. 
 
Figure 7: Inter-subunit contacts between the dimer-dimer interacting loop and the helix opposite it in 
a VAO octamer. The dimer in which the helix is shown has green carbon atoms and the dimer in which 
the loop is shown has orange carbon atoms. Nitrogen atoms are shown in blue and oxygen atoms in 
red. Lys-221, Pro-223, Met-226, Arg-482, Gln-485, Trp-486 and Thr-490, the residues that are primarily 
involved in inter-dimer contacts, are shown in stick representation. The potential hydrogen bonds 
between the ε-amino group of Lys-221 and the backbone carbonyl atoms of Gln-485 and Trp-486 and 
the hydroxyl group of Thr-490 are shown as black dashed lines. The VAO structure was downloaded 
from the PDB website (PDB ID: 1VAO). The figure was prepared using PyMOL (Schrödinger LLC, New 
York, NY, USA). 
The exact role of the differing oligomerisation states of the 4PO enzymes is yet to be elucidated. 
The dimeric ll-VAO displays only slightly impaired catalytic efficiencies and thermostability 
as compared to the wild-type enzyme. The fact that ll-VAO still readily oxidises 4-ethylphenol, 
which is a very poor substrate for EUGO, demonstrates that the observed differences in 
substrate specificity between VAO and EUGO are not caused by their different 
oligomerisation states. It seems unlikely, therefore, that VAO evolved so as to be able to form 
octamers to directly modulate its enzymatic properties. In vivo, octamerisation may be of 
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importance in modulating the interactions of VAO with other proteins. A possible function of 
octamerisation could be to prevent the binding of a cytochrome subunit such as is found in 
PCMH and EUGH. However, comparison of the structures of a PCMH heterotetramer and a 
VAO octamer demonstrates that the cytochrome binding site in PCMH lies far from the area 
that corresponds to the dimer-dimer interface of VAO, suggesting that preventing cytochrome 
binding is not the function of octamerisation of VAO (Fig. 1B). Another possibility is that 
octamerisation is simply an efficient way to cluster the active VAO dimers so as to achieve a 
high concentration of VAO molecules in a limited space. Alternatively, the oligomerisation 
state of VAO may be of importance in maintaining its subcellular localisation. VAO is not 
strictly compartmentalised in vivo, being localised to both the peroxisomes and cytosol of P. 
simplicissimum (27). Transport of proteins into peroxisomes typically takes place post-
translationally and is initiated by the recognition of a C-terminal peroxisomal targeting 
sequence. The sequence of the extreme C-terminus of VAO (WKL) is a putative variant of the 
canonical PTS1 peroxisomal targeting sequence (SKL). As in the octameric structure of VAO 
its C-terminus is buried at the dimer-dimer interface, it can be expected that VAO could only 
be transported into peroxisomes in its dimeric form, raising the intriguing possibility that the 
ability of VAO to form both dimers and octamers could allow it to maintain its dual 
localisation. More detailed studies on the physiological function of VAO are required in order 
to fully understand the role of octamer formation in vivo. 
In conclusion, our results demonstrate that the dimer-dimer interacting loop determines the 
oligomerisation state of VAO, with deletion of the loop changing the oligomerisation state of 
VAO from predominantly octameric to exclusively dimeric without significantly affecting the 
catalytic properties of the enzyme. All identified fungal 4PO subfamily members contain the 
loop, while all bacterial 4PO subfamily members do not. Octamerisation is not crucial for the 
enzymatic activity of VAO, but may have other roles in vivo such as promoting enzyme 
solubility, enabling or preventing interactions with other proteins or modulating the 
subcellular localisation of the enzyme. 
Materials and methods 
Materials 
Vanillyl alcohol, eugenol, and 4-ethylphenol were from Sigma-Aldrich (St Louis, MO, USA). 
All other chemicals were from commercial sources and of the purest grade available. The 
pBAD-EUGO plasmid was a kind gift from Prof. Dr. Marco Fraaije (University of Groningen, 
The Netherlands). 
Creation of the ll-VAO and lo-EUGO constructs 
A construct encoding for ll-VAO was created by PCR amplification from the pBC11 plasmid 
(28), a pEMBL19 derivative containing the gene encoding for wt-VAO. First, two constructs 
were PCR amplified. The first consisted of the 105 bp upstream from the VAO gene, the first 
657 bp of the VAO gene and a 3′ extension consisting of bp 706 to 728. The construct also 
contained a single point mutation in order to mutate Asp-219 to glycine. This construct was 
amplified using the following primers: forward primer: CAATTTCACACAGGAAACAGC 
Chapter 3 
78 
 
TATGACC, reverse primer: GGAAACAGATGAGCGATTTTGCTACCAGGTAGAGCCCCC 
ATGCCAG. The second construct consisted of bp 635-657 of the VAO gene at the 5′ end, again 
with a point mutation to change Asp-219 into glycine, followed by bp 706-1683 of the VAO 
gene and finally 147 bp from the plasmid sequence downstream of the VAO gene. This 
construct was PCR amplified using the following primers: forward primer: 
CTGGCATGGGGGCTCTACCTGGTAGCAAAATCGCTCATC TGTTTCC, reverse primer: 
CCAGTCACGACGTTGTAAAACGACGG. Subsequently, the construct encoding for ll-VAO 
was PCR amplified from the two overlapping constructs using the forward primer for the first 
construct and the reverse primer for the second construct. This construct was digested with 
HindIII and SacI and ligated into HindIII-SacI digested pBC11, yielding pBC11-ll-VAO. The 
pBAD-lo-EUGO plasmid was created using a similar strategy. Two overlapping constructs 
were PCR amplified from the pBAD-EUGO plasmid (14). The first construct consisted of the 
128 bp directly upstream of the EUGO gene, the first 600 bp of the EUGO gene and a 3′ 
extension consisting of bp 658 to 689 from the VAO gene. This construct was amplified using 
the following primers: forward primer: CGGCGTCACACTTTGCTATGCCATAGC, reverse 
primer: GGCTTTAGCCCCATCGTTTCGGGACGTTTAGGGCCGGGCAGTGCGCCCATCC 
CGGTG. The second construct consisted of bp 673-705 from the VAO gene, followed by bp 
601-1581 of the EUGO gene and 100 bp from the pBAD-EUGO plasmid downstream of the 
EUGO gene. This construct was PCR amplified using the following primers: forward primer: 
CGATGGGGCTAAAGCCAGAAGACCAGCCATGGAGCGACGCGTGGCAATTGTTCCCC
T, reverse primer: GCCAAGCTGGAGAC CGTTTAAACTCAATG. The construct encoding lo-
EUGO was subsequently PCR amplified from the two overlapping constructs using the 
forward primer for the first construct and the reverse primer for the second construct. The 
formed construct was digested with HindIII and NdeI and ligated into HindIII-NdeI digested 
pBAD-EUGO, yielding pBAD-lo-EUGO. 
Protein expression and purification 
wt-VAO was expressed from pBC11 in BL21 E. coli. Cells were grown at 37 °C in LB medium 
(Duchefa Biochemie, Haarlem, The Netherlands) supplemented with 100 μg/mL ampicillin to 
an OD600 of 0.6, after which protein expression was induced by adding 0.25 mM IPTG and 
cells were grown overnight at 37 °C. Subsequently, wt-VAO was purified essentially as 
described previously (29) and transferred into 50 mM potassium phosphate buffer, pH 7.5, for 
storage. ll-VAO was expressed and purified according to a modified version of this protocol. 
BL21 E. coli containing the pBC11-ll-VAO plasmid was grown in TB medium (Difco, Becton 
Dickinson, Franklin Lake, NJ, USA) supplemented with 100 μg/mL ampicillin at 37 °C until 
the OD600 of the culture was 0.5. Subsequently, protein expression was induced by the addition 
of 0.25 mM IPTG and the cultures were grown overnight at 30 °C. The cells were then 
harvested by centrifugation (2800 g, 20 min, 4 °C) and resuspended in 50 mM potassium 
phosphate buffer, pH 7.0, supplemented with 0.5 mM MgSO4, 0.5 mM dithiothreitol and two 
cOmpleteTM protease inhibitor pills (Roche, Basel, Switzerland) and 1 mg DnaseI (Roche) per 
50 mL. The resuspended cells were lysed by passing them three times through a pre-cooled 
SLM Aminco French pressure cell. Cell debris was removed by centrifugation (39,000 g, 45 
min, 4 °C). Subsequently, protamine sulphate was added to the supernatant to a final 
concentration of 0.5% (w/v), following which the precipitate was removed by centrifugation 
(39,000 g, 20 min, 4 °C). (NH4)2SO4 was added to the supernatant to 35% saturation and the 
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precipitate was pelleted by centrifugation (39,000 g, 20 min, 4 °C). The pellet was dissolved in 
50 mM potassium phosphate buffer, pH 7.0, 0.5 M (NH4)2SO4 and loaded onto a phenyl 
sepharose column equilibrated with the same buffer. After elution with a gradient from 0.5 to 
0 M (NH4)2SO4 in 50 mM potassium phosphate buffer, pH 7.0, ll-VAO was still bound to the 
column. ll-VAO was then eluted with water which was subsequently adjusted to 20 mM 
potassium phosphate buffer, pH 7.0. This sample was loaded onto a hydroxyapatite column 
equilibrated with the same buffer. After loading, bound proteins were eluted using a gradient 
from 20 to 1000 mM potassium phosphate buffer, pH 7.0. Fractions containing ll-VAO were 
pooled and the buffer was exchanged to 50 mM potassium phosphate buffer, pH 7.5, by 
dialysis. The pooled fractions were run over a Q-sepharose column in 50 mM potassium 
phosphate buffer, pH 7.5. The flow-through from this column was collected and contained 
pure ll-VAO.  
wt-EUGO and lo-EUGO were expressed in TOP10 E. coli containing the appropriate plasmid. 
Cells were grown at 37 °C in TB medium supplemented with 100 μg/mL ampicillin until the 
OD600 of the culture was 0.6. Then, protein expression was induced by adding 0.02% (w/v) L-
arabinose and cells were grown overnight at 30 °C. Subsequently, cells were harvested by 
centrifugation (2800 g, 20 min, 4 °C) and resuspended in 20 mM potassium phosphate buffer, 
pH 7.1, supplemented with 0.5 mM MgSO4 and two cOmpleteTM protease inhibitor pills 
(Roche) and 1 mg DnaseI (Roche) per 50 mL. The resuspended cells were lysed by passing 
them three times through a pre-cooled SLM Aminco French pressure cell and cell debris was 
removed by centrifugation (39,000 g, 45 min, 4 °C). The obtained supernatant was loaded onto 
a Q-sepharose column equilibrated with 20 mM potassium phosphate buffer, pH 7.1. Bound 
proteins were subsequently eluted using a linear gradient from 0 to 1 M KCl. Fractions 
containing the protein of interest were pooled and run over a Superdex 200 column in 20 mM 
potassium phosphate buffer, pH 7.1, 150 mM KCl. Subsequently, KCl was removed by dialysis 
and the samples were loaded onto a hydroxyapatite column in 20 mM potassium phosphate 
buffer, pH 7.1. Bound proteins were eluted using a linear gradient from 20 to 1000 mM 
potassium phosphate buffer, pH 7.1. Fractions containing the proteins of interest were pooled 
and dialysed to 20 mM potassium phosphate buffer, pH 7.1. Then, (NH4)2SO4 was added to 
0.5 M and the samples were loaded onto a phenyl sepharose column. Bound proteins were 
eluted using a gradient from 0.5 to 0 M (NH4)2SO4 in 20 mM potassium phosphate buffer, pH 
7.1. Fractions containing pure wt-EUGO or lo-EUGO were pooled, concentrated using an 
Amicon spin filter (Merck, Kenilworth, NJ, USA) and dialysed to 50 mM potassium phosphate 
buffer, pH 7.5. Purified wt-EUGO was not fully saturated with its FAD cofactor. To obtain 
fully flavinylated EUGO, 10 μM wt-EUGO was incubated with 200 μM FAD in 50 mM 
potassium phosphate buffer, pH 7.5 for 1 h at room temperature. Subsequently, remaining 
free FAD was removed by passing the sample over an Econo-Pac 10DG desalting column (Bio-
Rad, Hercules, CA, USA).  
Analytical methods 
Unless specified otherwise, all experiments were performed in 50 mM potassium phosphate 
buffer, pH 7.5. Absorption spectra were recorded at 25 °C on a Hewlett Packard 8453 diode 
array spectrophotometer (Agilent Technologies, Santa Clara, CA, USA). The concentration of 
wt-VAO and ll-VAO solutions was determined from their absorption at 439 nm, using the 
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previously determined extinction coefficient of the wild-type enzyme [ε = 12,500 M-1 cm-1 (7)]. 
The concentration of wt-EUGO and lo-EUGO solutions was determined from their absorption 
at 441 nm [ε = 14,200 M-1 cm-1, (14)]. CD spectra were recorded using 1 μM enzyme solutions 
at 20 °C or 80 °C on a Jasco J-715 spectropolarimeter (Jasco Inc., Easton, MD, USA). Thermal 
denaturation curves were recorded by monitoring the CD signal at 220 nm as the temperature 
was increased from 20 to 80 °C for wt-VAO and ll-VAO or from 20 to 95 °C for wt-EUGO and 
lo-EUGO. The temperature was increased in a linear gradient at a rate of 35 °C/h. Thermal 
midpoints of unfolding were determined by fitting a sigmoidal curve to the data using Igor 
Pro v. 6.10A (Wavemetrics, Lake Oswego, OR, USA). Analytical gel filtration was performed 
using a Superdex 200 HR 10/30 column on a Pharmacia Biotech Äkta system (GE Healthcare, 
Chicago, IL, USA). After loading, samples were eluted in 50 mM potassium phosphate buffer, 
pH 7.5, 150 mM KCl. Apparent molecular masses were determined from a calibration curve 
based on proteins of known molecular mass. 
Enzyme activity measurements 
All activity measurements were performed in 50 mM potassium phosphate buffer, pH 7.5, at 
25 °C. Enzymatic oxidation of vanillyl alcohol was followed by monitoring the absorption of 
the formed vanillin at 340 nm (ε = 14,000 M-1 cm-1). Enzymatic oxidation of eugenol or 4-
ethylphenol was followed by monitoring oxygen consumption using a Hansatech Oxytherm 
system (Hansatech Instruments, King’s Lynn, UK). Steady-state kinetic parameters were 
determined by fitting observed initial rates to the Michaelis-Menten equation using Igor Pro 
v. 6.10A.  
Bioinformatics 
YP_703243.1 (EUGO) from Rhodococcus jostii RHA1 and P56216.1 (VAO) from Penicillium 
simplicissimum were blasted and the results were filtered to contain 15 unique sequences 
sharing a high percentage of sequence identity and with high alignment scores. AAM21269.1 
(EUGH) from Pseudomonas sp. OPS1 and WP_032489501.1 (PCMH) from Pseudomonas putida, 
were blasted, limiting the number of hits to 10. EXJ91673.1, EXJ73483.1, ETN44584.1 and 
XP_001545605.1 were identified via the blast with VAO as well as with EUGO. Therefore, a 
total of 46 unique sequences remained. These sequences were aligned and a phylogenetic tree 
was created using the Clustal Omega webserver (30). Manual verification of the alignment 
was performed and no changes were made to the alignment. The phylogenetic tree created by 
Clustal Omega was manually re-rooted to YP_006837036.1 and visualised using the iTOL 
webserver (31).  
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Summary 
A number of oxidoreductases from the VAO/PCMH flavoprotein family catalyse the oxidation 
of para-substituted phenols. One of the best-studied is vanillyl alcohol oxidase (VAO) from the 
fungus Penicillium simplicissimum. For oxidation of phenols by VAO to occur, they must first 
be bound in the enzyme’s active site in their phenolate form. The crystal structure of VAO 
reveals that two tyrosine residues, Tyr-108 and Tyr-503, are positioned so as to facilitate 
deprotonation to the phenolate. To investigate their role in catalysis, we created three VAO 
variants, Y108F, Y503F, and Y108F/Y503F, and studied their biochemical properties. Steady-
state kinetics indicated that the presence of at least one of the tyrosine residues is essential for 
efficient catalysis by VAO. Stopped-flow kinetics revealed that the reduction of VAO by 
chavicol or vanillyl alcohol occurs at two different rates: kobs1, which corresponds to its reaction 
with the deprotonated form of the substrate, and kobs2, which corresponds to its reaction with 
the protonated form of the substrate. In Y108F, Y503F, and Y108F/Y503F, the relative 
contribution of kobs2 to the reduction is larger than in wild-type VAO, suggesting 
deprotonation is impaired in these variants.  Binding studies disclosed that the competitive 
inhibitor isoeugenol is predominantly in its deprotonated form when bound to wild-type 
VAO, but predominantly in its protonated form when bound to the variants. These results 
indicate that Tyr-108 and Tyr-503 are responsible for the activation of substrates in VAO, 
providing new insights into the catalytic mechanism of VAO and related enzymes that oxidise 
para-substituted phenols.
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Introduction 
Vanillyl alcohol oxidase (VAO, EC 1.1.3.38) from Penicillium simplicissimum is a flavin-
dependent oxidase that catalyses the oxidation of para-substituted phenolic compounds using 
molecular oxygen as an electron acceptor (1–3). It is a 64 kDa (560 amino acid) protein that 
forms octameric structures with each subunit containing an FAD cofactor that is covalently 
linked to the protein via an 8α-N3-histidyl-FAD bond (4). VAO is a member of the 
VAO/PCMH flavoprotein family, which consists of homologous oxidoreductases that catalyse 
a wide range of reactions, but share a conserved FAD-binding domain (5, Chapter 2). 
Although VAO catalyses a range of reactions, such as the oxidation of benzylic alcohols to 
aldehydes, the oxidative deamination of benzylic amines, the hydroxylation of 4-allylphenols, 
and the hydroxylation or dehydrogenation of 4-alkylphenols, it displays a strict selectivity 
towards the oxidation of para-substituted phenols at the Cα atom of their side chain. The 
proposed catalytic mechanism of VAO provides an explanation for this selectivity (Scheme 1) 
(2, 6, 7). First, VAO’s substrates are bound in the active site in their deprotonated phenolate 
form. Subsequently, a hydride is transferred from the Cα atom of the substrate’s side chain to 
the N5 atom of FAD, yielding the reduced enzyme and a para-quinone methide intermediate. 
Finally, this intermediate either reacts with water or rearranges to yield the product of the 
reaction and FAD is reoxidised by molecular oxygen, which is converted to hydrogen 
peroxide. The initial deprotonation of the substrate’s phenolic hydroxyl group is likely a 
crucial step in this mechanism, as it promotes the hydride transfer reaction by enabling the 
formation of the para-quinone methide intermediate. Studies using the competitive inhibitor 
isoeugenol [2-methoxy-4-(1-propen-1-yl)phenol, Scheme 1] revealed that its pKa is lowered 
from 10 to 5 upon binding to VAO (2). A potential explanation for this decrease is provided 
by examining the crystal structure of VAO in complex with isoeugenol (4). Three polar 
residues, Tyr-108, Tyr-503 and Arg-504, form a phenolate binding pocket, with their side 
chains positioned within hydrogen bonding distance of isoeugenol’s phenolic hydroxyl group 
(Fig. 1). These residues may facilitate deprotonation of the substrate either by promoting 
preferential binding of the deprotonated form or by one of the tyrosine residues acting as a 
base and actively deprotonating the substrate in the active site.  All three residues are  
 
Scheme 1: (A) Oxidation of vanillyl alcohol (4-hydroxy-3-methoxybenzyl alcohol) as catalysed by VAO. 
First, the substrate is bound in the active site in its deprotonated phenolate form. This facilitates the 
transfer of a hydride from the Cα of the substrate to FAD, yielding a para-quinone methide intermediate 
and the reduced enzyme. The para-quinone methide subsequently rearranges to give the product 
vanillin (4-hydroxy-3-methoxybenzaldehyde) and FAD is reoxidised by molecular oxygen, which is 
converted to hydrogen peroxide. (B) Structures of chavicol (4-allylphenol) and isoeugenol [2-methoxy-
4-(1-propen-1-yl)phenol].  
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Figure 1: Structure of the phenolate binding pocket of VAO. Tyr-108, Tyr-503 and Arg-504 are shown 
in stick representation with cyan carbon atoms, the competitive inhibitor isoeugenol with pink carbon 
atoms and the FAD cofactor with yellow carbon atoms. Nitrogen atoms are shown in blue, oxygen 
atoms in red and phosphorus atoms in orange. Potential hydrogen bonds between the amino acids of 
the phenolate binding pocket and the phenolic hydroxyl group of isoeugenol are shown as black 
dashes. The protein backbone is shown in cartoon representation, with the FAD-binding domain in 
green and the substrate-binding domain in red. The structure of isoeugenol-bound VAO was 
downloaded from the PDB website (PDB ID: 2VAO). The figure was prepared using PyMOL 
(Schrödinger LLC, New York, NY, USA).  
conserved in the homologous flavoenzymes eugenol oxidase (EUGO) and para-cresol 
methylhydroxylase (PCMH, EC 1.17.99.1), which also catalyse the oxidation of para-
substituted phenols (8, 9). The role of Arg-474 in PCMH, which corresponds to Arg-504 in 
VAO, has been studied by site-directed mutagenesis and it was found to be of importance in 
achieving covalent incorporation of the enzyme’s cofactor and in enabling efficient catalysis 
by modulating the redox properties of both the cofactor and enzyme-bound substrates (10). 
Here, we investigated the role played by Tyr-108 and Tyr-503 in VAO using site-directed 
mutagenesis. Three VAO variants, Y108F, Y503F and Y108F/Y503F, were created, expressed 
and purified and their catalytic properties were studied. Our results reveal that the presence 
of at least one of these tyrosine residues is essential for efficient catalysis. 
Results 
The Y108F, Y503F and Y108F/Y503F variants were successfully expressed in Escherichia coli 
and purified. Like wild-type (wt)-VAO, all three variants contained a covalently bound FAD 
cofactor, as judged from the yellow pellet and colourless supernatant obtained after 
precipitation of the proteins with trichloroacetic acid. In their native form, all variants 
displayed an octameric quaternary structure, as determined using analytical size exclusion 
chromatography. The flavin absorption spectra of the variants were highly similar to that of 
wt-VAO (see spectral studies presented below), demonstrating that the introduced mutations 
do not lead to any major changes in the electronic environment of their flavin cofactor. To 
determine whether the introduced mutations affect the stability of VAO, thermal midpoints 
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of unfolding of the variants were determined using the ThermoFAD method (11). This yielded 
thermal midpoints of unfolding of 55 °C for wt-VAO, 53 °C for Y108F and Y503F, and 52 °C 
for Y108F/Y503F, suggesting the introduced mutations have a minor deleterious effect on the 
thermostability of VAO. 
Steady-state catalytic properties 
To determine the effect of the introduced mutations on the catalytic efficiency of VAO, we 
measured the steady-state kinetic parameters for the oxidation of two substrates: vanillyl 
alcohol (4-hydroxy-3-methoxybenzyl alcohol), which is oxidised to the aldehyde vanillin (4-
hydroxy-3-methoxybenzaldehyde), and chavicol (4-allylphenol, Scheme 1), which is 
hydroxylated to para-coumaryl alcohol [4-(3-hydroxyprop-1-en-1-yl)phenol]. The kinetic 
parameters for the oxidation of these substrates are listed in Table 1. Interestingly, the effect 
of the mutations varied depending on the substrate. With vanillyl alcohol, the kcat drops to 
approximately 2% of that of wt-VAO for both the Y108F and Y503F variants. With chavicol, a 
more minor drop in the kcat value to approximately 45% of that of the wild-type enzyme was 
observed for the Y108F and Y503F variants. With chavicol, the Y108F/Y503F variant displayed 
a kcat value of less than 2% of that of wt-VAO and with vanillyl alcohol, the activity was too 
low to accurately determine kinetic parameters. This indicates that the presence of at least one 
of the two tyrosine residues is essential for efficient catalysis. For each variant, the Km 
increased for each substrate. The magnitude of the increase ranged from three- to twelvefold. 
Stopped-flow kinetics of the reductive half-reaction 
To determine whether the decreased catalytic efficiencies observed for the VAO variants were 
due to impaired reduction of their FAD cofactor, spectral changes during the anaerobic 
reduction of the enzymes by vanillyl alcohol or chavicol were followed by stopped-flow 
spectroscopy. Where possible, photodiode array detection was used to monitor changes over 
a spectral range from 254 to 725 nm. However, with long measurement times (>10 s), the high-
intensity illumination required for this led to photoreduction of FAD. Therefore, in cases 
where the reduction reaction was slow, it was monitored using single wavelength detection 
at 439 nm, the absorption maximum of the oxidised FAD in VAO. This was the case for the 
reduction of the Y108F and Y503F variants by 2 mM vanillyl alcohol and for all reactions 
involving the Y108F/Y503F variant. 
Observed rates for the anaerobic reduction of wt-VAO and the Y108F and Y503F variants by 
2 mM vanillyl alcohol at pH 6.2 and 7.5 are given in Table 2. The anaerobic reduction of wt-
VAO by vanillyl alcohol at pH 7.5 has been studied previously and was found to be a biphasic 
process with rate constants at saturating substrate concentration of kred1 = 24 s‒1 and kred2 = 3.5 
s‒1 (6). The two different rates of reduction were interpreted to be caused by the presence of 
two conformations of the enzyme. The rate of the slower phase, kred2, lies close to kcat and is 
rate-limiting for catalysis. Our results with wt-VAO are in good agreement with these data. 
The effect of the Y108F and Y503F mutations on the rate of reduction by vanillyl alcohol was 
similar. In each variant, the reduction was a biphasic process. Each of the rates of reduction 
has dropped significantly as compared with wt-VAO. The rates of the two phases are in the 
same range and kobs2 is similar to the rate of steady-state catalysis, suggesting that flavin 
reduction is rate-limiting in these variants. In addition to the decrease in both reduction rates, 
the relative contribution of the two kinetic events to the drop in absorption at 439 nm 
(amplitude a) has changed. In wt-VAO, kobs1 has a greater contribution than kobs2 (a1:a2 ≈ 2:1),  
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Table 1: Steady-state kinetic parameters for the oxidation of vanillyl alcohol and chavicol by VAO 
variants. Kinetic parameters were determined at 25 °C in 50 mM potassium phosphate buffer, pH 7.5. 
Ki is the inhibition constant for substrate inhibition, which was observed for all variants when using 
chavicol as a substrate. ND: not determined due to low reaction rate (observed rate <0.01 s−1 at 2 mM 
vanillyl alcohol).  
Vanillyl alcohol 
VAO variant kcat (s−1) Km (μM) kcat/Km (s-1 mM-1) 
wild-type 2.6a 149a 17 
Y108F 0.042 ± 0.006 1750 ± 420 0.024 
Y503F 0.055 ± 0.002 990 ± 60 0.056 
Y108F/Y503F ND ND ND 
Chavicol 
VAO variant kcat (s−1) Km (μM) kcat/Km (s-1 mM-1) Ki (mM) 
wild-type 7.4 ± 0.1 6.5 ± 0.3 1138 7.0 ± 1.1 
Y108F 3.4 ± 0.1 67 ± 7 51 2.9 ± 0.4 
Y503F 3.3 ± 0.1 21 ± 2 157 0.45 ± 0.04 
Y108F/Y503F 0.13 ± 0.01 74 ± 6 1.8 1.4 ± 0.2 
aData taken from (12). 
Table 2: Observed rates of reduction of VAO variants by 2 mM vanillyl alcohol. Rates were determined 
by fitting appropriate exponential functions to single wavelength traces of the absorption at 439 nm 
obtained after mixing 10 μM enzyme with 2 mM vanillyl alcohol in 50 mM potassium phosphate buffer, 
pH 6.2 or 7.5, under anaerobic conditions at 25 °C using a stopped-flow apparatus. Values in 
parentheses give the relative contribution of kobs1 and kobs2, the two phases associated with flavin 
reduction, to the drop in absorption. The observed rates for the oxidation of 2 mM vanillyl alcohol 
under steady-state conditions (kss) at pH 7.5 are given for comparison. ND = not determined due to low 
reaction rate. 
pH 7.5 
VAO variant kobs1 (s−1) kobs2 (s−1) kss (s−1) 
wild-type 27 ± 1 (0.67) 3.5 ± 0.1 (0.33) 2.4 
Y108F 0.061 ± 0.002 (0.17) 0.023 ± 0.001 (0.83) 0.024 
Y503F 0.075 ± 0.001 (0.26) 0.025 ± 0.001 (0.74) 0.037 
Y108F/Y503F ND ND < 0.01 
pH 6.2 
VAO variant kobs1 (s−1) kobs2 (s−1)  
wild-type 35 ± 1 (0.23) 2.9 ± 0.1 (0.77)  
Y108F 0.27 ± 0.01 (0.03) 0.0085 ± 0.0001 (0.97)  
Y503F 0.33 ± 0.01 (0.03) 0.018 ± 0.001 (0.97)  
Y108F/Y503F ND ND  
 
whereas in the Y108F and Y503F variants, kobs2 has a greater contribution than kobs1 (a1:a2 ≈ 1:5 
for Y108F and 1:3 for Y503F). At pH 6.2, reduction by vanillyl alcohol was also biphasic for all 
variants. For wt-VAO, the rates of the two phases are very similar to those at pH 7.5. However, 
their contributions to the reduction have changed, with kobs2 having a greater contribution than 
kobs1 (a1:a2 ≈ 1:3). In the Y108F and Y503F variants, kobs1 is somewhat higher than observed at 
pH 7.5 and kobs2 is slightly lower in Y108F and does not change significantly in Y503F. As 
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observed for wt-VAO, the contribution of the two rates to the change in absorption shifts, with 
kobs2 becoming more predominant (a1:a2 ≈ 1:32 for each variant). 
Spectra obtained during the anaerobic reduction of wt-VAO by 100 μM chavicol are shown in 
Figure 2. After mixing wt-VAO with chavicol, the characteristic peak of the enzyme’s oxidised 
flavin cofactor (maximum at 439 nm) rapidly disappears, indicating that FAD is reduced by 
the substrate. At the same time, the absorption between 320 and 430 nm increases, yielding an 
intense peak with a maximum at 373 nm. This peak reaches its maximum intensity after 
approximately 600 ms, after which it decreases in intensity. The formation of a species with 
similar spectral characteristics has been observed during the anaerobic reduction of wt-VAO 
by vanillyl alcohol (λmax = 362 nm) or 4-(methoxymethyl)phenol (λmax = 364 nm) and was 
attributed to a complex between the para-quinone methide intermediate and the reduced 
enzyme formed after the electron transfer reaction has taken place (6). Intermediate spectra 
obtained upon spectral deconvolution of the stopped-flow data are shown in Figure 2. The 
data were fit to a three-phase consecutive model, yielding four distinct spectral intermediates. 
Species 1 represents the oxidised enzyme. Species 3 displays the highest absorption at 373 nm 
and complete loss of the characteristic oxidised flavin spectrum. It likely represents the para-
quinone methide–reduced enzyme complex. Species 2 displays incomplete formation of the 
para-quinone methide intermediate as indicated by its lower absorption at 373 nm. In addition, 
part of the FAD cofactor is still in its oxidised form in this species, as evidenced by the 
absorption in the range 440‒500 nm. The spectra of species 1, 2, and 3 display an isosbestic 
point at 423 nm and a spectrum calculated by assuming that the spectrum of species 2 is a 
simple composite of those of species 1 (20%) and 3 (80%) was virtually indistinguishable from 
the actual spectrum of species 2. This is consistent with species 2 not representing a real 
reaction intermediate, but rather reflecting the fact that there are two separate rates of 
conversion of species 1 to species 3. Species 4 displays a spectrum that is typical of a reduced 
flavoprotein, suggesting that this species is formed by the breakdown of the para-quinone 
methide intermediate by its reaction with water, yielding the product para-coumaryl alcohol. 
Thus, the anaerobic reduction of wt-VAO by chavicol proceeds as follows. First, the substrate 
binds to the enzyme. Subsequently, the FAD cofactor is reduced by the substrate leading to 
the formation of a para-quinone methide‒reduced enzyme complex with two kinetic phases 
that both contribute to this reduction being distinguished. Following reduction, the para-
quinone methide intermediate reacts with water to yield para-coumaryl alcohol. Rate 
constants for these processes were obtained by fitting curves of the absorption at 440 nm to a 
triphasic exponential function. Rate constants for the two reduction rates (kobs1 and kobs2) are 
given in Table 3. kobs2 is similar to the steady-state reaction rate, suggesting it is rate-limiting 
for catalysis. The observed rate of decay of the para-quinone methide intermediate, kobs3, was 
similar for all variants (0.1–0.2 s‒1) and is too slow to be catalytically relevant. Presumably, 
breakdown of this intermediate is faster in the presence of oxygen, as has been observed 
previously for the para-quinone methide intermediate formed upon reduction of wt-VAO by 
4-(methoxymethyl)phenol (6). 
Upon reduction of the Y108F and Y503F variants by chavicol, the spectral changes observed 
were similar to those seen with wt-VAO, with reduction of FAD occurring concomitantly with 
the appearance of a putative para-quinone methide intermediate (Fig. 2). The absorption 
maximum of this intermediate is shifted to lower wavelengths in the variants (363 nm for 
Y108F and 368 nm for Y503F) compared with wt-VAO (373 nm). Maximum abundance of the 
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Figure 2: Spectral changes observed during the anaerobic reduction of VAO variants by chavicol. Top 
panels show spectra obtained after mixing 10 μM wt-VAO, Y108F, or Y503F with 100 μM chavicol in a 
stopped-flow apparatus under anaerobic conditions in 50 mM potassium phosphate buffer, pH 7.5, at 
25 °C. Initially, FAD is reduced and a complex between the reduced enzyme and a para-quinone 
methide intermediate is formed (black solid lines). Subsequently, the para-quinone methide 
intermediate decays, likely due to it reacting with water to yield the product (para-coumaryl alcohol) 
and the reduced enzyme (red dashed lines). For wt-VAO, spectra were obtained 0.001, 0.004, 0.009, 
0.019, 0.079, 0.60, 2.3, 4.3, 7.2, 12, 25, and 75 s after mixing. For Y108F, spectra were obtained 0.001, 0.071, 
0.17, 0.31, 0.64, 1.1, 2.2, 6.1, 12, 20, 45, and 120 s after mixing. For Y503F, spectra were obtained 0.001, 
0.071, 0.17, 0.31, 0.64, 1.1, 5.0, 8.7, 17, 44, and 120 s after mixing. Bottom panels show spectra of reaction 
intermediates obtained after spectral deconvolution of the stopped-flow data for wt-VAO, Y108F, and 
Y503F. Data was fit to a three-phase model (1→2→3→4), yielding four spectrally distinct species: 1 
(black solid line), 2 (red short dashes), 3 (blue dots) and 4 (green long dashes). One- or two-phase 
models were not able to satisfactorily explain the data. The rates obtained for the three phases (average 
of at least 3 measurements) are: k1 = 134 s-1, k2 = 3.7 s-1, and k3 = 0.093 s-1 for wt-VAO, k1 = 29 s-1, k2 = 1.7 s-
1, and k3 = 0.051 s-1 for Y108F, and k1 = 13 s-1, k2 = 2.7 s-1, and k3 = 0.083 s-1 for Y503F. These rates are in 
good agreement with those obtained by fitting to single wavelength traces at 440 nm (see Table 3). 
intermediate was observed after 2.2 s for the Y108F variant and after 1.5 s for the Y503F 
variant,after which the intermediate decays. Spectral deconvolution again revealed a three-
phase process (Fig. 2). As with wt-VAO, species 1 and 3 represent the oxidised enzyme and 
the para-quinone methide–reduced enzyme complex respectively. Species 2 again displays an 
absorption spectrum that is a composite of that of species 1 and 3 and is likely not a real 
reaction intermediate. Species 4 appears to represent a mixture of para-quinone methide–
reduced enzyme complex and free reduced enzyme. This is likely due to the decay of the para-
quinone methide not being complete at the end of the measurement (120 s). Fitting the data at 
440 nm to triple exponential functions revealed that kobs1 and kobs2 are both decreased in each 
variant as compared with wt-VAO (Table 3). However, neither rate in either variant decreased 
more than tenfold. Thus, the effect of the Y108F and Y503F mutations on the rate of reduction 
of VAO by chavicol is less severe than that on the rate of reduction by vanillyl alcohol  
(kobs1 and kobs2 decreased >100-fold in each variant). Interestingly, a similar effect on the relative 
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Table 3: Observed rates of reduction of VAO variants by 100 μM chavicol. Rates were determined by 
fitting appropriate exponential functions to traces of the absorption at 440 nm [from photodiode array 
detection (wt-VAO, Y108F, and Y503F)] or 439 nm [from single wavelength detection (Y108F/Y503F)] 
obtained after mixing 10 μM enzyme with 100 μM chavicol in 50 mM potassium phosphate buffer, pH 
6.2 or 7.5, under anaerobic conditions at 25 °C using a stopped-flow apparatus. Values in parentheses 
give the relative contribution of kobs1 and kobs2, the two phases associated with flavin reduction, to the 
drop in absorption. The observed rates for the oxidation of 100 μM chavicol under steady-state 
conditions (kss) at pH 7.5 are given for comparison. NO = not observed. 
pH 7.5 
VAO variant kobs1 (s−1) kobs2 (s−1) kss (s−1) 
wild-type 139 ± 1 (0.76) 4.5 ± 0.1 (0.24) 6.8 
Y108F 33 ± 1 (0.13) 1.6 ± 0.1 (0.87) 2.0 
Y503F 14 ± 1 (0.07) 2.6 ± 0.1 (0.93) 2.3 
Y108F/Y503F 19 ± 1 (0.05) 0.11 ± 0.01 (0.95) 0.069 
pH 6.2    
VAO variant kobs1 (s−1) kobs2 (s−1)  
wild-type 132 ± 1 (0.30) 3.7 ± 0.1 (0.70)  
Y108F NO 0.79 ± 0.01 (1.00)  
Y503F NO 1.7 ± 0.1 (1.00)  
Y108F/Y503F 21 ± 1 (0.06) 0.027 ± 0.001 (0.94)  
 
contributions of kobs1 and kobs2 to reduction was observed with chavicol as with vanillyl alcohol, 
with kobs1 contributing most in wt-VAO, but kobs2 contributing most in the Y108F and Y503F 
variants. Reduction of the Y108F/Y503F variant by chavicol was monitored using single 
wavelength detection at 439 nm. In this case, the data fit best to a double exponential function. 
Interestingly, kobs1 is in the same range as for the Y108F and Y503F variants, whereas kobs2 is an 
order of magnitude smaller. This brings it into the same range as kobs3 observed for wt-VAO 
and the Y108F and Y503F variants. This provides an explanation for the absence of a third 
phase, as the decay of the para-quinone methide intermediate is now likely no longer 
distinguishable from the second flavin reduction phase. As with Y108F and Y503F, kobs2 makes 
the largest contribution to flavin reduction. For all variants, kobs2 lies close to the observed rate 
of steady-state catalysis, suggesting it is rate-limiting. 
Upon reduction of wt-VAO and the Y108F and Y503F variants by 100 μM chavicol at pH 6.2, 
similar spectral changes were observed as at pH 7.5. Formation of a para-quinone methide 
intermediate and concomitant reduction of FAD were followed by the decay of the para-
quinone methide intermediate, which was too slow to be catalytically relevant. The observed 
reduction rates are given in Table 3. For wt-VAO, the reduction is a biphasic process. The two 
rates are similar to those observed at pH 7.5, however, as with vanillyl alcohol, the 
contribution of the rates to the drop in absorbance changes, with kobs2 becoming more 
predominant (a1:a2 ≈ 1:2 at pH 6.2 compared with a1:a2 ≈ 3:1 at pH 7.5). For the Y108F and Y503F 
variants, only a single reductive phase was observed, with rate constants that are similar to 
those of kobs2 at pH 7.5, suggesting that the observed rate can be attributed to the same process 
as kobs2 and that the process associated with kobs1 does not make an observable contribution to 
the reduction at pH 6.2. For the Y108F/Y503F variant, the reduction was observed to be 
biphasic with the rates of the two phases and their relative contributions being similar to those 
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observed at pH 7.5. However, the contribution of the slower phase to the reduction may be 
underestimated. After reduction of Y108F/Y503F a residual absorbance of 0.03 was measured 
(usually approximately 0.015). With the Y108F and Y503F variants it was observed that after 
the reduction was complete, the absorption at 440 nm increased, likely due to the formation 
of a charge transfer interaction between the reduced enzyme and a bound substrate molecule. 
Due to the slow rate of reduction of the Y108F/Y503F variant, formation of such a charge 
transfer complex could occur on a similar timescale as the reduction, which would cause part 
of the absorbance drop associated with the reduction to be masked. 
To study the pH-dependence of the reaction in more detail, the anaerobic reduction of wt-
VAO by 50 μM chavicol was studied in the pH range 6.1-9.5. The overall spectral changes, as 
monitored using photodiode array detection, were similar to those observed during the 
experiments presented in Figure 2 at all pH values. Reduction of FAD and concomitant 
formation of a para-quinone methide–reduced enzyme complex was followed by the decay of 
the para-quinone methide intermediate to yield the fully reduced enzyme spectrum. As before, 
the absorption at 440 nm was fit to a triphasic exponential function, yielding two rates that 
are associated with flavin reduction: kobs1 and kobs2. The values of kobs1 and kobs2 remained similar 
in this pH range, with the lowest and highest values never differing more than a factor two 
(Fig. 3 inset). The pH-dependence of the fractional contribution of kobs1 to the reduction is 
shown in Figure 3. The contribution of kobs1 increases with pH. Attempts to fit the data to the 
Henderson-Hasselbach equation, which allows the determination of the pKa of an ionisable 
group were unsuccessful. Although the data display a sigmoidal form, the slope of the 
  
 
Figure 3: pH-dependence of the contribution of kobs1 to the reduction of 10 μM wt-VAO by 50 μM 
chavicol. Anaerobic substrate and enzyme solutions in Britt-Robinson buffers of appropriate pH values 
were mixed in a stopped-flow apparatus and absorbance changes were monitored using a photodiode 
array detector. Fitting curves to the absorbance at 440 nm yielded two reduction rates: kobs1 (fast) and 
kobs2 (slow). The graph shows the fraction of the change in absorbance associated with reduction that is 
contributed by kobs1 [fraction kobs1 = aobs1/(aobs1+aobs2), where a is the amplitude]. The solid line is a fit of a 
sigmoidal function to the data, from which a midpoint pH value (fraction kobs1 = fraction kobs2 = 0.5) of 
6.9 was estimated. The inset shows the values of kobs1 (▲) and kobs2 (●). The error on each data point is 
less than 5%. 
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sigmoid is lower than described by the Henderson-Hasselbach equation. To estimate the 
midpoint at which the contribution of kobs1 and kobs2 to reduction is equal, the data was fit to a 
sigmoidal curve with the slope as a variable, yielding a midpoint of pH 6.9. 
Isoeugenol binding studies 
To evaluate whether the introduced mutations affect the protonation state of phenolic 
compounds bound to VAO, we studied the binding of the competitive inhibitor isoeugenol to 
the VAO variants. In solution, the phenolic hydroxyl group of isoeugenol has a pKa of 
approximately 10 and its absorption spectrum is dependent on its protonation state (2). In 
particular, deprotonated isoeugenol displays significantly higher absorption at 320 nm than 
protonated isoeugenol (ε320 = 0.21 mM−1 cm−1 at pH 6 and 8.8 mM−1 cm−1 at pH 12). Therefore, 
the absorption of isoeugenol at 320 nm upon binding to VAO can act as a reporter on its 
protonation state. The pKa of isoeugenol bound to wt-VAO is approximately 5 (2). To evaluate 
whether this has been perturbed by the introduced mutations, the VAO variants were titrated 
with isoeugenol at pH 7.5. At this pH, isoeugenol is almost entirely protonated in solution, 
but almost entirely deprotonated when bound to wt-VAO.  
Spectral changes observed upon titration of wt-VAO with isoeugenol are shown in Figure 4. 
Upon addition of isoeugenol, the intensity of the absorption peak of oxidised FAD at 439 nm 
decreases, while the absorption at wavelengths below 335 nm increases, which is due to the 
absorption of the added isoeugenol. Plots of the absorption at 439 nm and 320 nm against the 
concentration of isoeugenol displayed a curvature indicative of a binding event (Fig. 4 inset). 
The data at each of these wavelengths could be satisfactorily fit to a model assuming a simple 
1:1 complex formation between isoeugenol and VAO. This yielded a dissociation constant of 
6.8 ± 0.5 μM from the data at 439 nm and 6.8 ± 1.0 μM from the data at 320 nm. The increase 
in the absorption at 320 nm associated with binding of isoeugenol to VAO is indicative of the 
fact that, as expected, it is primarily in its deprotonated form upon binding to the enzyme. 
Somewhat different spectral changes were observed upon titration of the Y108F variant with 
isoeugenol (Fig. 4). As with wt-VAO, the intensity of the peak at 439 nm decreases and 
absorption below 335 nm increases. In addition, a broad absorption band appears at 
wavelengths between 500 and 680 nm. Such a broad absorption band at high wavelengths is 
indicative of a charge transfer interaction between isoeugenol and FAD, likely caused by π-
stacking of the aromatic rings of isoeugenol and isoalloxazine. Similar charge transfer bands 
have been observed upon binding of various aromatic compounds to the flavoprotein subunit 
of PCMH (13). Fitting of the data at 439 nm yielded a dissociation constant of 18 ± 2 μM, 
suggesting binding of isoeugenol is slightly impaired in the Y108F variant as compared with 
wt-VAO. The absorption at 550 nm also displayed curvature indicative of a single binding 
event and fitting yielded a dissociation constant of 20 ± 1 μM. This suggests that the drop in 
absorption at 439 nm and charge transfer band at wavelengths above 500 nm are both caused 
by the same binding event, the formation of a 1:1 complex between isoeugenol and Y108F. The 
absorption at 320 nm, however, did not display the major increase associated with binding to 
wt-VAO. This suggests that isoeugenol is primarily in its protonated form when bound to 
Y108F and that the protonated form of isoeugenol forms a charge transfer complex with the 
FAD cofactor of Y108F. 
  
Chapter 4 
96 
 
 
Figure 4: Spectral changes observed upon titration of wt-VAO, Y108F, Y503F, or Y108F/Y503F with the 
competitive inhibitor isoeugenol. Isoeugenol was added to a 10 μM enzyme solution in 50 mM 
potassium phosphate buffer, pH 7.5. After each addition, an absorption spectrum was recorded. Spectra 
recorded at isoeugenol concentrations of 6.6, 13.2, 19.8, 36.0, 51.9, 98.3, 211, and 312 μM are shown. The 
displayed spectra are corrected for dilution due to the addition of isoeugenol. Arrows indicate the 
direction of the observed changes in absorption upon increasing isoeugenol concentration. Insets show 
the absorption measured at 320 (▲), 439 (●), and 550 (■) nm, with fitted lines used to determine 
dissociation constants. Absorbance values in these insets are not corrected for dilution.   
For Y503F, the absorption peak at 439 nm also decreased in intensity upon addition of 
isoeugenol (Fig. 4). Fitting to the data at 439 nm yielded a dissociation constant of 91 ± 7 μM, 
indicating that binding of isoeugenol is significantly weaker than for wt-VAO. Similar to 
Y108F, the appearance of a charge transfer band at wavelengths above 500 nm was observed. 
However, the measured absorption of this band was too low to reliably determine the 
dissociation constant. The absorption at 320 nm essentially increased linearly with the 
isoeugenol concentration, suggesting it is due to the presence of deprotonated isoeugenol in 
solution and that isoeugenol is predominantly in its protonated form upon binding to Y503F. 
With Y108F/Y503F, the results of the titration strongly resemble those with Y108F (Fig. 4). 
Dissociation constants of 11 ± 1 and 7.0 ± 0.4 μM were obtained by fitting to the data at 439 
and 550 nm respectively. The appearance of a charge transfer band is observed and the 
absorption at 320 nm does not show the large increase associated with binding to wt-VAO. 
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This suggests that, like for the Y108F and Y503F variants, isoeugenol is predominantly in its 
protonated form when in complex with Y108F/Y503F. 
Crystal structures  
To evaluate the effects of the mutations on the architecture of VAO’s active site, the crystal 
structures of the Y108F and Y503F variants were solved at 2.8 Å resolution by molecular 
replacement using the VAO monomer [PDB ID: 2VAO (4)] as a search model. Attempts to 
solve the structure of the Y108F/Y503F variant were hampered by fragility of the crystals. The 
overall structures of both Y108F and Y503F are essentially identical to that of wt-VAO, as 
indicated by an RMSD of 0.5 Å for 1105 and 1108 pairs of Cα atoms, respectively. The 
asymmetric unit contains two monomers, which form the functional octamer through 
crystallographic symmetry, as in wt-VAO. 
The geometry of the active site in the mutated enzymes is largely conserved, with the aromatic 
ring of Phe-108 or Phe-503 located at the same position as the corresponding tyrosine residue 
in wt-VAO, where they each form a hydrogen bond with the phenolic hydroxyl group of 
isoeugenol (Fig. 5) (4). Additionally, Tyr-108 interacts with Ser-426 via a hydrogen bond. This 
interaction is disrupted in the Y108F variant, causing a shift of the Phe-108 side chain towards 
the FAD cofactor (Fig. 5B). In the Y503F variant, the plane of the aromatic ring of Phe-503 is 
slightly tilted compared to Tyr-503 in wt-VAO (Fig. 5C). This may partly be due to the lack of 
the hydrogen bond between Tyr-503 and Arg-504 that is present in wt-VAO. 
In summary, both the overall structure of the Y108F and Y503F variants and the geometry of 
their active sites are extremely similar to wt-VAO. Therefore, changes in reactivity are not due 
to major structural perturbations, but can be attributed to the disruption of the hydrogen 
bonding capacity conferred by the two tyrosine residues. 
 
 
Figure 5: Structure of the phenolate binding pocket of VAO in the wild-type enzyme [A, carbon atoms 
in white (PDB ID: 2VAO)] and in the Y108F and Y503F variants (B and C respectively, carbon atoms in 
grey). The refined 2Fo − Fc electron density map (contoured at 1.2σ) is shown for the mutated residues 
Phe-108 and Phe-503 as blue chicken-wire. The wt-VAO crystal structure in complex with the 
competitive inhibitor isoeugenol (A, carbon in green) is taken as a reference to analyse the mutant 
proteins. Phe/Tyr-108, Phe/Tyr-503, Arg-504, Ser-426, isoeugenol, and the FAD cofactor (carbon in 
yellow) are displayed in stick representation with the surrounding protein backbone shown in cartoon 
representation. Potential hydrogen bonds are depicted as black dashed lines.  Nitrogen atoms are 
shown in blue, oxygen atoms in red and phosphorus atoms in pink. As reported in (4), binding of 
isoeugenol does not significantly influence the geometry of the active site. In B and C, the side chains 
of Tyr-108 and Tyr-503 respectively from wt-VAO are shown for comparison. As described in the text, 
in the Y503F variant Phe-503 is slightly tilted with respect to the corresponding Tyr-503 in wt-VAO. The 
figure was prepared using CCP4mg (14). 
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Conservation of the phenolate binding pocket in VAO homologues 
To determine whether the residues that form the phenolate binding pocket in VAO are also 
present in homologous proteins, we evaluated their conservation in a group of homologues 
of VAO, EUGO, PCMH and the related flavocytochrome eugenol hydroxylase from 
Pseudomonas sp. OPS1 (EUGH) (15) that we identified in a previous study and named the 4-
phenol oxidising (4PO) subfamily (12, Chapter 3). Additionally, we determined whether they 
are present in the decarboxylases CndG and FeeG, which catalyse the oxidative 
decarboxylation of N-substituted tyrosine derivatives (16, 17). These also belong to the 4PO 
subfamily and their catalytic mechanism is believed to involve the initial formation of a para-
quinone methide intermediate followed by the expulsion of carbon dioxide. This analysis 
revealed that Tyr-108, Tyr-503 and Arg-504 are strictly conserved suggesting they are of 
importance for catalysis in these related enzymes.  
Discussion 
Our results demonstrate that the presence of at least one of the active site tyrosine residues 
Tyr-108 and Tyr-503 is essential for efficient catalysis by VAO, with the kcat values for 
Y108F/Y503F being less than 2% of those for wt-VAO for each tested substrate. The effect of 
the single tyrosine to phenylalanine mutations on catalytic efficiency was dependent on the 
substrate. The oxidation of vanillyl alcohol was severely impaired in both the Y108F and 
Y503F variants, whereas the oxidation of chavicol was only slightly impaired as compared 
with wt-VAO. 
Stopped-flow kinetics revealed that reduction of the FAD cofactor of VAO by vanillyl alcohol 
or chavicol proceeds at two distinct rates: kobs1 (fast) and kobs2 (slow). kobs2 lies close to the rate 
of steady-state catalysis and, therefore, is probably rate-limiting. The observed reduction in 
the rate of steady-state catalysis for the tyrosine to phenylalanine variants corresponds with 
the observed reduction in kobs2, demonstrating that impaired flavin reduction is the cause of 
the reduced rate of catalysis. Titration with the competitive inhibitor isoeugenol indicated that, 
at pH 7.5, this molecule is predominantly in its deprotonated phenolate form when bound to 
wt-VAO, but predominantly in its protonated form when bound to Y108F, Y503F, or 
Y108F/Y503F. In combination, these results suggest that Tyr-108 and Tyr-503 play a role in 
activating VAO’s substrates for their reaction with its FAD cofactor by enabling their 
deprotonation in the active site of the enzyme. Interestingly, the relative contributions of the 
two reduction rates, kobs1 and kobs2, to the change in absorption associated with flavin reduction 
changes upon the introduction of the tyrosine to phenylalanine mutations. At pH 7.5, kobs1 
contributes more to the drop in absorption in wt-VAO, whereas in the Y108F, Y503F, and 
Y108F/Y503F variants, kobs2 contributes more to the drop in absorption. The relative 
contributions of the two rates shift when the reduction is performed at pH 6.2, with the 
relative contribution of kobs2 becoming greater. The reduction of the Y108F/Y503F variant by 
chavicol was an exception to this observation. However, this may be due to the contribution 
of kobs2 to the reduction at pH 6.2 being underestimated due to the concomitant formation of a 
charge transfer interaction between the reduced enzyme and substrate. For the reduction of 
wt-VAO by chavicol, the contribution of kobs1 increases with pH in the pH range 6.1-9.5. The 
data was fit to a sigmoidal curve with a midpoint pH, at which kobs1 and kobs2 contribute equally 
to the reduction, of 6.9.  
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Based on these results, we propose a somewhat modified model for the reaction mechanism 
of VAO (Scheme 2). Substrates can bind in the active site of VAO with their phenolic hydroxyl 
group either in its protonated or deprotonated form. The affinity of the enzyme for the 
substrate depends on the protonation state of the substrate, with wt-VAO displaying a higher 
affinity for deprotonated substrates. Subsequently, the substrate reacts with VAO, a reaction 
that occurs at different rates depending on the protonation state of the substrate. With the 
deprotonated substrate, the reaction simply involves the transfer of a hydride to the FAD 
cofactor to yield the para-quinone methide intermediate. Reaction with the protonated 
substrate requires the deprotonation of the substrate’s phenolic hydroxyl group either prior 
to or at the same time as the hydride transfer reaction. The proton is transferred to either Tyr-
108 or Tyr-503, which may be transiently deprotonated in the enzyme’s active site. This is 
stimulated by Arg-504, which is positioned so as to form a cation-π interaction with Tyr-108, 
lowering its pKa. This model explains the two rates of flavin reduction observed for each 
substrate, with kobs1 representing the reaction with deprotonated substrate and kobs2 
representing the reaction with protonated substrate. This is supported by the fact that the 
contribution of kobs1 to flavin reduction increases with pH, as at higher pH values a larger 
percentage of the substrate is in its deprotonated form. The results of the isoeugenol titrations 
support the idea that substrates bind to Y108F, Y503F, and Y108F/Y503F predominantly in 
their protonated form at pH 7.5, as opposed to wt-VAO where it predominantly binds in its 
deprotonated form. This explains the change in the relative contributions of kobs1 and kobs2 to 
flavin reduction upon introduction of the tyrosine to phenylalanine mutations. The mutations 
prevent the preferential binding of the deprotonated form of the substrates observed with wt-
VAO due to the loss of hydrogen bonding interactions that stabilise the negative charge on 
the phenolate oxygen. In support of this, the crystallographic analysis revealed that, though 
the mutations do not produce any major structural perturbation of the active site architecture, 
they modify the hydrogen bonding network that is essential to activate the substrate for the 
reaction with the flavin cofactor.  
The fact that the curve of the fractional contribution of kobs1 to the reduction versus pH does 
not obey the Henderson-Hasselbach equation may be attributable to the effects of functional 
groups near the phenolic hydroxyl group on its protonation state, which can have a distorting 
effect on the titration behaviour of ionisable groups in proteins (18). Additionally, 
interconversion of the enzyme‒protonated substrate (Eox-SH) and enzyme‒deprotonated 
substrate (Eox-S-) complexes may involve more significant changes than simply the 
deprotonation of the substrate’s phenolic hydroxyl group. The fact that a charge transfer 
interaction is observed between the enzyme variants and protonated isoeugenol during 
titrations with this molecule, but not between the wild-type enzyme and deprotonated 
isoeugenol, suggests that the ligand may bind to the enzyme in a slightly different orientation 
depending on its protonation state. Thus, conversion of the Eox-SH complex to the Eox-S- 
complex may require a reorientation of the substrate within the active site, and possibly minor 
changes in the conformation of active site residues. This could explain the reasonably low 
rates observed for kobs2. Although in our view this model provides the most satisfactory 
explanation of our observations, an alternative mechanism where the two observed reduction 
rates reflect the presence of two forms of the enzyme, one in which both Tyr-108 and Tyr-503 
are protonated and one in which one of the two tyrosine residues is deprotonated, cannot be 
fully ruled out.  
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Scheme 2: Proposed model for the reductive half-reaction of VAO. Substrates can bind to the enzyme 
with their phenolic hydroxyl group in its protonated (SH) or deprotonated (S‒) form. Upon binding of 
the deprotonated form, the enzyme is reduced, yielding the para-quinone methide‒reduced enzyme 
complex. Reduction by deprotonated substrate corresponds to kobs1 from the stopped-flow kinetic 
experiments presented here. Upon binding of the protonated form, the substrate must be deprotonated 
in order to allow flavin reduction to occur, i.e. the Eox-SH complex must be converted to the Eox-S− 
complex. This corresponds to kobs2 from the stopped-flow kinetic experiments. After the reduction, the 
product is released from the reduced enzyme. This step is too slow to be catalytically relevant, 
suggesting product release is faster in the presence of molecular oxygen.   
The effect of the single Y108F and Y503F mutations on the rate of reduction of VAO was 
dependent on the substrate used. With the benzylic alcohol vanillyl alcohol, a far more severe 
drop in both kobs1 and kobs2 was observed than with the 4-allyphenol chavicol. However, the 
change in the relative contributions of kobs1 and kobs2 to flavin reduction is similar. Possibly, the 
large effect on the reduction rate seen with vanillyl alcohol is due to incorrect positioning of 
the substrate in the active site of Y108F and Y503F. Hydrogen bonds between the substrate’s 
phenolic hydroxyl group and the two tyrosine residues may be of importance in maintaining 
it in the correct orientation for the hydride transfer reaction to take place. This effect may be 
less important for chavicol than for vanillyl alcohol, as interactions involving its longer side 
chain may lock it into position in the active site. In this context, it is interesting to note that the 
Km for the oxidation of chavicol by wt-VAO is significantly lower than that for the oxidation 
of vanillyl alcohol, indicating tighter binding of chavicol. 
In addition to the 4PO subfamily members mentioned above, a catalytic motif composed of 
two tyrosine residues has been proposed to be involved in substrate activation in other 
enzymes in which catalysis proceeds through a para-quinone methide intermediate, such as 
the cofactor-independent hydroxycinnamoyl-CoA hydratase-lyase from Pseudomonas 
fluorescens AN103 (19) and bacterial phenolic acid decarboxylases [(20) [although an 
alternative mechanism has also been proposed (21, 22)])]. This suggests that these structurally 
unrelated proteins have obtained similar mechanisms for the activation of the phenolic 
hydroxyl groups of their substrates through convergent evolution.  
Catalytic motifs composed of two tyrosine residues have also been implicated in substrate 
activation in a number of enzymes that catalyse oxidation reactions that do not involve a para-
substituted phenol. They have been proposed to facilitate the activation of hydroxyl groups 
for their oxidation to carbonyls in other oxidoreductases from the VAO/PCMH family, such 
as aclacinomycin oxidoreductase from Streptomyces galilaeus ATCC 31615 (23), Dbv29 from 
Nonomuraea sp. ATCC 39727 (24), GilR from Streptomyces griseoflavus (25), and the monolignol 
oxidoreductase BBE-like protein 15 from Arabidopsis thaliana (26). These enzymes all belong to 
the same clade of the VAO/PCMH family, which primarily contains enzymes with a 
bicovalently bound FAD cofactor (27, Chapter 2). Despite their homology with VAO, a 
sequence and structural alignment of the five proteins demonstrated that the tyrosine pair 
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found in these enzymes is not equivalent to that found in VAO, suggesting the motifs evolved 
separately. 
In summary, the results presented here indicate that two tyrosine residues, Tyr-108 and Tyr-
503, are responsible for activating the phenolic substrates of VAO for oxidation by facilitating 
the binding of their deprotonated phenolate form in the active site, shedding light on the 
catalytic mechanism of VAO and other homologous flavoenzymes that oxidise para-
substituted phenols. 
Materials and methods 
Materials 
Vanillyl alcohol and isoeugenol were from Sigma-Aldrich (St. Louis, MO, USA). Chavicol was 
from Quest International (Naarden, NL). All other chemicals were from commercial sources 
and of the purest grade available.  
Cloning, protein expression and purification 
Constructs encoding for the Y108F and Y503F variants were created by linear whole-plasmid 
amplification from the pBC11 (28) plasmid using the mutagenic primers 
CATCTCTATTGGAAGGAATTCCGGATTTGGCGGTGCTGCGCC (Y108F) and 
ATGGATGGGGC GAATTTCGAACCCATCTGGC (Y503F) (nucleotides in italics are the sites 
of mutation for introduction of the tyrosine to phenylalanine mutations, the underlined 
nucleotide indicates the site of a silent mutation that introduces an EcoRI site). After 
amplification and concomitant ligation, template DNA was digested using DpnI and the 
mutagenised plasmids were transformed into DH5α E. coli. Correct plasmids, as confirmed 
by sequencing, were transformed into BL21 E. coli for protein expression. The construct 
encoding for the Y108F/Y503F variant was created in a similar manner, using the plasmid 
encoding for the Y108F variant as the template for amplification and the primer for the Y503F 
variant. All variants were expressed and purified as described previously for wt-VAO (12). 
Analytical methods 
Unless specified otherwise, all experiments were performed in 50 mM potassium phosphate 
buffer, pH 7.5. Absorption spectra of purified proteins were recorded using a Hewlett Packard 
8453 diode array spectrophotometer (Agilent Technologies, Santa Clara, CA, USA) and 
enzyme concentrations were determined using the extinction coefficient of wt-VAO at 439 nm 
[ε = 12,500 M−1 cm−1 (1)]. For trichloroacetic acid precipitations, 5% (w/v) trichloroacetic acid 
was mixed with 10 μM enzyme and samples were incubated on ice for 30 min. Subsequently, 
the precipitated protein was pelleted by centrifugation (21,000 g, 15 min, 4 °C), and the 
presence of FAD in the pellet or supernatant was judged from its colour. The absence of FAD 
from the supernatants was confirmed by measuring their absorption spectra. Analytical gel 
filtration was performed using a Superdex 200 HR 10/30 column on an Äkta Pure 
chromatography system (GE Healthcare, Chicago, IL, USA). Samples of enzyme at a 
concentration of 10 μM were loaded onto the column and subsequently eluted in 50 mM 
potassium phosphate buffer, pH 7.5, containing 150 mM KCl. Molecular masses were 
determined based on a calibration curve of proteins of known mass. Thermal unfolding of the 
VAO variants was monitored by the ThermoFAD method (11) using a MiniOpticon real-time 
PCR system (Bio-Rad, Hercules, CA, USA). Protein solutions at a concentration of 7 μM were 
subjected to a temperature gradient from 25–70 °C and the fluorescence of the FAD cofactor 
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was measured every 0.5 °C with excitation and emission wavelengths of 485 ± 30 and 625 ± 30 
nm respectively. Thermal midpoints of unfolding were determined by finding the maximum 
of the derivative of the unfolding curves. 
Steady-state kinetics  
All experiments were performed at 25 °C in 50 mM potassium phosphate buffer, pH 7.5. The 
oxidation of vanillyl alcohol to vanillin was followed by monitoring the absorption of the 
product at 340 nm (ε = 14,000 M−1 cm−1). The oxidation of chavicol was followed by monitoring 
oxygen consumption using a Hansatech Oxytherm system (Hansatech Instruments, King’s 
Lynn, UK). Steady-state kinetic parameters were determined by fitting the obtained data to 
the Michaelis-Menten equation (vanillyl alcohol) using Igor Pro v. 6.10A (Wavemetrics, Lake 
Oswego, OR, USA) or to a modified version of the Michaelis-Menten equation that includes a 
term to take substrate inhibition into account (chavicol): 
𝑘𝑜𝑏𝑠 =  
𝑘𝑐𝑎𝑡 ∗ [𝑆]
𝐾𝑚 + [𝑆] +
[𝑆]2
𝐾𝑖
 
Where kobs is the measured initial rate, kcat is the turnover number, Km is the Michaelis constant, 
Ki is the inhibition constant for substrate inhibition and [S] is the substrate concentration. 
Stopped-flow kinetics 
The reduction of VAO variants by vanillyl alcohol or chavicol was followed using an SX20 
stopped-flow system (Applied Photophysics, Leatherhead, UK) equipped with a photodiode 
array detector or a photomultiplier detector as applicable. Enzyme and substrate solutions in 
50 mM potassium phosphate buffer, pH 6.2 or 7.5 as appropriate, containing 5 mM glucose 
were made anaerobic by first flushing them with N2 gas for 10 min and then adding 0.3 μM 
glucose oxidase. Subsequently, the enzyme and substrate solutions were mixed to final 
concentrations of 10 μM enzyme and 2 mM (vanillyl alcohol) or 100 μM (chavicol) substrate 
and spectral changes were monitored at 25 °C. Rate constants were obtained by global fitting 
of multiple single wavelength traces to appropriate exponential functions using Igor Pro. 
Spectral deconvolution of multiwavelength data was performed using Pro-Kineticist (Applied 
Photophysics). To study the pH-dependence of the reduction of wt-VAO by chavicol in more 
detail, the reaction was performed at various pH values in the pH range 6.1-9.5. Experiments 
were performed in Britt-Robinson buffers consisting of 40 mM acetic acid, 40 mM H3PO4, and 
40 mM H3BO3 set to the correct pH using KOH. The ionic strength of the buffers was set to 0.2 
M by the addition of K2SO4. Subsequently, enzyme and substrate solutions were made 
anaerobic as described above, mixed to final concentrations of 10 μM enzyme and 50 μM 
chavicol, and the reduction was monitored at 25 °C and data was analysed as described above. 
Isoeugenol binding studies 
Changes in the spectral properties of the VAO variants upon binding of the competitive 
inhibitor isoeugenol were monitored using a Cary 4000 spectrophotometer (Agilent 
Technologies). Isoeugenol was titrated to 10 μM enzyme in 50 mM potassium phosphate 
buffer, pH 7.5, and an absorption spectrum was recorded after every addition. Dissociation 
constants were determined by fitting the data at a specific wavelength to a model assuming 
formation of a 1:1 enzyme–isoeugenol complex using the following formula with Igor Pro: 
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𝐴 = 𝜀𝐸 ∗ [𝐸]𝑓 + 𝜀𝐸𝐼 ∗ [𝐸𝐼] + 𝜀𝐼 ∗ [𝐼]𝑓 
Where: 
[𝐸𝐼] =
[𝐸]𝑡 + [𝐼]𝑡 + 𝐾𝑑 − √([𝐸]𝑡 + [𝐼]𝑡 + 𝐾𝑑)2 − 4 ∗ [𝐼]𝑡 ∗ [𝐸]𝑡
2
 
And: 
[𝐸]𝑓 = [𝐸]𝑡 − [𝐸𝐼] 
And: 
[𝐼]𝑓 = [𝐼]𝑡 − [𝐸𝐼] 
With εE, εEI, and εI being the molar extinction coefficients of the free enzyme, the enzyme–
inhibitor complex, and the free inhibitor respectively, [E]f being the concentration of free 
enzyme, [EI] the concentration of enzyme–inhibitor complex, [I]f the concentration of free 
inhibitor, [E]t the total enzyme concentration, [I]t the total inhibitor concentration and Kd the 
dissociation constant. 
Crystallisation and structure determination 
VAO variants were crystallised by the hanging drop vapour diffusion method. Protein 
solutions at a concentration of 180–220 μM in 50 mM potassium phosphate buffer, pH 7.5, 
were mixed 1:1 (v/v) with a mother liquor containing 6% (w/v) PEG4000 in 100 mM sodium 
acetate buffer, pH 4.6, and equilibrated against the mother liquor at 20 °C. Prior to data 
collection, crystals were transferred to a cryoprotectant solution containing 10% (w/v) 
PEG4000 and 20% (w/v) glycerol in 100 mM sodium acetate buffer, pH 4.6, and cryo-cooled 
in liquid nitrogen. X-ray diffraction data was collected at the X06DA beamline of the Swiss 
Light Source synchrotron in Villigen, Switzerland (SLS) and at the ID30B beamline of the 
European Synchrotron Radiation Facility in Grenoble, France (ESRF). Images were integrated 
using MOSFLM (29) and data was scaled using programs of the CCP4 suite (30). Detailed data 
processing statistics are shown in Table 4. Structures of VAO variants were solved by 
molecular replacement using PHASER (31) with the structure of wt-VAO (PDB ID: 2VAO) 
devoid of all ligands and water molecules as a search model. Subsequently, structures were 
refined by alternating refinement using REFMAC5 (32) and manual model building using 
COOT (33). Atomic coordinates and structure factors were deposited in the Protein Data Bank 
under the PDB ID codes 5MXJ (Y108F-VAO) and 5MXU (Y503F-VAO). 
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Table 4: Data collection and refinement statistics. 
 Y108F Y503F 
PDB ID Code 5MXJ 5MXU 
Space group I4 I4 
Resolution (Å) 2.8 2.8 
a, b, c (Å) 137.9, 137.9, 132.9 138.0, 138.0, 132.9 
Rsyma,b,c (%) 8.7 (67.9) 10.1 (63.8) 
CC1/2a,c  0.99 (0.54) 0.99 (0.54) 
Completenessb (%) 89.7 (91.9) 91.8 (94.3) 
Unique reflections 27138 27846 
Multiplicityc 2.3 (2.1) 2.4 (2.4) 
I/c 9.0 (1.3) 7.0 (1.3) 
Number of atoms:   
      protein  8697 8706 
      FAD/glycerol/water 2 × 53/3 × 6/260 2 × 53/2 × 6/232 
Average B value for all atoms (Å2) 52.1 52.6 
Rcrystc,d (%) 18.0 (34.2) 17.5 (30.2) 
Rfreec,d (%) 25.9 (33.7) 24.9 (37.4) 
Rms bond length (Å) 0.01 0.01 
Rms bond angles () 1.56 1.48 
Ramachandran outliers (%) 0 0 
a Data processing statistics were based on CC1/2 as described in (34, 35). 
b Rsym = |Ii − <I>|/Ii, where Ii is the intensity of ith observation and <I> is the mean intensity of the 
reflection.  
c Values in parentheses are for reflections in the highest resolution shell. 
d Rcryst = |Fobs − Fcalc|/|Fobs| where Fobs and Fcalc are the observed and calculated structure factor 
amplitudes, respectively. Rcryst and Rfree were calculated using the working and test sets, respectively 
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Summary 
The oxidation of alcohols to carbonyl compounds is one of the most important reactions in 
organic chemistry. Biocatalysis provides an attractive alternative to traditional methods of 
alcohol oxidation. Enzyme-catalysed oxidations are often highly regioselective, enabling the 
oxidation of polyols without the need for complex protection schemes. Many oxidative 
enzymes also display exquisite enantioselectivity and thus can be used for the preparation of 
enantiopure secondary alcohols by kinetic resolution or deracemisation. The use of 
biocatalysts also has advantages from the point of view of sustainability. This is particularly 
true for oxidases, which catalyse the oxidation of their substrates using molecular oxygen as 
the final electron acceptor. This chapter provides an overview of the known alcohol oxidases, 
the reactions they catalyse and, where available, examples of their use for synthetic purposes.
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Introduction 
The oxidation of alcohols is one of the most important reactions in synthetic organic chemistry, 
as the products that are formed can be used as precursors for a wide variety of compounds. 
Primary alcohols can be oxidised to either aldehydes or carboxylic acids, while the oxidation 
of secondary alcohols usually results in the formation of ketones. Conventionally, alcohol 
oxidation is achieved using stoichiometric amounts of chemical oxidants. Well-known 
examples include metal-based oxidants (e.g. chromium, ruthenium or manganese 
compounds), various forms of activated dimethyl sulfoxide and hypervalent iodine 
compounds (1). These traditional oxidants suffer from a number of drawbacks. Their lack of 
specificity can lead to undesired side reactions and they display poor regio- and 
stereoselectivity, necessitating the use of complex protection schemes if multiple reactive 
functional groups are present in a compound. Additionally, their use in stoichiometric 
amounts is undesirable from an environmental perspective, especially for industrial-scale 
applications. In recent years, progress has been made in the development of compounds that 
can catalyse the oxidation of alcohols with cheap oxidants, e.g. molecular oxygen, acting as 
the final electron acceptor. These include various transition metal-based catalysts (e.g. copper, 
ruthenium or palladium compounds) and organocatalysts such as the nitroxyl radical 2,2,6,6-
tetramethylpiperidine-N-oxyl (TEMPO) (2, 3).  
Another promising alternative to the use of traditional chemical oxidants is biocatalysis (4, 5). 
In contrast to chemical oxidation methods, enzymatic oxidation reactions are often highly 
regioselective. The asymmetric environment of an enzyme’s active site also allows many 
enzymatic reactions to proceed stereoselectively, a feat that is hard to accomplish by chemical 
means. Additionally, enzymatic catalysis has advantages from the point of view of 
sustainability, as enzymes can be produced in a biological system and are active under mild 
reaction conditions and in aqueous environments. Enzymatic reactions also do not require the 
addition of toxic compounds (such as transition metals) and thus are ideally suited for use in 
the pharmaceutical and food industries. A large number of enzymes are known to be capable 
of oxidising alcohols to carbonyl compounds. These enzymes are either dehydrogenases or 
oxidases, depending on the identity of their final electron acceptor. Dehydrogenases do not 
react with oxygen and instead depend on the presence of alternative electron acceptors, such 
as NAD(P)+, quinones or heme for their activity. Therefore, the use of dehydrogenases in 
organic synthesis requires the addition of stoichiometric amounts of these cofactors or of 
efficient systems for their regeneration. Oxidases on the other hand, use cheap and ubiquitous 
oxygen as a final electron acceptor, making them attractive candidates for biocatalytic 
applications. This chapter provides an overview of the known classes of alcohol oxidase 
enzymes, the reactions they catalyse and examples of their application in organic chemical 
synthesis.  
Flavin-dependent alcohol oxidases  
Most alcohol oxidases are flavoenzymes, which contain a flavin cofactor (FAD or FMN). 
Flavoenzymes usually bind this cofactor non-covalently, but a number of oxidases have been 
identified where the flavin is anchored to the enzyme through either one or two covalent 
bonds (6). The flavin acts as a redox cofactor, shuttling electrons from the alcohol substrate to 
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molecular oxygen. Although flavin-dependent oxidases convert a large variety of different 
alcohols, a number of general mechanistic principles can be defined that appear to hold true 
for the majority of the enzymes. The reactions can be divided into a reductive half-reaction, 
during which two electrons are transferred from the alcohol substrate to the oxidised flavin 
cofactor, and an oxidative half-reaction, during which the flavin is re-oxidised by the transfer 
of two electrons to molecular oxygen. At the start of the reductive half-reaction, the alcohol is 
bound in the active site of the enzyme, with its Cα atom positioned at a distance of 
approximately 3.5 Å from the flavin N5 atom (7). In many cases, the enzyme stimulates the 
deprotonation of the hydroxyl group of the alcohol, which facilitates oxidation by promoting 
the formation of a C=O bond (7, 8). Subsequently, two electrons are transferred from the 
alcohol Cα atom to the flavin N5 atom, yielding reduced flavin and the carbonyl product. The 
electron transfer is generally believed to proceed via the direct transfer of a hydrogen anion 
(9, 10). During the oxidative half-reaction the reduced flavin cofactor is reoxidised by 
molecular oxygen (11, 12).  
Many flavin-dependent alcohol oxidases belong to one of two protein families: the glucose-
methanol-choline oxidase (GMC) family or the vanillyl alcohol oxidase/para-cresol 
methylhydroxylase (VAO/PCMH) family (13). Members of each family can be recognised by 
the presence of a characteristic FAD-binding domain that is conserved within the family (14, 
15). The presence of a more variable substrate-binding domain, which determines the 
architecture of the active site, allows great variety in the type of substrates that are oxidised 
by members of each family. The different types of flavin-dependent alcohol oxidases and the 
reactions they catalyse are discussed below.  
Methanol oxidase 
Methanol oxidase (MO, also known as alcohol oxidase, EC 1.1.3.13) is a member of the GMC-
type oxidase family. MO is found in a large number of fungi and methylotrophic yeasts. A 
number of MOs are commercially available, including the enzymes from Pichia pastoris, 
Candida boidinii and Hansenula polymorpha (16–19). The subunit molecular masses of MOs 
range from 65 to 85 kDa and most of the characterised enzymes form octamers, though 
tetrameric variants have also been reported (20, 21). Each MO subunit contains a non-
covalently bound FAD cofactor, which is sometimes post-translationally modified to arabino-
FAD (22, 23). 
MOs catalyse the oxidation of short-chain unbranched primary alcohols with chain lengths of 
up to 5 carbon atoms (Scheme 1). Usually, methanol is the best substrate, with the catalytic 
efficiency decreasing as the chain length of the substrate increases. Many MOs readily oxidise 
unsaturated alcohols and alcohols with substituents such as chloro, bromo, thiol or cyano 
groups. Secondary and branched chain alcohols are generally poor MO substrates. Many MOs 
can also oxidise formaldehyde to formic acid, though at a far lower rate than they oxidise 
methanol.  
 
A potential application of MO in organic synthesis is the in situ formation of reactive 
aldehydes. Siebum et al. utilised MO from P. pastoris in the one-pot synthesis of the aldol 1 
from 4-penten-1-ol and acetone (Scheme 2) (24). This was achieved via a cascade reaction,  
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Scheme 1: Oxidation of primary alcohols catalysed by methanol oxidase (MO). 
where conversion of the alcohol to the corresponding aldehyde by MO was followed by 
enantioselective aldol addition catalysed by 2-deoxyribo-5-phosphate aldolase. This 
procedure yielded 1 in a yield of 30% and an enantiomeric excess of 70%. 
 
Scheme 2: Synthesis of (S)-4-hydroxyoct-7-en-2-one (1) using methanol oxidase (MO) and an aldolase 
(24). 
MO has also been applied in the synthesis of enantiomerically pure 2-hydroxyketones 2 from 
benzaldehyde and various aliphatic alcohols (Scheme 3) (25). This was achieved using a one-
pot cascade reaction, where oxidation of the alcohols to aldehydes by MO was combined with 
enantioselective carboligation by benzaldehyde lyase. For short unbranched saturated 
alcohols this procedure yielded the (R)-enantiomers of 2, generally in good yields and 
excellent enantiomeric excess. The procedure with methanol was extended by the 
enantioselective reduction of the formed 2-hydroxy-1-phenylethan-1-one by an alcohol 
dehydrogenase, yielding enantiomerically pure (S)-1-phenylethane-1,2-diol in quantitative 
yield and an enantiomeric excess of >99% (26).  
Recently, a similar cascade was employed for the synthesis of chiral benzoins from benzyl 
alcohols (27). The oxidation of benzyl alcohols by MO from Pichia pastoris was combined 
with the enantioselective carboligation of the formed aldehydes catalysed by benzaldehyde 
lyase. With benzyl alcohol as a substrate, the cascade was employed for the synthesis of 4.6 g 
enantiomerically pure (R)-benzoin 3 (Scheme 4, 82% isolated yield). Various substituted 
benzyl alcohols, particularly those bearing substituents at the para-position, were also 
successfully converted.  
Isoamyl alcohol oxidase 
Isoamyl alcohol oxidase (IAAO) from the fungus Aspergillus oryzae oxidises branched chain 
alkanols. IAAO is a 73 kDa glycoprotein that is predicted to contain covalently-bound FAD 
(28). IAAO has a relatively narrow substrate range. Its best substrate is 3-methylbutan-1-ol 
(isoamyl alcohol), which is converted to 3-methylbutanal (isovaleraldehyde). IAAO is also  
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R1 Conversion to 2 (%) ee (%) 
H >99 - 
Me >99 99 
Et 15 98 
Pr 91 98 
Pentyl 0 - 
iPr 0 - 
s-Bu 0 - 
Vinyl 0 - 
Scheme 3: Synthesis of 2-hydroxyketones (2) from alcohols and benzaldehyde using methanol 
oxidase (MO) and benzaldehyde lyase (25). 
 
Scheme 4: Synthesis of (R)-benzoin (3) from benzyl alcohol using methanol oxidase (MO) and 
benzaldehyde lyase (27). 
active with 1-pentanol, 1-hexanol and 4-methylpentan-1-ol. Alcohols with less than 5 or 
more than 6 carbon atoms are poor substrates for IAAO. 
Long-chain alcohol oxidase 
Long-chain alcohol oxidase (LCAO, EC 1.1.3.20, also known as fatty alcohol oxidase) oxidises 
various primary and secondary long-chain alcohols to the corresponding aldehydes or 
ketones. LCAO has been identified in various fungi and in a number of plants, e.g. Arabidopsis 
thaliana (29–31). LCAOs are membrane-bound proteins with subunit molecular masses of 
approximately 70 kDa and contain a flavin cofactor. The sequences of LCAOs from Candida 
and Arabidopsis contain a CXXC heme-binding motif and the enzyme from Candida cloacae has 
been shown to contain a covalently bound heme cofactor (32, 33). The specific roles played by 
LCAO’s two cofactors during catalysis have yet to be determined. The substrate scope of 
LCAO from Candida maltosa has been studied in detail and shown to be rather broad (30). Its 
best substrates are medium-chain 1-alkanols (1-octanol and 1-decanol), but its catalytic scope 
extends to the oxidation of medium- and long-chain 1-alkenols, alkanediols, ω-hydroxyacids, 
aromatic primary alcohols and medium-chain 2-alkanols. The oxidation of 2-alkanols by 
LCAO proceeds enantioselectively, with the (R)-enantiomers being preferentially converted. 
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LCAO from Aspergillus fumigatus has been combined with an ω-transaminase to achieve the 
synthesis of primary amines 4 from a range of medium-chain 1-alkanols (Scheme 5) (34). 
Alkanols with a chain length of 4 to 11 carbon atoms could be converted, with C6-C8 1-alkanols 
giving the highest conversions.  
 
n R1 Conversion to 3 (%) 
3 H 20 
4 H 75 
5 H >99 
6 H >99 
7 H >99 
8 H 82 
9 H 46 
10 H 16 
5 Br 74 
5 Cl 98 
7 Cl 96 
5 C≡N 42 
5 C≡CH >99 
5 NH2 - 
5 OH - 
5 SH - 
 
Scheme 5: Synthesis of primary amines (4) from 1-alkanols using long-chain alcohol oxidase and an 
ω-transaminase (34). 
Compounds with halogen, nitrile or alkyne substituents at the C-terminal end of the 1-
alkanol were converted, but compounds with an amino, hydroxyl or thiol substituent at this 
position were not. Secondary alcohols and benzylic or allylic alcohols were also not 
converted.  
Aryl alcohol oxidase  
Aryl alcohol oxidase (AAO, also known as veratryl alcohol oxidase or aromatic alcohol 
oxidase, EC 1.1.3.7) is a GMC-type oxidase primarily found in white-rot lignin-degrading 
fungi (35). AAOs are monomeric glycoproteins with molecular masses of 70-80 kDa and 
contain a non-covalently bound FAD cofactor. The most extensively studied AAO is the 
enzyme from Pleurotus eryngii (36). AAO oxidises a wide variety of primary α-aryl alcohols to 
the corresponding aldehydes (Scheme 6) (37, 38). Substituents on the aromatic ring have a 
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large effect on AAO activity, with electron-donating substituents (e.g. methoxy groups) 
leading to increased activity, but electron-withdrawing substituents (e.g. nitro groups) 
leading to diminished activity. para-Hydroxy substituted compounds are poorly converted by 
AAO. In addition to α-aryl alcohols, primary γ-aryl alcohols can be oxidised, but only when 
an α-β double bond is present [e.g. cinnamyl alcohol (3-phenylprop-2-en-1-ol)]. The aliphatic 
alcohol 2,4-hexadien-1-ol is also a good substrate, suggesting that AAO requires the presence 
of a conjugated double bond system, but not necessarily an aromatic ring, to enable catalysis. 
AAO also oxidises various α-aryl aldehydes to carboxylic acids, particularly when electron 
withdrawing substituents (e.g. nitro, chloro or fluoro groups) are present on the aromatic ring 
(39). This reaction proceeds via the hydration of the aldehydes to their gem-diols, which are 
subsequently oxidised by the enzyme.  
 
Scheme 6: Oxidation of α-aryl alcohols catalysed by aryl alcohol oxidase (AAO). 
Using deuterated 4-methoxybenzyl alcohol it was shown that the transfer of a hydride anion 
to the FAD cofactor during catalysis by AAO occurs enantioselectively, with the pro-R 
hydrogen being preferentially removed (40). The enantioselectivity of AAO was confirmed by 
evaluating its reactivity with secondary alcohols. Despite being a poor substrate, 1-(4′-
methoxyphenyl)ethanol was resolved by AAO, with the R-enantiomer remaining in an 
enantiomeric excess of >98% after long-term conversion. The authors also identified an AAO 
mutant (F501A) that has heightened reactivity towards secondary alcohols and enhanced 
enantioselectivity compared to the wild-type enzyme. Further optimisation of the reactivity 
of AAO towards secondary alcohols may open the door to its use in the production of 
enantiomerically pure secondary α-aryl alcohols. Although, P. eryngii AAO is poorly active 
with para-hydroxy substituted phenols, AAO from Bjerkandera adusta is able to oxidise these 
substrates (41). 
5-(Hydroxymethyl)furfural oxidase 
Another enzyme that catalyses the oxidation of α-aryl alcohols is the GMC-type oxidase 5-
(hydroxymethyl)furfural oxidase (HMFO, EC 1.1.3.47). HMFO from Methylovorus sp. MP688 
is a 70 kDa protein that contains a non-covalently bound FAD cofactor. The enzyme is capable 
of oxidising 5-(hydroxymethyl)furfural (HMF) to 2,5-furandicarboxylic acid (FDCA) (42). 
HMF can be obtained from biomass by the conversion of sugars such as glucose and fructose 
and is a key building block for the synthesis of biobased chemicals (43). Its conversion to 
FDCA is of interest as this compound can function as a starting material for the synthesis of 
polyesters. HMFO catalyses all three two-electron oxidations that are required for this 
conversion (Scheme 7) (42, 44). As with AAO, the oxidation of the aldehydes to carboxylic 
acids proceeds via the oxidation of the gem-diol formed by hydration of the aldehydes. 
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Dijkman et al. demonstrated that 95% conversion of 4 mM HMF to FDCA could be achieved 
using HMFO, albeit with a relatively high enzyme concentration (20 μM) and 24 h reaction 
time. Variants of the enzyme that displayed improved conversion of HMF to FDCA have also 
been described (45). The oxidation of HMF to FDCA by AAO has also been explored (46). 
However, efficient production of FDCA could not be achieved using only AAO, as it did not 
convert  2,5-formylfurancarboxylic acid (FFCA), the final intermediate in the reaction 
sequence, to FDCA. Conversion of FFCA formed from HMF by AAO to FDCA could be 
achieved by the subsequent addition of a peroxygenase. However, a reaction time of 120 h 
was required to achieve 91% conversion of 3 mM HMF to FDCA. 
 
Scheme 7: Three-step oxidation of 5-(hydroxymethyl)furfural to 2,5-furandicarboxylic acid by 5-
(hydroxymethyl)furfural oxidase (HMFO). 
In addition to the oxidation of HMF, HMFO catalyses the oxidation of various primary 
benzylic alcohols. As for AAO, the presence of a conjugated double bond system (not 
necessarily an aromatic ring) in a substrate is the minimum requirement to allow catalysis by 
HMFO, as it also oxidises cinnamyl alcohol and 2,4-hexadien-1-ol. 
Vanillyl alcohol oxidase 
The canonical member of the VAO/PCMH family is vanillyl alcohol oxidase from Penicillium 
simplicissimum (VAO, EC 1.1.3.38) (47). VAO is a 64 kDa protein that is present in solution as 
an equilibrium of dimers and octamers. The octamer is the predominant form, but both forms 
are catalytically active (48). The enzyme contains an FAD cofactor, which is covalently bound 
to a histidine residue (47, 49). VAO catalyses the oxidation of various primary or secondary 
para-hydroxyl substituted benzylic alcohols, to the corresponding aldehydes or ketones 
(Scheme 8) (47, 50). Interestingly, the oxidation of secondary α-aryl alcohols by VAO occurs 
enantioselectively, e.g. the reaction with 1-(4′-hydroxyphenyl)ethanol is selective towards the 
(S)-enantiomer, with an E-value of 57 (51). This raises the possibility that VAO could be used 
for the production of enantiomerically pure secondary α-aryl alcohols by the resolution of 
racemic alcohols. The catalytic scope of VAO is not limited to the oxidation of alcohols: the 
enzyme also catalyses the deamination of benzylic amines, the demethylation of 4-
(methoxymethyl)phenol, the hydroxylation of 4-allylphenols, and the hydroxylation or 
dehydrogenation of 4-alkylphenols (50, 51).  
In addition to the P. simplicissimum enzyme, an enzyme that displays VAO activity has been 
identified in the fungus Byssochlamys fulva V107 (52). This enzyme forms dimers with a 
subunit mass of approximately 58 kDa and catalyses the oxidation of 4-hydroxybenzylic 
alcohols, 4-alkylphenols and 4-allyphenols, but not of 4-hydroxybenzylic amines or 4-
(methoxymethyl)phenol. Jin et al. identified a VAO homologue of bacterial origin in 
Rhodococcus jostii RHAI, which they named eugenol oxidase (EUGO) (53). EUGO is more 
efficient at catalysing the oxidation of vanillyl alcohol than P. simplicissimum VAO. However,   
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Scheme 8: Oxidation of 4-hydroxybenzylic alcohols catalysed by vanillyl alcohol oxidase (VAO). 
4-alkyphenols and 4-(methoxymethyl)phenol are poor substrates for EUGO. The oxidation of 
the secondary alcohol 1-(4′-hydroxy-3′-methoxyphenyl)ethanol by EUGO was found to occur 
enantioselectively (54). Conversion of racemic 1-(4′-hydroxy-3′-methoxyphenyl)ethanol led to 
enrichment of the (S)-enantiomer, though the achieved ee values were modest at ≤65%.    
 (S)-2-Hydroxy acid oxidases 
(S)-2-Hydroxy acid oxidases (HAO, EC 1.1.3.15) catalyse the oxidation of 2-hydroxy acids to 
2-keto acids. The enzymes display enantioselectivity, preferentially converting the (S)-
enantiomers of their substrates. Unlike most other flavin-dependent oxidases, HAOs contain 
FMN as a cofactor, rather than FAD. Three types of HAO can be defined based on their 
substrate specificity: glycolate oxidase, L-lactate oxidase and long-chain 2-hydroxy acid 
oxidase. 
Glycolate oxidase (GlyO) is found in a variety of plants and mammals, with the most 
extensively studied variant being the enzyme from spinach (Spinacia oleracea), which is 
commercially available (55–57). GlyO’s best substrate is glycolic acid, which is oxidised to 
glyoxylic acid (Scheme 9). Glyoxylic acid can be oxidised further to yield oxalic acid, though 
this process is less efficient than the oxidation of glycolic acid (58). 
 
Scheme 9: Oxidation of glycolic acid catalysed by glycolate oxidase (GlyO). 
GlyO also catalyses the enantioselective oxidation of (S)-2-hydroxy acids with longer chain 
lengths (up to 9 carbon atoms) (59). Adam et al. used spinach GlyO to produce various (R)-2-
hydroxy acids by the kinetic resolution of racemates, obtaining the (R)-enantiomers in 
excellent enantiomeric excesses at approximately 50% conversion (59). This process was 
extended by the subsequent enantioselective reduction of the formed 2-keto acids using a 
lactate dehydrogenase, yielding the (R)-2-hydroxy acids 5a and 5b in yields of >84% and 
enantiomeric excesses of >93% (Scheme 10) (60). Permeabilised whole-cell preparations of P. 
pastoris containing overexpressed spinach GlyO and catalase have also been used as a 
biocatalyst for the production of various enantiopure (R)-2-hydroxy acids (61).  
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L-lactate oxidase (LLO) is found in lactic acid bacteria, with well-known enzymes being those 
from Aerococcus viridans and Pediococcus sp., both of which are commercially available (62–64). 
LLO oxidises (S)-lactic acid to pyruvate. The enzyme is highly specific towards (S)-lactic acid, 
as it does not accept glycolic acid or 2-hydroxybutyric acid as a substrate (63). The oxidation 
of (S)-lactic acid by LLO has been combined with the non-enantioselective reduction of the 
formed pyruvate by sodium borohydrate to achieve the synthesis of (R)-lactic acid starting 
from racemic lactic acid, (S)-lactic acid or pyruvate (65). 
Long-chain 2-hydroxy acid oxidases (LHAO) oxidise various 2-hydroxy acids with chain 
lengths of over three carbon atoms. Sources of LHAO include rat and pig kidney (66, 67). 
Good substrates of the enzyme include the (S)-enantiomers of aliphatic 2-hydroxy acids such 
as 2-hydroxybutyric acid and 2-hydroxyisocaproic acid, and aromatic 2-hydroxy acids, such 
as mandelic acid and phenyllactic acid (67–70). 
 
Scheme 10: Synthesis of (R)-2-hydroxy acids (5) by deracemisation using glycolate oxidase (GlyO) 
and lactate dehydrogenase (60). 
Cholesterol oxidase 
Cholesterol oxidase (ChoX, EC 1.1.3.6) is a bacterial flavoenzyme that catalyses the oxidation 
of the C3 hydroxyl group of cholesterol, yielding cholest-5-en-3-one. Most ChoXs also catalyse 
its subsequent isomerisation to cholest-4-en-3-one through the transfer of a proton from C4 to 
C6 via an active site base (Scheme 11) (71). Two different forms of ChoX exist: one which 
belongs to the GMC family, in which the FAD cofactor is non-covalently bound to the enzyme, 
and one which belongs to the VAO/PCMH family, in which the FAD cofactor is covalently 
bound to the enzyme (71). Examples of both forms of the enzyme are commercially available, 
e.g. Streptomyces sp. ChoX for the GMC-type and Brevibacterium sp. ChoX for the VAO/PCMH-
type. In addition to cholesterol, ChoX is active with various other sterols, such as 
pregnenolone and cholestanol (71, 72). Rhodococcus erythropolis ChoX can also catalyse the 
enantioselective oxidation of smaller cyclic unsaturated alcohols, such as 3-methylcyclohex-
2-en-1-ol (73). 
ChoX can be a useful tool in the synthesis of rare steroids, which are of use as reference 
compounds for bioanalytical purposes. Alexander and Fisher reported the synthesis of 7α-
hydroxycholest-4-en-3-one (8), an intermediate in the biosynthesis of bile acid, from 3β-
hydroxycholest-5-en-7-one (6) (Scheme 12) (74). Three chemical steps were used to convert 6 
to cholest-5-en-3β,7α-diol (7), which was converted to 8 using ChoX. 
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Scheme 11: Oxidation and isomerisation of cholesterol catalysed by cholesterol oxidase (ChoX). 
 
Scheme 12: Synthesis of 7α-hydroxycholest-4-en-3-one (8) using cholesterol oxidase (ChoX) (74). 
ChoX has also been applied in the synthesis of 7β-hydroxytestosterone (11) starting from 
dehydroepiandrosterone (9) (Scheme 13) (75). A C8 ester group was introduced at the C17 
position of 9 to mimic the bulky side chain cholesterol has at this position. Subsequently, the 
hydroxyl group at C7 was introduced enantioselectively by chemical means, yielding 
compound 10, which served as a substrate for ChoX. After conversion of 10 by ChoX, the C17 
acyl substituent was removed using porcine lipase, yielding 11 in an overall yield of 17 %. 
 
Scheme 13: Synthesis of 7β-hydroxytestosterone (11) using cholesterol oxidase (ChoX) (75). 
Guo et al. used ChoX in the synthesis of 5β-pregn-7-en-3α,17α,20-triol (15) starting from 12 
(Scheme 14) (76). 12 was converted to 13 by introduction of the Δ7 double bond by 
bromination-dehydrobromination, followed by removal of the acetate groups by solvolysis. 
Subsequently, 13 was oxidised and isomerised to 14 by ChoX. 14 was converted to 15 by 
hydrogenation over Pd/C, followed by reduction of the carbonyl groups using LiAlH4. 
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Scheme 14: Synthesis of 5β-pregn-7-en-3α,17α,20-triol (15) involving cholesterol oxidase (ChoX) (76). 
Glycerol 3-phosphate oxidase 
Glycerol 3-phosphate oxidase (GPO, EC 1.1.3.21) is an FAD-dependent oxidase, which 
catalyses the oxidation of L-glycerol 3-phoshpate to dihydroxyacetone phosphate, which is a 
useful precursor for the synthesis of sugars by asymmetric aldol additions. GPOs from various 
bacterial sources are commercially available. Krämer and Steckhan used immobilised GPO in 
combination with D-fructose 1,6-bisphosphate aldolase to convert L-glycerol 3-phosphate and 
glyceraldehyde to D-fructose 1-phosphate and L-sorbose 1-phosphate, which were 
subsequently dephosphorylated using acid phosphatase to obtain the unmodified 
monosaccharides (77). GPO has also been applied in a one-pot multi-enzyme cascade reaction 
for the synthesis of the carbohydrate fragments 17a-c starting from glycerol and aldehydes 
16a-c (Scheme 15) (78).  
   
Scheme 15: Synthesis of carbohydrate fragments (17) from glycerol and aldehydes by a multi-enzyme 
cascade involving glycerol 3-phosphate oxidase (GPO) (78). 
In this cascade, glycerol was first phosphorylated by an acid phosphatase, followed by the 
oxidation of the formed glycerol 3-phosphate to dihydroxyacetone phosphate by GPO. 
Subsequently, the dihydroxyacetone phosphate was stereoselectively coupled to the relevant 
aldehyde by an aldolase, followed by dephosphorylation of the product by acid phosphatase. 
The use of four aldolases with varying steroeselectivities enabled the synthesis of all four 
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stereoisomers of 17a, though in some cases the stereoselectivity of the coupling reaction was 
poor. When followed by reductive amination using H2, Pd/C, this enzymatic cascade could be 
used for the chemoenzymatic synthesis of the sugar D-fagomine (18) from glycerol and 
aldehyde 16c. 
Choline oxidase 
Choline oxidase (ChlO, EC 1.1.3.17) is a GMC-type oxidase that catalyses the oxidation of 
choline to the carboxylic acid betaine, via the aldehyde intermediate betaine aldehyde 
(Scheme 16). The most extensively studied ChlO is the enzyme from Arthrobacter globiformis, 
which is commercially available (79). A. globiformis ChlO is a homodimer composed of 60 kDa 
subunits which contain a covalently bound FAD cofactor (80). The choline analogues N,N-
dimethylethanolamine, N-methylethanolamine, triethanolamine, diethanolamine and 3,3-
dimethyl-1-butanol can also be oxidised by ChlO (79, 81). Linear aliphatic alcohols and 
aldehydes are not oxidized by the enzyme.  
 
Scheme 16: Oxidation of choline catalysed by choline oxidase (ChlO). 
Glucose oxidase 
Glucose oxidase (GOX, EC 1.1.3.4) catalyses the oxidation of the C1 hydroxyl group of β-
D-glucose, yielding D-glucono-1,5-lactone, which spontaneously hydrolyses to gluconic acid 
(Scheme 17). GOX from Aspergillus niger is a dimeric glycoprotein and belongs to the GMC-
type oxidoreductase family. Each 75 kDa subunit contains a non-covalently bound FAD 
cofactor. GOX has a rather narrow substrate range. α-D-Glucose, pentoses, hexoses other than 
D-glucose and various deoxy analogues of β-D-glucose are poor substrates. An exception is 2-
deoxy-D-glucose which is a reasonably good substrate (82). This narrow substrate range limits 
the synthetic utility of GOX. Nevertheless, GOX has been applied as a biocatalyst for the 
production of gluconic acid (83), which is an important antioxidant in food and drinks, and 
also for the synthesis of D-glucosaminic acid, a chiral synthon for the asymmetric synthesis of 
amino acids (84). Although aldoses other than glucose are poor GOX substrates, Pezzotti and 
Therisod demonstrated that GOX can be used for the synthesis of aldonic acids from D-
mannose, D-galactose and D-xylose (85). 
 
 
Scheme 17: Oxidation of β-D-glucose catalysed by glucose oxidase (GOX). 
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Pyranose-2-oxidase 
Pyranose 2-oxidase (P2O, EC 1.1.3.10) is a GMC-type oxidase. The enzyme catalyses the 
oxidation of D-glucose and other aldopyranoses at the C2 position yielding the corresponding 
ketoaldoses. P2O has been isolated from a number of wood-degrading white-rot 
basidiomycetes (86). The native enzyme is a homotetramer of 280 kDa, with each subunit 
containing one molecule of FAD, which is covalently linked to a histidine residue (87). P2O 
selectively oxidises aldopyranoses at the C2 position, but can also oxidise the C3 position if 
the C2 hydroxyl group is absent, as in the case of 2-deoxy-D-glucose. Unlike GOX, P2O can 
oxidise both the β- and α-anomers of D-glucose. P2O is also active with other aldopyranoses 
such as D-xylose, L-sorbose, D-allose and D-galactose, but D-glucose and its deoxy analogues 
are by far the best substrates (88, 89).   
P2O is a valuable enzyme for synthetic purposes (89). Oxidation of the C2 hydroxyl group of 
D-glucose yields 2-keto-D-glucose (D-glucosone, 19), which is an important intermediate for 
the synthesis of rare sugars, fine chemicals, and drugs (Scheme 18). Catalytic hydrogenation 
of D-glucosone yields the important sweetener D-fructose (20). This two-step chemoenzymatic 
synthesis is known as the ‘Cetus process’ (90).  Enzymatic dehydratation of D-glucosone with 
pyranosone dehydratase results in the formation of the β-pyrone antibiotic cortalcerone (21) 
(91). P2O can also be used for the regioselective oxidation of D-galactose. The resulting 
D-galactosone (22) can be converted according to the Cetus procedure into the rare sugar 
D-tagatose (23) (92). The enzyme also catalyses the oxidation of 2-deoxy-D-glucose to 2-deoxy-
3-keto-D-glucose (24), which is subsequently oxidised by hydrogen peroxide (or oxygen) and 
decarboxylated to form a mixture of 1-deoxy-D-ribulose (25) and 1-deoxy-D-xylulose (26), a 
precursor in vitamin synthesis (93, 94). P2O oxidises the reducing sugar moiety of various 1,6-
disaccharides to their 2-ketoaldose forms, which can subsequently be converted to the ketose 
forms by an aldose reductase (95). The enzyme has also been applied in the synthesis of 
regioselectively functionalized dextran (a polysaccharide composed of glucose units linked 
primarily through α-(1-6)-glycosidic bonds) (96). This was achieved by oxidizing sucrose at 
the C2 position of its glucose moiety and subsequently polymerizing the modified sucrose 
using  the enzyme dextransucrase.  
Alditol oxidase 
Alditol oxidase (AldO, EC 1.1.3.41) is a biocatalytically interesting member of the VAO/PCMH 
family. The most extensively studied AldO is that from the bacterium Streptomyces coelicolor 
A3(2) (97). Similar enzymes have been identified in Streptomyces sp. H-7775 (known as sorbitol 
oxidase) and the thermophilic bacteria Streptomyces sp. IKD472 (known as xylitol oxidase) and 
Acidothermus cellulolyticus 11B (98–100). AldO from S. coelicolor is a monomeric protein with a 
molecular mass of 46 kDa. The enzyme contains an FAD cofactor, which is covalently bound 
to a histidine residue (97, 101). AldO catalyses the regioselective oxidation of the primary 
hydroxyl groups of various polyols (Scheme 19). The best substrates are alditols such as xylitol 
and D-sorbitol, which are oxidised to the corresponding D-aldoses (97). AldO oxidises various 
other polyols, with a strong preference for substrates with a hydroxyl group at the C2 position. 
In some cases, the final product is a carboxylic acid rather than an aldehyde. This has been 
shown to be the case for the oxidation of 1,2-pentanediol and 1-phenyl-1,2-ethanediol and is 
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due to the oxidation of the gem-diol formed upon hydration of the aldehyde product (102). 
AldO displays selectivity regarding the configuration of the chiral centre at the C2 position of 
its 1,2-diol substrates. D-sorbitol is a significantly better substrate than its C2 epimer D-
mannitol, due to the orientation of D-mannitol’s C2 hydroxyl group leading to steric clashes 
with the active site residue His-343 (97, 101). The conversions of 1,2-pentanediol and 1-phenyl-
1,2-ethanediol to the corresponding aldehydes proceed enantioselectively. The (R)-
enantiomers are preferentially converted with E-values of >145 and 74 respectively (102). 
Hexose oxidase  
Hexose oxidase (HOX, EC 1.1.3.5) is a carbohydrate oxidase which, like GOX, oxidises the C1 
hydroxyl group of aldose substrates, yielding lactones which can hydrolyse to form aldonic 
acids. HOX was first isolated from the marine red alga Chondrus crispus (103). HOX consists  
 
Scheme 18: Oxidations catalysed by pyranose-2-oxidase (P2O). From top to bottom: the oxidation of D-
glucose to D-glucosone (19), which can subsequently be hydrogenated to D-fructose (20) or dehydrated 
to cortalcerone (21); the oxidation of D-galactose to D-galactosone (22), which can subsequently be 
hydrogenated to D-tagatose (23); the oxidation of 2-deoxy-D-glucose to 2-deoxy-3-keto-D-glucose (24), 
which is subsequently oxidatively decarboxylated to yield 1-deoxy-D-ribulose (25) and 1-deoxy-D-
xylulose (26).  
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Scheme 19: Oxidations catalysed by alditol oxidase (AldO). Top: the oxidation of xylitol to D-xylose. 
Bottom: the oxidation of (R)-1-phenyl-1,2-ethanediol to (R)-2-hydroxy-2-phenylacetic acid. This 
reaction is enantioselective, as (R)-1-phenyl-1,2-ethanediol is more efficiently converted than the 
corresponding (S)-enantiomer. 
of two subunits (37 kDa and 25 kDa), which are formed upon proteolytic activation of a 62 
kDa precursor protein, with two of each subunit combining to form the native enzyme (104, 
105). HOX is a member of the VAO/PCMH family and contains a bicovalently bound FAD 
cofactor (106). 
HOX has a far more relaxed substrate specificity than GOX, catalysing the oxidation of a 
variety of mono-, di-, tri-, and tetra-aldose sugars, including D-glucose, D-galactose, xylose, 
lactose, maltose, cellobiose, arabinose, maltotriose, and maltotetraose. The monosaccharides 
D-glucose and D-galactose are the substrates that are most efficiently converted (107). Due to 
its broad substrate specificity, HOX has great potential for the synthesis of lactones or aldonic 
acids from various sugars.  
Oligosaccharide oxidases 
A number of oxidases have been identified that, like GOX and HOX, catalyse the oxidation of 
the C1 hydroxyl group of aldose moieties, but which are primarily active with oligosaccharide 
substrates. These oligosaccharide oxidases all belong to the VAO/PCMH family. One of these 
enzymes is lactose oxidase (LAO) from Microdochium nivale. LAO is a 55 kDa protein that 
contains an FAD cofactor, which is predicted to be bicovalently linked to the enzyme (108, 
109). The enzyme is able to oxidise mono-, oligo- and polysaccharides, with the highest 
oxidation rates being observed with the glucooligosaccharides D-cellotriose and D-
cellotetraose (108). A highly similar oxidase is glucooligosaccharide oxidase (GOOX) from 
Sarocladium strictum (formerly Acremonium strictum) (110). Mature GOOX has a molecular 
mass of 61 kDa and contains a bicovalently bound FAD cofactor (111). GOOX oxidises the 
reducing end glycosyl residues of oligosaccharides linked by α- or β-1,4 bonds and the 
monosaccharide D-glucose (110, 112). Oligosaccharide oxidases that oxidise 
glucooligosaccharides have also been identified in sunflower (Helianthus annuus) and the 
fungus Paraconiothyrium sp. (113, 114). 
Another related enzyme is chitooligosaccharide oxidase (ChitO) from Fusarium  graminearum. 
ChitO also contains a bicovalently linked FAD cofactor and oxidises the C1 hydroxyl group 
of  the reducing end of its oligosaccharide substrates (115). The main difference with other 
oligosaccharide oxidases is that ChitO preferentially oxidises chitooligosaccharides 
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(oligosaccharides composed of N-acetyl-D-glucosamine units). The catalytic efficiencies for 
the oxidation of chitooligosaccharides by ChitO are three orders of magnitude larger than 
those for the oxidation of their non N-acetylated analogues (115). Xylitol oxidase (XylO) from 
Myceliophthora thermophila C1 is an oligossacharide oxidase that preferentially oxidises 
xylooligosaccharides, with xylobiose, xylotriose and xylotetraose being the substrates that are 
most efficiently converted (116).  
Non-flavin alcohol oxidases 
Although the majority of characterised alcohol oxidases are flavin-dependent enzymes, a 
small number of enzymes are known to use a different cofactor, such as copper or non-heme 
iron, to catalyse alcohol oxidation. These enzymes and their potential applications in organic 
synthesis are discussed below.  
Galactose oxidase 
Galactose oxidase (GAO, EC 1.1.3.9) is a copper-containing oxidase that catalyses the 
oxidation of a wide range of carbohydrates and primary alcohols to the corresponding 
aldehydes. The oxidation of hexose substrates, such as D-galactose, by GAO is highly 
regioselective, as only the hydroxyl group at the C6 position is oxidised (Scheme 20).  
 
Scheme 20: Oxidation of D-galactose catalysed by galactose oxidase (GAO). 
GAO from Fusarium sp. NRRL 2903 (previsouly known as Dactylium dendroides) is the most 
extensively characterised GAO and is commercially available (117). It is a monomeric protein 
with a molecular mass of 69 kDa and contains a single copper ion as a cofactor (118). The 3D 
structure of GAO revealed that in the active site the mononuclear copper is coordinated by 
two tyrosine residues (Tyr-272 and Tyr-495), two histidine residues (His-496 and His-581) and 
one solvent molecule (119). The side chain of Tyr-272 is post-translationally modified to form 
a covalent thioether linkage with a cysteine residue (Cys-228). This promotes the formation of 
a Tyr-272 radical, which is present in the active form of the enzyme. The catalytic mechanism 
of GAO has been studied in detail (117, 120). Substrate binding induces a proton transfer from 
the alcohol substrate to Tyr-495, followed by hydrogen atom transfer from the substrate to the 
Tyr-272 radical. This results in the intermediate redox state of the enzyme [Cu(II), no radical 
present]. Subsequently, one-electron reduction of the copper cofactor and release of the 
aldehyde product brings the enzyme into the fully reduced state [Cu(I), no radical present]. 
The reduced enzyme can then be reoxidised by molecular oxygen. 
GAO is active towards D-galactose and many derivatives thereof, polysaccharides containing 
a D-galactose moiety, dihydroxyacetone and benzyl alcohol derivatives (117). Besides being 
strictly regioselective, GAO is highly stereoselective. L-Galactose is not a substrate and the 
oxidation of glycerol results exclusively in the formation of (S)-glyceraldehyde. In the case of 
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chiral alcohol substrates, only the enantiomer with a conformation resembling that of 
D-galactose is converted (121).  
GAO has been employed in the regioselective modification of various carbohydrates at the C6 
position. Leppänen et al. used GAO in the allylation of methyl α-D-galactopyranoside (27) 
(Scheme 21) (122). Following the oxidation of 27 by GAO, the formed aldehydes were reacted 
with allyl halides in the presence of indium as a metal mediator, yielding 28a-c. This 
procedure has been extended to the allylation and propargylation of oligo- and 
polysaccharides (123). 
Fuchs et al. used a similar procedure for the synthesis of homoallyl alcohols from benzyl 
alcohol and various derivatives thereof (124). Following oxidation of the alcohols by E. coli 
containing overexpressed GAO, the formed aldehydes were allylated by reacting them with 
allyl bromide or allylboronic acid pinacol ester.  
 
Scheme 21: Synthesis of homoallylic alcohol sugar derivatives (28) involving galactose oxidase (GAO) 
(122). 
GAO has been used for the C6-biotinylation of the nucleotide sugars UDP-galacatose and 
UDP-N-acetlygalactosamine and the synthesis of various poly-N-acetyllactosamine 
derivatives (125–128). It has also been employed in a multi-enzyme cascade for the synthesis 
of the non-natural sugar L-fructose from the simple achiral building blocks glycerol and 
dihydroxyacetone phosphate (129). Here, glycerol is first stereosselectively converted to L-
glyceraldehyde by GAO. Then, L-glyceraldehyde is coupled to dihydroxyacetone phosphate 
by a stereoselective aldol addition catalysed by an aldolase and the formed L-fructose 1-
phosphate is dephosphorylated by acid phosphatase, yielding L-fructose.  
GAO has also been applied in combination with a transaminase in a one-pot cascade 
reaction for the synthesis of amines 29 from alcohols (Scheme 22) (130). Using two different 
ω-transaminases, various aromatic alcohols could be aminated, though the efficiency of the 
conversion varied greatly depending on the nature of substituents on the aromatic ring. The 
procedure starting from cinnamyl alcohol   extended by reductive amination of the formed 
amine 29a with 1-naphtaldehyde and N-methylation of the formed secondary amine, to 
yield the antifungal agent naftifine (30) in an overall yield of 51 %. 
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GAO variants that display activity towards various aromatic secondary alcohols (1-
phenylethanol and derivatives thereof) have been created by directed evolution (131). These 
variants enantioselectively converted the R--enantiomer of 1-(3′-fluorophenyl)ethanol. Using 
one of the variants, racemic 1-(3′-fluorophenyl)ethanol was kinetically resolved, yielding the 
(S)-enantiomer in an enantiomeric excess of 99 %. Various other racemic secondary aromatic 
alcohols were also succesfully resolved in this manner. One of these variants was also used in 
combination with an aldehyde oxidase to achieve the conversion of 5-
(hydroxymethyl)furfural to 2,5-furandicarboxylic acid (132, 133). 
Mannitol oxidase 
Mannitol oxidase from the snail Helix aspersa (MannO, EC 1.1.3.40) is a non-flavin enzyme 
capable of oxidising sugar alcohols (134). The cofactor of this membrane protein has not been 
identified and the mechanism of substrate oxidation is unknown. Like AldO, MannO oxidises 
the C1 hydroxyl group of its substrates, with D-mannitol being converted to D-mannose (135).  
 
R1 Transaminase* Conversion to 29 (%) 
Ph Vf >99 
2′-ClC6H4 Vf Trace 
2′-MeOC6H4 Vf 18 
3′-ClC6H4 Vf 96 
3′-MeOC6H4 Vf 81 
3′-MeC6H4 Pd >99 
4′-ClC6H4 Vf 44 
4′-MeOC6H4 Pd 68 
4′-MeC6H4 Pd 82 
4′-FC6H4 Pd 75 
Piperonyl Vf 35 
Piperonyl Pd 36 
3-Phenylallyl Vf 3 
3-Phenylallyl Pd 92 
a Vf = Vibrio fluvialis ω-transaminase; Pd = Paracoccus denitrificans ω-transaminase 
 
Scheme 22: Synthesis of aromatic amines (29) by a two-step transamination cascade involving 
galactose oxidase (GAO) (130). 
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However, MannO’s substrate specificity differs from AldO’s, with D-arabinitol and D-
mannitol being the enzyme’s best substrates and xylitol being a poor substrate, suggesting 
the two enzymes have different preferences regarding the stereochemical configuration of 
their substrates (134).   
Secondary alcohol oxidase 
A few non-flavin oxidases have been identified that can catalyse the oxidation of aliphatic 
secondary alcohols to ketones. These oxidases are found in various Pseudomonas strains, where 
they are involved in the degradation of polyvinyl alcohol, and have been classified as 
secondary alcohol oxidase (SAO, EC 1.1.3.18) or polyvinyl alcohol oxidase (EC 1.1.3.30) (136). 
Relatively little is known about the biochemical properties and substrate oxidation 
mechanism of SAO. The SAOs that have been purified display similar catalytic properties and 
contain a single non-heme iron atom per protein molecule, but differ in properties such as 
molecular weight (ranging from 26 to 75 kDa), pI (ranging from 4.5 to 10) and localisation 
(most are secreted, but a single membrane-associated SAO has been described) (137–141). In 
addition to polyvinyl alcohol, SAO oxidises various medium-chain secondary alcohols, with 
substrates with chain lengths of six to eight carbon atoms being oxidised most efficiently 
(though the observed decrease in activity for alcohols with longer chain lengths may be due 
to their poor solubility in water). Cyclic alcohols (cyclohexanol) and aromatic secondary 
alcohols (1-phenylethanol) are also oxidised by SAO. Unfortunately, no information is 
available on whether these oxidations take place enantioselectively. Further investigations 
into the catalytic scope of these enzymes could pave the way for their use in enzymatic 
methods for the production of enantiomerically pure aliphatic secondary alcohols. 
Practical considerations 
Hydrogen peroxide removal 
Although the use of molecular oxygen as a final electron acceptor is advantageous from the 
point of view of its cost and easy availability, the production of hydrogen peroxide as a by-
product can be problematic. The accumulation of hydrogen peroxide may lead to the 
inactivation of the biocatalyst and undesired side-reactions with products or substrates. The 
production of hydrogen peroxide is also undesirable from a waste management perspective. 
Thus, a method to convert hydrogen peroxide into chemically and environmentally benign 
compounds is required. The simplest and most commonly used method to dispose of 
hydrogen peroxide during enzymatic reactions is the addition of catalase to the reaction 
mixture. This commercially available enzyme catalyses the decomposition of hydrogen 
peroxide into water and oxygen. This has the added advantage of regenerating 50% of the 
oxygen consumed by the oxidase. Alternatively, cascade reactions may be designed where the 
hydrogen peroxide formed by an oxidase is used to enable a subsequent reaction by a 
hydrogen peroxide-dependent enzyme, such as a peroxidase or peroxygenase. For example, 
both GOX and MO have been used for the in situ generation of hydrogen peroxide to enable 
the synthesis of chiral sulfoxides from thioethers using a peroxidase from Coprinus cinereus 
(142–144). 
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Enzyme immobilisation 
One factor hampering the large-scale adoption of biocatalysis is the relative instability of 
enzymes, particularly at elevated temperatures and in organic solvents. The immobilisation 
of enzymes can increase enzyme stability, lengthening the lifetime of a biocatalyst. 
Immobilisation also greatly facilitates the separation of the catalyst from the reaction products 
in an active form and thus enables catalyst reuse. Various immobilisation techniques have 
been described including binding to solid supports, entrapment in polymer matrices or 
carrier-free methods such as the formation of cross-linked enzyme aggregates or crystals 
[reviewed in (145, 146)]. The development of an effective immobilisation protocol is not trivial, 
but immobilisation of a number of the oxidases mentioned above, e.g. GOX (147), GlyO (148) 
and P2O (149), has already been investigated.  
Outlook and future perspectives 
The use of biocatalysts is a promising alternative to traditional methods of alcohol oxidation. 
As illustrated above, alcohol oxidases have a broad catalytic scope, being capable of oxidising 
a wide range of substrates with exquisite regio- and enantioselectivity. In future, this catalytic 
scope will increase further, as the number of characterised enzymes grows and our ability to 
modulate their reactivity by mutagenesis increases. The development and identification of 
more stable enzymes, together with further advances in techniques for their immobilisation, 
will contribute to the creation of robust biocatalysts suitable for repeated use in industrial 
processes. The low toxicity and biological origin of enzymes and the mild reaction conditions 
under which they are active, make biocatalytic processes attractive from the point of view of 
sustainability. Development of one-pot multi-step biocatalytic cascade reactions, will enable 
the design of efficient redox processes without the need for costly intermediate purification 
steps (150). Thus, alcohol oxidases have the potential to be valuable biocatalysts in organic 
synthesis, on both the laboratory- and industrial-scale.   
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alcohol oxidase, XylO: xylooligosaccharide oxidase
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Summary 
Vanillyl alcohol oxidase (VAO) and eugenol oxidase (EUGO) are flavin-dependent enzymes 
that catalyse the oxidation of para-substituted phenols. This makes them potentially 
interesting biocatalysts for the conversion of lignin-derived aromatic monomers to value-
added compounds. To facilitate their biocatalytic exploitation, it is important to develop 
methods by which variants of the enzymes can be rapidly screened for increased activity 
towards substrates of interest. Here, we present the development of a screening assay for the 
substrate specificity of para-phenol oxidases based on the detection of hydrogen peroxide 
using the ferric-xylenol orange complex method. The assay was used to screen the activity of 
VAO and EUGO towards a set of twenty-four potential substrates. This led to the 
identification of 4-cyclopentylphenol as a new substrate of VAO and EUGO and 4-
cyclohexylphenol as a new substrate of VAO. Screening of a small library of VAO and 
EUGO active-site variants for alterations in their substrate specificity led to the identification 
of a VAO variant (T457Q) with increased activity towards vanillyl alcohol and a EUGO 
variant (V436I) with increased activity towards chavicol and 4-cyclopentylphenol. This assay 
provides a quick and efficient method to screen the substrate specificity of para-phenol 
oxidases, facilitating the enzyme engineering of known para-phenol oxidases and the 
evaluation of the substrate specificity of novel para-phenol oxidases.
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Introduction 
Lignin, one of the major constituents of lignocellulosic biomass, is a heterogenous aromatic 
polymer, formed from the monolignols para-coumaryl alcohol, coniferyl alcohol and sinapyl 
alcohol through a radical coupling process (1, 2). It is obtained as a by-product during the 
processing of plant biomass in biorefineries and as such represents an attractive renewable 
feedstock of aromatic compounds. In order to harness the full potential of lignin as a 
renewable chemical feedstock, it is desirable to develop novel methods to depolymerise it to 
monomeric aromatic compounds and subsequently convert these to value-added compounds. 
One way in which lignin-derived aromatic molecules can be converted to value-added 
compounds is through the action of oxidative enzymes. Two such enzymes are the flavin-
dependent oxidases vanillyl alcohol oxidase (VAO, EC 1.1.3.38) from Penicillium 
simplicissimum and eugenol oxidase (EUGO) from Rhodococcus jostii RHA1 (3, 4), which both 
belong to auxiliary activity family 4 (AA4) of the carbohydrate active enzyme (CAZy) 
database (5). 
VAO and EUGO are members of the VAO/PCMH flavoprotein family, which includes 
flavoenzymes characterised by the presence of a conserved FAD-binding domain (6, 7, 
Chapter 2). VAO and EUGO both catalyse the two-electron oxidation of para-substituted 
phenols at the Cα position of their substituent (Scheme 1). Molecular oxygen acts as the 
electron acceptor for the reaction, being converted to hydrogen peroxide. Despite the fact that 
VAO and EUGO share significant sequence similarity (45% identical) and very similar 
secondary and tertiary structures, they differ in terms of their oligomerisation state and 
substrate specificity (8, 9). VAO displays a broad substrate specificity, catalysing the oxidation 
of alcohols to aldehydes, the oxidative deamination of amines, the oxidative demethylation of 
ethers, the dehydrogenation or hydroxylation of alkyl groups and the hydroxylation of allyl 
groups (10, 11). EUGO displays a somewhat narrower substrate specificity. Although alcohols 
and 4-allylphenols are good substrates for the enzyme, 4-alkylphenols and ethers are hardly 
accepted (4). In terms of its oligomerisation state, VAO is predominantly octameric in solution, 
though active dimers may also be present under certain conditions (3, 12). In contrast, EUGO 
is exclusively dimeric in solution, with its structure strongly resembling that of a dimer of 
VAO (9). 
A number of the reactions catalysed by VAO and EUGO are of interest for potential industrial 
applications. The oxidation of vanillyl alcohol (4-hydroxy-3-methoxybenzyl alcohol) or 
vanillyl amine [4-(aminomethyl)-2-methoxyphenol] yields vanillin (4-hydroxy-3-
methoxybenzaldehyde), the main flavour and fragrance compound in vanilla (14). VAO can 
also be used for the synthesis of chiral secondary alcohols, with the oxidation of short-chain 
linear 4-alkylphenols yielding the (R)-enantiomers of the corresponding alcohols in high 
enantiomeric excess (15). The hydroxylation of 4-allylphenols by VAO or EUGO has been 
employed in multi-enzyme cascades for the synthesis of the plant lignan pinoresinol and 
model lignin compounds (16–18). The hydroxylation of eugenol (4-allyl-2-methoxyphenol) by 
VAO has also garnered interest as the first step in fermentation processes for the conversion 
of eugenol to ferulic acid, which can be used as a precursor for vanillin (19–24). 
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Scheme 1: Examples of reactions catalysed by VAO and/or EUGO. Both enzymes can catalyse the 
oxidation of vanillyl alcohol (14) to the aldehyde vanillin and of eugenol (18) to coniferyl alcohol. VAO 
converts 4-ethylphenol (3) to a mixture of products consisting of 4-vinylphenol and 1-(4′-
hydroxyphenyl)ethanol. The hydroxylation reaction occurs enantioselectively, predominantly yielding 
the (R)-enantiomer of the alcohol. In contrast, previous studies failed to reveal any activity towards 3 
for EUGO (13). 
Up to now, the molecular determinants of the differences in substrate specificity between 
VAO and EUGO are unclear. The differing oligomerisation states of the enzymes do not 
appear to be involved, as a VAO variant that exclusively forms dimers displayed similar 
catalytic properties to the wild-type enzyme (13). To improve our understanding of the 
determinants of the substrate specificity of these para-phenol oxidases and to facilitate efforts 
to modify their reactivity by enzyme engineering, it would be beneficial to be able to rapidly 
screen variants of VAO and EUGO for activity towards multiple substrates. To enable this, 
we here describe a method for the rapid screening of the substrate specificity of para-phenol 
oxidases using the ferric-xylenol orange complex method for the detection of hydrogen 
peroxide. 
The ferric-xylenol orange complex method (xylenol orange assay) is a colourimetric method 
for the determination of the concentration of hydroperoxides. When an assay solution 
containing Fe2+ ions and xylenol orange is added to a sample containing a hydroperoxide 
under acidic conditions, the hydroperoxide will oxidise Fe2+ to Fe3+. The Fe3+ subsequently 
forms a complex with xylenol orange that can be quantified from its absorbance at 560 nm (25, 
26). The assay has been applied to measure the concentration of lipid or protein 
hydroperoxides in biological samples and as an activity assay for the lipid hydroperoxide-
forming enzyme lipoxygenase (27–29). Detection of hydrogen peroxide via the ferric-xylenol 
orange complex method can be used to detect the activity of oxidases and has been applied in 
a biosensor for lactose and in an in-gel screening assay for L-amino acid oxidase activity (30, 
31). 
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Methods used previously to determine the activity of VAO or EUGO typically relied on the 
measurement of the absorption of reaction products or the consumption of oxygen (4, 10). 
These assays are not suitable for high-throughput substrate specificity screening as they are 
either dependent on the identity of the phenolic reaction product (measuring absorption of 
the product) or cannot easily be performed for multiple samples simultaneously (measuring 
consumption of oxygen). In contrast, the xylenol orange assay does not depend on the identity 
of the phenolic reaction product and multiple samples can be evaluated simultaneously by 
performing the assay in a 96-wells plate. The xylenol orange assay is also better suited for our 
purpose than assays based on the detection of hydrogen peroxide via the formation of a 
coloured compound by peroxidases, as the phenolic substrates converted by VAO and EUGO 
are typically also substrates for peroxidases (32). 
The method reported here consists of an efficient benchtop purification of His-tagged versions 
of VAO and EUGO, followed by a rapid screening of their activity towards a set of twenty-
four potential substrates using the xylenol orange assay. After developing the procedure 
using the wild-type enzymes, we applied the assay to screen fourteen active-site variants for 
alterations in their substrate specificity. This led to the identification of new substrates of the 
wild-type enzymes and two variants that displayed increased activity towards at least one 
substrate. 
Results 
Purification and characterisation of His-VAO and EUGO-His 
To enable screening of the substrate specificity of multiple VAO and EUGO variants, we first 
needed a method for the rapid and efficient purification of the enzymes. To this end, we 
expressed the enzymes from new expression vectors containing genes encoding His-tagged 
variants of the enzymes. VAO was expressed as an N-terminally His-tagged protein, His-VAO, 
and EUGO was expressed as a C-terminally His-tagged protein, EUGO-His. To evaluate 
whether these constructs can be used for our study, we expressed and purified the His-tagged 
wild-type enzymes and evaluated whether their catalytic properties are similar to those of the 
non-His-tagged proteins. 
Both His-tagged enzymes were successfully expressed in E. coli and purified by a simple 
benchtop procedure consisting of a single affinity chromatography step using a Ni-NTA 
column followed by buffer exchange using a desalting column. The purified enzymes 
contained flavin, as determined from their characteristic flavin absorption spectra (Fig. S1+S2). 
Upon precipitation of the proteins using trichloroacetic acid, a yellow pellet and colourless 
supernatant were obtained, demonstrating that the flavin cofactor is covalently bound to the 
protein. To determine whether the presence of a His-tag on the protein affects catalysis, we 
determined the steady-state kinetic parameters for the oxidation of vanillyl alcohol by His-
VAO and EUGO-His (Table 1). This revealed that the catalytic properties of the His-tagged 
enzymes are highly similar to those of the non-His-tagged enzymes, demonstrating that the 
introduction of the His-tag does not affect catalysis. Therefore, these His-tagged variants of 
VAO and EUGO provide a suitable experimental system to rapidly purify variants of the 
enzymes and study their catalytic properties. 
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Table 1: Steady-state kinetic parameters for the oxidation of vanillyl alcohol by VAO, His-VAO, 
EUGO and EUGO-His in 50 mM potassium phosphate buffer, pH 7.5, at 25 °C.   
 
Enzyme kcat (s−1) Km (μM) kcat/Km (s-1 mM−1) 
VAO 2.6a 149a 17 
His-VAO 2.5 ± 0.1 129 ± 15 19 
EUGO 7.1a 79a 90 
EUGO-His 8.0 ± 0.2 47 ± 5 170 
a Data taken from (13). 
Development of the xylenol orange assay using His-VAO and EUGO-His 
To determine whether the xylenol orange assay can be used to accurately measure the activity 
of His-VAO and EUGO-His, we used it to follow the oxidation of vanillyl alcohol and eugenol 
by the enzymes in time. To this end, 2 mM vanillyl alcohol or eugenol was allowed to react 
with EUGO-His or His-VAO for time periods ranging from one to twenty min, after which 
the amount of hydrogen peroxide formed was determined using the xylenol orange assay. In 
all cases, the measured hydrogen peroxide concentration was found to increase in time. The 
increase was linear for the first ten min of the reactions, with the exception of the oxidation of 
vanillyl alcohol by EUGO-His, where the increase was linear for the first 7.5 min of the 
reaction (Fig. 1). 
 
Figure 1: Conversion of eugenol or vanillyl alcohol by His-VAO or EUGO-His followed in time using 
the xylenol orange assay. His-VAO (orange circles for vanillyl alcohol, green diamonds for eugenol) or 
EUGO-His (blue squares for vanillyl alcohol, red triangles for eugenol) was incubated with 2 mM 
substrate in 50 mM potassium phosphate buffer, pH 7.5, at room temperature (19–20 °C). Reactions 
were allowed to proceed for the specified time, after which the amount of hydrogen peroxide formed 
was determined using the xylenol orange assay. Error bars represent the standard deviation of triplicate 
measurements. Dashed lines are fits to the linear range of the data that were used to determine reaction 
rates (see Table 2). 
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Reaction rates were determined by fitting the linear range of the data. These rates (Table 2) 
were similar to the kcat values determined previously using other methods, as would be 
expected considering that our reactions were performed using saturating substrate 
concentrations. Thus, determination of the amount of hydrogen peroxide formed using the 
xylenol orange assay is a suitable way to determine the rates of reactions catalysed by His-
VAO or EUGO-His. 
Table 2: Reaction rates for the oxidation of 2 mM vanillyl alcohol or eugenol by His-VAO or EUGO-
His in 50 mM potassium phosphate buffer, pH 7.5, at room temperature (19–20 °C) as determined 
using the xylenol orange assay. The kcat values for the non-His-tagged enzymes measured previously 
using other methods are shown for comparison. These kcat values were measured under identical 
experimental conditions, with the exception of the temperature, which was 25 °C instead of 19–20 °C.  
 (His)-VAO EUGO-(His) 
 Vanillyl 
alcohol 
Eugenol Vanillyl 
alcohol 
Eugenol 
kobs xylenol orange assay 
(s−1) 
1.5 ± 0.1 8.0 ± 0.3 6.6 ± 0.1 3.2 ± 0.1 
kcat (s−1) 2.6a 11a 7.1a 2.9a 
a Data taken from (13). 
Subsequently, we used the xylenol orange assay to evaluate the conversion of a set of twenty-
four (potential) substrates by wild-type His-VAO and EUGO-His. The set of compounds 
contained various 4-(cyclo)alkylphenols, 4-hydroxybenzyl alcohols, 4-allylphenols and a 4-
hydroxybenzylic amine. In addition to these para-substituted phenols, 2-hydroxy- and 3-
hydroxybenzyl alcohol were included in the set of compounds in order to screen for variants 
that no longer have a strict specificity for para-substituted phenols. For a full list of the 
compounds and their structural formulae, see Table 3. 
The rate of conversion of these compounds by His-VAO and EUGO-His at a substrate 
concentration of 2 mM was determined by allowing the enzymes to react with the substrate 
for ten min and measuring the amount of hydrogen peroxide formed using the xylenol orange 
assay. Rates of the reactions of His-VAO and EUGO-His with the tested substrates, calculated 
by assuming that the formation of hydrogen peroxide in time is linear during the reaction 
period, are shown in Figure 2. For substrates where a kcat value has been determined for the 
non-His-tagged enzymes under similar experimental conditions, this value is shown for 
comparison. The reaction rates measured using the xylenol orange assay are generally in good 
agreement with previously obtained data regarding the substrate specificity of VAO and 
EUGO. For compounds for which the kcat had previously been determined and found to lie 
above the detection limit, the reaction rates measured with the xylenol orange assay typically 
lie close to the kcat values. This is to be expected, as the substrate concentration used for the 
xylenol orange assay (2 mM) is at least ten times the Km for all these compounds and as such 
the measurements were performed under saturating substrate concentrations. The only cases 
where no activity was observed with the xylenol orange assay despite the kcat lying above the 
detection limit were the oxidation of 4-n-butylphenol (6) by His-VAO and 5-indanol (20) by 
EUGO-His. The kcat for the oxidation of 4-n-butylphenol by VAO (1.2 s−1) is only slightly higher 
than the detection limit of the assay (0.83 s−1) and therefore it is not too surprising that no 
activity was detected for its oxidation using the xylenol orange assay. However, the kcat for the 
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Table 3. Compounds tested in the substrate specificity screening. 
Entry 
Compound name 
(trivial name) 
Structure 
1 
4-methylphenol  
(para-cresol)  
2 
2-methoxy-4-methylphenol 
(para-creosol) 
 
3 4-ethylphenol 
 
4 4-n-propylphenol 
 
5 4-isopropyphenol 
 
6 4-n-butylphenol 
 
7 4-sec-butylphenol 
 
8 4-n-pentylphenol 
 
9 
 4-n-hexylphenol 
 
10 4-n-nonylphenol 
 
11 2-hydroxybenzyl alcohol 
 
12 3-hydroxybenzyl alcohol 
 
13 4-hydroxybenzyl alcohol 
 
14 
4-hydroxy-3-methoxybenzyl alcohol  
(vanillyl alcohol) 
 
15 4-hydroxy-3,5-dimethoxybenzyl alcohol 
 
16 4-hydroxy-2-methoxybenzyl alcohol 
 
17 
4-allylphenol 
(chavicol)  
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18 
4-allyl-2-methoxyphenol 
(eugenol) 
 
19 4-allyl-2,6-dimethoxyphenol 
 
20 5-indanol 
 
21 5,6,7,8-tetrahydro-2-naphthol 
 
22 4-cyclopentylphenol 
 
23 4-cyclohexylphenol 
 
24 
4-(aminomethyl)-2-methoxyphenol  
(vanillyl amine) 
 
 
oxidation of 5-indanol by EUGO (2.4 s−1) lies well above the detection limit of the xylenol 
orange assay. To investigate this discrepancy further, the rate of oxidation of 2 mM 5-indanol 
by EUGO-His was determined by monitoring the consumption of oxygen during the reaction. 
The rate of oxygen consumption was found to be 0.064 s−1, significantly lower than the 
detection limit for the xylenol orange assay. This is in reasonable agreement with the rate of 
oxidation of 2 mM 5-indanol by EUGO determined by Nguyen et al. (0.18 s−1; the higher 
activity may be attributable to the addition of 10% DMSO as a cosolvent) (9). Therefore, at a 
substrate concentration of 2 mM, the rate of conversion of 5-indanol by EUGO-His is 
significantly lower than the detection limit of the xylenol orange assay. For all substrates 
where the previously determined kcat value is lower than the detection limit, no activity was 
observed using the xylenol orange assay. 
Interestingly, our substrate specificity screening revealed that a number of compounds not 
previously described as substrates of VAO or EUGO are converted by the enzymes. Chavicol 
(17), which had previously been shown to be a substrate for VAO, was also converted by 
EUGO-His, though at a lower rate than by His-VAO. More surprisingly, both His-VAO and 
EUGO-His were active with 4-cyclopentylphenol (22), which had not previously been shown 
to be a substrate for either enzyme. Particularly with His-VAO, 4-cyclopentylphenol was quite 
efficiently converted, with the observed rate of 3.9 s−1 being higher than that observed for all 
other substrates except eugenol and chavicol. The ability of His-VAO and EUGO-His to 
convert 4-cyclopentylphenol was confirmed by allowing 1 μM His-VAO or EUGO-His to react 
with 2 mM 4-cyclopentylphenol at 25 °C and analysing the reaction products by GC and 
GC/MS (Fig. S3+4). With both enzymes, the substrate was almost completely converted after 
2 h (>99% conversion). The reaction yielded a single product, which was identified as 4-(1-
cyclopenten-1-yl)phenol by GC/MS and 1H-NMR (25, Scheme 2, Fig. S4+5). The rate of  
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Figure 2: Rate of the reactions of His-VAO and EUGO-His with the compounds used in the substrate 
specificity screening in 50 mM potassium phosphate buffer, pH 7.5, at room temperature (19–20 °C) as 
determined using the xylenol orange assay. Solid bars give the reaction rates measured with the xylenol 
orange assay for His-VAO (green) and EUGO-His (blue). Error bars represent the standard deviation 
of duplicate measurements. Striped bars give kcat values measured previously by other methods with 
the non-His-tagged enzymes. These kcat values were measured under identical experimental conditions, 
with the exception of the temperature, which was 25 °C instead of 19–20 °C. The striped horizontal line 
indicates the detection limit of the xylenol orange assay, which corresponds to a reaction rate of 0.83 s−1. 
The kcat values were from the following sources. VAO: compounds, 5–8, 20, 21 (11), 3, 14, 18 (13), 2, 24 
(14), 1, 4 (33), 17 (34). EUGO: 20, 24 (4), 19 (9), 14, 18 (13). Numbering is according to Table 3. 
oxidation of 2 mM 4-cyclopentylphenol by His-VAO and EUGO-His was also determined by 
monitoring oxygen consumption during the reaction. This yielded rates of 3.7 s−1 for His-VAO 
and 1.7 s−1 for EUGO-His, in good agreement with the rates determined using the xylenol 
orange assay (3.9 s−1 and 1.3 s−1 for His-VAO and EUGO-His, respectively). 
 
Scheme 2: Oxidation of 4-cyclopentylphenol (22) to 4-(1-cyclopenten-1-yl)phenol (25) by His-VAO or 
EUGO-His, as catalysed in 50 mM potassium phosphate buffer, pH 7.5, at 25 °C. 
Taken together, these results demonstrate that the xylenol orange assay can be used to 
accurately measure the activity of His-VAO and EUGO-His towards a range of substrates and 
to identify hitherto unknown substrates of the enzymes. Therefore, it is a suitable assay for 
use in screening the substrate specificity of His-VAO and EUGO-His variants. Having 
established this, we set out to use the assay to screen a small library of His-VAO and EUGO-
His variants for changes in their substrate specificity. 
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Analysis of the substrate binding pockets of VAO and EUGO 
To design the variants, we examined the active sites of the proteins to identify residues that 
differ between them and therefore may be responsible for the observed differences in 
substrate specificity. Both enzymes contain a solvent-inaccessible substrate binding pocket on 
the si-side of the FAD cofactor. This pocket is lined by 19 residues of which 12 are identical in 
both enzymes (Fig. 3). The conserved residues include all those known to be directly involved 
in catalysis, including Arg-504 (numbering of amino acids is as in non-His-tagged VAO), 
which is thought to stabilise the negative charge that develops at the N1–C2=O2 locus of FAD 
upon its reduction, Tyr-108 and Tyr-503, which stabilise the deprotonated form of phenolic 
substrates in the active site, Asp-170, which promotes flavin reduction by stabilising the 
reduced FAD cofactor through hydrogen bonding with the protonated N5 atom, and His-422, 
to which the FAD cofactor is covalently bound (8,34,35, Chapter 4). The seven differing 
residues form a cluster on the side of the substrate opposite the flavin cofactor. Interestingly, 
the competitive inhibitor isoeugenol binds in a different orientation in each enzyme. In EUGO, 
it is flipped 180° as compared to in VAO. This is likely due to the presence of Gly-392 in EUGO 
instead of the bulky Phe-424 found at this position in VAO. Based on these observations, we 
hypothesised that differences in the cluster of differing residues may be responsible for the 
observed differences in substrate specificity between VAO and EUGO. To investigate this, we 
made seven His-VAO and seven EUGO-His variants, exchanging each of the differing 
residues for the amino acid that is found at this position in the other enzyme and set out to 
study their activity and substrate specificity using the xylenol orange assay (for a list of the 
residues and variants see Table 4, numbering as in the sequences of non-His-tagged VAO and 
EUGO). 
Substrate specificity screening of His-VAO and EUGO-His variants 
All fourteen variants were successfully expressed in E. coli and purified as described for the 
wild-type enzymes. A single variant, F424G His-VAO, did not contain any flavin after 
purification, as judged from the lack of a yellow colour and of the distinctive flavin absorption 
spectrum. Attempts to incorporate flavin into this variant by incubating it with FAD failed 
and it was not studied further. The other six His-VAO variants and all seven EUGO-His 
variants contained flavin as determined from their characteristic flavin absorption spectra (Fig. 
S1+S2). Upon precipitation of the proteins using trichloroacetic acid, a yellow pellet and 
colourless supernatant were obtained, demonstrating that the flavin cofactor is covalently 
bound to the protein. The absorption spectra of all seven EUGO-His variants had a similar 
shape to that of wild-type EUGO-His. A number of the His-VAO variants, most notably 
T457Q and C470L, displayed a somewhat altered flavin absorption spectrum, suggesting that 
in these variants the electronic environment of the flavin is slightly altered by the introduced 
mutations. The variants were screened for changes in their substrate specificity using the 
xylenol orange assay. The results of this screening assay are shown in Figure 4. 
For His-VAO, all six remaining variants displayed activity with at least some of the tested 
compounds. Two of the variants, L316M and T459I, displayed substrate specificity profiles 
that were similar to that of the wild-type enzyme. The I468V and C470L variants displayed 
similar activity to the wild-type enzyme with the substrates vanillyl alcohol (14), chavicol (17)  
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Figure 3: Structures of the substrate binding pockets of VAO and EUGO with the competitive inhibitor 
isoeugenol bound. Structures are shown in stick representation with residues that are identical in each 
protein shown in grey, residues that are different in each protein shown with green (VAO) or cyan 
(EUGO) carbon atoms, the FAD cofactor shown with yellow carbon atoms and isoeugenol shown with 
pink carbon atoms. Nitrogen atoms are shown in blue, oxygen atoms in red and phosphorus atoms in 
orange. The VAO and EUGO structures were downloaded from the PDB website (PDB IDs: 2VAO and 
5FXD respectively). Figure was prepared using PyMOL (Schrödinger LLC, New York, NY, USA). 
Table 4: List of residues forming part of the substrate binding pocket that are different in VAO and 
EUGO and of the His-VAO and EUGO-His variants that were made during this study. The residues 
are numbered according to their position in the non-His-tagged wild-type proteins. 
Position Residue in His-VAO Residue in EUGO-His His-VAO 
Variant 
EUGO-His 
Variant 
1 Leu-316 Met-282 L316M M282L 
2 Trp-413 Leu-381 W413L L381W 
3 Phe-424 Gly-392 F424G G392F 
4 Thr-457 Gln-425 T457Q Q425T 
5 Thr-459 Ile-427 T459I I427T 
6 Ile-468 Val-436 I468V V436I 
7 Cys-470 Leu-438 C470L L438C 
 
and eugenol (18). However, these variants did not display any activity towards linear 4-
alkylphenols. The T457Q variant was the only variant to have significantly increased activity 
with vanillyl alcohol as a substrate, displaying a reaction rate that was approximately 
threefold higher than that of the wild-type enzyme. However, with all other substrates the 
T457Q variant displayed a decrease in activity. The only variant for which activity was 
detected with a compound for which no activity was detected for wild-type His-VAO was 
W413L. This variant displayed activity towards 4-cyclohexylphenol (23), a compound that so 
far had not been described as a substrate for VAO or EUGO. In addition to this novel reactivity, 
the W413L variant displayed activity towards 4-cyclopentylphenol (22), eugenol, chavicol and 
4-isopropylphenol (5). No activity was detected with linear 4-alkylphenols or vanillyl alcohol. 
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Figure 4: Rates of the reactions of His-VAO and EUGO-His variants with the compounds used in the 
substrate specificity screening in 50 mM potassium phosphate buffer, pH 7.5, at room temperature (19-
20 °C) as determined using the xylenol orange assay. Error bars represent the standard deviations of 
duplicate measurements. For all compounds that are not included in the graphs, no variants gave a 
signal above the detection limit of the assay. The F424G His-VAO variant was not studied, as it did not 
contain any flavin cofactor. For the L381W, G392F and I427T EUGO-His variants, no response higher 
than the detection limit was measured for any compound. 
To confirm that W413L His-VAO oxidises 4-cyclohexylphenol, 1 μM enzyme was incubated 
with 2 mM 4-cyclohexylphenol for 4 h at 25 °C and the reaction products were analysed by 
GC and GC/MS (Fig. S6+7). This revealed that 4-cyclohexylphenol is indeed converted by the 
enzyme yielding a single product, though the degree of conversion was only 27%. GC/MS 
analysis revealed that the product displays a molecular ion at m/z = 174.1, suggesting that it is 
formed by the dehydrogenation of the substrate. As VAO typically dehydrogenates the Cα-
Cβ bond of alkyl groups, the product of 4-cyclohexylphenol oxidation is presumably 4-(1-
cyclohexen-1-yl)phenol. Similar experiments were performed using wild-type His-VAO and 
EUGO-His to evaluate whether they are also capable of converting 4-cyclohexylphenol. This 
revealed that after a 4 h incubation period, wild-type His-VAO had converted 51% of the 
substrate yielding the same product as observed with W413L His-VAO. In contrast, no 
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conversion of 4-cyclohexylphenol by wild-type EUGO-His was observed under these reaction 
conditions. 
The substrate specificity screening of the EUGO-His variants revealed that three of the seven 
variants, L381W, G392F and I427T, did not display measurable activity towards any of the 
tested compounds. One of the four remaining variants, M282L, displayed a substrate 
specificity profile that was similar to that of wild-type EUGO-His. Another variant, Q425T, 
displayed similar activity to the wild-type enzyme with vanillyl alcohol, but did not display 
measurable activity towards any other compounds. The L438C variant displayed lowered 
activity towards all substrates as compared to the wild-type enzyme. The V436I variant 
displayed lowered activity towards vanillyl alcohol and eugenol. However, this variant had 
significantly increased activity towards chavicol and 4-cyclopentylphenol and also displayed 
activity towards the dimethoxylated substrate 2,6-dimethoxy-4-allylphenol (19). This 
compound had previously been described to be a substrate for EUGO (9), but the kcat value for 
its oxidation (0.49 s-1) is lower than the detection limit of our assay, explaining the lack of 
activity detected for wild-type EUGO-His. No variants were identified that displayed activity 
towards compounds that had previously been identified as substrates for VAO, but not for 
EUGO, such as linear 4-alkylphenols. 
In summary, the majority of the studied variants displayed similar or significantly reduced 
activity towards all tested compounds when compared to the corresponding wild-type 
enzyme. Two variants were identified that had significantly (more than twofold) increased 
activity towards one or more substrates. 
Discussion 
Here, we described the development of a method for the efficient screening of variants of VAO 
and EUGO for alterations in their substrate specificities. The method is based on a facile 
benchtop purification of His-tagged versions of the enzymes, followed by a substrate 
specificity screening using a xylenol orange assay. After demonstrating that this method 
allows accurate determination of reaction rates of the wild-type enzymes with a range of 
substrates, we used it to screen a library of fourteen His-VAO or EUGO-His variants towards 
a set of twenty-four (potential) substrates. The use of the xylenol orange assay, a 
spectrophotometric detection method for the oxidase product hydrogen peroxide, allows the 
simultaneous measurement of activity towards a range of substrates in a high-throughput 
fashion. This compares favourably to previous methods for measuring the activity of VAO 
and EUGO. These either relied on measuring the absorption of the product of the reaction, 
making the detection method dependent on the substrate used and on prior knowledge of the 
identity of the product, or on measuring the consumption of oxygen, which is not practical 
for high-throughput screening purposes. Although generic methods for the high-throughput 
screening of oxidase activity have been developed in the past, they typically rely on 
peroxidase-coupled activity assays, where a peroxidase uses the formed hydrogen peroxide 
to catalyse the production of a coloured product (36). This type of assay is not suitable for use 
with VAO or EUGO, as their phenolic substrates are typically also converted by peroxidases 
(32). 
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Although the number of substrates and variants used in our screen is relatively small, the 
xylenol orange assay is highly scalable, particularly when robotic pipetting systems are 
available. In our case, the limiting factor for the number of variants that can be screened is the 
protein purification method, which relies on the use of gravity-flow Ni-NTA columns. 
However, we did demonstrate that this single purification step allowed us to obtain 
sufficiently pure His-VAO and EUGO-His variants. High-throughput methods for the 
production and purification of His-tagged proteins using E. coli expression systems have been 
described (37). Such a system could be used to achieve the purification of a large number of 
His-VAO or EUGO-His variants for use in the substrate specificity screening. Alternatively, 
cell free extracts of E. coli expressing the variants could be used for the assay. However, in our 
hands this gave poor results, most likely due to degradation of the formed hydrogen peroxide 
by catalase present in the E. coli extracts. 
The substrate specificity profiling of wild-type His-VAO and EUGO-His led to the 
identification of 4-cyclopentylphenol as a substrate of the enzymes. Its conversion yielded 4-
(1-cyclopenten-1-yl)phenol as the sole product. This is in agreement with the previous finding 
that while VAO can catalyse both the hydroxylation and the dehydrogenation of 4-
alkylphenols, the dehydrogenation reaction is preferred when the alkyl side chain is relatively 
large (11). Our results also revealed that His-VAO and the W413L His-VAO variant catalyse 
the dehydrogenation of 4-cyclohexylphenol, presumably to 4-(1-cyclohexen-1-yl)phenol. 
However, this reaction was not catalysed by EUGO-His. 
Although the substrate specificity profiling of fourteen His-VAO or EUGO-His variants did 
not lead us to a thorough understanding of the molecular determinants of the differing 
substrate specificities of the enzymes, it did give some interesting insights into the importance 
of certain non-catalytic active site residues for enzyme activity. One interesting finding was 
that the F424G His-VAO variant did not contain any FAD when purified from E. coli and 
attempts to incorporate FAD into the protein failed. Possibly, the extra flexibility conferred by 
the introduction of a glycine residue in this variant destabilises the structure of the active site, 
leading to impaired flavin binding. Three of the seven EUGO-His variants, L381W, G392F and 
I427T, did not display any activity in the substrate specificity profiling, despite containing 
covalently bound flavin. Presumably, the introduced mutations affect the structure of the 
active site in such a way that the substrate is no longer bound in an orientation that is 
productive for catalysis. 
The I468V and C470L His-VAO variants also displayed interesting changes in substrate 
specificity, maintaining similar reaction rates to the wild-type enzyme with vanillyl alcohol, 
chavicol and eugenol, but displaying no activity towards linear 4-alkylphenols. Ile-468 and 
Cys-470 are positioned close together at the top of the substrate-binding pocket (Fig. 3). 
Possibly, the identity of these two residues is important for maintaining VAO’s reactivity with 
linear 4-alkylphenols. As the ability to convert linear 4-alkylphenols is one of the main 
differences between VAO and EUGO in terms of substrate specificity, it would be interesting 
to investigate whether further mutagenesis at these positions could create a EUGO variant 
that is capable of catalysing this reaction. 
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Only two variants that displayed significantly increased activity towards a compound for 
which activity was also detected with the wild-type enzymes were identified. T457Q His-VAO 
had a threefold increased reaction rate for the oxidation of vanillyl alcohol compared to wild-
type His-VAO and I436V EUGO-His had three- and fourfold increased reaction rates for the 
oxidation of chavicol and 4-cyclopentylphenol respectively when compared to wild-type 
EUGO-His. It also displayed increased activity towards 4-allyl-2,6-dimethoxyphenol, though 
the magnitude of the increase could not be quantified as the reaction rate of wild-type EUGO-
His with this compound is below the detection limit of the assay. 
In summary, we developed an efficient method for screening variants of VAO and EUGO for 
changes in their substrate specificity consisting of the benchtop purification of His-tagged 
versions of the enzymes followed by substrate specificity screening using a xylenol orange 
assay. This method was employed for the substrate specificity profiling of the wild-type 
enzymes and of fourteen enzyme variants, leading to the identification of 4-cyclopentylphenol 
as a new substrate for both wild-type enzymes and of 4-cyclohexylphenol as a new substrate 
for wild-type His-VAO. Two variants, T457Q His-VAO and V436I EUGO-His were found to 
display significant increases in activity towards certain substrates. This method has the 
potential to be used to screen larger variant libraries in future, facilitating efforts to design 
VAO and EUGO variants for biocatalytic applications. 
Materials and methods 
Materials 
4-Hydroxy-3,5-dimethoxybenzyl alcohol was from Alfa Aesar (Haverhill, MA, USA). 4-n-
Butylphenol and 4-n-nonylphenol were from Lancaster Synthesis (Haverhill, MA, USA). 
Ferrous sulphate heptahydrate was from Merck (Burlington, MA, USA). 4-Allylphenol 
(chavicol) was from Quest International (Naarden, The Netherlands). 4-Allyl-2,6-
dimethoxyphenol, 4-allyl-2-methoxyphenol (eugenol), 4-(aminomethyl)-2-methoxyphenol 
hydrochloride (vanillyl amine), 4-sec-butylphenol, 4-cyclohexylphenol, 4-cyclopentylphenol, 
4-ethylphenol, 4-n-hexylphenol, 2-hydroxybenzyl alcohol, 3-hydroxybenzyl alcohol, 4-
hydroxybenzyl alcohol, 4-hydroxy-2-methoxybenzyl alcohol, 4-hydroxy-3-methoxybenzyl 
alcohol (vanillyl alcohol), 5-indanol, 4-isopropylphenol, 2-methoxy-4-methylphenol (para-
creosol), 4-methylphenol (para-cresol), 4-n-pentylphenol, 4-n-propylphenol, 5,6,7,8-
tetrahydronaphthol and xylenol orange tetrasodium salt were from Sigma-Aldrich (St. Louis, 
MO, USA). All other chemicals were from commercial sources and of the purest grade 
available. The pJ404-His-VAO and pBAD-EUGO-His plasmids were a kind gift from Prof. Dr. 
Marco Fraaije (University of Groningen). 
Site-directed mutagenesis 
Plasmids encoding the His-VAO and EUGO-His variants were created by linear whole-
plasmid amplification from the pJ404-His-VAO and pBAD-EUGO-His plasmids respectively. 
The pJ404-His-VAO plasmid contains a version of the vaoA gene from P. simplicissimum that 
is codon-optimised for expression in E. coli behind the IPTG-inducible T5 promoter. The gene 
is extended with a sequence that encodes an N-terminal 6x-His-tag followed by a single 
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glycine residue. The pBAD-EUGO-His plasmid contains the eugo gene from Rhodococcus jostii 
RHA1 with an extension that encodes the polypeptide sequence 
GKLGPEQKLISEEDLNSAVDHHHHHH at the C-terminus of the protein. The extension 
contains both a C-terminal 6x-His tag and a Myc-tag (EQKLISEEDL). This construct is placed 
behind the L-arabinose-inducible pBAD promoter. Constructs encoding variants of the 
enzymes were amplified from the corresponding plasmid using the mutagenic primers listed 
in Table 5. Following the amplification reaction, remaining template DNA was digested with 
DpnI and the mutated plasmids were transformed into DH5α E. coli. Subsequently, plasmid 
DNA was isolated and the introduction of the correct mutations was confirmed by sequencing. 
The mutated plasmids were transformed into BL21 (for His-VAO) or TOP10 (for EUGO-His) 
E. coli for protein expression. 
Table 5: List of primers used for site-directed mutagenesis in this study. Sites in italics indicate the 
position of the mutations introduced to achieve the amino acid substitution. Underlined sites 
indicate the position of mutations introduced to remove or introduce a restriction site to enable 
screening for the introduction of the correct mutations by restriction enzyme digestion (these are 
either the same mutations used for the amino acid substitution or silent mutations close to this 
site). The identity of the used restriction enzymes is given in the third column (+ indicates that a 
restriction site for this enzyme was introduced, - indicates that a restriction site for this enzyme 
was removed).  
Variant Primer Restriction 
Site 
L316M His-VAO ATCCGCCATATTCTGATGGATGCTGCAGTGCTGGGTGACA
AG 
+PstI 
W413L His-VAO TATGATGAACTGAAGCTTATTGATTGGTTGCCG +HindIII 
F424G His-VAO AATGGTGCCCACCTGGGTTTCAGCCCGATTGCGAAGGTGT
CTGGT 
−PvuI 
T457Q His-VAO TGCCAGGAAGCAGGTCTAGACTTCATTGGTCAATTCACTG
TTGGTATG 
+XbaI 
T459I His-VAO TTCATTGGTACGTTCATTGTTGGTATGCGTGAG None 
I468V His-VAO ATGCGTGAGATGCATCATGTTGTTTGCATCGTGTTT +NsiI 
C470L His-VAO ATGCGTGAGATGCATCATATTGTTTTAATCGTGTTTAACA
AG 
+NsiI 
M282L EUGO-
His 
CTGCGCAACATCTTCTT GACGCGGCCGCGGTG None 
L381W EUGO-
His 
CTGGACGAACTGCAGTGGCTGGACTGGGTGCCC +PstI 
G392F EUGO-His AACGGCGGGCACATCTTTTTCTCACCGGTGTCGGCGCCG +AgeI 
Q425T EUGO-
His 
AAGGACTACGCCGCGACATTCATCATCGGGCTC None 
I427T EUGO-His TACGCCGCGCAATTCACGATCGGGCTCCGCGAG +PvuI 
V436I EUGO-His CGCGAGATGCACCACATATGCCTGTTCATCTAC +NdeI 
L438C EUGO-His CTCCGCGAGATGCATCACGTGTGCTGCTTCATCTACGACA
CG 
+NsiI 
 
Protein expression and purification 
For the expression of His-VAO and its variants, BL21 E. coli containing the correct plasmid 
was grown in 100 mL LB medium (Duchefa Biochemie, Haarlem, The Netherlands) containing 
100 μg/mL ampicillin at 37 °C until the OD600 was 0.6. Subsequently, protein expression was 
induced by adding IPTG to a final concentration of 0.8 mM and cells were grown overnight 
at 25 °C. Next, cells were harvested by centrifugation (4200 g, 15 min, 4 °C) and resuspended 
in 50 mM potassium phosphate buffer, pH 7.5, containing 500 mM NaCl, 5% glycerol (v/v), 
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0.5 mM MgSO4 and one cOmpleteTM protease inhibitor pill (Roche, Basel, Switzerland) and 1 
mg DnaseI (Roche) per 50 mL. Cells were lysed by sonication using 6 cycles of 30 seconds at 
maximum power with an MSE sonication probe. Samples were cooled on ice during 
sonication. Following this, cell debris was removed by centrifugation (39,000 g, 45 min, 4 °C) 
and the supernatant was loaded onto a gravity flow column containing 2 mL HisPur Ni-NTA 
resin (Thermo Scientific, Waltham, MA, USA) equilibrated in 50 mM potassium phosphate 
buffer, pH 7.5, containing 500 mM NaCl and 5% glycerol. The column was washed with this 
buffer until all unbound proteins had eluted as judged from the absorption of the flow-
through at 280 nm. Subsequently, His-VAO was eluted using 50 mM potassium phosphate 
buffer, pH 7.5, containing 500 mM NaCl, 5% glycerol (v/v) and 200 mM imidazole. Fractions 
containing His-VAO were pooled and transferred to 50 mM potassium phosphate buffer, pH 
7.5, containing 150 mM NaCl and 10% glycerol by passing them over an Econo-Pac 10DG 
desalting column (Bio-Rad, Hercules, CA, USA) equilibrated in this buffer. This procedure 
typically yielded 1–3 mg protein from 100 mL E. coli culture. 
After purification of F424G His-VAO, the protein did not contain any flavin cofactor. In an 
attempt to obtain flavin-containing protein, the purified F424G His-VAO variant was 
incubated with 1 mM FAD in 50 mM potassium phosphate buffer, pH 7.5, containing 75 mM 
NaCl and 5% glycerol at room temperature for 4 h. Subsequently, free FAD was removed by 
passing the mixture over an Econo-Pac 10DG desalting column (Bio-Rad) equilibrated in 50 
mM potassium phosphate buffer, pH 7.5, containing 150 mM NaCl and 10% glycerol. 
Fractions containing the protein were collected and analysed for flavin content by measuring 
their absorption spectra. This revealed that the protein did not contain any FAD. No further 
attempts were made to incorporate FAD into the F424G His-VAO variant. 
For the expression of EUGO-His and its variants, TOP10 E. coli containing the correct plasmid 
was grown in 100 mL TB medium (Difco, Becton Dickinson, Franklin Lake, NJ, USA) 
containing 100 μg/mL ampicillin at 37 °C until the OD600 was 0.6. Subsequently, protein 
expression was induced by adding L-arabinose to a final concentration of 0.02% (w/v) and 
cells were grown overnight at 30 °C. Next, cells were harvested by centrifugation (4200 g, 15 
min, 4 °C) and resuspended in 50 mM potassium phosphate buffer, pH 7.5, containing 20 mM 
imidazole, 0.5 mM MgSO4 and one cOmpleteTM protease inhibitor pill (Roche) and 1 mg 
DnaseI (Roche) per 50 mL. Cells were lysed by sonication using 6 cycles of 30 seconds at 
maximum power with an MSE sonication probe. Samples were cooled on ice during 
sonication. Following this, cell debris was removed by centrifugation (39,000 g, 45 min, 4 °C) 
and the supernatant was loaded onto a gravity flow column containing 2 mL HisPur Ni-NTA 
resin (Thermo Scientific) equilibrated in 50 mM potassium phosphate buffer, pH 7.5, 
containing 20 mM imidazole. The column was washed with this buffer until all unbound 
proteins had eluted as judged from the absorption of the flow-through at 280 nm. 
Subsequently, EUGO-His was eluted using 50 mM potassium phosphate buffer, pH 7.5, 
containing 500 mM imidazole. Fractions containing EUGO-His were pooled and transferred 
into 50 mM potassium phosphate buffer, pH 7.5, by passing them over an Econo-Pac 10DG 
desalting column (Bio-Rad) equilibrated in this buffer. This procedure typically yielded 5–10 
mg protein from 100 mL E. coli culture. 
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Analytical methods 
All experiments were performed in 50 mM potassium phosphate buffer, pH 7.5, unless 
indicated otherwise. Absorption spectra were recorded on a Hewlett Packard 8453 
photodiode array spectrophotometer (Agilent Technologies, Santa Clara, CA, USA). 
Concentrations of His-VAO and its variants were determined using the extinction coefficient 
of non-His-tagged VAO at 439 nm [ɛ = 12,500 M−1 cm−1 (3)] and concentrations of EUGO-His 
and its variants were determined using the extinction coefficient of non-His-tagged EUGO at 
441 nm [ɛ = 14,200 M−1 cm−1 (4)]. For trichloroacetic acid precipitations, 10 μL 50% (w/v) 
trichloroacetic acid solution was added to 90 μL 11 μM enzyme solution in 50 mM potassium 
phosphate buffer, pH 7.5, (EUGO-His and variants) or 50 mM potassium phosphate buffer, 
pH 7.5, containing 150 mM NaCl and 10% glycerol (His-VAO and variants) to yield final 
concentrations of 5% (w/v) trichloroacetic acid and 10 μM enzyme. Mixtures were incubated 
on ice for 30 min, after which the precipitate was pelleted by centrifugation (21,000 g, 15 min, 
4 °C). The presence of flavin in the pellet or supernatant was judged from their colour and 
fluorescence upon irradiating them with UV light. Steady-state kinetic parameters for the 
oxidation of vanillyl alcohol to vanillin by His-VAO and EUGO-His were determined by 
following the absorption of the product at 340 nm (ɛ = 14,000 M−1 cm−1) and fitting the obtained 
reaction rates to the Michaelis-Menten equation using Igor Pro v. 6.10A (Wavemetrics, Lake 
Oswego, OR, USA). Oxygen consumption measurements were performed using a Hansatech 
Oxytherm system (Hansatech Instruments, King’s Lynn, UK). 
Enzymatic reactions for the xylenol orange assay 
Enzymatic reactions were performed in 96-wells plates. Substrate solution (180 µL) was added 
to 20 µL enzyme solution to give a reaction mixture containing 20 nM enzyme and 2 mM 
substrate in 50 mM potassium phosphate buffer, pH 7.5. For measurements where the 
oxidation of eugenol or vanillyl alcohol was followed in time, the reaction mixtures were 
incubated for the desired time (ranging from 1–20 min) at room temperature (19–20 °C), after 
which 20 μL of the reaction mixture was removed and the hydrogen peroxide concentration 
was determined using the xylenol orange assay as described below. Reaction rates were 
determined by fitting a curve to the linear range of the data using Igor Pro. For substrate 
specificity screening, the reaction mixtures were incubated for 10 min at room temperature 
(19–20 °C), after which a 20 μL sample was taken and the hydrogen peroxide concentration 
was determined using the xylenol orange assay as described below. Three of the tested 
compounds, 4-n-nonylphenol, 4-hydroxybenzyl alcohol and 4-cyclohexylphenol, were poorly 
soluble in water at the used concentration and therefore were added to the reaction mixtures 
as (partial) suspensions. Reaction rates were estimated by assuming that there is a linear 
increase in hydrogen peroxide concentration during the reaction time. 
Xylenol orange assay 
20 μL of the sample to be analysed was added to 180 μL xylenol orange assay mix in a 96-
wells plate. This yielded a final assay mixture containing 100 μM xylenol orange, 250 μM 
FeSO4, 25 mM H2SO4 and the tenfold diluted analyte solution. This mixture was incubated in 
the dark at room temperature (19–20 °C) for 30 min, after which the absorption at 560 nm was 
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measured using an xMark microplate spectrophotometer (Bio-Rad). A calibration curve of 
hydrogen peroxide solutions with known concentrations in the range 10–200 μM 
(concentration prior to addition to the xylenol orange assay mixture) was used to convert the 
measured absorbance values to the hydrogen peroxide concentration in the analyte solution. 
To ensure that the measured hydrogen peroxide concentrations reflect actual hydrogen 
peroxide formed during the enzymatic reaction, a detection limit of 10 μM hydrogen peroxide, 
which corresponds to the lowest point of the calibration curve, was used. All samples where 
the measured hydrogen peroxide concentration was lower than this were deemed to have had 
no significant formation of hydrogen peroxide during the reaction period. 
Conversion of 4-cyclopentylphenol and 4-cyclohexylphenol and identification of the reaction products 
For GC and GC/MS analysis, reaction mixtures (100 μL) containing 2 mM substrate and 1 μM 
enzyme in 50 mM potassium phosphate buffer, pH 7.5, (EUGO-His) or 50 mM potassium 
phosphate buffer, pH 7.5, containing 30 mM NaCl and 2% (w/v) glycerol (His-VAO), were 
incubated for 2 h (4-cyclopentylphenol) or 4 h (4-cyclohexylphenol) at 25 °C under shaking 
(500 rpm). Subsequently, the reactions were stopped by extracting the reaction mixtures twice 
with 100 μL EtOAc. The EtOAc layers were combined and dried over Na2SO4. Reaction 
products were analysed by GC and GC/MS. GC was performed on an Agilent 6890 GC system 
equipped with an Agilent 7673 injector using a 60 m x 0.25 mm x 0.25 μm DB-1 column 
(Agilent Technologies). The injector temperature was 220 °C and the FID temperature was 
250 °C. The split ratio was 10:1. Samples from reactions with 4-cyclopentylphenol were run at 
a flow rate of 1.7 mL/min using the following temperature programme: 100 °C for 5 min, 
followed by a temperature gradient to 230 °C with an increment of 10 °C/min, followed by 3 
min at 230 °C. Samples from reactions with 4-cyclohexylphenol were run at a flow rate of 1.7 
mL/min using the following temperature programme: 100 °C for 4 min, followed by a 
temperature gradient to 160 °C with an increment of 10 °C/min, followed by 10 min at 160 °C, 
followed by a temperature gradient to 230 °C with an increment of 10 °C/min, followed by 3 
min at 230 °C. Reported conversion percentages are average values from duplicate 
experiments. GC/MS was performed on an Agilent 6890 GC system equipped with an Agilent 
7975C MS detector and an Agilent 7683B injector using a 30 m × 0.25 mm × 0.25 μm HP-5MS 
column (Agilent Technologies). The injector temperature was 275 °C. The split ratio was 100:1. 
Samples were run at a flow rate of 1.1 mL/min using the following programme: 50 °C for 3 
min, followed by a temperature gradient to 100 °C with an increment of 5 °C/min, followed 
by a temperature gradient to 250 °C with an increment of 10 °C/min, followed by 3 min at 
250 °C. 
For 1H-NMR analysis, a reaction mixture (25 mL) containing 2.5 mM 4-cyclopentylphenol and 
0.5 μM EUGO-His was incubated in 50 mM potassium phosphate buffer, pH, 7.5, at 25 °C for 
16 h under shaking (500 rpm). Following this, reaction products were extracted twice with 25 
mL EtOAc. The EtOAc layers were combined and dried over Na2SO4. Subsequently, EtOAc 
was removed by evaporation and the remaining solid was dissolved in CDCl3. 1H-NMR 
spectra were recorded on an Avance III 400 MHz NMR spectrometer (Bruker, Billerica, MA, 
USA) at 400 MHz. This revealed that the obtained product was a mixture of 40% 4-
cyclopentylphenol and 60% 4-(1-cyclopenten-1-yl)phenol.  
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4-cyclopentylphenol. 1H-NMR (400 MHz, CDCl3) δ (ppm): 7.12 (ap d, J = 8.5 Hz, 2H), 6.77 (ap d, 
J = 8.5 Hz, 2H), 4.66 (s, 1H), 2.93 (m, 1H), 2.14–1.96 (m, 2H), 1.87–1.72 (m, 2H), 1.75–1.59 (m, 
2H), 1.61–1.46 (m, 2H). 
4-(1-cyclopenten-1-yl)phenol. 1H-NMR (400 MHz, CDCl3) δ (ppm): 7.33 (ap d, J = 8.6 Hz, 2H), 
6.78 (ap d, J = 8.9 Hz, 2H), 6.04 (m, 1H), 4.80 (br s, 1H), 2.73–2.56 (m, 2H), 2.56–2.45 (m, 2H), 
2.09–1.96 (m, 2H). 
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Supplementary Figures 
 
Figure S1: Absorption spectra of His-VAO variants recorded in 50 mM potassium phosphate buffer, 
pH 7.5, at 25 °C.  
 
Figure S2: Absorption spectra of EUGO-His variants recorded in 50 mM potassium phosphate buffer, 
pH 7.5, at 25 °C.  
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Figure S3: GC chromatograms of the reaction products of the conversion of 4-cyclopentylphenol by 
His-VAO or EUGO-His. 2 mM 4-cyclopentylphenol and 1 μM enzyme were incubated for 2 h at 25 °C 
in 50 mM potassium phosphate buffer, pH 7.5, (EUGO-His) or 50 mM potassium phosphate buffer, 
pH 7.5, containing 30 mM NaCl and 2% (w/v) glycerol (His-VAO). Subsequently, the reaction 
products were extracted and analysed by GC. For both reactions, a single product, 4-(1-cyclopenten-1-
yl)phenol, was formed at >99% conversion. Retention times: 4-cyclopentylphenol: 15.6 min, 4-(1-
cyclopenten-1-yl)phenol: 16.7 min. 
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Figure S4: Mass spectra of 4-cyclopentylphenol (top) and 4-(1-cyclopenten-1-yl)phenol formed from 
its conversion by His-VAO (bottom) as obtained by GC/MS analysis. 2 mM 4-cyclopentylphenol and 1 
μM enzyme were incubated for 2 h at 25 °C in 50 mM potassium phosphate buffer, pH 7.5, containing 
30 mM NaCl and 2% (w/v) glycerol. Subsequently, the reaction products were extracted and analysed 
by GC/MS. A single product peak was observed, the mass spectrum of the corresponding compound 
is shown in the bottom panel. The product formed by the conversion of 4-cyclopentylphenol by 
EUGO-His displayed an identical mass spectrum. A 4-cyclopentylphenol standard also displayed a 
single peak on the chromatogram, the mass spectrum of the corresponding compound is shown in the 
top panel. 
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Figure S5: 1H-NMR spectra of 4-cyclopentylphenol and the products of the conversion of 4-
cyclopentylphenol by EUGO-His. 2.5 mM 4-cyclopentylphenol and 0.5 μM EUGO-His were 
incubated in 50 mM potassium phosphate buffer, pH 7.5, at 25 °C for 16 h. Subsequently, reaction 
products were extracted and analysed by 1H-NMR. This revealed that the product is a mixture of 4-
cyclopentylphenol (40%) and 4-(1-cyclopenten-1-yl)phenol (60%). Peaks below 1.5 ppm are due to 
impurities in the CDCl3. 4-cyclopentylphenol: 1H-NMR (400 MHz, CDCl3) δ (ppm): 7.12 (ap d, J = 8.5 Hz, 
2H), 6.77 (ap d, J = 8.5 Hz, 2H), 4.66 (s, 1H), 2.93 (m, 1H), 2.14 – 1.96 (m, 2H), 1.87 – 1.72 (m, 2H), 1.75 – 
1.59 (m, 2H), 1.61 – 1.46 (m, 2H). 4-(1-cyclopenten-1-yl)phenol: 1H-NMR (400 MHz, CDCl3) δ (ppm): 7.33 
(ap d, J = 8.6 Hz, 2H), 6.78 (ap d, J = 8.9 Hz, 2H), 6.04 (m, 1H), 4.80 (br s, 1H), 2.73 – 2.56 (m, 2H), 2.56 – 
2.45 (m, 2H), 2.09 – 1.96 (m, 2H). 
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Figure S6: GC chromatograms of the reaction products of the conversion of 4-cyclohexylphenol by 
W413L His-VAO, His-VAO or EUGO-His. 2 mM 4-cyclohexylphenol and 1 μM enzyme were 
incubated for 4 h at 25 °C in 50 mM potassium phosphate buffer, pH 7.5, (EUGO-His) or 50 mM 
potassium phosphate buffer, pH 7.5, containing 30 mM NaCl and 2% (w/v) glycerol (His-VAO and 
W413L His-VAO). Subsequently, the reaction products were extracted and analysed by GC. With 
W413L His-VAO and His-VAO, a single product, 4-(1-cyclohexen-1-yl)phenol, was formed at 27% 
and 51% conversion respectively (average of two reactions). With EUGO-His, no conversion of the 
substrate was observed. Retention times: 4-cyclohexylphenol: 20.9 min, 4-(1-cyclohexen-1-yl)phenol: 
23.5 min. 
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Figure S7: Mass spectra of 4-cyclohexylphenol (top) and 4-(1-cyclohexen-1-yl)phenol formed from its 
conversion by W413L His-VAO (bottom) as obtained by GC/MS analysis. 2 mM 4-cyclohexylphenol 
and 1 μM enzyme were incubated for 4 h at 25 °C in 50 mM potassium phosphate buffer, pH 7.5, 
containing 30 mM NaCl and 2% (w/v) glycerol. Subsequently, the reaction products were extracted 
and analysed by GC/MS. Two peaks were observed, one corresponding to unconverted substrate and 
a single product peak, the mass spectrum of the product is shown in the bottom panel. The product 
formed by the conversion of 4-cyclohexylphenol by wild-type His-VAO displayed an identical mass 
spectrum. A 4-cyclohexylphenol standard also displayed a single peak on the chromatogram, the 
mass spectrum of the corresponding compound is shown in the top panel.
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Summary 
The enantioselective oxyfunctionalisation of C-H bonds is a highly interesting reaction, as it 
provides access to chiral alcohols that are important pharmaceutical building blocks. 
However, it is hard to achieve using traditional methods. One way in which it can be achieved 
is through the action of oxidative enzymes. Although many reports of the 
oxyfunctionalisation capabilities of enzymes at an analytical scale have been published, 
reports on the use of enzymes to achieve oxyfunctionalisation on a synthetically relevant scale 
are fewer. Here, we describe the scale-up of the conversion of 4-ethylphenol to (R)-1-(4′-
hydroxyphenyl)ethanol using the flavin-dependent enzyme vanillyl alcohol oxidase. The 
process was optimised by testing different reaction media and substrate and enzyme 
concentrations and by performing it under an oxygen atmosphere. Under optimised reaction 
conditions, 4.1 g (R)-1-(4′-hydroxyphenyl)ethanol at 97% ee was obtained from 10 g 4-
ethylphenol (isolated yield 36%). These results highlight some of the challenges that can be 
encountered during scale-up of an enzymatic oxyfunctionalisation process to a synthetically 
relevant scale and will be of use for the development of enzymatic processes for the synthesis 
of industrially relevant compounds.
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Introduction 
The selective oxyfunctionalisation of C-H bonds under mild reaction conditions is of great 
interest to synthetic organic chemists. In recent years, much effort has been put into 
developing metal-based catalysts that can introduce oxygen atoms using environmentally 
benign oxidants such as molecular oxygen (1, 2). An attractive alternative to traditional 
chemical catalysts is the use of enzymes capable of introducing oxygen atoms, which often 
display exquisite regio- and enantioselectivity and are active under mild reaction conditions. 
Well-known classes of oxygenating enzymes include heme-dependent cytochrome P450 
enzymes and peroxygenases, non-heme iron oxygenases and flavin-dependent oxygenases 
(3–7). Some of these enzymes have been utilised to obtain valuable products from preparative-
scale transformations (8–12). For many others, however, our knowledge of their 
oxyfunctionalisation capabilities is limited to the analytical scale. In order to stimulate the use 
of oxidoreductases in industrial chemical synthesis, it is crucial to demonstrate that they can 
be used to obtain compounds on a synthetically relevant scale (13).  
Chiral alcohols, which are often important intermediates in the synthesis of active 
pharmaceutical ingredients, present an interesting target for these preparative-scale 
transformations (14). One class of alcohols that are important pharmaceutical building blocks 
are chiral α-aryl alcohols (15, 16). A number of biocatalytic approaches for their synthesis have 
been described, including enantioselective reduction of a prochiral ketone, kinetic resolution 
or deracemisation of racemic alcohols and the enantioselective hydration of vinylphenol 
derivatives (17–22). Another potential enzymatic synthesis route for chiral α-aryl alcohols is 
the direct oxyfunctionalisation of alkyl-substituted aromatic molecules. An enzyme that can 
be used for this purpose is vanillyl alcohol oxidase from Penicillium simplicissimum (VAO, EC 
1.1.3.38), which is capable of catalysing the enantioselective hydroxylation of 4-alkylphenols. 
Here, we describe the development of the multigram scale enzymatic synthesis of (R)-1-(4′-
hydroxyphenyl)ethanol using VAO. 
VAO catalyses the oxidation of a wide range of para-substituted phenols at their Cα atom 
using molecular oxygen as an electron acceptor (23–25). VAO displays a broad substrate scope, 
catalysing the oxidation of benzylic alcohols or amines, the oxidative demethylation of 4-
(methoxymethyl)phenol and the hydroxylation of 4-allylphenols. In addition, VAO oxidises 
phenols bearing unfunctionalised alkyl chains as the para-substituent. This leads to mixtures 
of hydroxylated and dehydrogenated products, with the ratio between the two being 
determined by the size of the alkyl chain (25, 26, Chapter 6) and the composition of the 
reaction medium (27). The hydroxylation of short chain 4-alkylphenols proceeds with high 
regio- and enantioselectivity. The conversion of 4-ethylphenol, 4-propylphenol or 2-methoxy-
4-propylphenol by VAO yields the corresponding 1-(4′-hydroxyphenyl)alcohols as the sole 
hydroxylation product, in addition to more minor amounts of vinylic by-products from 
dehydrogenation of the substrate and ketone by-products from further oxidation of the 
formed alcohols (Scheme 1) (28). The hydroxylation reaction is highly enantioselective, with 
the (R)-enantiomers of the alcohol product being formed at 94% ee in all cases. 
The catalytic mechanism of VAO provides an explanation for this regio- and enantioselectivity 
(29–31, Chapter 4). Binding of the phenolate form of the substrate to the active site is followed 
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by hydride transfer from the Cα atom of the substrate to the N5 atom of the FAD cofactor 
(Scheme 2). This yields a planar para-quinone methide intermediate, which is subsequently 
hydrated in the enzyme‘s active site. The enantioselectivity of the hydration is determined by 
the presence of an active site base (Asp-170) that activates water for attack at one side of the 
planar para-quinone methide. Accumulation of the (R)-enantiomer is further enhanced by the 
fact that the (S)-enantiomer of 1-(4′-hydroxyphenyl)ethanol is more easily oxidised further to 
4-hydroxyacetophenone than the (R)-enantiomer is (25).  A VAO variant (D170S/T457E) 
where the active site base was moved to the other side of the substrate displayed reversed 
enantioselectivity, converting 4-ethylphenol to (S)-1-(4′- hydroxyphenyl)ethanol at 80% ee (32). 
Its ability to catalyse regio- and enantioselective hydroxylations using only molecular oxygen 
as a cosubstrate makes VAO an interesting candidate for biocatalytic applications. 
 
Scheme 1: Conversion of 4-ethylphenol (1) by VAO. Thickness of the arrows gives a qualitative 
indication of the relative rates at which the depicted reactions occur. VAO readily converts 4-
ethylphenol to (R)-1-(4′-hydroxyphenyl)ethanol (2), with (S)-1-(4′-hydroxyphenyl)ethanol (3) and 4-
vinylphenol (4) being formed as by-products. The formed alcohol can subsequently be oxidised further 
to 4-hydroxyacetophenone (5), with the (S)-enantiomer being more readily converted than the (R)-
enantiomer. Scheme adapted from (25). 
The synthetic utility of VAO at small scale has been demonstrated previously. The conversion 
of 4-ethylphenol and 2-methoxy-4-propylphenol was performed at 100 mg scale, yielding 33.2 
mg (28%) and 52 mg (45%) respectively of the corresponding purified alcohols (28). To 
evaluate the potential of VAO to be used as a biocatalyst for the synthesis of chiral alcohols 
on a more synthetically relevant scale, we scaled up the conversion of 4-ethylphenol to the 10 
g scale.  
Results 
Optimisation of Reaction Conditions 
As a first step in the scale-up process, we optimised the reaction conditions for the conversion 
of 4-ethylphenol (1) at an analytical scale by testing the effect of the addition of organic 
solvents to the reaction medium. To this end, the conversion of 5 mg 1 was performed in 84 
mM potassium phosphate buffer, pH 7.5, in the presence of 10% acetone or acetonitrile. The 
composition of reaction mixtures after the reaction as determined by gas chromatography is 
given in Table 1. Using acetone as a cosolvent gave the best results, with complete conversion  
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Scheme 2: Mechanism of the enantioselective hydroxylation of 4-ethylphenol by VAO. First, 4-
ethylphenol binds in the enzyme’s active site in its phenolate form. Following this, a hydride is 
transferred from the Cα atom of its ethyl group to the N5 atom of FAD, yielding a para-quinone methide 
intermediate and reduced FAD. Subsequently, a water molecule is activated by Asp-170 and attacks 
the Cα atom of the para-quinone methide intermediate, yielding the alcohol product. Stopped-flow 
kinetics analysis has demonstrated that this occurs after (or possibly concomitant with) the reoxidation 
of FAD by molecular oxygen (30). The position of Asp-170 relative to the planar para-quinone methide 
intermediate explains the preferential formation of the (R)-enantiomer of 1-(4′-hydroxyphenyl)ethanol. 
of 1 and 83% of the formed product being (R)-1-(4′-hydroxyphenyl)ethanol (2) after 4 h. The 
formation of 2 is underestimated, as part of the 1-(4′-hydroxyphenyl)ethanol undergoes 
elimination of water during the gas chromatographic analysis, yielding 4-vinylphenol (4) [as 
confirmed by GC analysis of racemic pure 1-(4′-hydroxyphenyl)ethanol]. Further scale-up 
was performed using the reaction medium containing 10% acetone.  
Table 1: Products obtained from the conversion of 4-ethylphenol (1) by VAO in the presence of organic 
solvents. 5 mg 1 (at a concentration of 2.9 mM) and 0.4 U VAO were incubated in 84 mM potassium 
phosphate buffer, pH 7.5, at 30 °C in the presence of 10% acetone or 10% acetonitrile. After the 
incubation period, reaction products were extracted and analysed by GC. Compounds are numbered 
as in Scheme 1. GC chromatograms are shown in Fig. S1. The given numbers are the amount of a 
compound as a percentage of the total present upon analysis.  
Reaction conditions 1 (%) 2 (%) 3 (%) 2-ee (%) 4 (%) 5 (%) 
10% acetone, 4 h - 83 0.7 98 14 3.0 
10% acetonitrile, 22h 5.9 76 2.5 94 14 1.3 
 
Scaling up the reaction to 100 mg scale with increased substrate concentrations revealed that 
almost complete conversion (97%) could be achieved using a substrate concentration of 23 
mM and 2 U VAO (Table 2, reaction a). Increasing the substrate concentration further to 45 
mM led to lower conversion (87%) even though the same enzyme to substrate ratio was used 
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(Table 2, reaction b). Therefore, 23 mM substrate with 0.02 U VAO/mg substrate was chosen 
as the conditions for scale-up. 
We subsequently tested whether we could eliminate the need for protein purification by 
performing the reaction using a cell-free extract of Escherichia coli expressing an N-terminally 
His-tagged variant of VAO. The plasmid encoding for this His-tagged VAO, pJ404-His-VAO, 
contains a version of the gene encoding for VAO that is codon-optimised for expression in E. 
coli. This construct allows VAO to be expressed at higher levels than the previously used 
plasmid, pBC11 (33), which contains the vaoA gene from P. simplicissimum. Using this cell-free 
extract, the conversion of 100 mg 1 gave a similar result to that using the purified enzyme 
(Table 2, reaction c). Apparently, the use of E. coli cell-free extract did not lead to any 
undesired side reactions taking place. Therefore, the cell-free extract was used for further 
scale-up reactions.  
Scale-up to 10 g Scale 
Having established the optimised reaction conditions for the conversion of 1 to 2, we next set 
out to scale up the reaction to a more synthetically relevant scale of 10 g of substrate. First, the 
reaction was scaled up to 1 g of substrate using the same reaction conditions as for 100 mg. 
This led to almost complete conversion (93%) of 1 and to similar formation of 2 as was 
obtained at 100 mg scale (Table 2, reaction d). Analysis of the reaction products by 1H-NMR 
allowed quantification of the products without being hindered by the decomposition of 1-(4′-
hydroxyphenyl)ethanol to 4 observed during GC analysis, revealing that the enzymatic 
reaction yields less than 3% of 4 as a by-product (Table 2, reaction d). To obtain pure 2, it was 
purified from the crude reaction mixture by recrystallisation, yielding 244.3 mg (21%) pure 2 
at 99% ee (Fig. S3+S4).  
Subsequently, the reaction was scaled up to our final target scale of approximately 10 g of 
starting material. However, using the same reaction conditions with 13.4 g 1 led to lower 
conversion of the substrate [63% (Table 2, reaction e)]. A possible explanation is that the larger 
reaction volume required for this conversion led to oxygen depletion becoming limiting for 
the reaction. Therefore, we performed the reaction with 10 g 1 under identical conditions, but 
with the reaction vessel under oxygen atmosphere for the first 9 h of the reaction. Under these 
conditions, the substrate was almost completely converted after 24 h [94% (Table 2, reaction 
f)]. After recrystallisation, pure 2 was obtained in 36% isolated yield and 97% ee (Fig. S3+S4).  
Discussion 
Here, we described the scale-up of the synthesis of (R)-1-(4′-hydroxyphenyl)ethanol starting 
from 4-ethylphenol using VAO. Optimisation of reaction conditions at analytical scale 
revealed that the reaction proceeds efficiently in the presence of 10% acetone. The addition of 
acetone likely improves the solubility of the aromatic substrate and products. In addition, the 
solubility of oxygen in acetone is increased as compared to in water [277 mg/L in acetone at 
25 °C and 44 mg/L in water at 20 °C at 1 bar pure oxygen atmosphere (34)], preventing oxygen 
depletion from becoming limiting for the reaction.  
Multigram scale enantioselective hydroxylation 
177 
 
Table 2: Products obtained from the conversion of 4-ethylphenol (1) by VAO. 1 and VAO or His-VAO 
cell-free extract were incubated in 88 mM potassium phosphate buffer, pH 7.5, containing 10% acetone 
at 30 °C for 24 h. Subsequently, reaction products were extracted and analysed by GC or 1H-NMR. 
Compounds are numbered as in Scheme 1. GC chromatograms are shown in Fig. S2, 1H-NMR spectra 
in Fig. S4. The given numbers are the amount of a compound as a percentage of the total present upon 
analysis. CFE: cell-free extract.   
Reaction Substrate Enzyme 
1 
(%) 
2 
(%) 
3 (%) 2+3 (%) 2-ee (%) 4 (%) 5 (%) 
a GC 
100 mg 
23 mM 
2 U VAO 3.1 83 4.0  91 8.3 1.5 
b GC 
100 mg 
45 mM 
2 U VAO 13 58 4.1  87 24 1.0 
c GC 
100 mg 
23 mM 
2 U  
His-VAO 
CFE 
0.8 74 2.1  95 23 0.9 
d GC 
1.0 g 
23 mM 
20 U  
His-VAO 
CFE 
6.5 83 1.3  97 8.6 0.8 
 
1H-
NMR 
  7.5   88  2.6 1.8 
e GC 
13.4 g 
23 mM 
268 U  
His-VAO 
CFE 
37 51 1.9  93 9.2 1.1 
f [a] GC 
10.0 g 
23 mM 
202 U  
His-VAO 
CFE 
6.0 82 4.1  90 6.5 1.0 
 
1H-
NMR 
  6.3   89  2.7 1.8 
[a] Reaction vessel was kept under pure O2 atmosphere for the first 9 h
Tests at the 100 mg scale revealed that the substrate concentration could be increased to 23 
mM, while still maintaining almost full conversion of the substrate. However, upon further 
increasing the substrate concentration to 45 mM, lower conversions were obtained. This may 
be due to the limited solubility of the aromatic substrate. Cell-free extract of E. coli was 
successfully substituted for the purified enzyme, eliminating the cost associated with protein 
purification.  
The reaction was successfully scaled up from the 100 mg to the 1 g scale using essentially the 
same reaction conditions. However, upon further scale-up to approximately 10 g of substrate, 
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lower conversions were observed due to oxygen depletion becoming limiting for the reaction. 
This was solved by performing the reaction under an oxygen atmosphere. This observation 
that maintaining sufficient oxygen levels is crucial to allow the reaction to proceed is in 
agreement with previous studies regarding biotransformations using monooxygenase-
containing whole-cell biocatalysts, where oxygen depletion was found to be limiting for the 
reaction under certain conditions (8, 35, 36). As the use of an oxygen atmosphere may be 
undesired when performing chemical reactions at an industrial scale, due to it posing an 
explosion hazard, alternative ways in which to obtain sufficient oxygenation of the reaction 
medium such as the use of bubble aeration should be considered in future. 
One aspect of the process described here that can still be improved, is the fact that despite 
obtaining 82% formation of 2 in the largest scale reaction, the isolated yield of 36% is relatively 
low. This low yield is attributable to significant losses of material during both the extraction 
of the product from the reaction mixture (6.51 g crude product obtained from 10 g starting 
material) and during recrystallisation. The loss of material during the extraction procedure 
may be attributable to the relatively high polarity of the product making its extraction into 
organic solvents inefficient. This may be solved in future by testing other solvents for 
extraction or by performing more rounds of extraction. From the GC data, it can be calculated 
that the crude compound obtained after extraction contains 5.34 g 2, which corresponds to a 
crude yield of 47%. A further 25% of the product was lost during its purification by 
recrystallisation. Although this loss is significant, recrystallisation is likely the most suitable 
method to increase the ee of the product by removing the (S)-1-(4′-hydroxyphenyl)ethanol 
formed as a by-product.  
In short, we described the scale-up of the synthesis of (R)-1-(4′-hydroxyphenyl)ethanol by the 
enantioselective hydroxylation of 4-ethylphenol using VAO. Under optimised reaction 
conditions, 94% conversion of 10 g 4-ethylphenol was obtained after 24 h. Purification of the 
product yielded (R)-1-(4′-hydroxyphenyl)ethanol in 36% isolated yield and 97% ee.  These 
results highlight some of the issues that may be encountered during scale-up of an enzymatic 
hydroxylation reaction from analytical scale to a synthetically relevant scale and may be of 
use in facilitating such scale-up for the synthesis of chiral pharmaceutical intermediates in an 
industrial setting. 
Materials and methods 
Materials 
4-Ethylphenol and 4-hydroxyacetophenone were from abcr (Karlsruhe, Germany). An 
analytical standard for 1-(4′-hydroxyphenyl)ethanol was synthesised as a racemic mixture 
from 4-hydroxyacetophenone: 
A solution of 4-hydroxyacetophenone (3.4 g, 25 mmol) in MeOH (50 mL) was stirred at 15-
20 °C and a solution of NaBH4 (0.57 g, 15 mmol) in 0.2 M aqueous NaOH (10 mL) was added. 
Subsequently, the reaction mixture was stirred at room temperature for 20 h. After this, MeOH 
was removed by evaporation and water (10 mL) was added to the residue. The mixture was 
extracted with CHCl3/isopropanol (3/1) and the organic layer was dried over Na2SO4 and the 
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solvent was removed by evaporation. The residue (2.2 g, yellow solid) was chromatographed 
on silica gel with dichloromethane/MeOH (50/1), yielding pure (R,S)-1-(4′-
hydroxyphenyl)ethanol (1.45 g, white solid, 42%). 1H-NMR (d6-DMSO, 400MHz): δ (ppm): 
9.10 (s, 1H), 7.12 (dt, J = 8.02 Hz, 2H), 6.68 (dt, J = 8.69 Hz, 2H), 4.85 (d, J = 4.29 Hz, 1H), 4.63-
4.57 (m, 1H), 1.27 (d, J = 6.44 Hz, 3H).   
The elution times of the 1-(4′-hydroxyphenyl)ethanol enantiomers upon gas chromatography 
analysis were assigned by comparison with 1-(4′-hydroxyphenyl)ethanol formed by 
conversion of 1 by VAO [primarily (R)-enantiomer].  
All other chemicals were from commercial sources and of the purest grade available. 
Expression and purification of VAO 
For small-scale tests with purified enzyme, VAO was expressed and purified as described 
previously (37, Chapter 3). For larger-scale reactions using cell-free extracts, N-terminally His-
tagged VAO was expressed from the pJ404-His-VAO plasmid, which contains a version of the 
vaoA gene from P. simplicissimum that is codon-optimised for expression in E. coli behind an 
IPTG-inducible T5 promoter. BL21 E. coli cells containing this plasmid were grown at 37 °C in 
LB medium containing 100 μg/mL ampicillin until the OD600 of the cultures was 0.6. 
Subsequently, IPTG was added to a concentration of 0.8 mM and the cells were grown 
overnight at 25 °C. Following this, cells were harvested by centrifugation (4,000 g, 10 min, 
10 °C), resuspended in 50 mM potassium phosphate buffer, pH 7.0, containing 0.5 mM 
dithiothreitol, 0.5 mM MgSO4 and one cOmpleteTM protease inhibitor pill (Roche, Basel, 
Switserland) and 1 mg DnaseI (Roche) per 50 mL, and lysed by passing them through a pre-
cooled SLM Aminco French Pressure Cell three times. Subsequently, cell debris was removed 
by centrifugation (39,000 g, 45 min, 4 °C) and the obtained soluble fractions were used for the 
reactions.  
VAO activity was determined by monitoring the conversion of vanillyl alcohol (4-hydroxy-3-
methoxybenzyl alcohol) to vanillin (4-hydroxy-3-methoxybenzaldehyde) at 25 °C in 50 mM 
potassium phosphate buffer, pH 7.5, by measuring the absorption of the product at 340 nm (ε 
= 14,000 M-1 cm-1) using a Hewlett Packard 8453 diode array spectrophotometer (Agilent 
Technologies, Santa Clara, CA, USA). 
Gas chromatography 
Gas chromatography experiments were performed on a GC-2010 plus (Shimadzu, Kyoto, 
Japan) with an FID detector (260 °C) and a Hydrodex β-6TBDM column (25 m x 2.45 mm, 
Machery-Nagel, Düren, Germany). Hydrogen was used as a carrier gas at a flow rate of 1.5 
mL/min and the injector temperature was 80 °C. Runs were performed using a 20 min gradient 
from 80 to 220 °C followed by 10 min at 220 °C. 
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Analytical-scale conversions of 4-ethylphenol 
1 (5 mg, 41 μmol), VAO (0.4 U, 0.8 mL of a 0.5 U/mL solution in 50 mM potassium phosphate 
buffer, pH 7.5) the specified organic solvent (1.4 mL) and 100 mM potassium phosphate buffer, 
pH 7.5, (11.8 mL) were stirred at 30 °C. After the reaction, the solution was concentrated under 
reduced pressure. The residue was extracted with EtOAc (4 x 5 mL). The organic layer was 
dried over Na2SO4 and filtered, and the solvent was removed by evaporation. The residue was 
dissolved in MeOH (1 mL) and analysed by GC. 
Scale-up to the 100 mg scale was performed using the same procedure, but with the volume 
of the reaction mixture adapted to achieve the desired substrate concentration and using 2 U 
VAO (or His-VAO cell-free extract).  
Synthesis of (R)-1-(4′-hydroxyphenyl)ethanol at 1 g scale 
1 (1 g, 8.2 mmol) was dissolved in acetone (34.5 mL). 100 mM potassium phosphate buffer, 
pH 7.5, (296 mL) and His-VAO cell-free extract (20 U, 14.3 mL of a 1.4 U/mL solution) were 
added to the solution. The solution was stirred with a magnetic stirrer. The reaction solution 
was stirred for 24 h at 30 °C (water bath) under air atmosphere. After 24 h, the solution was 
concentrated under reduced pressure at 50 °C (water bath).  During concentration, a slimy 
white solid was formed. The suspension was filtered and the aqueous phase was extracted 
with EtOAc. The organic phase was washed with brine, dried over Na2SO4 and concentrated 
under reduced pressure to give a crude compound (502 mg, green beige solid). This 
compound was analysed by GC and 1H-NMR to evaluate the success of the conversion. 
Subsequently, the crude product was purified by recrystallisation. EtOAc (3 mL) was added 
to the crude product and the suspension was heated to 80 °C (oil bath) until all solid was 
dissolved. Subsequently, the solution was cooled to room temperature, during which a solid 
crystallised. The solid was filtered and washed with a hexane/EtOAc mixture (1/1). The solid 
was dried under reduced pressure at 50 °C (water bath) to give the product (244.3 mg, white 
solid, 22%). 
Synthesis of (R)-1-(4′-hydroxyphenyl)ethanol at 10 g scale 
1 (10 g, 82 mmol) was dissolved in acetone (345 mL). 100 mM potassium phosphate buffer, 
pH 7.5, (3075 mL) and His-VAO cell-free extract (202 U, 31 mL of a 6.5 U/mL solution) were 
added to the solution. The solution was stirred with an overhead stirrer (230 rpm). The 
reaction vessel was evacuated and then brought under O2 atmosphere. The solution was 
stirred for 9 h under O2 atmosphere and, subsequently, 15 h under air atmosphere at 30 °C 
(water bath). After 24 h, the solution was concentrated under reduced pressure at 50 °C (water 
bath).  During concentration, a slimy white solid was formed. The suspension was filtered and 
the aqueous phase was extracted with EtOAc. The organic phase was washed with brine, 
dried over Na2SO4 and concentrated under reduced pressure to give a crude compound (6.51 
g, green beige solid). This compound was analysed by GC and 1H-NMR to evaluate the 
success of the conversion. Subsequently, the crude product was purified by 
recrystallisation. EtOAc (38 mL) was added to the crude compound and the suspension was 
heated to 90 °C (oil bath) until all solid was dissolved. Subsequently, the solution was cooled 
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to room temperature, during which a solid crystallised. The solid was filtered and washed 
with a hexane/EtOAc mixture (1/1). The solid was dried under reduced pressure at 50 °C 
(water bath) to give the product (4.10 g, white solid, 36%). 
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Supplementary Figures 
 
 
Figure S1: GC chromatograms showing the products obtained from the conversion of 4-ethylphenol 
by VAO. Reaction mixtures containing 5 mg 4-ethylphenol (at a concentration of 2.9 mM) and 0.4 U 
VAO in 84 mM potassium phosphate buffer, pH 7.5, containing 10% acetone or 10% acetonitrile were 
incubated at 30 °C for the specified reaction times. Subsequently, the reaction products were extracted 
and analysed by GC. Retention times: 4-ethylphenol (1): 10.2 min, 4-vinylphenol (4): 12.8 min, (R)-1-
(4′-hydroxyphenyl)ethanol (2): 22.5 min, (S)-1-(4′-hydroxyphenyl)ethanol (3): 22.6 min, 4-
hydroxyacetophenone (5): 23.2 min. 
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Figure S2: GC chromatograms showing the products obtained from the conversion of 4-ethylphenol 
by VAO. Reaction mixtures containing 4-ethylphenol and VAO or His-VAO cell-free extract were 
incubated in 88 mM potassium phosphate buffer, pH 7.5, containing 10% acetone for 24 hours at 
30 °C. Subsequently, the reaction products were extracted and analysed by GC. Reactions are labelled 
as in Table 2. Retention times: 4-ethylphenol (1): 10.0 min, 4-vinylphenol (4): 12.5 min, (R)-1-(4′-
hydroxyphenyl)ethanol (2): 22.3 min, (S)-1-(4′-hydroxyphenyl)ethanol (3): 22.5 min, 4-
hydroxyacetophenone (5): 23.0 min. 
 
Figure S3: GC chromatograms of purified (R)-1-(4′-hydroxyphenyl)ethanol. Pure (R)-1-(4′-
hydroxyphenyl)ethanol was obtained from crude product mixtures from the conversion of 4-
ethylphenol by His-VAO cell-free extract by recrystallisation and analysed by GC. The 4-vinylphenol 
observed in the GC chromatograms is formed by the decomposition of 1-(4′-hydroxyphenyl)ethanol 
during analysis, as demonstrated by the absence of any signal corresponding to 4-vinylphenol in the 
1H-NMR spectrum of the product and the presence of 4-vinylphenol upon GC analysis of pure 
racemic 1-(4′-hydroxyphenyl)ethanol. Reactions are labelled as in Table 2. Retention times: 4-
vinylphenol (4): 12.5 min, (R)-1-(4′-hydroxyphenyl)ethanol (2): 22.3 min, (S)-1-(4′-
hydroxyphenyl)ethanol (3): 22.5 min. 
Chapter 7 
188 
 
 
Multigram scale enantioselective hydroxylation 
189 
 
 
Chapter 7 
190 
 
 
 
Figure S4: 1H-NMR spectra of the reaction products of the conversion of 4-ethylphenol by His-VAO 
cell-free extract recorded in d6-DMSO. Spectra of the crude product mixtures obtained after 
(multi)gram scale conversion of 4-ethylphenol by His-VAO cell-free extract and of pure (R)-1-(4′-
hydroxyphenyl)ethanol obtained from the crude product mixtures by recrystallisation are shown. The 
spectrum of a racemic 1-(4′-hydroxyphenyl)ethanol standard is shown for comparison. Peaks at 2.5 
and 3.3 ppm are from the solvent. 1-(4′-hydroxyphenyl)ethanol (2+3): δ (ppm): 9.10 (s, 1H), 7.12 (dt, J = 
8.02 Hz, 2H), 6.68 (dt, J = 8.69 Hz, 2H), 4.85 (d, J = 4.29 Hz, 1H), 4.63-4.57 (m, 1H), 1.27 (d, J = 6.44 Hz, 
3H). Impurities in the crude product were identified and quantified using the following diagnostic 
peaks: 4-ethylphenol (1): 6.98 ppm (m, 2H), 4-vinylphenol (4): 5.55-5.60 ppm (m, 1H), 5.02-5.05 ppm (m, 
1H), 4-hydroxyacetophenone (5): 7.83 ppm (m, 2H), 6.84 ppm (m, 2H).
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Summary 
Flavoprotein oxidases are a diverse class of biocatalysts, most of which catalyse the 
oxidation of C-O, C-N or C-C bonds. Flavoprotein oxidases that are known to catalyse the 
oxidation of C-S bonds are rare. Here, we report that various flavoprotein oxidases 
previously thought to solely act on alcohols also catalyse the oxidation of thiols to 
thiocarbonyls. These results highlight the versatility of enzymatic catalysis and provide a 
potential biocatalytic route to reactive thiocarbonyl compounds, which have a variety of 
applications in synthetic organic chemistry.
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Introduction 
Flavoprotein oxidases constitute a diverse class of oxidoreductases that contain a flavin 
cofactor in the form of flavin adenine dinucleotide (FAD) or flavin mononucleotide (FMN). 
They catalyse the oxidation of a wide range of substrates, with molecular oxygen functioning 
as the final oxidant. Their catalytic cycle consists of two half-reactions. During the reductive 
half-reaction, two electrons are transferred from the substrate to the flavin cofactor, a process 
that is generally believed to occur via the direct transfer of a hydride to the flavin’s N5 atom 
(1, 2). In the oxidative half-reaction, the flavin cofactor is reoxidised by molecular oxygen, 
which is reduced to hydrogen peroxide. Unlike many other oxidative enzymes, e.g. 
dehydrogenases, oxidases do not require stoichiometric amounts of expensive organic 
cofactors, making them interesting candidates for biocatalytic applications. Most of the 
characterized flavoprotein oxidases catalyse the oxidation of C-O, C-N or C-C bonds to the 
corresponding double bonds (3). A small number of flavoprotein oxidases are known to 
oxidise sulfur-containing compounds. Prenylcysteine lyase (EC 1.8.3.5) and farnesylcysteine 
lyase (EC 1.8.3.6) catalyse the oxidative cleavage of thioethers into aldehydes and thiols, while 
sulfhydryl oxidases (EC 1.8.3.2 and 1.8.3.3) catalyse the formation of disulfide bonds from 
thiols. It has been reported that the flavin-dependent alcohol oxidases glucose oxidase from 
Aspergillus niger (GOX, EC 1.1.3.4) and methanol oxidase from Hanselula polymorpha (MO, or 
alcohol oxidase, EC 1.1.3.13) can catalyse the oxidation of thiols as well as of alcohols (4, 5). 
However, the reaction was not studied in detail. Here, we describe the finding that the flavin-
dependent alcohol oxidases alditol oxidase from Streptomyces coelicolor (AldO, EC 1.1.3.41) and 
5-(hydroxymethyl)furfural oxidase from Methylovorus sp. strain MP688 (HMFO, EC 1.1.3.47) 
catalyse the oxidation of thiols that are structurally similar to their alcohol substrates, yielding 
the corresponding thiocarbonyls. 
Results 
AldO is a flavin-dependent oxidase that catalyses the regioselective oxidation of the primary 
hydroxyl groups of a broad range of polyols, with the best substrates being alditols such as 
xylitol, D-sorbitol and L-threitol (6, 7). The oxidation of polyols by AldO occurs 
stereoselectively. For example, D-sorbitol is converted significantly more efficiently than its 
C2 epimer D-mannitol. AldO belongs to the VAO/PCMH family of structurally homologous 
flavoproteins. These flavoproteins contain a conserved FAD-binding domain as well as a 
variable substrate-binding domain, which determines their substrate specificity (8, Chapter 
2). The enzyme contains an FAD cofactor which is covalently linked to a histidine residue (9). 
To investigate whether AldO reacts with thiols, the enzyme was first expressed and purified 
as a fusion protein with an N-terminal maltose-binding protein tag. This fusion protein (m-
AldO) displays highly similar catalytic properties to the wild type enzyme (6). Oxygen 
consumption measurements showed that m-AldO catalyses the oxidation of DL-dithiothreitol 
(DL-DTT), which is structurally identical to the known AldO substrate threitol, except for the 
presence of thiol rather than hydroxyl groups at the terminal carbon atoms. Steady-state 
kinetic analysis revealed that m-AldO oxidises racemic DTT with kcat = 0.79 s-1 and Km = 3.7 
mM (Table 1). Enantiopure L-DTT was converted with similar efficiency. m-AldO also oxidises 
dithioerythritol, but the reaction with this epimer of DTT is less efficient, primarily due to a 
higher Km. The tested thiols are remarkably good substrates for m-AldO. The catalytic 
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efficiency for the oxidation of L-DTT is very similar to that for the oxidation of its alcohol 
analogue L-threitol. In fact, of all known m-AldO substrates, only xylitol and D-sorbitol 
display higher catalytic efficiencies than L-DTT (6, 7). 
HPLC analysis revealed that three main products are formed during the oxidation of DL-DTT 
by m-AldO (Fig. S1). Addition of the hydrogen peroxide scavenger sodium pyruvate to the 
reaction mixture demonstrated that two of the products are formed by side reactions 
involving hydrogen peroxide. The third compound, which is the product of the enzymatic 
reaction, was collected and identified by 1H-NMR as the dithiohemiacetal 2 [Scheme 1 (L-
enantiomers shown), Fig. S2]. Formation of this product presumably occurs via the 
thioaldehyde intermediate 1, which is formed upon oxidation of DL-DTT by m-AldO and 
subsequently undergoes an intramolecular cyclisation to yield 2. This dithiohemiacetal is 
rather sensitive to oxidation, being entirely oxidised to the corresponding sulfenic acid after 6 
days of storage at -20 °C dissolved in acetonitrile. By comparison to a reference compound, 
one of the two side products was identified as the disulfide trans-4,5-dihydroxy-1,2-dithiane, 
which was shown to be formed upon reaction of DL-DTT with hydrogen peroxide. The second 
unidentified compound is likely the disulfide formed after reaction of two molecules of 2 upon 
its oxidation by hydrogen peroxide. Alternatively, it may be the mixed disulfide formed 
between one molecule of 2 and one molecule of DTT. 
 
Scheme 1: The oxidation of L-dithiothreitol catalysed by m-AldO. 
To further investigate the reaction of m-AldO with L-DTT, changes in the spectral properties 
of the enzyme’s flavin cofactor during the reductive half-reaction were followed using a 
stopped flow-apparatus. Upon mixing m-AldO and L-DTT under anaerobic conditions, a 
rapid increase in absorbance was observed at 530 nm (Fig. 1A). This increase in absorbance at 
high wavelengths is indicative of the formation of a charge transfer complex between the 
thiolate anion form of L-DTT and the FAD cofactor. Such flavin-thiol charge transfer 
complexes have been observed in various members of the sulfhydryl oxidase family, though 
in these cases it is due to an interaction with an active site cysteine residue (10, 11). Fitting the 
data to a single exponential function yielded a rate of 555 s-1 for the formation of the charge 
transfer complex at an L-DTT concentration of 25 mM. Subsequently, the absorbance at 530 
nm decays concomitantly with the absorbance at 450 nm, suggesting the charge transfer 
interaction is broken by transfer of electrons from L-DTT to the flavin cofactor (Fig. 1B). The 
decay of the absorbance at 530 nm was biphasic, with kobs1 = 2.6 s-1 and kobs2 = 0.84 s-1. At an L-
DTT concentration of 25 mM the decay in absorbance at 450 nm could only be satisfactorily 
fit using a triple exponential function. Two of the phases had similar rate constants to those 
observed for the decay of the absorbance at 530 nm, kobs1 = 2.8 s-1 and kobs2 = 0.83 s-1. The third 
phase was too slow to be catalytically relevant (kobs3 = 0.089 s-1) and its contribution to the drop 
in absorbance was very minor. Of the two catalytically relevant phases, the slower phase had 
the largest contribution to the decrease in absorbance. The rate of this phase displayed a 
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hyperbolic dependence on substrate concentration, approaching a value of 1.13 s-1 at non-
limiting substrate concentrations. This suggests this phase represents irreversible reduction 
of the flavin cofactor. As the rate constant for reduction is close to kcat, the electron transfer 
from L-DTT to the flavin is the rate-limiting step in catalysis. The faster phase was poorly 
defined, likely due to its rate constant lying in the same range as the slower phase and its 
contribution to the drop in absorbance being more minor, and did not display any 
distinguishable dependence on substrate concentration. This phase may represent spectral 
changes associated with another step in catalysis, e.g. product release. Alternatively, the 
enzyme may exist in two distinct conformations, in which the reduction proceeds at different 
rates. Monitoring spectral changes using a photodiode array detector would help clarify what 
process is responsible for this phase. However, the high-intensity illumination required for 
this led to rapid photoreduction of the FAD cofactor.  Enzyme-monitored turnover 
experiments under aerobic conditions revealed that during steady-state catalysis m-AldO is 
predominantly present as the charge transfer complex (Fig. 1C).  
 
 
Figure 1: Spectral changes observed during the reaction of m-AldO with L-DTT as measured using a 
stopped-flow apparatus. Traces show the absorbance at 530 nm (solid lines) and 450 nm (dashed lines). 
Traces were obtained after mixing 10 μM m-AldO with 25 mM L-DTT under anaerobic (A+B) or aerobic 
conditions (C). Measurements were performed at least in triplicate, representative traces are shown. 
The VAO/PCMH family, to which AldO belongs, displays a remarkably broad range of 
reactivities. The oxidation of alcohols and amines, hydroxylation of alkyl groups, C-C bond 
formation and the demethylation of ethers have all been described (12–15). The results 
presented above show that the oxidation of thiols can be added to this list. To determine 
whether the oxidation of thiols is also performed by more strict alcohol oxidases from the 
glucose-methanol-choline (GMC) family, we investigated the recently discovered 5-
(hydroxymethyl)furfural oxidase (HMFO) from Methylovorus sp. strain MP688 (16).  HMFO 
catalyses the oxidation of primary alcohols. Its substrate range includes phenylic, furanic and 
linear unsaturated alcohols. In addition, HMFO is active towards several aldehydes. However, 
this activity is restricted to aldehydes which are spontaneously hydrated to the gem-diol form 
when dissolved in water (17).  
We tested HMFO for activity towards phenylmethanethiol, which is the thiol analogue of its 
known substrate benzyl alcohol, and the related (4′-nitrophenyl)methanethiol. Interestingly, 
both thiols were readily oxidised by HMFO. The steady-state kinetic parameters of HMFO for 
these two aromatic thiol substrates are shown in Table 1. The kcat values for both thiols are 
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slightly lower than those for their alcohol counterparts (Table 1). Also, the Km values for both 
thiols are significantly higher than for the alcohols. Taken together, the catalytic efficiency of 
HMFO is higher for alcohols than for thiols. Still, both tested thiols can be regarded as good 
substrates with kcat values of  >2 s-1 and Km values in the millimolar range. 
Table 1: Steady-state kinetic parameters for the oxidation of thiols and their alcohol analogues by 
flavoprotein oxidases. Steady state kinetic parameters were determined at 25 °C in the following 
buffers: m-AldO: 20 mM potassium phosphate buffer, pH 7.2; HMFO: 50 mM potassium phosphate 
buffer, pH 8.0; GOX: 50 mM citrate buffer, pH 5.5.  
Enzyme Substrate kcat (s-1) Km (mM) kcat/Km 
 (s-1 mM-1) 
m-AldO DL-dithiothreitol 
 
0.79 ± 0.01 3.7 ± 0.1 0.21 
m-AldO L-dithiothreitol 
 
0.71 ± 0.01 2.4 ± 0.1 0.30 
m-AldO L-threitol 
 
6.3a 25a 0.25 
m-AldO dithioerythritol 
 
0.45 ± 0.02 29 ± 3 0.016 
m-AldO erythritol 
 
N.D. >100 N.D. 
HMFO phenylmethanethiol 
 
2.1 ± 0.1 3.5 ± 0.8 0.58 
HMFO benzyl alcohol 
 
13.5b 1.4b 9.6 
HMFO 
(4′-nitrophenyl) 
methanethiol 
 
3.0 ± 0.09 15 ± 1.4 0.20 
HMFO 
(4′-nitrophenyl) 
methanol 
 
4.5 ± 0.1 0.078 ± 0.01 58 
GOX 1-thio--D-glucose 
 
50 ± 12 71 ± 21 0.70 
GOX D-glucose 
 
223 ± 2 35 ± 1 6.4 
a Data taken from (6). 
b Data taken from (16). 
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The products formed upon oxidation of the two aromatic thiol substrates by HMFO were 
identified using GC/MS and LC/MS. At pH 7.0, phenylmethanethiol is oxidised to the 
corresponding aromatic thioaldehyde, benzothialdehyde (3) (Scheme 2, Fig. S3+S4). No 
formation of 1,2-dibenzyldisulfane was observed, demonstrating that HMFO does not 
catalyse the formation of disulfide bonds. At pH 8.0, two products are formed. While after 10 
minutes only benzothialdehyde was formed, after 60 minutes benzaldehyde (4) was detected 
as well. This suggests that the thioaldehyde is slowly hydrated, yielding the aldehyde as the 
final product. This is analogous to the reaction performed by amine oxidases, where the 
oxidation of amines to imines is followed by their reaction with water, yielding aldehydes or 
ketones (18). To confirm the involvement of water, the reaction at pH 8.0 was performed in 
the presence of 18O-labelled water. In the presence of H218O, benzaldehyde with m/z = 108 was 
observed, whereas in unlabelled water only m/z = 106 was detected (Fig. S4). This confirms 
that, at pH 8.0, water performs a nucleophilic attack on the initially formed thioaldehyde, 
yielding benzaldehyde as the final product. Using (4′-nitrophenyl)-methanethiol as a 
substrate, the reaction at pH 8.0 again yielded the corresponding aldehyde. Because this 
aldehyde is easily hydrated to the gem-diol (19), it was oxidised further by HMFO, yielding 4-
nitrobenzoic acid as the final product. In addition to these main products, several minor peaks 
were detected by GC and LC analysis, probably due to the reactive nature of the formed 
thioaldehyde. 
 
Scheme 2: The oxidation of phenylmethanethiol to benzothialdehyde (3) and benzaldehyde (4) 
catalysed by HMFO. 
We also investigated a number of commercially available oxidases for their reactivity towards 
thiols. GOX is a fungal glycoprotein, which also belongs to the GMC family and is widely 
applied as an oxidative biocatalyst. Like HMFO, GOX contains a non-covalently bound FAD 
cofactor. GOX regioselectively oxidizes β-D-glucose to 1,5-D-gluconolactone, which 
spontaneously hydrolyses to gluconic acid (20). Glucose oxidase (GOX) from Aspergillus niger 
has been reported to display activity towards 1-thio-β-D-glucose (5). Oxygen consumption 
measurements showed that this enzyme indeed oxidises 1-thio-β-D-glucose with kcat = 50 s-1, 
Km = 71 mM, and with substrate inhibition occurring with a Ki of 42 ± 13 mM (Table 1). 
However, the oxidation of 1-thio-β-D-glucose by GOX is less efficient than that of its alcohol 
analogue D-glucose, which occurs with a higher kcat (223 s-1) and lower Km (35 mM) (Table 1). 
Methanol oxidase (MO) is another fungal GMC-type oxidase. MO contains a non-covalently 
bound FAD cofactor and catalyses the oxidation of linear unbranched primary alcohols of up 
to five carbon atoms in length (21).  Oxygen consumption measurements showed that MO 
from Candida boidinii is able to oxidise ethanethiol, displaying a specific activity of 0.32 ± 0.03 
U/mg at a substrate concentration of 20 mM, as compared to a specific activity of 0.51 ± 0.02 
U/mg for the oxidation of 20 mM ethanol. 
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Discussion 
In summary, all tested flavin-dependent alcohol oxidases are capable of catalysing the 
oxidation of thiols, yielding thiocarbonyls. Though various free flavins are also known to react 
with some thiols, these reactions solely yield disulfides as products, suggesting they are 
mechanistically distinct from the flavoenzyme-catalysed reactions described here (22, 23). In 
the reaction of m-AldO with L-DTT, the thiol substrate binds to the enzyme as a thiolate anion, 
leading to a strong charge transfer interaction with the oxidised flavin cofactor. Binding of the 
substrate in its thiolate form is likely stimulated by two positively charged residues, Arg-322 
and Lys-375, that are in close proximity to the terminal hydroxyl group of the substrate in the 
crystal structure of AldO with xylitol bound (9). Subsequently, the flavin is slowly reduced 
by the transfer of two electrons from the substrate, yielding the thiocarbonyl product. The 
electron transfer probably occurs through the direct transfer of a hydride from the Cα atom 
of the substrate to the N5 atom of the flavin cofactor, as is believed to be the case for the 
oxidation of alcohols and amines by flavoprotein oxidases (1, 2). In the case of the oxidation 
of DTT by m-AldO, the formed thioaldehyde rearranges intramolecularly to yield 
dithiohemiacetal 2. For the aromatic thiols oxidised by HMFO, such a rearrangement is not 
possible because of the absence of a second thiol group and in the case of phenylmethanethiol 
the formed thioaldehyde 3 is stable enough to be detected. Because HMFO has a broad 
substrate scope, this biocatalyst can be used to generate a large variety of thioaldehydes. The 
fusion protein m-AldO also has a broad substrate scope and could potentially be used to 
generate more stable thioaldehydes in cases where no second thiol group is present to enable 
intramolecular cyclisation. Because the ability to oxidise thiols appears to be a general 
property of flavin-dependent oxidases, many other enzymes may be used for similar purposes. 
Thus, our results not only highlight the promiscuity and versatility of enzymatic catalysis, but 
also provide a potential biocatalytic route to reactive thiocarbonyl compounds, which have a 
variety of applications in synthetic organic chemistry (24). 
Materials and methods 
Materials 
DL-dithiothreitol was from Serva (Heidelberg, Germany). L-dithiothreitol, dithioerythritol, 
erythritol, trans-4,5-dihydroxy-1,2-dithiane, 1-thio-β-D-glucose, phenylmethanethiol, (4′-
nitrophenyl)methanethiol, benzyl alcohol, (4′-nitrophenyl)methanol, methanol oxidase 
(alcohol oxidase) from Candida boidinii and ethanethiol were from Sigma-Aldrich (St. Louis, 
MO, USA). Glucose oxidase from Aspergillus niger was from Boehringer Mannheim 
(Mannheim, Germany). D-glucose was from Merck (Kenilworth, NJ, USA). Ethanol was from 
VWR Chemicals (Radnor, PA, USA). The purity of thiol substrates was checked by NMR 
spectroscopy. No evidence for the presence of alcohol impurities was found. 
Protein expression and purification  
m-AldO was expressed from the pBAD-m-AldO plasmid (6) which contains the m-AldO 
construct behind the L-arabinose-inducible pBAD promoter. TOP10 E. coli containing the 
pBAD-m-AldO plasmid was grown at 37 °C in Terrific Broth medium (Difco, Becton 
Dickinson, Franklin Lake, NJ, USA) supplemented with 100 µg/mL ampicillin until the OD600 
of the culture was 0.8. Subsequently, the cells were incubated on ice for 15 min, protein 
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expression was induced by adding L-arabinose at 0.02 % (w/v) and the cells were grown at 
17 °C for 40 h. After this period, the cells were transferred to 20 mM potassium phosphate 
buffer, pH 7.2, supplemented with 4 mM MgCl2 and two cOmpleteTM protease inhibitor pills 
(Roche, Basel, Switzerland) and 1 mg DnaseI (Roche) per 50 mL and lysed by passing them 
through a pre-cooled SLM Aminco French pressure cell three times. The soluble fraction 
obtained after centrifugation (39,000 g, 45 min, 4 °C) was loaded onto an amylose resin column 
(New England Biolabs, Ipswich, MA, USA). Non-binding proteins were removed by washing 
with 20 mM potassium phosphate buffer, pH 7.2, after which bound proteins were eluted with 
20 mM potassium phosphate buffer, pH 7.2, supplemented with 10 mM maltose. 
Subsequently, m-AldO was purified further using a SourceQ anion exchange column. After 
loading, bound proteins were eluted using a linear 40 min gradient from 0 to 0.5 M KCl in 20 
mM potassium phosphate buffer, pH 7.2. HMFO was purified as a His6-SUMO-HMFO fusion 
protein as described elsewhere (16). 
Determination of steady-state kinetic parameters 
Concentrations of m-AldO, GOX and HMFO solutions were determined using previously 
published molar absorption coefficients [ε452 = 12,500 M-1 cm-1 for m-AldO (6), ε450 = 14,100 M-
1 cm-1 for GOX (25) and ε456 = 10,700 M-1 cm-1 for HMFO (17)]. The concentration of MO solutions 
was determined using a BCA assay kit (Thermo Scientific, Waltham, MA, USA). Initial rates 
of the enzymatic reactions were determined by monitoring oxygen consumption using a 
Hansatech Oxytherm system (Hansatech Instruments) for m-AldO, GOX and MO and 
REDFLASH sensor spots and a Firesting O2 detector and light source (Pyroscience, Aachen, 
Germany) for HMFO. m-AldO activity was measured in 20 mM potassium phosphate buffer, 
pH 7.2, HMFO activity in 50 mM potassium phosphate buffer, pH 8.0, GOX activity in 50 mM 
citrate buffer, pH 5.5, and MO activity in 100 mM potassium phosphate buffer, pH 7.5. All 
measurements were performed at 25 °C. Steady-state kinetic parameters were determined by 
fitting the measured initial rates to the Michaelis-Menten equation using Igor Pro v. 6.10A 
(Wavemetrics, Lake Oswego, OR, USA). In cases where substrate inhibition was observed, the 
initial rates were fit to a modified version of the Michaelis-Menten equation that includes a 
term to take substrate inhibition into account: 
𝑘𝑜𝑏𝑠 =  
𝑘𝑐𝑎𝑡 ∗ [𝑆]
𝐾𝑚 + [𝑆] +
[𝑆]2
𝐾𝑖
 
Where kobs is the measured initial rate, kcat is the turnover number, Km is the Michaelis constant, 
Ki is the inhibition constant for substrate inhibition and [S] is the substrate concentration. 
Identification of reaction products 
To analyse the products of the oxidation of DL-DTT by m-AldO, reaction mixtures containing 
10 µM m-AldO and 25 mM DL-DTT in 20 mM potassium phosphate buffer, pH 7.2, were 
incubated under shaking (350 rpm) at 25 °C, in the presence or absence of 50 mM sodium 
pyruvate. After 3 or 6 h, the enzyme was removed by ultrafiltration and 0.5% (v/v) 
trifluoroacetic acid was added to the flow-through. HPLC analysis of the products was 
performed using a system consisting of an Alltima C18 column (150 x 4.6 mm, Hichrom, 
Reading, UK), a Waters 600E pump system and a Waters 996 photodiode array detector 
(Waters, Milford, MA, USA). The reaction products were eluted using a 15 min linear gradient 
from 0 to 15% (v/v) acetonitrile in water, with both eluents containing 0.1% (v/v) 
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trifluoroacetic acid, and detected by monitoring the absorbance at 210 nm. To identify the 
product of the enzymatic reaction, the corresponding peak was collected and the product was 
extracted twice with 1 volume of EtOAc. Subsequently, the solvent was removed by 
evaporation under nitrogen flow and the residue was dissolved in deuterated acetonitrile. 
NMR-spectra were recorded on a 600 MHz Avance 3 NMR-spectrometer (Bruker, Billerica, 
MA, USA). To test whether free FAD is capable of catalysing the conversion of DL-DTT under 
similar conditions, 10 µM FAD and 25 mM DL-DTT were incubated in 20 mM potassium 
phosphate buffer, pH 7.2, for 6 h at 25 °C under shaking (350 rpm). Subsequently, reaction 
products were analysed by HPLC as described above. No conversion of DL-DTT was observed 
under these reaction conditions. 
Phenylmethanethiol (10 mM) was oxidised by 5 M HMFO in 50 mM Tris/HCl buffer, pH 7.0 
or 8.0, or 50 mM potassium phosphate buffer, pH 6.0, containing 100 U/mL catalase (Sigma-
Aldrich) to remove hydrogen peroxide. The reactions were performed at 25 C under shaking 
(1000 rpm). Reactions were stopped after 10, 60 or 300 min by extracting with 125 L to 250 
L CHCl3. Control reactions with free riboflavin or FAD (5 μM) were performed at pH 7.0. 
The reaction products were analysed on a HP6890 GC-system with an HP 5973 Mass selective 
detector (Agilent Technologies, Santa Clara, CA, USA) using an HP1 column (25 m x 0.25 mm 
x 0.25 m, Agilent). After a pre-run of 5 min at 60 C, the temperature was increased to 230 C 
at 10 C/min followed by a post-run of 5 min at 300 C. The split ratio was set to 50:1 and the 
detector temperature to 325 C. 
For the oxidation of (4′-nitrophenyl)methanethiol (20 mM), 5 M HMFO was used in 50 mM 
ammonium bicarbonate buffer, pH 8.0. After 0.5 or 5 h, the reactions were stopped by heating 
the sample for 5 min at 70 C, and removing denatured protein by centrifugation. Reaction 
products were analyzed with an Alltima HP C18 column, 3μm (Hichrom) on a Surveyor LC 
(Thermo Finnigan, San Jose, CA, USA), using a gradient of acetonitrile (B) in 50 mM 
ammonium bicarbonate buffer, pH 8.0 (A). After 2 min of 100% A, B was increased from 0% 
to 80% in 30 min and kept constant at 80% for 5 min. Subsequently, B was decreased from 80% 
to 0% in 1 min, followed by 100% A for the last 10 min of the run. Detection was performed 
using a diode array detector between 200 and 600 nm. Mass detection was performed on a 
LCQ Fleet MS (Thermo) using APCI ionisation of the sample. 
To check for side products formed by hydrogen peroxide during catalysis, 
phenylmethanethiol and (4′-nitrophenyl)methanethiol (both 10 mM) were incubated with 10 
mM hydrogen peroxide and products were analysed as described. 
H218O incorporation 
To investigate the role of water in the formation of benzaldehyde from benzothialdehyde, 5 
M HMFO was used to oxidise 10 mM phenylmethanethiol in the presence of 30 % H218O and 
100 U/mL catalase in 50 mM Tris/HCl buffer, pH 8.0. After 2 h (25 C, 1000 rpm) the products 
were analysed as described above. 
Stopped-flow kinetics 
Changes in the spectral properties of m-AldO’s FAD cofactor during its reaction with L-DTT 
were analysed using an SX20 stopped-flow apparatus (Applied Photophysics, Leatherhead, 
UK). All experiments were performed at 25 °C in 20 mM potassium phosphate buffer, pH 7.2. 
m-AldO (10 µM) was mixed with various concentrations of L-DTT and the absorbance was 
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monitored at selected wavelengths using a photomultiplier detector. For experiments where 
anaerobic conditions were required, the enzyme and substrate solutions contained 10 mM 
putrescine. Prior to mixing, the solutions were flushed with nitrogen and subsequently 
putrescine oxidase was added to a concentration of 10 µg/ml to scavenge residual oxygen. 
Observed rate constants were obtained by fitting the measured traces to single, double or 
triple exponential functions as appropriate. 
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Supplementary Figures 
 
Figure S1: HPLC analysis of the products formed upon oxidation of DL-dithiothreitol catalysed by 
alditol oxidase. 10 µM m-AldO and 25 mM DL-DTT were incubated in 20 mM potassium phosphate 
buffer, pH 7.2, at 25 °C in the presence of 50 mM sodium pyruvate. After 6 h, the enzyme was 
removed by ultrafiltration and products were analysed by HPLC. Retention times: dithiohemiacetal 2: 
17.9 min, unidentified compound 1: 20.9 min, DL-DTT: 22.2 min, trans-4,5-dihydroxy-1,2-dithiane: 26.4 
min, unidentified compound 2: 29.1 min. The broad peak with a retentiom time of 5-6 min is 
pyruvate. trans-4,5-dihydroxy-1,2-dithiane and unidentified compound 2 are formed by side-
reactions involving hydrogen peroxide, as they were far more abundant in the absence of the H2O2 
scavenger pyruvate. Unidentified compound 1 was present in similar minor amounts regardless of 
the presence of pyruvate. Possibly, it reflects the formation of a sulfenic acid by the oxidation of 2 by 
molecular oxygen. The structures used to label the peaks show the L-enantiomer of DTT and the 
dithiohemiacetal formed from its oxidation.   
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Figure S2: NMR spectra of dithiohemiacetal 2 formed by the oxidation of DL-DTT by m-AldO. (A) 1-D 
1H-NMR, (B) 1H-1H-COSY (C) 1H-13C HSQC. 10 µM m-AldO and 25 mM DL-DTT were incubated in 20 
mM potassium phosphate buffer, pH 7.2, at 25 °C in the presence of 50 mM sodium pyruvate. 
Compound 2 was purified from the reaction mixture using HPLC and analysed by NMR. During the 
measurement time, compound 2 was partially oxidised to the corresponding sulfenic acid. After 6 
days of storage at -20 °C dissolved in acetonitrile, 2 was completely converted to this sulfenic acid. 
2: 1H-NMR (600 MHz, CD3CN) δ (ppm): 4.64 ppm (dd, J = 9.3, 3.8 Hz, 1H), 4.32 (m, 1H), 3.87 ppm (m, 
1H), 3.30 ppm (dd, J = 11.0, 4.8 Hz, 1H), 2.66 ppm (dd, J = 11.0, 2.5 Hz, 1H), 2.34 ppm (d, J = 9.3 Hz, 
1H). 1H-13C- HSQC (600 MHz, CD3CN): 13C, δ (ppm): 80.8, 78.0, 49.3, 38.4. Sulfenic acid oxidation 
product: 1H-NMR (600 MHz, CD3CN) δ (ppm): 4.76 (d, J = 4.42 Hz, 1H), 4.27 (m, 1H), 4.14 (m, 1H), 3.58 
(d, J = 4.7 Hz, 1H), 3.41 (d, J = 4.3 Hz, 1H), 3.19 (dd, J = 10.7, 4.8 Hz, 1H), 2.66 (dd J = 10.8, 3.8 Hz, 1H). 
1H-13C-HSQC (600 MHz, CD3CN) 13C, δ (ppm): 79.4, 77.6, 63.2, 37.0. 
Oxidation of thiols 
207 
 
 
Figure S3: GC/MS analysis of the oxidation of phenylmethanethiol by HMFO. 10 mM 
phenylmethanethiol and 5 μM HMFO were incubated for 5 h in 50 mM Tris/HCl buffer, pH 7.0 or 8.0, 
at 25 °C. Following this, reaction products were extracted and analysed by GC/MS. (A) At pH 7.0, 
phenylmethanethiol is partially converted to benzothialdehyde. (B) The same reaction at pH 8.0 yields 
benzaldehyde as an additional product. Retention times: benzaldehyde: 6.9 min, phenylmethanethiol: 
9.6 min, benzothialdehyde: 10.8 min. 
 
Figure S4: Mass spectra of the products of the oxidation of phenylmethanethiol by HMFO. 10 mM 
phenylmethanethiol and 5 μM HMFO were incubated for 5 h in 50 mM Tris/HCl buffer, pH 7.0 or 8.0, 
at 25 °C. Following this, reaction products were extracted and analysed by GC/MS (see also Fig. S3). (A) 
Phenylmethanethiol (Mw = 124 u). (B) Benzothialdehyde (Mw = 122 u).  (C) Benzaldehyde (Mw = 106 u, 
only observed when the reaction was performed at pH 8.0). (D) When the reaction is performed at pH 
8.0 in the presence of 30 % H218O, benzaldehyde with 18O incorporated (Mw = 108 u) is observed.  
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Historically, the industrial application of enzymes has been dominated by the use of 
hydrolases such as glycosidases, proteases and lipases (1). In recent years, however, the 
potential of oxidoreductases for industrial applications has been increasingly recognised (2). 
Oxidoreductases that are of interest in this context include copper-containing enzymes, such 
as laccases and lytic polysaccharide monooxygenases, heme-containing enzymes such as 
peroxygenases and peroxidases and flavin-dependent enzymes such as GMC-type and 
VAO/PCMH-type oxidoreductases (3). In order to facilitate the adoption of these enzymes by 
industry, it is of importance to develop enzymes with improved properties for potential 
industrial applications. This can be achieved by identifying and characterising novel enzymes 
in sequenced genomes or modifying existing enzymes by protein engineering. Efforts to 
modify existing enzymes are greatly facilitated by recent advances in the development of 
random mutagenesis methods (such as directed evolution) and in the computational 
modelling of enzymatic reactions, which enables protein engineering by rational design 
methods (4, 5). These efforts can also be supported by fundamental enzymological studies, as 
a better understanding of the mechanisms by which enzymes achieve catalysis will facilitate 
their redesign. In addition to modifying the enzymes themselves, it is also necessary to define 
which factors are of importance in designing an efficient biocatalytic process and what 
impediments may be encountered when scaling up such a process from the laboratory to the 
industrial scale. In the research presented in this thesis, a number of these aspects have been 
explored.  
Fundamental enzymological studies provided interesting new insights into the molecular 
mechanisms of oligomerisation (Chapter 3) and substrate activation (Chapter 4) in 4-phenol 
oxidising (4PO) flavoproteins. To facilitate the biocatalytic application of these enzymes, the 
development of an assay to efficiently screen variants of vanillyl alcohol oxidase (VAO) and 
eugenol oxidase (EUGO) for changes in their substrate specificities (Chapter 6) and the scale-
up of the synthesis of the chiral secondary alcohol (R)-1-(4′-hydroxyphenyl)ethanol using 
VAO (Chapter 7) were also described. Below, these results are discussed in the context of 
other recent developments in our understanding of the occurrence, function and mechanisms 
of 4PO subfamily members. Remaining questions and challenges that are yet to be overcome 
in enabling the biocatalytic application of these enzymes are also discussed. In addition, the 
potential applications of the oxidation of thiols to thiocarbonyls by flavin-dependent oxidases, 
as described in Chapter 8, are discussed briefly. 
Occurrence and physiological function of 4PO oxidases 
Physiological function of 4PO oxidases 
Although the 4PO oxidases VAO and EUGO have been extensively studied in terms of their 
in vitro biochemical properties, their exact function in vivo remains somewhat elusive. The 
ascomycetous fungus Penicillium simplicissimum and the actinobacterium Rhodococcus jostii 
RHA1 both grow in environments rich in plant biomass and it has been reported that 
Rhodococcus jostii RHA1 possesses the ability to degrade lignin (6, 7). As VAO and EUGO 
catalyse the oxidation of monomeric phenolic compounds, it seems likely that they are 
involved in the catabolism of lignin-derived aromatic molecules. For VAO, it has been 
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proposed that 4-(methoxymethyl)phenol is the physiological substrate, as it is the only 
substrate that has been shown to induce expression of the enzyme (Scheme 1) (8). In vivo, the 
4-hydroxybenzaldehyde formed by its oxidation by VAO is oxidised further to 4-
hydroxybenzoate. This is then hydroxylated on the aromatic ring to yield 3,4-
dihydroxybenzoate (protocatechuate), which can be broken down further through the β-
ketoadipate pathway (9). As the oxidation of various other substrates by VAO also yields 4-
hydroxybenzaldehyde [or derivatives thereof (10, 11)] it is plausible that VAO could be a 
multifunctional enzyme, catalysing the conversion of various lignin-derived compounds to 
aldehydes that are subsequently further broken down via the same pathway as observed for 
4-(methoxymethyl)phenol. Although the physiological role of EUGO has not been studied, it 
seems likely that it performs a similar function. 
 
Scheme 1: Pathway for the breakdown of 4-(methoxymethyl)phenol by Penicillium simplicissimum. In 
the first step, 4-(methoxymethyl)phenol is converted to 4-hydroxybenzaldehyde by VAO. Next, the 
aldehyde is converted to 4-hydroxybenzoate, which is then hydroxylated to yield 3,4-
dihydroxybenzoate (protocatechuate). This compound is further broken down in the β-ketoadipate 
pathway, the first step of which is its oxidative intradiol ring cleavage to yield β-carboxymuconate. 
Other compounds that are converted to an aldehyde by VAO (e.g. vanillyl alcohol) could be degraded 
in a similar manner. Scheme adapted from (8). 
A recent survey of the occurrence of genes encoding putative VAO-like oxidases in sequenced 
fungal genomes showed that they are widespread within the fungal kingdom (12). No clear 
correlation was observed between the habitat or lifestyle of the fungi and the presence of genes 
encoding VAO-like oxidases. However, many of the species in which VAO-like oxidase genes 
were identified are either plant pathogens or wood-decay fungi, consistent with a lifestyle 
where lignin-derived compounds would be present in their environment. Characterisation of 
the proteins encoded by some of these genes or evaluation of the effect of their deletion on the 
physiology of the host organism may be of use for the further elucidation of the physiological 
function of this class of enzymes.  
Oligomerisation state of 4PO oxidases 
One of the most striking differences between VAO and EUGO lies in their oligomerisation 
state, with VAO predominantly forming octamers that can be described as tetramers of stable 
dimers and EUGO being exclusively dimeric (13, 14). In Chapter 3, the molecular determinant 
of this difference in oligomerisation state was found to be a loop that is located at the dimer-
dimer interface of a VAO octamer. Deletion of this loop led to the formation of a VAO variant 
that is exclusively dimeric in solution. This variant displayed similar catalytic properties to 
the wild-type enzyme, suggesting that the function of octamerisation is not to modulate the 
reactivity of the enzyme. Therefore, it seems likely that octamerisation is important for VAO’s 
function in vivo, e.g. by promoting interactions with partner proteins or by simply enabling 
the clustering of a large number of VAO dimers in a small volume. Achieving a better 
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understanding of the role played by VAO-like oxidases in fungal physiology may be of help 
in understanding the function of the octamerisation of VAO. 
Recently, an attempt was made to characterise five novel fungal VAO-like oxidases after 
expressing them in Komagataella phaffii (formerly Pichia pastoris) (15). Unfortunately, the 
enzymes could not be characterised in terms of their activity, as expression in K. phaffii led to 
the isolation of proteins containing a remarkably stable anionic flavin semiquinone. However, 
size exclusion analysis revealed that all five of the enzymes displayed an octameric quaternary 
structure, despite two of them not containing a dimer-dimer interacting loop. This suggests 
that VAO-like proteins can also achieve octamer formation through other mechanisms. 
Interestingly, a multiple sequence alignment revealed that the two proteins that contain no 
dimer-dimer interacting loop have an N-terminal extension that is not found in the other 
proteins. As the crystal structure of P. simplicissimum VAO reveals that the N-terminus of the 
protein is located close to the dimer-dimer interface (16), it is possible that this N-terminal 
extension might take over the role of the dimer-dimer interacting loop in enabling the 
octamerisation of these proteins. Even more surprisingly, a bacterial VAO-like protein from 
Cycloclasticus sp. was also reported to display an octameric quaternary structure, despite not 
containing a dimer-dimer interacting loop or an N-terminal extension (15). More extensive 
characterisation of this protein is required to determine what factors are involved in enabling 
its octamerisation.  
Catalytic mechanism of 4PO subfamily members  
Mechanism of substrate activation 
The results presented in Chapter 4 led to a new model for the catalytic mechanism for the 
conversion of vanillyl alcohol (4-hydroxy-3-methoxybenzyl alcohol) and chavicol (4-
allylphenol) by VAO. According to this model, substrates can bind to the active site with their 
phenolic hydroxyl group either in its deprotonated or protonated form. When the substrate 
binds in its deprotonated form, it simply reacts with the FAD cofactor via hydride transfer to 
give the para-quinone methide intermediate. When the substrate binds in its protonated form, 
it must first be actively deprotonated by the enzyme to enable hydride transfer to occur. This 
occurs more slowly than the reaction of the deprotonated substrate with the enzyme and 
therefore, two distinct rates for the reduction of the flavin cofactor by its substrates are 
observed. Two tyrosine residues, Tyr-108 and Tyr-503, are responsible for stabilising the 
deprotonated form of the substrate in the active site, thus achieving preferential binding of 
the deprotonated substrate. When the substrate binds in its protonated form, one of the two 
tyrosine residues likely acts as a base, removing the proton and activating the substrate for 
reaction with FAD.    
A recent computational study provided insights into how substrates migrate from the bulk 
solution into VAO’s active site. This indicated that substrates migrate through a channel 
found at the monomer-monomer interface of a VAO dimer before entering the active site 
through a gate formed by His-466 and Tyr-503 (17). These simulations also suggested that the 
substrate (in this case para-creosol) cannot migrate into the active site in its deprotonated form 
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due to a high energy barrier encountered when the substrate is roughly 15 Å from the FAD 
cofactor. Therefore, it seems likely that the substrate becomes deprotonated only upon passing 
this position in the enzyme. Thus, after entering the active site, the pKa of the substrate drops 
due to the presence of Tyr-108 and Tyr-503, leading to an equilibrium of deprotonated and 
protonated substrate being bound in the active site, with the deprotonated form 
predominating. After this, the deprotonated form of the substrate can rapidly react with the 
FAD cofactor. The reaction with the protonated form is slower, this may be due to it binding 
in a slightly different, non-optimal orientation within the active site. 
Oxygen reactivity 
Another interesting aspect of the 4PO subfamily members that has not yet been explored is 
why some of the enzymes are oxidases capable of using molecular oxygen as an electron 
acceptor (EUGO and VAO), while others are dehydrogenase that rely on the presence of 
alternative electron acceptors for their activity [para-cresol methylhydroxylase (PCMH)]. 
Inspection of the crystal structure of VAO revealed that there is a chloride anion bound in a 
pocket located on the re-side of the FAD cofactor (16). A similar pocket has been described as 
being the site at which oxygen reacts with FAD in the VAO/PCMH family members alditol 
oxidase and berberine bridge enzyme and chloride has previously been found to bind to the 
oxygen binding site of flavin-dependent oxidases such as glucose oxidase and monomeric 
sarcosine oxidase (18–20). Therefore, it seems likely that this pocket may be the site of the 
reaction with oxygen in VAO. Interestingly, inspection of the crystal structures of EUGO and 
PCMH revealed that this pocket is also present in EUGO, but that in PCMH a proline residue 
(Pro-155) extends into the pocket, sterically blocking it (Fig. 1) (21, 22). This proline residue is 
conserved in all close homologues of PCMH identified in the bioinformatics analysis 
presented in Chapter 3. A leucine residue is found at the corresponding position in VAO and 
EUGO and a leucine or isoleucine residue is found at this position in all of the close 
homologues of these oxidases identified in Chapter 3. In contrast to the situation in PCMH, 
where the side chain of Pro-155 extends into the pocket found in VAO and EUGO, the side 
chains of Leu-171 in VAO and Leu-152 in EUGO point away from the pocket, thus potentially 
providing space for oxygen to bind to the enzyme and react with FAD.  
To test whether this structural difference is responsible for the differences in oxygen reactivity 
between these enzymes, a EUGO variant was created where Leu-152 was replaced by the 
proline found at this position in PCMH: L152P EUGO. Based on its absorption and circular 
dichroism spectra and the yellow pellet obtained upon precipitation of the protein using 
trichloroacetic acid, the purified L152P variant is correctly folded and contains covalently 
bound FAD. Preliminary studies of the reactivity of this variant using stopped-flow 
spectroscopy revealed that upon anaerobically mixing L152P EUGO and 2 mM vanillyl 
alcohol the enzyme is completely reduced by the substrate, albeit significantly more slowly 
than the wild-type enzyme is (Fig. 2A). Upon mixing reduced enzyme with buffer containing 
atmospheric oxygen levels, however, full reoxidation of the enzyme was not achieved, even 
after a reaction time of 60 s (Fig. 2B). This suggests that the putative oxygen binding pocket is 
indeed the site of the reaction of oxygen with FAD in EUGO. More detailed studies on this 
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Figure 1: Space-filling model of the structures of the putative oxygen binding pocket of VAO and EUGO 
and the corresponding region in PCMH. VAO is shown with green carbon atoms, EUGO with pink 
carbon atoms and PCMH with grey carbon atoms. The FAD cofactors are shown with yellow carbon 
atoms. Nitrogen atoms are shown in blue and oxygen atoms in red. The chloride anion bound to the 
putative oxygen binding pocket of VAO is shown in orange. The crystal structures of VAO, EUGO and 
PCMH were downloaded from the PDB website (PDB IDs: 1VAO, 5FXD and 1DIQ respectively). Figure 
was prepared using PyMOL (Schrödinger LLC, New York, NY, USA). 
variant, including a comprehensive stopped-flow kinetics analysis, are required to fully 
understand the effect of the introduced mutation on the oxygen reactivity of EUGO. 
Determination of the crystal structure of the variant, to demonstrate that the introduced 
proline residue indeed blocks the putative oxygen binding pocket, would also be of use. 
Further mutagenesis at this position could be used to study the effect that changing the 
environment of the oxygen binding pocket has on the reaction of EUGO with oxygen. It would 
also be highly interesting to evaluate whether the flavoprotein subunit of PCMH can be 
turned into an oxidase by replacing Pro-155 by other amino acids. 
Mechanism of reaction with 4-alkylphenols 
Another intriguing open question regards the mechanism of the reaction of VAO and EUGO 
with 4-alkylphenols. It has been shown previously that, despite readily converting 4-
ethylphenol and 4-propylphenol, VAO does not efficiently convert 4-methylphenol (para-
cresol) due to the formation of a covalent adduct between this substrate and the enzyme’s 
FAD cofactor (16, 23). A recent computational study, where the reaction mechanism of VAO 
with 3-methoxy-4-methylphenol (para-creosol) and vanillyl alcohol was studied by QM 
modelling, revealed a potential explanation for the fact that this covalent adduct is exclusively 
formed with 4-methylphenols (12). After hydride transfer from para-creosol to FAD yields the 
para-quinone methide intermediate and reduced FAD, the active site base Asp-170 adopts a 
conformation that allows it to deprotonate the N5 atom of the reduced FAD. The deprotonated 
FAD subsequently attacks the Cα of the para-quinone methide, leading to formation of the 
adduct. Adduct formation is a reversible process. After it breaks down, the formed para-
quinone methide can react with water, explaining the slow formation of hydroxylated product 
observed with para-creosol. In the case of vanillyl alcohol, the more bulky side chain of the 
substrate prevents Asp-170 from adopting the conformation in which it can deprotonate the 
N5 of reduced FAD, thus preventing adduct formation. 
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Figure 2: Traces of the absorption of the FAD cofactor of wild-type EUGO (solid lines) and L152P EUGO 
(dashed lines) at 441 nm during their reductive (A) and oxidative (B) half-reactions. (A) Traces of the 
absorbance at 441 nm after mixing 10 μM oxidised enzyme with 2 mM vanillyl alcohol in 50 mM 
potassium phosphate buffer, pH 7.5, under anaerobic conditions at 25 °C. (B) Traces of the absorbance 
at 441 nm after mixing 10 μM reduced enzyme (reduced by mixing with 1.4 equivalents of vanillyl 
alcohol under anaerobic conditions) with 127 μM oxygen in 50 mM potassium phosphate buffer, pH 
7.5, at 25 °C. Even upon longer reaction times (maximum 60 s) full reoxidation of the FAD cofactor of 
L152P EUGO was not achieved. 
When VAO is incubated with 4-ethylphenol or 4-propylphenol under anaerobic conditions, a 
covalent adduct similar to that observed with para-cresol is formed (23). However, the rate of 
formation of this species observed in stopped-flow experiments under anaerobic conditions 
is too slow to be catalytically relevant and the substrates are readily converted by the enzyme. 
This implies that in the reaction of VAO with 4-ethylphenol or 4-propylphenol, after 
formation of the para-quinone methide intermediate, the enzyme’s FAD cofactor is rapidly 
reoxidised by its reaction with molecular oxygen and that this stimulates the breakdown of 
the para-quinone methide intermediate by its reaction with water or intramolecular 
rearrangement. Thus, the outcome of the reaction of a 4-alkylphenol with VAO is a 
combination of the rate at which a covalent adduct is formed between the para-quinone 
methide intermediate and FAD (and the rate of the reverse reaction) and the rate at which the 
para-quinone methide intermediate breaks down either by reacting with water or rearranging 
intramolecularly. The rate of adduct formation may be affected by the identity of the substrate, 
with more bulky substrates impairing adduct formation by preventing the deprotonation of 
the N5 of FAD by Asp-170. For many substrates, the breakdown of the para-quinone methide 
intermediate is connected to the reoxidation of FAD by molecular oxygen (23, 24). In addition, 
the rate of this reoxidation may be affected by the presence of a para-quinone methide 
intermediate in the active site, as has been observed with 4-(methoxymethyl)phenol (24). This 
illustrates that in order to gain a comprehensive understanding of the factors governing the 
reactivity of 4-alkyphenols with 4PO oxidases it is not sufficient to understand how the 
identity of the substrate effects processes occurring during the reductive half-reaction. The 
effect of the presence of a particular para-quinone methide intermediate in the active site on 
the reaction of the enzyme with molecular oxygen must also be taken into account. 
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In this context, it is interesting to study why VAO readily converts 4-alkylphenols such as 4-
ethylphenol, whereas EUGO does not. A potential explanation could be that, in EUGO, 4-
ethylphenol more easily forms an adduct with the enzyme’s FAD cofactor than in VAO. It 
would be of interest to study the reaction of EUGO with 4-ethylphenol in more detail, e.g. by 
studying whether the enzyme is reduced by 4-ethylphenol and whether the spectral 
properties of the enzyme upon reduction are consistent with the formation of an FAD–4-
ethylphenol adduct. If evidence for the formation of an adduct is obtained, it would be of 
interest to obtain its crystal structure. Finally, QM modelling of the reaction of VAO and 
EUGO with 4-ethylphenol may give us a more comprehensive understanding of why VAO 
can convert this compound, but EUGO cannot. 
Towards the biocatalytic application of 4PO subfamily members 
The 4PO subfamily members have been shown to be of use for a number of biocatalytic 
applications such as the synthesis of vanillin or model lignin compounds (25–34). They may 
also be of interest for the synthesis of chiral α-aryl alcohols and in Chapter 7 we demonstrated 
that VAO can be used to obtain such a compound on a multigram scale. Further research into 
this subfamily of enzymes could increase their potential for industrial applications.  
Expanding the catalytic scope of the 4PO subfamily 
First of all, it would be interesting to further explore the natural diversity of 4PO enzymes by 
characterising potential family members identified by mining genome databases. This might 
lead to the identification of enzymes with desired properties from the perspective of industrial 
applications such as higher reaction rates with interesting substrates, the ability to convert 
substrates that are not accepted by the currently-known enzymes or heightened 
thermostability or tolerance to organic solvents. Such improved properties could also be 
achieved by the modification of existing enzymes, either by rational design or directed 
evolution. All such attempts will be facilitated by the high-throughput substrate specificity 
screening assay presented in Chapter 6. 
One interesting target for such mutagenesis efforts would be to obtain VAO variants with 
heightened reactivity towards 4-methylphenols, which would enable the design of an efficient 
enzymatic process for the synthesis of vanillin from para-creosol. It would also be of interest 
to obtain a EUGO variant that is able to catalyse the oxidation of 4-alkylphenols. This might 
be facilitated by further QM computational studies that could provide a more comprehensive 
picture of the factors governing the formation of adducts between the FAD cofactor of VAO 
or EUGO and 4-alkylphenols. 
Another interesting question is whether the catalytic scope of 4PO subfamily members can be 
extended beyond the strict specificity for para-substituted phenols. In light of the results 
presented in Chapter 8, one might hypothesise that compounds with activating groups other 
than a hydroxyl group on the aromatic ring might also be accepted as substrates by 4PO 
subfamily members. For example, substrates with a thiol or amino group at this position 
might be converted by the enzymes, with catalysis proceeding via a thioquinone methide or 
quinone methide imine respectively. In this light, the ability of VAO and EUGO to catalyse 
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the conversion of 4-ethylthiophenol and 4-aminobenzyl alcohol was evaluated using oxygen 
consumption measurements. No significant oxygen consumption was observed using 
substrate concentrations of 200 µM and enzyme concentrations of 460 nM and 630 nM for 
VAO and EUGO respectively (in 50 mM potassium phosphate buffer, pH 7.5, at 25 °C). 
Nevertheless, it might be interesting to perform long-term incubations of these substrates with 
the enzymes to evaluate whether their conversion can be achieved. 
Another interesting question is whether our current understanding of the 4PO subfamily 
members could allow us to design an oxidase that specifically catalyses the oxidation of the 
Cα atom of ortho-substituted phenols. This reaction could proceed via a mechanism similar to 
that observed in 4PO subfamily members, involving an ortho-quinone methide intermediate. 
However, modifying an existing 4PO subfamily member so as to achieve this reaction may be 
extremely challenging, as it would entail completely remodelling the enzyme’s active site so 
as to move the phenolate binding pocket to a different position. However, combining the 
mechanistic understanding gathered from previous mutagenesis studies (35, Chapter 4) with 
computational studies that allow us to understand the structure of the transition state during 
catalysis by 4PO subfamily members (12), may allow the construction of an ortho-phenol 
oxidase using de novo enzyme design methods (36). Achieving this goal would demonstrate 
that we truly understand all factors that are required to enable catalysis in 4PO subfamily 
members. 
Development of biocatalytic processes involving 4PO enzymes 
The characterisation of novel 4PO subfamily members and the redesign of existing ones by 
mutagenesis will lead to the identification of enzymes that (more) efficiently catalyse reactions 
that are of interest for biocatalytic applications. In order for these enzymes to be successfully 
applied, efforts must also be made to understand what factors are of importance in designing 
large-scale biocatalytic processes involving them.  
The main limiting factor identified during the scale-up of the synthesis of (R)-1-(4′-
hydroxyphenyl)ethanol from 4-ethylphenol presented in Chapter 7 was oxygen depletion, 
which became the limiting factor for the conversion achieved at the largest scale tested. This 
is likely due to the large reaction volume leading to the rate of oxygen transfer into the reaction 
medium becoming insufficient. This was solved by performing the reaction under an oxygen 
atmosphere. However, this is not desirable for industrial applications, as the use of pure 
oxygen presents an explosion hazard. Use of reactor set-ups that increase the rate of transfer 
of oxygen into the reaction medium, e.g. by bubble aeration (37), is a possible solution. 
Another option is the addition of higher amounts of organic solvents in which the solubility 
of oxygen is higher than in water to the reaction medium. The addition of higher amounts of 
organic solvents could also increase the substrate loadings that can be used, further facilitating 
the design of a cost-effective biocatalytic process.  
Another factor that was found to be important in the research presented in Chapter 7 is to 
minimise the amount of by-products formed during a reaction. During the VAO-mediated 
synthesis of (R)-1-(4′-hydroxyphenyl)ethanol, a significant amount of the desired product (at 
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least 20%) was lost during its purification by recrystallisation. Although alternative 
purification methods such as column chromatography may be used to purify the product with 
lower losses, they are less attractive for use in industrial processes. The creation of VAO 
variants that lead to less (or ideally no) by-product formation could be a useful solution to this 
issue. 
Potential applications of thiol oxidation by flavoprotein oxidases 
Chapter 8 presents the finding that flavin-dependent alcohol oxidases are capable of oxidising 
thiol analogues of their alcohol substrates to the corresponding thiocarbonyl compounds 
(Scheme 2). This was found to hold true for all tested oxidases, suggesting it is a general 
property of this class of enzymes. The oxidation of thiols by 5-(hydroxymethyl)furfural 
oxidase has recently been applied for the synthesis of enantiomerically pure secondary thiols 
by the kinetic resolution of racemates (38). In addition, the thiocarbonyl compounds formed 
upon oxidation of thiols are of interest for a number of applications.  For example, they can 
be applied as dienophiles in Diels-Alder type cycloadditions for the synthesis of sulphur-
containing heterocycles (39, 40). Nucleophilic addition to thiocarbonyls is also of interest as 
the similar electronegativity of sulphur and carbon allows addition to the sulphur atom in 
some cases, enabling C-S bond formation (39, 41). Considering the fact that all tested 
flavoprotein oxidases can convert thiols as well as alcohols, it would be interesting to study 
whether their reactivity extends to the oxidation of other functional groups as well. For 
example, it would be interesting to test whether they are capable of oxidising selenols, which 
display chemical properties that are quite similar to those of thiols (42). 
 
Scheme 2: Oxidation of thiols to thiocarbonyls by alditol oxidase (m-AldO) and  
5-(hydroxymethyl)furfural oxidase (HMFO). 
Summarising remarks 
The research presented in this thesis provides advances in our understanding of the molecular 
mechanisms governing oligomerisation and catalysis in 4PO subfamily members. In addition, 
it contains the description of the development of a high-throughput screening assay for the 
activity of 4PO subfamily oxidases and the scale-up of the synthesis of a chiral secondary 
alcohol using VAO. Intriguing open questions still exist regarding the exact physiological 
function of 4PO subfamily members and certain aspects of their catalytic mechanisms such as 
the molecular mechanisms by which their reactivity with oxygen is governed and why they 
differ in terms of their reactivity with 4-alkylphenols. A comprehensive understanding of the 
factors governing catalysis in these enzymes will enable us to modify them so as to have 
properties that are desirable from the point of view of biocatalytic applications. 
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Unconventional avenues of exploration, such as reactions that fall outside the known catalytic 
scope of the enzymes, may yield unexpected results with interesting potential applications. It 
will be fascinating to see what surprising advances the future will bring regarding 4PO 
subfamily members, the VAO/PCMH flavoprotein family and the biocatalytic application of 
enzymes in general. 
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